data_2lfn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2lfn _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.258 0.551 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.31 140.19 50.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.326 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.12 129.3 34.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.125 0.488 . . . . 0.0 110.317 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.89 HG23 ' HA3' ' A' ' 34' ' ' GLY . 80.9 mt -95.68 135.21 30.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.555 -176.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.93 161.3 34.19 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.868 ' HD3' HG12 ' A' ' 36' ' ' ILE . 25.8 Cg_exo -64.33 60.86 0.25 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 123.332 2.688 . . . . 0.0 112.871 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -150.73 -44.32 0.12 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -58.46 8.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.59 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 5.8 m -122.8 97.28 5.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.32 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -162.96 15.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.175 0.512 . . . . 0.0 110.201 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -78.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.996 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.647 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 26.9 t0 -77.75 59.12 1.97 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.165 0.507 . . . . 0.0 110.419 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t0 51.72 46.98 25.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.846 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.647 ' CE2' ' HB3' ' A' ' 13' ' ' ASP . 10.7 m-85 -102.2 160.79 14.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.543 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -125.04 145.5 50.52 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.607 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.432 ' HB2' HG22 ' A' ' 5' ' ' ILE . 61.4 Cg_endo -74.65 103.63 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.861 1.707 . . . . 0.0 111.154 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.927 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 33.9 m-85 -100.39 120.56 40.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.157 -175.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.29 87.35 7.27 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 57.8 m -78.15 113.62 16.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.954 -176.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.534 -179.467 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.55 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -80.13 123.39 27.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.806 0.336 . . . . 0.0 110.648 -175.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.61 78.69 1.62 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.927 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 14.7 m -86.9 99.32 11.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.012 0.434 . . . . 0.0 111.439 -175.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.86 142.7 13.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.36 122.42 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.89 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -66.25 117.9 10.3 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.292 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.14 139.18 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.868 HG12 ' HD3' ' A' ' 7' ' ' PRO . 2.4 mt -59.62 108.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.634 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.77 -21.27 9.09 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.982 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.0 m -76.08 160.85 29.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.575 0.226 . . . . 0.0 110.84 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.91 145.48 40.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.762 0.315 . . . . 0.0 110.269 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.21 110.76 23.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.882 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.46 -30.84 26.35 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.603 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.407 ' HB3' ' H ' ' A' ' 43' ' ' SER . . . -94.17 -142.24 0.24 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.716 0.293 . . . . 0.0 110.732 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.407 ' H ' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -84.44 102.12 12.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 -176.295 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.401 ' H ' HG11 ' A' ' 44' ' ' VAL . 1.9 p -80.29 115.8 23.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -116.32 143.91 44.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.089 0.471 . . . . 0.0 111.123 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 35.3 m -99.23 83.56 2.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.944 175.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.492 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 23.7 m -102.47 154.13 19.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.478 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.538 ' HA ' ' HD1' ' A' ' 15' ' ' TYR . 4.1 ttmt -65.68 -70.26 0.25 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.287 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.3 t70 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.808 -176.954 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.269 0 CA-C-O 121.066 0.46 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.3 mt -80.25 80.8 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.154 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.453 HG23 HD13 ' A' ' 61' ' ' ILE . 15.3 mm -77.85 137.33 22.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.174 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -78.66 11.78 2.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.79 0.329 . . . . 0.0 111.107 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 66.28 4.18 3.07 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.392 0.677 . . . . 0.0 112.374 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.55 32.92 5.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.9 0.381 . . . . 0.0 111.207 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.3 25.7 3.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.986 0.422 . . . . 0.0 110.154 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.56 155.71 48.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.911 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.423 HG22 ' CE2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.912 0.387 . . . . 0.0 110.014 174.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 120.984 0.421 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.9 137.25 32.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.186 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.93 138.48 33.13 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.655 HG23 ' HA3' ' A' ' 34' ' ' GLY . 6.2 mt -105.51 134.27 47.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.364 0.602 . . . . 0.0 112.196 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.42 147.1 19.03 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 171.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -51.47 -34.46 51.47 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.346 2.697 . . . . 0.0 112.992 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -101.58 67.75 1.14 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.103 0.478 . . . . 0.0 110.498 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.11 -61.52 1.36 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.025 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 54.4 m -116.24 142.93 46.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.5 m -159.63 32.86 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.073 0.463 . . . . 0.0 110.863 -172.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.411 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -79.06 -68.67 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.411 ' H ' ' HB ' ' A' ' 12' ' ' ILE . 8.3 t0 -95.44 -165.55 1.31 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.591 167.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.548 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 3.7 t70 -77.85 50.72 0.88 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.377 0.608 . . . . 0.0 109.573 170.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.627 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 8.2 m-85 -85.85 79.61 9.2 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.627 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.641 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -79.3 156.97 75.94 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.329 -177.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.08 116.02 3.94 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.464 2.109 . . . . 0.0 111.305 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.557 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 25.8 m-85 -126.82 131.38 51.25 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.593 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.9 m -94.83 99.03 11.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.363 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.46 ' HB3' HD21 ' A' ' 29' ' ' LEU . 1.6 m -82.92 121.25 26.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.724 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.605 179.377 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.46 HD21 ' HB3' ' A' ' 20' ' ' CYS . 7.2 mt -80.23 88.0 5.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.004 0.431 . . . . 0.0 111.203 -175.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.14 79.84 1.15 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.784 175.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.5 OUTLIER -88.63 109.61 20.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 0.0 111.227 -178.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.95 153.39 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.987 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 t -62.09 130.64 26.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.744 0.307 . . . . 0.0 110.704 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.655 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -66.39 132.44 32.8 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.289 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.417 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 2.1 t -80.54 137.51 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.069 0.462 . . . . 0.0 110.703 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mt -64.15 111.75 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.265 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.13 59.11 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.497 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.417 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 15.1 m -110.36 170.89 7.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.715 0.293 . . . . 0.0 110.515 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.49 136.25 54.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.498 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.506 ' HB3' HG21 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -115.47 133.4 56.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.433 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.79 29.65 9.18 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.235 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -121.44 -156.09 0.67 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.5 83.86 4.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.009 0.433 . . . . 0.0 110.375 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.506 HG21 ' HB3' ' A' ' 40' ' ' CYS . 2.0 t -79.59 109.72 14.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.027 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.13 160.07 28.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.992 0.425 . . . . 0.0 111.163 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 59.0 m -93.59 100.84 13.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 171.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 69.3 m -108.15 144.48 35.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.363 -172.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.548 ' HE3' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -79.3 117.36 20.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.51 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.641 ' HB2' ' HD2' ' A' ' 16' ' ' LYS . 65.8 t0 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.952 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.505 HD11 ' HH ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.834 0.35 . . . . 0.0 110.553 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.21 97.11 4.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.797 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -88.63 150.44 3.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.387 -178.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -101.85 45.07 0.98 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.906 0.384 . . . . 0.0 110.661 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 73.27 -56.33 0.66 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.367 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.09 -27.04 65.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -92.66 17.08 10.81 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.476 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.0 m -127.41 119.79 26.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.798 0.332 . . . . 0.0 110.88 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.042 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 121.091 0.472 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -67.82 120.76 14.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.586 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.03 125.05 28.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.785 176.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.472 HD12 ' HB2' ' A' ' 40' ' ' CYS . 3.5 mt -104.28 132.9 49.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -170.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.72 149.0 16.85 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 167.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.11 43.06 0.8 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.648 2.232 . . . . 0.0 113.539 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -150.32 26.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.051 0.453 . . . . 0.0 110.677 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.19 -23.6 47.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.726 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 m -146.12 145.97 30.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.5 m -162.36 25.2 0.11 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.801 0.334 . . . . 0.0 111.075 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.16 -65.67 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 15' ' ' TYR . 3.6 t70 -100.52 -151.12 0.4 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 168.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -83.03 47.46 1.23 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.933 0.873 . . . . 0.0 108.693 169.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.55 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 5.8 m-85 -82.35 78.81 8.95 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.677 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -79.81 149.92 71.55 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.27 126.63 19.0 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.397 2.065 . . . . 0.0 111.052 176.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.679 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 9.2 m-85 -129.1 129.85 45.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.971 0.415 . . . . 0.0 111.373 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 13.9 m -83.56 84.14 7.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.357 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 20.6 m -72.67 96.84 2.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.111 0.482 . . . . 0.0 111.386 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.84 175.37 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.237 0.443 0 CA-C-O 121.069 0.462 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.435 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -122.96 139.2 54.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.97 -177.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.93 76.05 2.3 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.679 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 3.8 m -79.54 100.75 7.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.998 0.428 . . . . 0.0 111.042 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.42 145.34 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 p -58.1 135.24 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.806 0.336 . . . . 0.0 110.708 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.464 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -56.81 118.97 13.21 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.003 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.23 118.92 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 120.91 0.386 . . . . 0.0 110.352 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.59 124.54 8.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.458 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.08 13.93 81.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.27 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.72 167.12 15.0 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 3' ' ' THR . 2.5 mt-30 -113.23 145.79 40.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.472 ' HB2' HD12 ' A' ' 5' ' ' ILE . 13.9 m -125.99 120.08 29.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.197 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.48 61.81 3.16 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.289 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.03 -166.16 2.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.77 98.44 1.96 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.904 0.383 . . . . 0.0 110.462 176.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.4 t -87.3 91.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.199 0.523 . . . . 0.0 109.661 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.44 162.67 17.94 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.511 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -87.5 112.62 22.41 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.444 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 64.0 m -115.24 149.24 38.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.932 0.396 . . . . 0.0 111.167 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.85 119.33 17.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.839 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.5 t0 . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 121.518 0.675 . . . . 0.0 110.252 175.826 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 120.937 0.399 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mt -79.97 102.35 5.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.433 HD12 ' HB2' ' A' ' 31' ' ' CYS . 62.3 mt -99.61 135.33 35.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.56 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -64.23 145.04 56.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.28 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.37 45.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.108 0.48 . . . . 0.0 111.671 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -154.19 19.28 0.5 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.295 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -123.01 13.89 9.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.3 m -127.96 143.81 51.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.849 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 120.808 0.337 . . . . 0.0 110.684 178.005 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 121.062 0.458 . . . . 0.0 110.432 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.67 138.3 42.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.224 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.52 133.46 38.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.765 0.317 . . . . 0.0 110.181 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 35' ' ' VAL . 12.3 mm -106.4 137.55 36.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.517 0.675 . . . . 0.0 112.466 -173.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.17 151.61 23.07 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.76 ' HD3' HG12 ' A' ' 36' ' ' ILE . 31.2 Cg_endo -64.68 58.46 0.27 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.136 2.557 . . . . 0.0 113.312 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -139.89 -26.39 0.79 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.126 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.64 -52.0 57.57 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.73 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.0 m -143.95 135.82 26.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.941 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.89 30.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.29 -73.53 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.02 177.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 15' ' ' TYR . 9.9 t0 -83.79 -161.97 0.59 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 168.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.494 ' HB3' ' HG3' ' A' ' 48' ' ' LYS . 29.0 t0 -77.21 40.61 0.27 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.691 0.758 . . . . 0.0 109.541 172.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.563 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 8.1 m-30 -90.5 84.69 5.99 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.8 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 150.38 72.37 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.2 128.46 22.81 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.328 2.019 . . . . 0.0 111.846 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.871 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 9.4 m-85 -132.12 149.97 52.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.408 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -109.85 81.04 1.38 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.753 176.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 2.7 m -78.91 102.97 8.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.454 0.645 . . . . 0.0 110.937 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.441 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 4.9 tp-100 . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.908 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.824 HD13 ' HB ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -79.57 114.74 18.73 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.147 -177.009 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.5 85.65 1.15 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.529 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.871 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.93 143.74 28.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.326 0.584 . . . . 0.0 111.627 -177.206 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.68 158.84 29.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 168.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.8 t -64.06 133.29 29.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.63 119.83 15.76 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -78.72 108.53 12.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.24 0.543 . . . . 0.0 110.817 -174.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.76 HG12 ' HD3' ' A' ' 7' ' ' PRO . 3.1 mp -64.97 116.34 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.777 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.75 1.05 74.3 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.766 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.572 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -120.29 -173.91 2.67 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -114.86 143.63 44.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.01 0.433 . . . . 0.0 111.376 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.7 152.54 40.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.757 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.37 -1.24 33.14 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.863 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -148.34 -161.92 1.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.563 -0.318 . . . . 0.0 110.576 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.14 128.76 37.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.168 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.22 122.48 34.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.314 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HG3' ' HB2' ' A' ' 20' ' ' CYS . 1.3 mmpm? -121.59 166.92 13.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.28 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 13.8 m -131.03 96.8 4.14 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 66' ' ' CYS . 0.8 OUTLIER -123.56 165.09 17.73 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 -174.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HG3' ' HB3' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -81.37 -151.09 0.08 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.322 -0.619 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.642 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.415 HD13 ' HE1' ' A' ' 18' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.58 0 CA-C-O 121.148 0.499 . . . . 0.0 109.882 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mt -78.93 93.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.741 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.824 ' HB ' HD13 ' A' ' 29' ' ' LEU . 7.1 mm -79.03 139.65 18.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.579 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -81.04 -0.38 39.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.332 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 64.8 28.68 12.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.013 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.4 -56.01 2.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.087 0.47 . . . . 0.0 110.899 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.91 54.18 2.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.178 0.513 . . . . 0.0 110.67 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 47' ' ' CYS . 16.0 t -150.7 164.16 36.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.435 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.815 178.348 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 121.001 0.429 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.63 151.63 44.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.263 176.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.0 136.64 37.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.921 0.391 . . . . 0.0 111.608 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.856 HG22 ' HA3' ' A' ' 34' ' ' GLY . 45.1 mt -103.53 126.4 57.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.793 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.88 156.43 27.78 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.771 ' HD3' HG12 ' A' ' 36' ' ' ILE . 25.4 Cg_endo -62.14 -5.58 6.68 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.811 2.341 . . . . 0.0 112.619 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.91 7.39 23.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.549 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.2 m -61.42 -48.0 83.18 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 170.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 3.6 m -96.15 163.47 13.09 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.52 33.59 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.897 0.855 . . . . 0.0 108.759 -169.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.03 -109.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.469 -172.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.02 80.58 2.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.4 t70 49.76 42.67 24.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.459 0.647 . . . . 0.0 111.323 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.469 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 11.4 m-85 -108.03 134.49 50.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.075 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.82 160.66 48.08 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.711 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.69 115.54 3.98 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.497 2.131 . . . . 0.0 111.878 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.696 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 30.1 m-85 -123.61 126.92 47.5 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.14 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.76 88.59 7.71 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.731 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 65.8 m -75.08 103.27 5.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.073 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.871 -177.211 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.657 ' HB2' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.84 89.95 4.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.88 71.72 2.14 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.347 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.696 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 35.9 m -85.39 93.17 8.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.914 0.387 . . . . 0.0 110.265 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.21 145.78 7.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 t -58.56 131.31 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.856 ' HA3' HG22 ' A' ' 5' ' ' ILE . . . -64.83 144.54 48.32 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.634 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.46 103.68 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.771 HG12 ' HD3' ' A' ' 7' ' ' PRO . 2.7 mp -58.15 118.16 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.885 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.21 -8.17 41.32 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.796 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.25 -178.86 3.47 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.85 141.6 37.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.794 0.331 . . . . 0.0 110.694 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.55 124.05 32.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.625 175.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.56 -17.16 55.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.275 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.57 -170.0 1.7 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.549 0.214 . . . . 0.0 110.479 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.53 109.47 2.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.862 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.77 103.31 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.243 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.548 ' HB3' ' SG ' ' A' ' 66' ' ' CYS . 1.9 mmpt? -113.18 149.6 33.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.668 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 21.9 m -90.92 93.79 9.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.931 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -124.19 -175.48 3.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.413 -177.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.76 141.0 18.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 C--N 1.318 -0.792 0 CA-C-O 121.272 0.558 . . . . 0.0 109.532 176.342 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.155 0.503 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.657 HG22 ' HB2' ' A' ' 28' ' ' SER . 2.1 mp -116.01 115.58 49.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.068 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 31' ' ' CYS . 1.3 mp -104.55 118.5 51.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 175.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -78.44 62.18 3.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.707 -173.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 67.46 -69.74 0.13 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.965 0.906 . . . . 0.0 113.314 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.34 54.89 0.94 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -171.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.24 28.56 0.25 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 174.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 45.5 t -160.42 147.98 16.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.003 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.166 0.507 . . . . 0.0 110.087 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.099 0.476 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.97 142.68 48.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.947 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.482 ' HA ' ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -77.54 125.2 28.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.999 0.428 . . . . 0.0 110.524 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.613 HG23 ' HA3' ' A' ' 34' ' ' GLY . 32.2 mt -89.76 127.2 42.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.072 -174.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.31 128.51 6.4 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 170.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.435 ' CG ' HG12 ' A' ' 36' ' ' ILE . 84.7 Cg_exo -43.45 -37.88 8.06 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.89 3.06 . . . . 0.0 114.476 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -86.58 33.57 0.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -45.56 42.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -132.32 141.54 48.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.102 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.3 17.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.417 0.627 . . . . 0.0 109.513 -175.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.43 -84.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.968 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -100.32 53.78 0.89 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.32 -173.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.42 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 23.4 t70 62.82 21.66 12.94 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.679 0.752 . . . . 0.0 110.229 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.661 ' HE2' HG23 ' A' ' 67' ' ' VAL . 3.9 m-85 -80.6 130.19 34.97 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.493 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.557 ' HE3' ' HB2' ' A' ' 49' ' ' ASP . 0.8 OUTLIER -126.82 157.63 70.91 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -177.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.15 115.02 3.8 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.589 2.193 . . . . 0.0 111.57 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.633 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 27.0 m-85 -120.3 133.4 55.47 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.993 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -81.88 84.83 6.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.717 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 m -78.55 79.7 4.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.296 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--N 1.324 -0.54 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.556 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.235 0.318 0 CA-C-O 121.184 0.516 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.704 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 4.2 mt -87.22 146.63 25.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.504 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.93 48.13 0.99 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.867 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.704 ' SG ' ' HB3' ' A' ' 29' ' ' LEU . 2.0 m -79.03 106.85 11.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.124 0.488 . . . . 0.0 111.328 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.4 m -86.07 164.27 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.637 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.82 135.47 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 123.167 0.292 . . . . 0.0 110.484 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.613 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -64.59 116.51 9.1 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.209 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.02 135.02 26.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.78 0.324 . . . . 0.0 110.623 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.435 HG12 ' CG ' ' A' ' 7' ' ' PRO . 1.4 mt -64.93 110.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.51 -9.7 49.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.113 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.6 m -90.8 171.19 9.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.882 0.372 . . . . 0.0 110.48 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.482 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 1.6 mp0 -124.3 140.25 53.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.837 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -75.82 146.72 39.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.205 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.25 -51.78 3.43 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.385 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.41 -90.18 0.15 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.746 0.308 . . . . 0.0 110.642 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.17 138.37 29.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.648 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.2 t -80.89 125.94 39.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.013 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -117.85 157.69 26.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 32.9 m -102.55 99.95 10.01 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 4.0 m -116.07 147.28 41.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.993 0.425 . . . . 0.0 111.461 -175.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -98.74 136.39 38.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.776 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.557 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 48.7 t0 . . . . . 0 C--N 1.325 -0.488 0 CA-C-O 121.295 0.569 . . . . 0.0 110.628 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.483 HD21 ' HH ' ' A' ' 18' ' ' TYR . 1.3 mp . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 120.865 0.365 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.08 87.71 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.995 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.582 ' HB ' ' HB2' ' A' ' 29' ' ' LEU . 37.9 mm -63.85 127.54 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.599 -178.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.77 44.69 1.18 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.812 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 67.4 -68.08 0.16 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.536 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.18 54.43 2.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 0.0 112.028 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.515 ' HB2' HG22 ' A' ' 61' ' ' ILE . 35.7 m120 -126.48 -14.9 5.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.688 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 4.6 m -109.77 88.79 2.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.575 -174.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.661 HG23 ' HE2' ' A' ' 15' ' ' TYR . 2.6 t . . . . . 0 N--CA 1.467 0.423 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.94 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.429 ' HB ' HG22 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -89.88 118.91 29.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.619 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.68 119.84 22.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.049 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.584 HD13 ' HB2' ' A' ' 40' ' ' CYS . 85.4 mt -87.07 127.92 40.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -172.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -117.37 136.96 12.96 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 166.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.591 ' HG3' HG12 ' A' ' 36' ' ' ILE . 74.5 Cg_endo -72.96 44.73 0.82 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.031 2.488 . . . . 0.0 113.94 -172.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -157.18 26.01 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.739 0.304 . . . . 0.0 111.22 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -58.1 3.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.415 0.626 . . . . 0.0 109.629 174.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -92.64 136.16 33.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.285 174.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.89 26.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.027 0.441 . . . . 0.0 110.371 -175.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -66.48 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 15' ' ' TYR . 3.2 t70 -100.6 -149.07 0.37 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.348 169.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -81.84 40.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.686 0.755 . . . . 0.0 109.394 171.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.54 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 1.9 m-85 -82.96 111.7 19.07 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.606 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.4 143.16 26.07 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.0 125.1 16.27 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.481 2.12 . . . . 0.0 111.163 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.678 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 9.7 m-85 -134.84 123.9 24.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.028 0.442 . . . . 0.0 110.8 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.8 t -87.09 93.15 9.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.026 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 26.1 m -74.57 100.44 3.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.263 0.554 . . . . 0.0 109.793 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.892 -173.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.672 0.272 . . . . 0.0 110.639 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.641 ' HG ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -79.84 78.41 6.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.003 0.43 . . . . 0.0 110.918 -178.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.95 86.05 1.37 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.615 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 4.0 m -109.13 115.39 29.94 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.771 0.319 . . . . 0.0 110.955 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.9 154.78 4.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 59' ' ' LEU . 2.1 t -55.98 139.33 15.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.464 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.415 ' CA ' HG21 ' A' ' 5' ' ' ILE . . . -65.26 88.34 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.849 174.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.444 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 61.1 t -79.45 137.04 22.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.914 0.388 . . . . 0.0 110.215 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.591 HG12 ' HG3' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -63.41 110.04 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.552 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.38 -4.61 33.19 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.585 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.444 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 43.1 m -78.08 127.58 32.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.991 0.424 . . . . 0.0 110.711 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -93.94 94.25 8.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.288 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.584 ' HB2' HD13 ' A' ' 5' ' ' ILE . 12.4 t -74.9 118.74 18.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.287 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.9 -2.82 59.41 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.195 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.472 ' HB1' ' H ' ' A' ' 43' ' ' SER . . . -115.3 -132.83 0.33 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.669 0.271 . . . . 0.0 111.018 -177.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.538 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 70.5 m -86.93 99.42 11.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.013 0.435 . . . . 0.0 111.352 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.429 HG22 ' HB ' ' A' ' 3' ' ' THR . 0.6 OUTLIER -79.67 81.64 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.122 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.535 ' HE3' HD12 ' A' ' 29' ' ' LEU . 3.7 mttm -91.35 175.72 6.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.794 -172.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 89.2 m -127.71 106.05 8.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.597 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 91.2 m -120.84 149.38 42.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.809 0.337 . . . . 0.0 111.088 -174.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.24 97.67 11.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.253 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 . . . . . 0 C--N 1.321 -0.669 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.096 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.441 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 3.4 mp . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 121.106 0.479 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.9 mt -79.63 102.57 5.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.38 146.83 5.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.292 -171.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -69.21 121.34 16.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.71 175.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.641 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . . . -78.94 35.32 0.25 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 111.894 -173.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.14 13.55 6.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.906 0.384 . . . . 0.0 110.561 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -138.71 38.29 2.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.239 0.542 . . . . 0.0 110.79 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 11.1 m -130.11 153.94 47.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.767 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.442 ' H ' HG23 ' A' ' 67' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.0 110.529 179.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.807 0.337 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -146.31 127.8 15.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.234 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.49 123.68 26.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.152 0.501 . . . . 0.0 110.189 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.486 HG21 ' HA3' ' A' ' 34' ' ' GLY . 8.6 mt -89.58 127.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.57 -172.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.4 137.48 14.21 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 168.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.77 -4.99 5.23 Favored 'Trans proline' 0 N--CA 1.478 0.581 0 C-N-CA 123.364 2.71 . . . . 0.0 114.114 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -119.74 34.32 5.27 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.36 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -33.86 76.22 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.572 0.701 . . . . 0.0 110.295 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 89.3 m -135.21 146.18 48.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.906 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.69 17.6 0.8 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.952 0.406 . . . . 0.0 110.652 -169.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.405 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -78.53 -71.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 15' ' ' TYR . 3.8 t0 -93.67 -159.73 0.71 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.578 171.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 21.2 t70 -80.43 41.57 0.55 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.634 0.73 . . . . 0.0 109.295 172.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.755 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 10.4 m-85 -85.57 71.74 10.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.783 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.433 ' HB2' ' HD2' ' A' ' 17' ' ' PRO . 4.3 ptpt -79.58 156.01 75.79 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.831 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 16' ' ' LYS . 29.7 Cg_endo -61.32 126.54 19.57 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.978 2.452 . . . . 0.0 112.777 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.908 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 21.6 m-85 -127.95 123.93 36.07 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.081 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.1 m -80.75 80.95 7.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 53.6 m -77.03 121.43 23.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.574 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.131 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.424 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -103.09 148.27 25.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.401 -177.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.79 77.63 1.87 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.734 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.908 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 28.9 m -86.49 120.18 27.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.16 0.505 . . . . 0.0 112.112 -176.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.4 ' H ' HG21 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -107.21 144.59 15.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 169.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 p -58.6 131.44 22.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.008 0.432 . . . . 0.0 111.058 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.486 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -67.56 117.08 8.46 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.699 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.2 t -78.92 131.22 34.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.904 0.383 . . . . 0.0 110.42 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.94 120.63 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.653 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.99 -4.95 68.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.642 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.8 m -95.24 166.34 11.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.643 0.259 . . . . 0.0 110.703 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 3' ' ' THR . 18.9 mt-30 -114.9 124.9 52.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.566 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.466 ' HB2' HD12 ' A' ' 5' ' ' ILE . 1.7 t -81.17 135.64 35.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.204 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.76 2.94 23.09 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.829 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -120.24 -157.59 0.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.1 92.38 4.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.965 0.412 . . . . 0.0 110.628 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.44 ' HB ' ' SG ' ' A' ' 40' ' ' CYS . 1.6 p -78.6 109.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.519 0.676 . . . . 0.0 109.613 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -118.22 171.11 8.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.827 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.755 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 59.7 m -112.71 104.01 12.04 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 173.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.494 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.8 OUTLIER -122.99 157.32 32.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.42 -177.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.668 ' HD2' ' HE1' ' A' ' 15' ' ' TYR . 2.5 ptmt -97.71 155.69 16.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.868 0.366 . . . . 0.0 110.76 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.844 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.634 HD22 ' HH ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.138 0.494 . . . . 0.0 110.484 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -79.98 76.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.438 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 47' ' ' CYS . 1.3 mt -84.59 152.12 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.559 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -72.34 139.55 47.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.592 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.99 -25.57 67.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.596 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.27 -5.9 55.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.143 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.17 -12.64 26.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.988 0.423 . . . . 0.0 110.842 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.79 172.14 11.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.019 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.699 HG23 ' HB2' ' A' ' 46' ' ' CYS . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.344 . . . . 0.0 111.48 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.186 0 CA-C-O 121.251 0.548 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.96 123.75 22.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.887 -176.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 m -79.82 134.33 36.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.308 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.58 HD13 ' HB2' ' A' ' 40' ' ' CYS . 37.8 mt -98.19 136.27 29.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.229 0.538 . . . . 0.0 112.43 -172.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.47 ' N ' HG21 ' A' ' 5' ' ' ILE . . . -136.3 128.84 4.66 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 168.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.468 ' HA ' ' HG3' ' A' ' 17' ' ' PRO . 38.5 Cg_exo -59.91 3.17 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.7 2.933 . . . . 0.0 114.58 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -85.59 -0.99 56.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.934 0.397 . . . . 0.0 110.827 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -56.61 13.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.204 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.59 149.48 49.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.137 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -173.76 16.89 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.094 0.473 . . . . 0.0 110.395 -175.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.467 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -79.63 -90.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.67 -175.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' H ' ' HB ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -86.16 66.46 9.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.211 -178.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t0 57.27 27.14 13.22 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.221 0.534 . . . . 0.0 110.897 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.641 ' CE1' ' HG3' ' A' ' 48' ' ' LYS . 54.5 m-85 -88.79 148.69 23.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.45 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.631 ' HB2' ' HD2' ' A' ' 17' ' ' PRO . 14.0 pttm -160.07 163.23 22.76 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.631 ' HD2' ' HB2' ' A' ' 16' ' ' LYS . 20.1 Cg_endo -59.25 130.63 36.93 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.492 2.128 . . . . 0.0 112.201 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.883 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 12.4 m-85 -131.72 132.15 43.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.539 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.597 ' HB2' HG23 ' A' ' 32' ' ' VAL . 6.1 m -94.01 93.59 7.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.39 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.73 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 2.8 m -85.31 111.28 19.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.931 0.396 . . . . 0.0 110.333 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.837 -176.492 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.447 -0.625 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.73 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -83.08 138.03 33.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.549 -170.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.43 94.72 1.93 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.891 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.883 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -95.98 149.21 21.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.116 0.484 . . . . 0.0 111.673 -177.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.597 HG23 ' HB2' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -127.21 163.4 30.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 171.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.56 128.52 32.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.82 110.74 3.6 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.049 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.51 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -79.58 129.01 38.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.888 0.375 . . . . 0.0 110.739 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 mp -57.6 127.13 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.255 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.04 15.5 81.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.794 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.51 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -118.23 163.07 17.22 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -102.14 157.29 16.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.906 0.384 . . . . 0.0 110.919 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.58 ' HB2' HD13 ' A' ' 5' ' ' ILE . 4.8 t -122.98 125.3 44.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.187 175.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.01 7.55 69.87 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.776 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.07 -166.24 1.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.56 119.63 18.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.013 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 t -86.9 104.3 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.35 164.26 11.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.994 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.0 m -115.81 88.94 2.99 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 57.9 m -112.52 163.45 14.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 -173.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.641 ' HG3' ' CE1' ' A' ' 15' ' ' TYR . 18.5 mtpt -82.06 171.19 14.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.967 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.344 -0.843 . . . . 0.0 108.996 169.163 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.074 0.464 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.7 mm -80.07 101.09 4.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.307 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.483 HG23 ' SG ' ' A' ' 66' ' ' CYS . 14.1 mt -105.02 134.7 45.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.027 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -88.74 36.06 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.651 -175.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 70.04 -42.78 0.52 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.85 -26.55 68.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.91 22.64 1.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.846 0.355 . . . . 0.0 110.773 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.483 ' SG ' HG23 ' A' ' 61' ' ' ILE . 3.2 m -133.14 143.15 49.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.89 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 121.167 0.508 . . . . 0.0 110.341 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.958 0.409 . . . . 0.0 111.306 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 m -79.35 113.56 17.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.6 113.22 16.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.851 0.358 . . . . 0.0 110.04 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -89.16 131.1 37.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.471 0.653 . . . . 0.0 112.239 -173.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.0 156.79 20.88 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 166.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.16 -26.17 18.98 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.859 2.372 . . . . 0.0 113.241 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -89.53 33.82 0.83 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.962 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.43 -69.12 0.63 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.363 0.601 . . . . 0.0 109.95 175.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 m -92.68 137.03 32.72 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.05 38.9 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.419 0.628 . . . . 0.0 109.917 -168.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.53 -87.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.094 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.652 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 21.7 t0 -100.14 63.68 1.17 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.764 -176.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 56.47 28.11 13.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.334 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.705 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 20.6 m-85 -90.78 134.51 34.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.12 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.98 153.33 47.08 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.192 -178.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . 0.63 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 20.6 Cg_endo -61.97 120.32 7.86 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.629 2.22 . . . . 0.0 112.324 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.799 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 37.5 m-85 -133.29 125.27 28.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.881 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.0 95.76 6.79 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 37.1 m -82.44 121.79 27.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.23 -175.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.415 179.139 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.432 HD12 ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -106.71 137.53 44.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.841 0.353 . . . . 0.0 110.377 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.68 75.25 2.34 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.943 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.799 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 19.2 m -84.93 102.11 12.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.187 0.517 . . . . 0.0 110.831 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.1 m -78.89 150.59 5.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 t -61.96 135.84 26.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.378 0.424 . . . . 0.0 110.475 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.63 ' HA3' ' HB2' ' A' ' 17' ' ' PRO . . . -64.99 89.68 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.759 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.7 t -79.43 141.36 15.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.687 0.28 . . . . 0.0 110.287 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.35 101.98 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.442 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.02 -13.63 8.48 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.209 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.42 ' O ' ' HB ' ' A' ' 5' ' ' ILE . 53.6 m -72.83 129.11 37.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.008 0.433 . . . . 0.0 110.815 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -95.3 106.85 18.93 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.414 ' HB3' HG23 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -75.17 106.25 6.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.28 -176.167 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.87 -4.65 29.64 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.927 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.09 -82.79 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.346 . . . . 0.0 110.231 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.586 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 38.7 m -155.41 120.12 4.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.193 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.414 HG23 ' HB3' ' A' ' 40' ' ' CYS . 2.8 t -82.05 101.62 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.586 ' HE3' ' HB3' ' A' ' 43' ' ' SER . 1.2 mmpt? -114.24 136.16 53.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.708 ' HB2' HG21 ' A' ' 67' ' ' VAL . 74.5 m -101.01 96.33 7.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.514 174.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.3 m -111.76 163.69 13.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.382 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 13' ' ' ASP . 28.7 ttmt -110.18 -37.7 5.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.405 -176.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 123.898 0.879 . . . . 0.0 111.959 -172.166 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.187 0.517 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.11 74.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.973 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mt -80.24 147.21 6.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.265 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -85.92 151.97 23.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.02 94.03 0.31 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.77 0.319 . . . . 0.0 110.959 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -151.17 -78.94 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.249 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -85.03 54.21 3.02 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.157 0.504 . . . . 0.0 111.016 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 78.5 m -125.95 139.59 53.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.437 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.708 HG21 ' HB2' ' A' ' 46' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -175.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.35 141.32 46.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.99 -176.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.2 124.14 27.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 0.0 110.043 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.865 HG21 ' HA3' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -92.55 151.02 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.536 0.684 . . . . 0.0 112.343 -171.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 8' ' ' ASN . . . 159.1 176.26 30.95 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.256 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.915 ' HD3' HG12 ' A' ' 36' ' ' ILE . 24.1 Cg_exo -64.85 43.8 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.103 2.535 . . . . 0.0 112.785 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.452 ' H ' ' C ' ' A' ' 6' ' ' GLY . 48.3 t30 -131.22 -42.78 1.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.213 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -41.37 97.85 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.773 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -152.38 124.98 8.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.572 174.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -173.62 36.17 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -174.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.88 -82.39 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.822 -172.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -89.07 61.02 5.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.328 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.1 t0 51.51 54.04 11.74 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.543 0.687 . . . . 0.0 110.45 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -121.74 126.85 49.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.33 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.24 146.02 31.77 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.01 125.64 10.55 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.287 1.992 . . . . 0.0 111.454 177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.633 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 10.1 m-85 -126.07 131.1 52.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.036 0.445 . . . . 0.0 111.409 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.9 m -103.16 101.63 11.6 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.87 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.632 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 2.0 m -82.03 120.6 25.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.222 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.494 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.447 -0.609 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.632 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -79.37 157.45 27.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.785 -169.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.41 89.41 0.78 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.577 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.633 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 1.1 m -89.68 129.37 36.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.39 . . . . 0.0 111.108 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.1 m -104.32 156.76 5.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.08 128.1 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.865 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -64.35 129.16 36.92 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.181 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.486 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -79.31 123.49 36.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.002 0.429 . . . . 0.0 110.412 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.915 HG12 ' HD3' ' A' ' 7' ' ' PRO . 6.2 mt -68.52 112.32 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.772 -176.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.99 -16.11 30.64 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.751 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.486 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 14.1 m -90.24 176.91 6.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -135.74 98.3 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.787 0.327 . . . . 0.0 110.599 -175.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.686 ' HB2' HD12 ' A' ' 5' ' ' ILE . 65.6 m -79.8 127.5 32.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.299 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.32 6.81 32.19 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.618 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.47 ' HB2' ' H ' ' A' ' 43' ' ' SER . . . -92.47 -141.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.584 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 1.3 m -82.89 80.49 8.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 110.097 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -79.8 109.06 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.423 ' HG2' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -122.6 178.09 5.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.596 0.712 . . . . 0.0 111.547 -173.284 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 92.0 m -129.93 111.85 12.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.659 176.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.504 ' SG ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -121.92 146.62 46.94 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.934 0.397 . . . . 0.0 111.589 -171.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.41 ' C ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -78.77 115.66 18.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.803 175.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.266 173.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.32 95.18 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.321 0.582 . . . . 0.0 109.992 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -94.12 131.72 40.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.914 -177.755 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -86.16 15.57 5.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -173.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 72.93 -44.94 0.61 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.638 0.775 . . . . 0.0 112.496 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.39 18.37 0.31 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -128.04 16.89 6.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.593 0.711 . . . . 0.0 109.256 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER -114.15 140.32 48.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.155 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.232 0.539 . . . . 0.0 110.536 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 121.2 0.524 . . . . 0.0 109.981 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.402 ' HG1' HG22 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -66.45 132.16 47.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.464 -178.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 m -78.97 109.18 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.778 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.546 HG22 ' HA3' ' A' ' 34' ' ' GLY . 13.0 mt -80.14 130.82 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.69 151.4 22.36 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 170.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.623 ' HD3' HG12 ' A' ' 36' ' ' ILE . 34.9 Cg_endo -64.91 -3.65 7.37 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 122.821 2.347 . . . . 0.0 113.323 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -82.62 -6.07 59.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.273 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.89 -79.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.239 0.542 . . . . 0.0 110.743 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 128.77 54.76 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.12 46.73 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.272 0.558 . . . . 0.0 110.213 -174.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.91 -87.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.035 -176.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.554 ' HB3' ' CD2' ' A' ' 15' ' ' TYR . 27.8 t70 -81.22 54.08 2.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.438 0.637 . . . . 0.0 110.298 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.04 25.75 4.32 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.538 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.554 ' CD2' ' HB3' ' A' ' 13' ' ' ASP . 26.8 m-85 -78.52 124.33 28.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.301 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.698 ' HZ3' ' HB3' ' A' ' 49' ' ' ASP . 35.3 mttp -119.51 145.58 39.25 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.32 115.55 3.39 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.329 2.019 . . . . 0.0 111.397 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.577 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 31.5 m-85 -126.11 135.28 51.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -176.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.87 86.35 2.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.516 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.728 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 1.1 m -67.62 116.72 8.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.185 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.327 178.88 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.58 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.728 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -104.5 138.08 41.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.522 -172.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 60' ' ' ILE . . . -89.01 100.68 2.68 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 177.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.9 OUTLIER -94.8 101.94 13.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.897 0.379 . . . . 0.0 111.187 -177.081 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.429 ' H ' HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -83.27 151.43 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.6 t -63.48 133.71 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.546 ' HA3' HG22 ' A' ' 5' ' ' ILE . . . -62.56 116.91 10.02 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.096 177.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.404 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -79.59 125.28 38.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.755 0.312 . . . . 0.0 110.527 -178.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.623 HG12 ' HD3' ' A' ' 7' ' ' PRO . 0.8 OUTLIER -65.98 114.25 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.712 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.16 15.04 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.752 -177.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.404 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 5.7 m -134.11 176.88 8.19 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -113.57 135.43 53.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.958 0.409 . . . . 0.0 111.663 -174.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.14 99.04 12.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.684 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.68 13.19 58.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.8 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.406 ' HB2' ' H ' ' A' ' 43' ' ' SER . . . -114.7 -107.5 0.38 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.31 . . . . 0.0 110.342 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.406 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -123.59 118.95 28.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.402 HG22 ' HG1' ' A' ' 3' ' ' THR . 21.9 t -79.06 101.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.718 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -118.42 112.56 20.14 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.542 -176.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 33.3 m -81.77 93.59 6.86 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.718 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 38.7 m -108.83 144.69 36.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.748 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.2 123.78 29.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.698 ' HB3' ' HZ3' ' A' ' 16' ' ' LYS . 6.9 t0 . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.521 -174.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.548 HD23 ' HH ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.378 0.609 . . . . 0.0 111.642 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 28' ' ' SER . 0.9 OUTLIER -82.54 117.24 28.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.297 174.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.482 HD12 ' HB2' ' A' ' 31' ' ' CYS . 37.6 mt -101.19 148.38 7.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.977 -173.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -79.83 19.35 0.69 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.642 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.478 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . 71.01 -43.0 0.55 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.637 0.775 . . . . 0.0 112.901 176.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.46 -38.17 71.31 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . 0.453 HD21 ' HA ' ' A' ' 65' ' ' ASN . 1.3 m120 -84.31 20.79 1.55 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.827 0.346 . . . . 0.0 111.447 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.2 m -120.25 165.34 14.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.434 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.444 177.623 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.122 0.487 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.61 136.73 36.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.04 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.82 137.94 37.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.551 HG21 ' HA3' ' A' ' 34' ' ' GLY . 47.9 mt -114.47 121.58 66.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.211 0.529 . . . . 0.0 112.001 -174.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.64 149.39 18.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 167.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.0 -28.19 39.04 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.318 2.679 . . . . 0.0 113.049 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -91.08 43.39 1.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.944 0.402 . . . . 0.0 111.459 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.35 -27.79 25.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.507 0.67 . . . . 0.0 109.457 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.82 131.41 19.91 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.357 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.07 15.07 0.63 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.192 0.52 . . . . 0.0 110.601 -175.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.418 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -79.45 -79.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.457 0.646 . . . . 0.0 109.321 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.418 ' H ' ' HB ' ' A' ' 12' ' ' ILE . 43.2 t0 -79.18 -173.39 3.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 167.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -76.21 52.07 0.72 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.619 0.724 . . . . 0.0 109.678 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -89.74 132.35 35.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.445 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.584 ' HB2' ' CE2' ' A' ' 18' ' ' TYR . 2.1 mtmp? -120.09 152.27 54.14 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.169 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.38 119.07 6.06 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.572 2.181 . . . . 0.0 111.346 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 16' ' ' LYS . 37.8 m-85 -127.92 125.65 39.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.243 0.544 . . . . 0.0 111.4 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.8 m -82.71 95.78 7.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.324 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.591 ' SG ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -98.66 118.66 35.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.558 -174.602 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 . . . . . 0 C--N 1.319 -0.756 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.329 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.294 0 CA-C-O 120.797 0.332 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.591 HD13 ' SG ' ' A' ' 20' ' ' CYS . 1.8 mm? -79.15 103.09 8.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.196 0.522 . . . . 0.0 110.139 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.76 79.54 1.86 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.727 -0.67 . . . . 0.0 113.077 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.495 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 1.2 m -78.71 122.31 25.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.25 0.548 . . . . 0.0 111.598 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.12 153.13 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.26 128.5 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.432 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.551 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -62.34 122.59 28.72 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.458 176.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.522 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -78.43 129.09 37.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.977 0.418 . . . . 0.0 110.418 -175.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.58 113.45 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.528 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.39 22.2 59.08 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.369 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.522 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 4.2 m -117.1 161.93 18.63 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -104.48 137.07 42.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.14 0.495 . . . . 0.0 111.007 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.472 ' HB2' HD11 ' A' ' 5' ' ' ILE . 6.8 t -111.72 126.03 54.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.746 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.52 10.1 64.79 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.194 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.0 -171.23 1.79 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.44 106.42 3.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.816 0.341 . . . . 0.0 110.85 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.52 105.11 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.808 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -112.28 161.9 16.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.98 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -115.15 100.24 8.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.506 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 62' ' ' ASN . 0.9 OUTLIER -116.76 152.88 33.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.677 -176.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -93.45 154.26 18.02 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 175.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 120.924 0.393 . . . . 0.0 110.997 -177.061 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 mt . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 121.253 0.549 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -81.48 79.51 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 122.076 0.941 . . . . 0.0 110.502 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.79 110.67 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.27 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.544 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 3.4 t-20 -178.2 -22.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 O-C-N 123.406 0.441 . . . . 0.0 111.441 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.33 -53.12 55.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.55 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.7 5.02 1.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.823 0.344 . . . . 0.0 111.405 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -101.16 17.69 21.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.011 0.434 . . . . 0.0 111.124 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.34 157.64 32.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.514 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.0 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.521 176.309 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.708 0.289 . . . . 0.0 110.631 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.68 139.68 33.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.063 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 113.16 17.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.885 0.374 . . . . 0.0 110.075 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 40' ' ' CYS . 95.4 mt -83.38 129.48 37.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 0.0 112.473 -172.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.54 142.41 13.57 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 170.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.22 -20.62 39.6 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.37 2.714 . . . . 0.0 113.718 -176.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -82.55 19.16 1.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.853 0.358 . . . . 0.0 111.54 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -44.21 67.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 109.969 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.35 132.53 56.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.401 176.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.16 18.79 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.895 0.379 . . . . 0.0 111.223 -174.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -79.17 -68.05 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 15' ' ' TYR . 19.0 t0 -100.27 -166.95 1.38 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.238 171.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -79.71 48.39 0.93 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.667 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 2.8 m-30 -79.54 124.17 28.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.758 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -100.84 148.08 34.55 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.102 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -67.31 122.1 9.32 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.231 1.954 . . . . 0.0 110.717 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.848 ' HH ' HD13 ' A' ' 59' ' ' LEU . 18.7 m-85 -124.63 124.47 42.28 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.979 0.419 . . . . 0.0 111.49 -174.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.7 m -87.12 86.35 7.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.068 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.8 m -76.18 99.19 4.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.506 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.63 -175.942 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.72 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.575 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.463 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -94.09 136.2 34.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.076 0.465 . . . . 0.0 111.586 -173.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.93 71.74 1.93 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.595 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.712 ' HB2' HD12 ' A' ' 61' ' ' ILE . 4.0 m -79.37 109.82 14.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 111.076 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.87 143.13 13.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.668 176.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.61 133.07 29.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.16 0.505 . . . . 0.0 111.204 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.407 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -77.78 106.59 2.29 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 35' ' ' VAL . 1.5 t -78.99 157.04 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.836 0.35 . . . . 0.0 110.489 -177.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.37 114.19 2.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.124 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.82 10.19 55.49 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.196 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.5 m -96.07 172.63 7.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.722 0.296 . . . . 0.0 110.297 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -128.18 162.9 25.86 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.582 ' HB2' HD11 ' A' ' 5' ' ' ILE . 1.6 t -137.02 146.98 45.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.751 0.31 . . . . 0.0 110.979 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.9 24.15 3.16 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.855 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.31 -151.51 0.4 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.76 89.79 3.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.871 0.367 . . . . 0.0 110.959 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 p -79.67 108.85 13.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.586 0.708 . . . . 0.0 109.692 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -117.5 -175.45 2.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.624 -177.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 95.2 m -134.73 101.92 5.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.65 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.2 m -121.75 167.35 13.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.34 . . . . 0.0 111.178 -173.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.419 ' HE3' ' HB3' ' A' ' 48' ' ' LYS . 2.4 mmmt -87.08 145.73 26.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.408 172.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 C--N 1.323 -0.573 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.922 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.848 HD13 ' HH ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.022 0.439 . . . . 0.0 110.816 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.72 HD12 ' HB2' ' A' ' 28' ' ' SER . 0.9 OUTLIER -99.75 121.2 50.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.232 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.712 HD12 ' HB2' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -124.34 164.29 22.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.085 0.469 . . . . 0.0 111.693 -174.434 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -85.05 145.58 27.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.943 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.66 92.97 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -171.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.95 14.83 3.76 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.43 15.66 25.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.64 0.733 . . . . 0.0 109.83 174.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.4 m -108.35 173.48 6.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.248 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.487 ' H ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.252 0.549 . . . . 0.0 109.608 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.019 0.438 . . . . 0.0 110.014 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.58 130.84 42.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.266 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.08 122.38 26.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.993 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.823 HG22 ' HA3' ' A' ' 34' ' ' GLY . 56.5 mt -92.94 126.1 45.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.397 0.617 . . . . 0.0 112.18 -174.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -136.08 133.53 6.67 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 169.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.521 ' CG ' HG12 ' A' ' 36' ' ' ILE . 77.9 Cg_exo -51.28 -21.06 9.08 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.396 2.731 . . . . 0.0 113.828 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.64 13.4 3.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.68 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.46 -77.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.82 126.8 36.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.324 173.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.77 25.52 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.454 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -77.81 -64.37 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 15' ' ' TYR . 2.6 t70 -100.03 -151.54 0.4 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 169.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -79.29 35.18 0.26 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.42 0.629 . . . . 0.0 110.179 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 13' ' ' ASP . 22.4 m-85 -83.61 136.73 34.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.754 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.61 161.26 61.96 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.89 105.49 1.15 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.484 2.123 . . . . 0.0 111.605 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.415 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 41.9 m-85 -112.07 122.31 47.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.461 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.73 73.17 7.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.301 0.572 . . . . 0.0 109.699 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -71.26 107.85 4.46 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.016 -177.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.759 177.224 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 62' ' ' ASN . 1.6 mm? -79.75 110.83 15.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.101 -178.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.88 76.98 1.34 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.766 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -84.45 93.47 8.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.901 0.382 . . . . 0.0 110.976 178.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.428 ' H ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -89.34 139.22 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.582 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.2 p -66.72 134.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.261 0.553 . . . . 0.0 111.155 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.823 ' HA3' HG22 ' A' ' 5' ' ' ILE . . . -84.15 115.78 4.14 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.819 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.5 154.28 4.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.521 HG12 ' CG ' ' A' ' 7' ' ' PRO . 1.3 mt -60.85 117.21 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.074 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.17 -0.65 64.17 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.372 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -85.66 164.53 17.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.724 0.297 . . . . 0.0 110.3 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.57 139.41 43.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.783 0.325 . . . . 0.0 110.177 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.489 ' SG ' HG22 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -90.35 107.26 19.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.949 0.404 . . . . 0.0 110.733 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.18 -17.48 80.22 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.925 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.09 -163.9 0.9 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.76 128.45 34.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.525 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.489 HG22 ' SG ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -78.58 117.52 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -111.22 145.4 38.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.463 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 34.2 m -94.47 78.86 3.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.571 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.446 ' SG ' HG21 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -109.18 159.04 17.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.608 -176.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 pttm -87.28 -164.92 1.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.161 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 120.763 0.316 . . . . 0.0 110.214 178.654 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 120.778 0.323 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mt -82.98 78.98 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.161 0.505 . . . . 0.0 110.503 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . 0.446 HG21 ' SG ' ' A' ' 47' ' ' CYS . 0.2 OUTLIER -111.94 -153.88 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.791 177.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.53 ' HA ' ' HB2' ' A' ' 66' ' ' CYS . 20.9 t-20 52.46 25.72 3.74 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.239 0.543 . . . . 0.0 112.103 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.23 -5.9 15.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.12 0.486 . . . . 0.0 110.302 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -164.34 -56.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.367 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.28 44.1 1.06 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -170.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -111.38 120.6 42.73 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.348 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.801 -175.396 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.03 117.4 7.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.604 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.48 128.39 33.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.685 178.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.548 HD11 ' HB2' ' A' ' 40' ' ' CYS . 50.8 mt -93.03 133.64 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.983 -176.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.81 130.4 9.34 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 169.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.66 -37.53 75.09 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.738 2.959 . . . . 0.0 114.127 -175.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -86.83 36.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.974 0.416 . . . . 0.0 111.663 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.82 -52.0 7.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 173.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.7 m -137.33 116.03 12.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.024 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 24.3 m -161.38 20.79 0.12 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.427 0.632 . . . . 0.0 109.452 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.415 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -79.18 -82.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.428 -176.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.688 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 7.2 t70 -79.28 60.26 3.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.456 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.8 t0 48.8 45.28 22.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.764 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.688 ' CE2' ' HB3' ' A' ' 13' ' ' ASP . 26.5 m-85 -97.56 152.48 18.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.181 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.636 ' HB2' ' CE2' ' A' ' 18' ' ' TYR . 9.6 mttp -132.79 143.11 47.27 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.45 103.65 1.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.019 1.813 . . . . 0.0 110.6 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.994 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 24.4 m-85 -104.55 125.81 51.05 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.632 -173.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.35 93.76 9.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.524 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.621 ' HB3' ' HB2' ' A' ' 29' ' ' LEU . 18.0 m -85.12 125.97 33.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.8 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 110.601 177.132 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.621 ' HB2' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -95.58 143.09 27.17 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.255 -172.146 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.51 91.29 1.61 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.994 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 5.7 m -96.6 126.12 41.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.864 0.364 . . . . 0.0 111.627 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.42 144.47 14.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -60.66 129.84 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.173 0.511 . . . . 0.0 111.154 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.544 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -70.14 109.88 3.06 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.639 175.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.44 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -79.61 160.59 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -67.23 116.55 6.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.398 -175.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.12 23.66 60.93 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.446 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.44 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 49.8 m -95.2 126.62 40.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.689 0.281 . . . . 0.0 110.678 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -81.12 117.9 22.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.129 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.548 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -119.01 141.86 48.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.033 0.444 . . . . 0.0 111.536 -176.205 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.74 8.83 10.74 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.37 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.9 -167.2 1.59 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.63 103.03 11.85 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.668 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.3 t -81.6 100.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -113.87 162.11 16.77 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.756 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 89.6 m -103.03 92.87 4.73 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.124 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -109.9 145.72 36.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.7 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.425 ' H ' ' HG2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.41 156.23 24.26 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.111 0.481 . . . . 0.0 110.62 -177.861 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 t0 . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.189 178.613 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.3 mt . . . . . 0 N--CA 1.448 -0.574 0 CA-C-O 120.896 0.379 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 73.2 mt -79.78 99.75 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 mt -112.52 148.57 15.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.764 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -79.53 136.19 36.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.03 -20.45 24.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.18 65.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -93.8 -1.61 54.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.095 0.474 . . . . 0.0 110.806 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.36 103.82 15.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.652 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.0 m . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.476 -175.814 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.87 0.367 . . . . 0.0 110.22 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.88 129.5 38.29 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.228 -177.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.12 130.48 36.43 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.974 0.416 . . . . 0.0 110.457 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.667 HG23 ' HA3' ' A' ' 34' ' ' GLY . 29.0 mm -84.98 118.88 32.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.255 -174.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.53 117.55 4.37 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 169.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -43.96 -34.39 6.25 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.166 3.244 . . . . 0.0 114.235 -176.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -83.21 44.91 0.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 111.652 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.43 -44.76 7.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.559 0.695 . . . . 0.0 109.343 174.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m -139.67 137.69 35.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.177 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.25 30.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -95.23 -92.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.657 -173.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -79.08 57.77 2.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.798 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.84 20.82 3.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.445 0.641 . . . . 0.0 110.257 -173.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.402 ' HD1' ' HA ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -79.68 132.33 36.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.643 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.95 152.99 63.82 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.18 114.64 3.1 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.168 1.912 . . . . 0.0 111.137 175.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.618 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 18.9 m-85 -120.09 128.98 53.97 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.238 0.542 . . . . 0.0 110.874 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.07 88.57 7.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.943 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 1.3 m -73.67 99.73 3.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.742 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.509 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 120.741 0.305 . . . . 0.0 110.721 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -98.72 128.92 45.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.85 0.357 . . . . 0.0 110.732 178.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.69 72.42 2.56 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.704 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -79.22 92.54 5.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.003 0.43 . . . . 0.0 110.199 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 m -84.45 163.43 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.6 t -63.71 134.26 28.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.667 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -54.08 124.99 32.13 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.573 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -79.3 107.64 11.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.997 0.427 . . . . 0.0 110.721 -177.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.31 113.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.491 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.52 -2.44 77.52 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.502 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.527 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -112.72 171.8 7.31 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -101.82 152.34 21.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.937 0.399 . . . . 0.0 111.273 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.562 ' HB2' HD12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -81.54 156.73 25.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.855 175.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.5 -49.9 1.77 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.405 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -108.51 -76.86 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.655 0.264 . . . . 0.0 111.433 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.59 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -142.64 119.93 11.55 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.465 -176.631 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 p -84.53 116.56 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 43' ' ' SER . 0.1 OUTLIER -127.4 165.54 19.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.069 0.461 . . . . 0.0 110.909 -176.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.473 ' HB2' HG22 ' A' ' 67' ' ' VAL . 86.7 m -98.68 109.55 22.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.769 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 163.04 19.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.217 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -117.27 114.97 24.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.831 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.499 178.036 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.822 0.344 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.0 mt -81.12 95.73 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.9 mt -102.72 151.17 6.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.498 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.27 131.04 35.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.563 ' HB3' HD23 ' A' ' 29' ' ' LEU . . . -61.21 -22.11 64.47 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -171.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.69 76.37 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.38 0.91 53.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 111.326 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.45 127.82 39.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.939 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 46' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.58 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . 0.673 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.98 121.06 27.23 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.624 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 109.71 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.032 0.444 . . . . 0.0 110.134 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.61 HD12 ' SG ' ' A' ' 19' ' ' CYS . 3.3 mt -91.46 134.2 30.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.426 0.632 . . . . 0.0 112.665 -170.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.69 164.11 16.99 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 170.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.69 ' HD3' HG21 ' A' ' 36' ' ' ILE . 37.8 Cg_endo -66.73 -13.57 40.42 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.719 2.279 . . . . 0.0 113.213 -177.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -97.05 19.39 12.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.968 0.413 . . . . 0.0 111.221 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.02 -59.63 2.7 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.472 0.653 . . . . 0.0 110.327 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.5 m -93.98 117.35 29.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.331 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.2 m -157.09 21.12 0.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.91 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 mt -78.38 -63.23 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -99.63 -165.01 1.18 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -80.05 47.84 0.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -91.06 163.6 14.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.657 -176.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.43 ' HG3' ' CE2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -132.57 148.21 68.69 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.13 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.15 122.24 9.29 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.477 2.118 . . . . 0.0 112.128 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.851 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 34.2 m-85 -121.43 128.7 52.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.906 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.61 ' SG ' HD12 ' A' ' 5' ' ' ILE . 59.3 m -91.04 84.16 5.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.641 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 56.8 m -76.97 107.06 9.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.734 -176.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.049 -178.89 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 121.059 0.457 . . . . 0.0 110.233 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.587 HD12 ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -89.4 148.14 23.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.391 -178.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.0 76.32 2.17 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.81 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.851 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 33.3 m -87.34 99.26 11.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.021 0.439 . . . . 0.0 111.366 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 m -89.69 151.37 3.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 171.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.16 129.62 20.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.577 ' HA3' HG22 ' A' ' 5' ' ' ILE . . . -48.19 126.64 15.26 Favored Glycine 0 N--CA 1.447 -0.584 0 O-C-N 123.83 0.706 . . . . 0.0 111.912 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -78.06 114.02 18.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -177.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.69 HG21 ' HD3' ' A' ' 7' ' ' PRO . 7.3 mm -61.24 110.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.452 -172.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.71 9.51 61.17 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.833 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.542 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 70.4 m -112.21 151.04 30.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.057 0.456 . . . . 0.0 110.663 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.673 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 4.0 mt-30 -86.24 113.85 22.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.792 176.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.3 m -92.79 123.08 35.8 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.81 45.44 2.51 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.991 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.09 -178.24 5.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.82 125.4 27.07 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.528 HG11 HD11 ' A' ' 5' ' ' ILE . 17.2 t -79.36 97.42 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 11.4 mmpt? -105.42 124.36 49.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.038 -174.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 93.9 m -87.64 89.6 8.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 34.6 m -111.17 169.29 8.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.143 0.496 . . . . 0.0 111.498 -174.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.89 141.59 40.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.431 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--N 1.322 -0.629 0 CA-C-O 121.285 0.565 . . . . 0.0 110.043 176.838 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.037 0.446 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . 0.443 ' H ' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -87.03 78.65 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 -178.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.2 mt -76.37 129.64 37.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.859 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.4 t30 -82.71 42.64 0.79 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.398 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 70.92 -54.2 0.66 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.005 0.922 . . . . 0.0 113.084 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.39 59.42 2.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -173.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.01 25.5 0.82 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.393 0.616 . . . . 0.0 109.823 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -135.63 177.28 7.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.671 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.722 0.296 . . . . 0.0 110.576 177.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.951 0.405 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.11 129.78 44.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.412 HG23 ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -88.23 122.52 31.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.085 178.491 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.59 HD11 ' HB2' ' A' ' 40' ' ' CYS . 14.9 mt -94.14 140.63 16.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.013 0.435 . . . . 0.0 111.934 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.55 151.83 23.46 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 174.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.869 ' HD3' HG12 ' A' ' 36' ' ' ILE . 60.3 Cg_endo -72.77 46.03 0.98 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.851 2.368 . . . . 0.0 112.758 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -135.79 0.51 2.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.583 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.27 -54.07 10.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.241 0.543 . . . . 0.0 110.246 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -120.2 139.71 52.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.3 177.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.5 m -162.01 12.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.809 0.338 . . . . 0.0 110.55 -173.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . 0.44 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -78.36 -84.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.44 ' H ' ' HB ' ' A' ' 12' ' ' ILE . 2.6 t70 -83.45 -152.84 0.13 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 173.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.62 48.15 1.48 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.937 0.875 . . . . 0.0 109.531 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.729 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 25.5 m-85 -96.16 110.0 22.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.273 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.4 mtmm -107.65 156.97 37.01 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.83 117.41 4.31 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.208 1.939 . . . . 0.0 111.678 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -122.11 122.33 38.98 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.58 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.404 ' SG ' ' HB1' ' A' ' 42' ' ' ALA . 5.1 t -88.3 100.84 13.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.74 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.854 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -101.96 135.7 43.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.887 -176.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.356 -178.035 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.235 0.292 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.854 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -127.61 164.01 22.96 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.73 -174.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.54 76.95 0.25 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.759 -177.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -81.42 108.35 14.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.744 0.306 . . . . 0.0 110.227 176.135 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 m -91.46 161.53 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.84 130.5 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.766 0.317 . . . . 0.0 110.423 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.565 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -61.11 134.26 48.85 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.636 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . 0.487 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -78.94 116.65 23.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.055 0.455 . . . . 0.0 109.877 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.869 HG12 ' HD3' ' A' ' 7' ' ' PRO . 34.1 mt -67.22 120.12 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.849 -175.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.12 17.13 72.75 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.173 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' SER . . . . . 0.419 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -127.27 160.55 30.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.674 0.273 . . . . 0.0 110.695 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.412 ' HG3' HG23 ' A' ' 4' ' ' THR . 28.0 mt-30 -97.53 149.88 21.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.019 0.438 . . . . 0.0 110.873 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.59 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -121.41 156.99 31.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.231 178.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.56 16.3 21.68 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.753 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.404 ' HB1' ' SG ' ' A' ' 19' ' ' CYS . . . -124.35 -161.65 1.02 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -89.91 107.22 18.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.017 0.437 . . . . 0.0 111.084 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.45 109.38 17.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.952 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -130.93 -179.45 5.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.909 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 4.1 m -107.93 105.58 15.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.206 175.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 62.2 m -118.31 148.86 42.04 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.171 -174.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HD2' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -91.64 116.04 28.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.095 0.474 . . . . 0.0 110.239 176.601 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.09 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.029 0.442 . . . . 0.0 110.316 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -87.99 105.44 15.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.796 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.5 mt -112.35 135.16 52.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.446 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -67.43 150.68 48.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.614 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.75 164.91 18.41 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.365 177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 69.62 8.97 7.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.811 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.44 21.04 13.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.537 0.684 . . . . 0.0 109.98 175.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.9 m -123.42 140.52 52.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.09 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.313 -0.994 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.933 0.396 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.52 133.53 35.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.774 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.74 121.94 25.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.017 0.437 . . . . 0.0 110.516 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.539 HG22 ' HA3' ' A' ' 34' ' ' GLY . 3.7 mt -92.13 147.36 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.397 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.85 157.01 26.98 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 172.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.862 ' HD3' HG12 ' A' ' 36' ' ' ILE . 14.2 Cg_endo -56.97 -33.72 96.04 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.858 2.372 . . . . 0.0 112.095 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.84 62.21 4.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.448 0.642 . . . . 0.0 110.187 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.34 -49.59 4.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.089 175.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -123.32 152.68 41.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.137 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -151.82 19.49 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.725 0.774 . . . . 0.0 109.211 -174.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -74.22 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.191 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -100.96 -156.46 0.56 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.267 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -86.84 49.84 1.89 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.866 0.841 . . . . 0.0 108.771 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' TYR . . . . . 0.656 ' HB3' ' HB2' ' A' ' 46' ' ' CYS . 8.6 m-85 -86.9 110.48 20.02 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.523 -176.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HG3' ' CE2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -95.02 155.27 39.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.641 -177.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.91 127.48 22.5 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.18 2.587 . . . . 0.0 112.858 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' TYR . . . . . 0.875 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 21.4 m-85 -138.07 130.96 29.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' CYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 18.2 m -89.49 87.36 7.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.565 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' CYS . . . . . 0.578 ' HB3' HD23 ' A' ' 29' ' ' LEU . 91.1 m -75.43 94.56 3.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.907 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.553 ' HG3' ' HB1' ' A' ' 42' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.543 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.0 m . . . . . 0 C--O 1.234 0.238 0 CA-C-O 121.445 0.641 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LEU . . . . . 0.578 HD23 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mt -79.69 115.36 19.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.969 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.91 62.98 4.46 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.88 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' CYS . . . . . 0.875 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 6.2 m -89.41 101.84 14.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.125 0.488 . . . . 0.0 110.98 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.94 152.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.2 t -59.53 132.97 24.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.713 0.292 . . . . 0.0 110.405 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLY . . . . . 0.539 ' HA3' HG22 ' A' ' 5' ' ' ILE . . . -66.41 113.94 6.1 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.65 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.6 122.01 32.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.063 0.458 . . . . 0.0 110.653 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ILE . . . . . 0.862 HG12 ' HD3' ' A' ' 7' ' ' PRO . 1.1 mt -59.13 130.17 22.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.104 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.87 80.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.45 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 m -122.32 166.73 14.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -101.39 137.0 40.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.903 0.383 . . . . 0.0 111.046 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' CYS . . . . . 0.494 ' HB2' HD13 ' A' ' 5' ' ' ILE . 7.7 t -101.01 128.41 47.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.796 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.05 -0.58 57.24 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.449 -178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . 0.553 ' HB1' ' HG3' ' A' ' 21' ' ' GLN . . . -121.04 -162.21 0.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.095 0.474 . . . . 0.0 111.169 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.89 104.25 3.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.783 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.41 111.42 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -124.73 172.39 9.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.889 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' CYS . . . . . 0.656 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -118.16 119.94 36.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.657 0.265 . . . . 0.0 110.45 176.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.88 171.3 9.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.838 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.09 154.05 29.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.746 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ASP . . . . . 0.4 ' CG ' ' HZ3' ' A' ' 16' ' ' LYS . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.137 0.494 . . . . 0.0 110.954 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.7 tp . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 mt -79.97 97.48 2.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.014 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.6 mm -73.69 151.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.434 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -66.22 -68.35 0.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.275 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ALA . . . . . 0.431 ' HB3' ' H ' ' A' ' 64' ' ' ALA . . . -162.25 -96.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.397 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ALA . . . . . 0.431 ' H ' ' HB3' ' A' ' 63' ' ' ALA . . . -82.44 78.8 9.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.233 0.456 . . . . 0.0 112.233 -172.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.7 22.82 0.46 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.435 0.636 . . . . 0.0 109.923 171.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 87.0 m -123.23 86.95 2.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.612 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 120.965 0.412 . . . . 0.0 111.342 -175.232 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.539 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.778 0.323 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.68 35.36 0.62 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.258 0.551 . . . . 0.0 110.265 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.31 140.19 50.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.326 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.12 129.3 34.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.125 0.488 . . . . 0.0 110.317 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.89 HG23 ' HA3' ' A' ' 34' ' ' GLY . 80.9 mt -95.68 135.21 30.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.555 -176.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.93 161.3 34.19 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.868 ' HD3' HG12 ' A' ' 36' ' ' ILE . 25.8 Cg_exo -64.33 60.86 0.25 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 123.332 2.688 . . . . 0.0 112.871 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -150.73 -44.32 0.12 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -58.46 8.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.59 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 5.8 m -122.8 97.28 5.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.32 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.429 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -162.96 15.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.175 0.512 . . . . 0.0 110.201 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -78.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.996 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.647 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 26.9 t0 -77.75 59.12 1.97 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.165 0.507 . . . . 0.0 110.419 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t0 51.72 46.98 25.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.846 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.647 ' CE2' ' HB3' ' A' ' 13' ' ' ASP . 10.7 m-85 -102.2 160.79 14.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.543 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -125.04 145.5 50.52 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.607 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.432 ' HB2' HG22 ' A' ' 5' ' ' ILE . 61.4 Cg_endo -74.65 103.63 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.861 1.707 . . . . 0.0 111.154 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.927 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 33.9 m-85 -100.39 120.56 40.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.157 -175.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.29 87.35 7.27 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.657 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 57.8 m -78.15 113.62 16.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.954 -176.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -82.88 61.62 6.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.534 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.01 109.01 11.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.441 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.37 -164.79 1.08 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.693 -176.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.64 105.94 1.07 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.511 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.87 62.53 1.3 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.035 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.5 m -139.5 96.31 3.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.841 0.353 . . . . 0.0 110.753 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.93 -33.9 45.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.498 0.666 . . . . 0.0 110.226 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.44 129.82 55.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.019 173.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.55 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -80.13 123.39 27.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.806 0.336 . . . . 0.0 110.648 -175.868 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.61 78.69 1.62 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.927 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 14.7 m -86.9 99.32 11.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.012 0.434 . . . . 0.0 111.439 -175.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.86 142.7 13.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.36 122.42 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.89 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -66.25 117.9 10.3 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.292 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.14 139.18 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.868 HG12 ' HD3' ' A' ' 7' ' ' PRO . 2.4 mt -59.62 108.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.634 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.77 -21.27 9.09 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.982 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.0 m -76.08 160.85 29.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.575 0.226 . . . . 0.0 110.84 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.91 145.48 40.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.762 0.315 . . . . 0.0 110.269 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.21 110.76 23.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.882 175.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.539 ' HA2' ' O ' ' A' ' 1' ' ' SER . . . -84.46 -30.84 26.35 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.603 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.407 ' HB3' ' H ' ' A' ' 43' ' ' SER . . . -94.17 -142.24 0.24 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.716 0.293 . . . . 0.0 110.732 179.879 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.407 ' H ' ' HB3' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -84.44 102.12 12.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 -176.295 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.401 ' H ' HG11 ' A' ' 44' ' ' VAL . 1.9 p -80.29 115.8 23.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 174.698 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -116.32 143.91 44.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.089 0.471 . . . . 0.0 111.123 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.45 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 35.3 m -99.23 83.56 2.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.944 175.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.492 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 23.7 m -102.47 154.13 19.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.478 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.538 ' HA ' ' HD1' ' A' ' 15' ' ' TYR . 4.1 ttmt -65.68 -70.26 0.25 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.287 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -167.95 -51.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.808 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.46 ' C ' HG13 ' A' ' 51' ' ' VAL . 3.7 t0 78.54 -66.07 0.21 Allowed 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 124.32 1.013 . . . . 0.0 108.829 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.46 HG13 ' C ' ' A' ' 50' ' ' ASP . 0.4 OUTLIER 178.38 111.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.001 -178.023 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.97 45.01 1.04 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.181 0.515 . . . . 0.0 111.349 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -151.45 153.12 34.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.453 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 m 58.28 56.5 4.44 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.412 0.625 . . . . 0.0 109.974 -173.425 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.493 ' O ' ' HA ' ' A' ' 59' ' ' LEU . . . 151.56 57.29 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.605 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.8 -42.6 15.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.801 0.334 . . . . 0.0 110.223 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.85 67.03 7.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.408 0.623 . . . . 0.0 109.652 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.79 98.59 1.79 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -173.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.493 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 0.1 OUTLIER -60.96 123.3 17.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 110.992 -174.994 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.3 mt -80.25 80.8 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.154 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.453 HD13 HG23 ' A' ' 61' ' ' ILE . 15.3 mm -77.85 137.33 22.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.174 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -78.66 11.78 2.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.79 0.329 . . . . 0.0 111.107 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 66.28 4.18 3.07 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.392 0.677 . . . . 0.0 112.374 176.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.55 32.92 5.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.9 0.381 . . . . 0.0 111.207 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.3 25.7 3.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.986 0.422 . . . . 0.0 110.154 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.56 155.71 48.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.911 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.423 HG22 ' CE2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -75.2 -53.16 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.912 0.387 . . . . 0.0 110.014 174.95 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.4 ' H ' HG23 ' A' ' 67' ' ' VAL . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.196 -179.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.855 0.36 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.56 101.75 14.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.984 0.421 . . . . 0.0 110.628 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.9 137.25 32.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.186 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.93 138.48 33.13 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.655 HG23 ' HA3' ' A' ' 34' ' ' GLY . 6.2 mt -105.51 134.27 47.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.364 0.602 . . . . 0.0 112.196 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.42 147.1 19.03 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 171.686 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -51.47 -34.46 51.47 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.346 2.697 . . . . 0.0 112.992 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -101.58 67.75 1.14 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.103 0.478 . . . . 0.0 110.498 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.11 -61.52 1.36 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.025 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 54.4 m -116.24 142.93 46.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.5 m -159.63 32.86 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.073 0.463 . . . . 0.0 110.863 -172.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.411 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.9 OUTLIER -79.06 -68.67 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.784 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.411 ' H ' ' HB ' ' A' ' 12' ' ' ILE . 8.3 t0 -95.44 -165.55 1.31 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.591 167.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.548 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 3.7 t70 -77.85 50.72 0.88 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.377 0.608 . . . . 0.0 109.573 170.802 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.627 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 8.2 m-85 -85.85 79.61 9.2 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.627 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.641 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -79.3 156.97 75.94 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.329 -177.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.08 116.02 3.94 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.464 2.109 . . . . 0.0 111.305 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.557 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 25.8 m-85 -126.82 131.38 51.25 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.593 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.9 m -94.83 99.03 11.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.363 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.46 ' HB3' HD21 ' A' ' 29' ' ' LEU . 1.6 m -82.92 121.25 26.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.724 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -93.55 107.45 19.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.605 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.33 107.71 11.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.521 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.7 mtm -97.97 167.98 10.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.022 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -51.64 49.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.388 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.18 -45.42 3.05 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.008 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.04 105.04 10.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.048 0.451 . . . . 0.0 110.752 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.53 0.66 56.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.963 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.52 141.77 48.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.01 176.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.46 HD21 ' HB3' ' A' ' 20' ' ' CYS . 7.2 mt -80.23 88.0 5.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.004 0.431 . . . . 0.0 111.203 -175.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.14 79.84 1.15 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.784 175.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.557 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.5 OUTLIER -88.63 109.61 20.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 0.0 111.227 -178.373 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.95 153.39 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.987 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 t -62.09 130.64 26.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.744 0.307 . . . . 0.0 110.704 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.655 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -66.39 132.44 32.8 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.289 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.417 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 2.1 t -80.54 137.51 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.069 0.462 . . . . 0.0 110.703 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mt -64.15 111.75 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.265 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.13 59.11 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.497 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.417 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 15.1 m -110.36 170.89 7.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.715 0.293 . . . . 0.0 110.515 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.49 136.25 54.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.498 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.506 ' HB3' HG21 ' A' ' 44' ' ' VAL . 0.8 OUTLIER -115.47 133.4 56.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.433 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.79 29.65 9.18 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.235 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -121.44 -156.09 0.67 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.5 83.86 4.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.009 0.433 . . . . 0.0 110.375 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.506 HG21 ' HB3' ' A' ' 40' ' ' CYS . 2.0 t -79.59 109.72 14.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.027 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.678 ' HA ' ' HB1' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -124.13 160.07 28.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.992 0.425 . . . . 0.0 111.163 -176.135 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.627 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 59.0 m -93.59 100.84 13.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 171.157 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 69.3 m -108.15 144.48 35.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.363 -172.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.548 ' HE3' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -79.3 117.36 20.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.51 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.641 ' HB2' ' HD2' ' A' ' 16' ' ' LYS . 65.8 t0 -71.18 117.5 12.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.952 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -103.61 1.9 32.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.861 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.05 -55.51 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 m 51.91 57.93 6.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.544 0.687 . . . . 0.0 110.783 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -103.84 162.15 13.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.344 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.92 -4.43 31.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.179 0.514 . . . . 0.0 111.028 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.47 42.39 1.86 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -72.51 113.74 9.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.869 0.366 . . . . 0.0 110.217 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p -129.14 -93.86 0.43 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.835 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.94 98.26 1.22 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.505 HD11 ' HH ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -81.28 118.06 22.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.834 0.35 . . . . 0.0 110.553 -177.391 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.21 97.11 4.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.797 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.457 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.3 OUTLIER -88.63 150.44 3.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.387 -178.394 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -101.85 45.07 0.98 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.906 0.384 . . . . 0.0 110.661 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 73.27 -56.33 0.66 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.367 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.09 -27.04 65.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -92.66 17.08 10.81 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.476 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.0 m -127.41 119.79 26.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.798 0.332 . . . . 0.0 110.88 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.53 112.04 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.042 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.678 ' HB1' ' HA ' ' A' ' 45' ' ' LYS . . . . . . . . 0 C--O 1.245 0.863 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.186 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.456 ' HB2' ' H ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 120.525 0.203 . . . . 0.0 110.625 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.456 ' H ' ' HB2' ' A' ' 1' ' ' SER . . . -89.83 73.59 7.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.091 0.472 . . . . 0.0 110.391 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.488 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -67.82 120.76 14.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.586 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.03 125.05 28.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.785 176.066 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.472 HD12 ' HB2' ' A' ' 40' ' ' CYS . 3.5 mt -104.28 132.9 49.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -170.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.72 149.0 16.85 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 167.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.11 43.06 0.8 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.648 2.232 . . . . 0.0 113.539 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -150.32 26.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.051 0.453 . . . . 0.0 110.677 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.19 -23.6 47.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.726 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 m -146.12 145.97 30.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.5 m -162.36 25.2 0.11 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.801 0.334 . . . . 0.0 111.075 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.16 -65.67 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.4 ' C ' ' H ' ' A' ' 15' ' ' TYR . 3.6 t70 -100.52 -151.12 0.4 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 168.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -83.03 47.46 1.23 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.933 0.873 . . . . 0.0 108.693 169.252 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.55 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 5.8 m-85 -82.35 78.81 8.95 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.677 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -79.81 149.92 71.55 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.27 126.63 19.0 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.397 2.065 . . . . 0.0 111.052 176.425 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.679 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 9.2 m-85 -129.1 129.85 45.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.971 0.415 . . . . 0.0 111.373 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.483 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 13.9 m -83.56 84.14 7.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.357 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.542 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 20.6 m -72.67 96.84 2.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.111 0.482 . . . . 0.0 111.386 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -84.56 93.52 8.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.84 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.45 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -59.99 136.2 57.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.904 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.31 139.95 37.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.944 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.65 58.48 1.81 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.365 0.602 . . . . 0.0 110.995 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.21 -58.08 0.12 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.493 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.97 159.46 19.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.642 0.258 . . . . 0.0 110.349 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.13 -19.23 43.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.934 0.397 . . . . 0.0 110.724 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.08 153.9 42.6 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.863 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.45 HD21 ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -122.96 139.2 54.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.97 -177.071 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.93 76.05 2.3 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.679 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 3.8 m -79.54 100.75 7.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.998 0.428 . . . . 0.0 111.042 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.42 145.34 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 p -58.1 135.24 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.806 0.336 . . . . 0.0 110.708 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.464 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -56.81 118.97 13.21 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.003 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.23 118.92 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 120.91 0.386 . . . . 0.0 110.352 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.59 124.54 8.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.458 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.08 13.93 81.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.27 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.72 167.12 15.0 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.488 ' HA ' ' O ' ' A' ' 3' ' ' THR . 2.5 mt-30 -113.23 145.79 40.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.472 ' HB2' HD12 ' A' ' 5' ' ' ILE . 13.9 m -125.99 120.08 29.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.197 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.48 61.81 3.16 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.289 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.03 -166.16 2.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.77 98.44 1.96 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.904 0.383 . . . . 0.0 110.462 176.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.4 t -87.3 91.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.199 0.523 . . . . 0.0 109.661 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.44 162.67 17.94 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.511 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.55 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -87.5 112.62 22.41 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.783 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.444 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 64.0 m -115.24 149.24 38.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.932 0.396 . . . . 0.0 111.167 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.85 119.33 17.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.839 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.5 t0 -92.9 69.01 4.55 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.518 0.675 . . . . 0.0 110.252 175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.73 -2.04 27.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.506 174.766 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -23.06 6.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.416 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.2 -53.35 0.79 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.276 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.2 t-20 63.88 43.01 5.59 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.484 0.659 . . . . 0.0 109.745 -175.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.9 -55.05 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.062 -176.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 134.09 153.32 6.94 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.257 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -155.25 154.66 32.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.968 0.384 . . . . 0.0 110.804 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.95 -16.45 40.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.821 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.55 68.44 0.5 Allowed Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.93 96.71 10.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.937 0.399 . . . . 0.0 110.938 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mt -79.97 102.35 5.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.433 HD12 ' HB2' ' A' ' 31' ' ' CYS . 62.3 mt -99.61 135.33 35.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.56 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -64.23 145.04 56.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.28 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.37 45.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.108 0.48 . . . . 0.0 111.671 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -154.19 19.28 0.5 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.295 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -123.01 13.89 9.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.3 m -127.96 143.81 51.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.849 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 m -105.82 152.53 7.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.808 0.337 . . . . 0.0 110.684 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.867 -1.063 . . . . 0.0 109.528 179.058 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.21 103.78 9.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.062 0.458 . . . . 0.0 110.432 178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.67 138.3 42.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.224 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.52 133.46 38.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.765 0.317 . . . . 0.0 110.181 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.432 ' HB ' ' O ' ' A' ' 35' ' ' VAL . 12.3 mm -106.4 137.55 36.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.517 0.675 . . . . 0.0 112.466 -173.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.17 151.61 23.07 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.76 ' HD3' HG12 ' A' ' 36' ' ' ILE . 31.2 Cg_endo -64.68 58.46 0.27 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.136 2.557 . . . . 0.0 113.312 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -139.89 -26.39 0.79 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.126 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.64 -52.0 57.57 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.73 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.0 m -143.95 135.82 26.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.941 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.89 30.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.414 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.29 -73.53 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.02 177.783 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.501 ' C ' ' H ' ' A' ' 15' ' ' TYR . 9.9 t0 -83.79 -161.97 0.59 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 168.412 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.494 ' HB3' ' HG3' ' A' ' 48' ' ' LYS . 29.0 t0 -77.21 40.61 0.27 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.691 0.758 . . . . 0.0 109.541 172.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.563 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 8.1 m-30 -90.5 84.69 5.99 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.8 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 150.38 72.37 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.2 128.46 22.81 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.328 2.019 . . . . 0.0 111.846 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.871 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 9.4 m-85 -132.12 149.97 52.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.408 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.451 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -109.85 81.04 1.38 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.753 176.688 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.548 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 2.7 m -78.91 102.97 8.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.454 0.645 . . . . 0.0 110.937 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.441 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 4.9 tp-100 -76.15 108.39 9.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.908 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 m -168.12 147.73 4.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.442 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -105.36 -44.06 4.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.989 0.423 . . . . 0.0 110.398 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.25 -78.13 0.21 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.336 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.82 73.95 0.18 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.551 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -95.45 -36.45 11.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.919 0.39 . . . . 0.0 110.224 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.53 -147.88 0.16 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.96 162.01 27.1 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.824 HD13 ' HB ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -79.57 114.74 18.73 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.147 -177.009 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.5 85.65 1.15 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.529 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.871 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.93 143.74 28.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.326 0.584 . . . . 0.0 111.627 -177.206 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -123.68 158.84 29.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 168.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.8 t -64.06 133.29 29.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -55.63 119.83 15.76 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 175.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.572 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -78.72 108.53 12.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.24 0.543 . . . . 0.0 110.817 -174.83 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.76 HG12 ' HD3' ' A' ' 7' ' ' PRO . 3.1 mp -64.97 116.34 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.777 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.75 1.05 74.3 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.766 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.572 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -120.29 -173.91 2.67 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 12.8 mt-30 -114.86 143.63 44.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.01 0.433 . . . . 0.0 111.376 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.7 152.54 40.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.757 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.37 -1.24 33.14 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.863 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.441 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -148.34 -161.92 1.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.563 -0.318 . . . . 0.0 110.576 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.14 128.76 37.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.168 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.22 122.48 34.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.314 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.471 ' HG3' ' HB2' ' A' ' 20' ' ' CYS . 1.3 mmpm? -121.59 166.92 13.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.28 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.563 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 13.8 m -131.03 96.8 4.14 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.463 ' HB3' ' HB2' ' A' ' 66' ' ' CYS . 0.8 OUTLIER -123.56 165.09 17.73 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 -174.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.494 ' HG3' ' HB3' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -81.37 -151.09 0.08 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.63 -66.23 0.59 Allowed 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.642 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.5 t70 68.25 -51.87 0.54 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.313 0.856 . . . . 0.0 113.313 173.008 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.8 m -46.25 126.11 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -171.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.05 42.68 1.04 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.153 170.95 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -145.99 154.24 41.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.987 -175.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.24 -7.9 55.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.475 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.58 28.35 7.55 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.561 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -81.42 -67.1 0.81 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.047 0.451 . . . . 0.0 110.545 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.12 49.94 1.84 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.645 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.07 -156.31 47.13 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.415 HD13 ' HE1' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -111.55 90.7 3.41 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.148 0.499 . . . . 0.0 109.882 178.146 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mt -78.93 93.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.741 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.824 ' HB ' HD13 ' A' ' 29' ' ' LEU . 7.1 mm -79.03 139.65 18.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.579 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -81.04 -0.38 39.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.332 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 64.8 28.68 12.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.013 -178.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.4 -56.01 2.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.087 0.47 . . . . 0.0 110.899 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.91 54.18 2.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.178 0.513 . . . . 0.0 110.67 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.463 ' HB2' ' HB3' ' A' ' 47' ' ' CYS . 16.0 t -150.7 164.16 36.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.435 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.4 m -118.41 151.47 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.815 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.33 178.249 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.414 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.03 121.22 37.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.001 0.429 . . . . 0.0 111.062 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.63 151.63 44.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.263 176.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.0 136.64 37.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.921 0.391 . . . . 0.0 111.608 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.856 HG22 ' HA3' ' A' ' 34' ' ' GLY . 45.1 mt -103.53 126.4 57.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.793 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.88 156.43 27.78 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.771 ' HD3' HG12 ' A' ' 36' ' ' ILE . 25.4 Cg_endo -62.14 -5.58 6.68 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.811 2.341 . . . . 0.0 112.619 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.91 7.39 23.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.549 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.2 m -61.42 -48.0 83.18 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 170.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.469 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 3.6 m -96.15 163.47 13.09 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.52 33.59 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.897 0.855 . . . . 0.0 108.759 -169.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.03 -109.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.469 -172.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.02 80.58 2.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.4 t70 49.76 42.67 24.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.459 0.647 . . . . 0.0 111.323 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.469 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 11.4 m-85 -108.03 134.49 50.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.075 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.82 160.66 48.08 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.711 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 58.7 Cg_endo -68.69 115.54 3.98 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.497 2.131 . . . . 0.0 111.878 178.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.696 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 30.1 m-85 -123.61 126.92 47.5 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.14 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.76 88.59 7.71 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.731 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.491 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 65.8 m -75.08 103.27 5.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.073 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -88.47 166.93 13.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.871 -177.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.13 172.58 11.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.259 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.653 ' HG2' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -85.15 70.92 10.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.201 -176.94 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -76.07 0.19 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.726 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.1 -12.15 37.42 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.143 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -122.43 129.29 51.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.653 ' HA ' ' HG2' ' A' ' 23' ' ' MET . . . -90.06 45.62 1.29 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.259 0.552 . . . . 0.0 110.94 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.657 ' HB2' HG22 ' A' ' 60' ' ' ILE . 0.0 OUTLIER -140.57 174.3 10.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.757 -179.33 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.84 89.95 4.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.88 71.72 2.14 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.347 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.696 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 35.9 m -85.39 93.17 8.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.914 0.387 . . . . 0.0 110.265 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.21 145.78 7.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 t -58.56 131.31 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.856 ' HA3' HG22 ' A' ' 5' ' ' ILE . . . -64.83 144.54 48.32 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.634 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.46 103.68 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.771 HG12 ' HD3' ' A' ' 7' ' ' PRO . 2.7 mp -58.15 118.16 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.885 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.21 -8.17 41.32 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.796 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.25 -178.86 3.47 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.85 141.6 37.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.794 0.331 . . . . 0.0 110.694 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.55 124.05 32.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.625 175.984 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.414 ' HA2' ' O ' ' A' ' 1' ' ' SER . . . -89.56 -17.16 55.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.275 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.57 -170.0 1.7 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.549 0.214 . . . . 0.0 110.479 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.53 109.47 2.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.862 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -79.77 103.31 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.243 179.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.548 ' HB3' ' SG ' ' A' ' 66' ' ' CYS . 1.9 mmpt? -113.18 149.6 33.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.668 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.456 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 21.9 m -90.92 93.79 9.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.931 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.451 ' HB3' ' HB2' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -124.19 -175.48 3.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.413 -177.794 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.76 141.0 18.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -91.13 100.23 13.11 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.272 0.558 . . . . 0.0 109.532 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.39 24.51 12.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.144 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -123.66 -38.98 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.152 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.16 -66.57 0.92 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.211 -0.196 . . . . 0.0 110.812 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 74.47 -20.5 0.32 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.428 0.691 . . . . 0.0 112.632 174.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -14.14 60.8 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.06 63.42 1.45 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.26 138.82 31.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.663 0.268 . . . . 0.0 110.994 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.64 122.09 25.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.975 0.417 . . . . 0.0 110.113 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.79 75.19 1.17 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -172.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -89.3 137.72 32.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.155 0.503 . . . . 0.0 111.106 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.657 HG22 ' HB2' ' A' ' 28' ' ' SER . 2.1 mp -116.01 115.58 49.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.068 179.039 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.505 HD12 ' HB2' ' A' ' 31' ' ' CYS . 1.3 mp -104.55 118.5 51.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 175.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -78.44 62.18 3.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.707 -173.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 67.46 -69.74 0.13 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.965 0.906 . . . . 0.0 113.314 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.34 54.89 0.94 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -171.113 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.24 28.56 0.25 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 174.689 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.548 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 45.5 t -160.42 147.98 16.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.003 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.02 104.5 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.166 0.507 . . . . 0.0 110.087 175.713 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.476 -0.774 . . . . 0.0 110.263 -178.035 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 120.724 0.297 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.415 ' HA ' ' O ' ' A' ' 40' ' ' CYS . . . -84.81 124.36 31.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.099 0.476 . . . . 0.0 110.997 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.97 142.68 48.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.947 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.482 ' HA ' ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -77.54 125.2 28.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.999 0.428 . . . . 0.0 110.524 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.613 HG23 ' HA3' ' A' ' 34' ' ' GLY . 32.2 mt -89.76 127.2 42.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.072 -174.08 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.31 128.51 6.4 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 170.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.435 ' CG ' HG12 ' A' ' 36' ' ' ILE . 84.7 Cg_exo -43.45 -37.88 8.06 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.89 3.06 . . . . 0.0 114.476 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -86.58 33.57 0.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -45.56 42.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -132.32 141.54 48.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.102 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.3 17.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.417 0.627 . . . . 0.0 109.513 -175.379 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.43 -84.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.968 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -100.32 53.78 0.89 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.32 -173.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.42 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 23.4 t70 62.82 21.66 12.94 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.679 0.752 . . . . 0.0 110.229 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.661 ' HE2' HG23 ' A' ' 67' ' ' VAL . 3.9 m-85 -80.6 130.19 34.97 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.493 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.557 ' HE3' ' HB2' ' A' ' 49' ' ' ASP . 0.8 OUTLIER -126.82 157.63 70.91 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -177.802 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.15 115.02 3.8 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.589 2.193 . . . . 0.0 111.57 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.633 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 27.0 m-85 -120.3 133.4 55.47 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.993 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.617 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -81.88 84.83 6.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.717 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 m -78.55 79.7 4.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.296 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -77.52 130.68 37.28 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.496 ' HB3' HD21 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -146.09 179.68 7.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.551 0.691 . . . . 0.0 112.377 -170.9 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.7 174.69 10.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.373 174.479 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.45 -72.88 0.06 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.49 64.88 3.15 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.66 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.0 m -155.53 100.65 2.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.753 0.311 . . . . 0.0 110.634 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.47 -25.72 41.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.128 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.13 103.09 2.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.613 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.704 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 4.2 mt -87.22 146.63 25.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.504 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.93 48.13 0.99 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.867 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.704 ' SG ' ' HB3' ' A' ' 29' ' ' LEU . 2.0 m -79.03 106.85 11.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.124 0.488 . . . . 0.0 111.328 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.4 m -86.07 164.27 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.637 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.82 135.47 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 123.167 0.292 . . . . 0.0 110.484 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.613 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -64.59 116.51 9.1 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.209 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.02 135.02 26.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.78 0.324 . . . . 0.0 110.623 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.435 HG12 ' CG ' ' A' ' 7' ' ' PRO . 1.4 mt -64.93 110.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.51 -9.7 49.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.113 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.6 m -90.8 171.19 9.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.882 0.372 . . . . 0.0 110.48 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.482 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 1.6 mp0 -124.3 140.25 53.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.837 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.415 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -75.82 146.72 39.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.205 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.25 -51.78 3.43 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.385 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.41 -90.18 0.15 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.746 0.308 . . . . 0.0 110.642 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.17 138.37 29.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.648 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.2 t -80.89 125.94 39.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.013 175.822 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -117.85 157.69 26.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 66' ' ' CYS . 32.9 m -102.55 99.95 10.01 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 4.0 m -116.07 147.28 41.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.993 0.425 . . . . 0.0 111.461 -175.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -98.74 136.39 38.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.776 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.557 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 48.7 t0 -85.85 86.23 7.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.295 0.569 . . . . 0.0 110.628 -177.033 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.25 -75.06 0.18 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.966 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.31 32.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.785 0.802 . . . . 0.0 109.339 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.714 HG22 ' HA ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -94.09 -13.27 27.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.921 -172.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -60.59 -28.35 68.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.395 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.18 79.23 2.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.734 0.302 . . . . 0.0 111.365 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.402 ' HA3' ' O ' ' A' ' 58' ' ' GLY . . . -147.3 12.72 1.4 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.458 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.7 m120 69.3 -85.32 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.151 0.58 . . . . 0.0 111.415 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.45 19.43 13.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.988 0.423 . . . . 0.0 110.989 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.402 ' O ' ' HA3' ' A' ' 55' ' ' GLY . . . -159.0 165.79 34.32 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 178.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.483 HD21 ' HH ' ' A' ' 18' ' ' TYR . 1.3 mp -119.94 113.35 20.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.865 0.365 . . . . 0.0 110.203 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.08 87.71 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.995 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.714 ' HA ' HG22 ' A' ' 52' ' ' THR . 37.9 mm -63.85 127.54 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.599 -178.251 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.77 44.69 1.18 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.812 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 67.4 -68.08 0.16 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.536 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.18 54.43 2.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 0.0 112.028 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.515 ' HB2' HG22 ' A' ' 61' ' ' ILE . 35.7 m120 -126.48 -14.9 5.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.688 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.49 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 4.6 m -109.77 88.79 2.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.575 -174.569 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.661 HG23 ' HE2' ' A' ' 15' ' ' TYR . 2.6 t 51.24 -103.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.94 177.036 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.441 ' H ' ' HB ' ' A' ' 67' ' ' VAL . . . . . . . . 0 C--O 1.247 0.952 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -177.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 120.801 0.334 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.87 157.71 19.48 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.502 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.429 ' HB ' HG22 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -89.88 118.91 29.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.619 179.974 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.68 119.84 22.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.049 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.584 HD13 ' HB2' ' A' ' 40' ' ' CYS . 85.4 mt -87.07 127.92 40.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -172.529 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -117.37 136.96 12.96 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 166.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.591 ' HG3' HG12 ' A' ' 36' ' ' ILE . 74.5 Cg_endo -72.96 44.73 0.82 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.031 2.488 . . . . 0.0 113.94 -172.833 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -157.18 26.01 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.739 0.304 . . . . 0.0 111.22 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -58.1 3.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.415 0.626 . . . . 0.0 109.629 174.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.54 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -92.64 136.16 33.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.285 174.588 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.89 26.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.027 0.441 . . . . 0.0 110.371 -175.201 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -66.48 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.45 ' C ' ' H ' ' A' ' 15' ' ' TYR . 3.2 t70 -100.6 -149.07 0.37 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.348 169.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -81.84 40.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.686 0.755 . . . . 0.0 109.394 171.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.54 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 1.9 m-85 -82.96 111.7 19.07 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.606 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.4 143.16 26.07 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.0 125.1 16.27 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.481 2.12 . . . . 0.0 111.163 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.678 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 9.7 m-85 -134.84 123.9 24.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.028 0.442 . . . . 0.0 110.8 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.8 t -87.09 93.15 9.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.026 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.66 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 26.1 m -74.57 100.44 3.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.263 0.554 . . . . 0.0 109.793 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.31 -25.8 4.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.892 -173.612 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.757 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 0.8 OUTLIER -78.34 71.32 4.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.41 0.624 . . . . 0.0 111.054 -177.91 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.417 ' HB2' ' HE3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -133.66 26.27 4.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.727 177.393 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.81 -45.57 11.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.813 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -117.19 8.82 15.73 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.575 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.411 ' O ' ' HA ' ' A' ' 23' ' ' MET . 0.9 OUTLIER -144.59 150.56 37.66 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -99.44 8.53 44.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.246 0.546 . . . . 0.0 110.057 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.75 159.7 23.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.639 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.641 ' HG ' ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -79.84 78.41 6.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.003 0.43 . . . . 0.0 110.918 -178.434 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.757 ' HA3' ' HB2' ' A' ' 22' ' ' SER . . . -80.95 86.05 1.37 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.615 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.678 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 4.0 m -109.13 115.39 29.94 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.771 0.319 . . . . 0.0 110.955 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.9 154.78 4.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.429 HG21 HD11 ' A' ' 59' ' ' LEU . 2.1 t -55.98 139.33 15.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.464 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.415 ' CA ' HG21 ' A' ' 5' ' ' ILE . . . -65.26 88.34 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.849 174.731 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.444 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 61.1 t -79.45 137.04 22.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.914 0.388 . . . . 0.0 110.215 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.591 HG12 ' HG3' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -63.41 110.04 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.552 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.38 -4.61 33.19 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.585 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.444 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 43.1 m -78.08 127.58 32.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.991 0.424 . . . . 0.0 110.711 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -93.94 94.25 8.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.288 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.584 ' HB2' HD13 ' A' ' 5' ' ' ILE . 12.4 t -74.9 118.74 18.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.287 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.9 -2.82 59.41 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.195 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.472 ' HB1' ' H ' ' A' ' 43' ' ' SER . . . -115.3 -132.83 0.33 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.669 0.271 . . . . 0.0 111.018 -177.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.538 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 70.5 m -86.93 99.42 11.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.013 0.435 . . . . 0.0 111.352 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.429 HG22 ' HB ' ' A' ' 3' ' ' THR . 0.6 OUTLIER -79.67 81.64 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.122 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.535 ' HE3' HD12 ' A' ' 29' ' ' LEU . 3.7 mttm -91.35 175.72 6.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.794 -172.086 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 89.2 m -127.71 106.05 8.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.597 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 91.2 m -120.84 149.38 42.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.809 0.337 . . . . 0.0 111.088 -174.346 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.24 97.67 11.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.253 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -103.89 103.15 12.97 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.83 -61.2 2.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.048 0.452 . . . . 0.0 111.151 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 m -84.6 172.74 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.76 -179.033 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.56 155.6 20.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.299 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 70.24 23.38 5.15 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.703 0.627 . . . . 0.0 111.349 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.9 76.1 2.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.111 0.481 . . . . 0.0 111.017 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.485 ' HA3' ' HA ' ' A' ' 59' ' ' LEU . . . 123.91 -12.49 8.17 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -176.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.426 ' HB3' ' H ' ' A' ' 57' ' ' SER . 0.6 OUTLIER 61.71 -105.01 0.17 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.754 0.422 . . . . 0.0 111.224 178.442 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.426 ' H ' ' HB3' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -89.47 -12.14 40.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 0.0 111.315 -179.387 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -134.94 83.72 0.28 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.485 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . 3.4 mp -80.88 91.96 6.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.106 0.479 . . . . 0.0 111.053 -174.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.9 mt -79.63 102.57 5.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.38 146.83 5.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.292 -171.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 4.7 t30 -69.21 121.34 16.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.71 175.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.641 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . . . -78.94 35.32 0.25 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 111.894 -173.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.14 13.55 6.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.906 0.384 . . . . 0.0 110.561 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -138.71 38.29 2.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.239 0.542 . . . . 0.0 110.79 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 11.1 m -130.11 153.94 47.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.767 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.442 ' H ' HG23 ' A' ' 67' ' ' VAL . 0.1 OUTLIER -72.07 -62.96 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.0 110.529 179.238 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.883 -0.58 . . . . 0.0 109.652 179.683 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.77 0.319 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.95 144.71 33.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.337 . . . . 0.0 110.632 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.514 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -146.31 127.8 15.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.234 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.49 123.68 26.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.152 0.501 . . . . 0.0 110.189 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.486 HG21 ' HA3' ' A' ' 34' ' ' GLY . 8.6 mt -89.58 127.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.57 -172.1 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.4 137.48 14.21 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 168.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.77 -4.99 5.23 Favored 'Trans proline' 0 N--CA 1.478 0.581 0 C-N-CA 123.364 2.71 . . . . 0.0 114.114 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -119.74 34.32 5.27 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.36 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -33.86 76.22 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.572 0.701 . . . . 0.0 110.295 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.626 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 89.3 m -135.21 146.18 48.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.906 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.69 17.6 0.8 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.952 0.406 . . . . 0.0 110.652 -169.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.405 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.5 OUTLIER -78.53 -71.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.945 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.44 ' C ' ' H ' ' A' ' 15' ' ' TYR . 3.8 t0 -93.67 -159.73 0.71 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.578 171.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . 0.542 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 21.2 t70 -80.43 41.57 0.55 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.634 0.73 . . . . 0.0 109.295 172.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.755 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 10.4 m-85 -85.57 71.74 10.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.783 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.433 ' HB2' ' HD2' ' A' ' 17' ' ' PRO . 4.3 ptpt -79.58 156.01 75.79 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.831 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.433 ' HD2' ' HB2' ' A' ' 16' ' ' LYS . 29.7 Cg_endo -61.32 126.54 19.57 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.978 2.452 . . . . 0.0 112.777 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.908 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 21.6 m-85 -127.95 123.93 36.07 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.081 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.1 m -80.75 80.95 7.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.599 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 53.6 m -77.03 121.43 23.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.574 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.4 152.06 44.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.131 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.87 116.29 1.9 Allowed 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.873 0.733 . . . . 0.0 111.571 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.434 ' HG3' ' O ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -78.28 127.65 32.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.7 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.44 96.91 4.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.506 -177.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.83 -50.05 3.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.835 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.434 ' O ' ' HG3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -67.19 151.22 47.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.811 0.339 . . . . 0.0 110.665 177.547 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -92.38 -4.23 54.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.326 0.584 . . . . 0.0 110.127 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.424 ' HB2' HG21 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -108.36 135.86 48.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.024 178.6 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.575 ' HB2' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -103.09 148.27 25.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.401 -177.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.79 77.63 1.87 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.734 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.908 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 28.9 m -86.49 120.18 27.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.16 0.505 . . . . 0.0 112.112 -176.188 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.4 ' H ' HG21 ' A' ' 32' ' ' VAL . 0.1 OUTLIER -107.21 144.59 15.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 169.965 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 p -58.6 131.44 22.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.008 0.432 . . . . 0.0 111.058 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.486 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -67.56 117.08 8.46 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.699 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 11.2 t -78.92 131.22 34.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.904 0.383 . . . . 0.0 110.42 -177.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.94 120.63 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.653 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.99 -4.95 68.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.642 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 15.8 m -95.24 166.34 11.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.643 0.259 . . . . 0.0 110.703 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 3' ' ' THR . 18.9 mt-30 -114.9 124.9 52.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.566 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.466 ' HB2' HD12 ' A' ' 5' ' ' ILE . 1.7 t -81.17 135.64 35.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.204 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.76 2.94 23.09 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.829 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -120.24 -157.59 0.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.1 92.38 4.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.965 0.412 . . . . 0.0 110.628 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.44 ' HB ' ' SG ' ' A' ' 40' ' ' CYS . 1.6 p -78.6 109.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.519 0.676 . . . . 0.0 109.613 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -118.22 171.11 8.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.827 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.755 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 59.7 m -112.71 104.01 12.04 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 173.843 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.494 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.8 OUTLIER -122.99 157.32 32.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.42 -177.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.668 ' HD2' ' HE1' ' A' ' 15' ' ' TYR . 2.5 ptmt -97.71 155.69 16.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.868 0.366 . . . . 0.0 110.76 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.3 68.56 5.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.844 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.88 -19.37 61.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.9 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.4 67.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.154 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.33 53.77 0.86 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.929 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -122.07 102.46 8.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.878 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.06 142.73 56.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.946 -175.575 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.59 -159.34 9.7 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -105.75 15.51 26.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.296 0.569 . . . . 0.0 110.069 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.09 159.44 22.56 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.932 -176.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.91 164.44 53.02 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.771 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.634 HD22 ' HH ' ' A' ' 18' ' ' TYR . 0.1 OUTLIER -87.16 90.4 8.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.138 0.494 . . . . 0.0 110.484 -177.746 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.478 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -79.98 76.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.438 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.494 HD13 ' HB3' ' A' ' 47' ' ' CYS . 1.3 mt -84.59 152.12 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.559 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -72.34 139.55 47.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.592 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.99 -25.57 67.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.596 -178.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.27 -5.9 55.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.143 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.17 -12.64 26.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.988 0.423 . . . . 0.0 110.842 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.79 172.14 11.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.019 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.699 HG23 ' HB2' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -59.91 -50.62 79.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.344 . . . . 0.0 111.48 179.927 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.865 0 CA-C-O 119.109 -0.472 . . . . 0.0 109.788 -178.339 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.787 0 CA-C-O 120.95 0.405 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.76 67.19 1.98 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.251 0.548 . . . . 0.0 109.622 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.96 123.75 22.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.887 -176.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 m -79.82 134.33 36.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.308 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.58 HD13 ' HB2' ' A' ' 40' ' ' CYS . 37.8 mt -98.19 136.27 29.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.229 0.538 . . . . 0.0 112.43 -172.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.47 ' N ' HG21 ' A' ' 5' ' ' ILE . . . -136.3 128.84 4.66 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 168.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.468 ' HA ' ' HG3' ' A' ' 17' ' ' PRO . 38.5 Cg_exo -59.91 3.17 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.7 2.933 . . . . 0.0 114.58 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -85.59 -0.99 56.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.934 0.397 . . . . 0.0 110.827 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -56.61 13.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.204 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -135.59 149.48 49.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.137 179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.437 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -173.76 16.89 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.094 0.473 . . . . 0.0 110.395 -175.732 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.467 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -79.63 -90.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.67 -175.32 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' H ' ' HB ' ' A' ' 12' ' ' ILE . 0.2 OUTLIER -86.16 66.46 9.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.211 -178.746 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t0 57.27 27.14 13.22 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.221 0.534 . . . . 0.0 110.897 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.641 ' CE1' ' HG3' ' A' ' 48' ' ' LYS . 54.5 m-85 -88.79 148.69 23.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.45 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.631 ' HB2' ' HD2' ' A' ' 17' ' ' PRO . 14.0 pttm -160.07 163.23 22.76 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.631 ' HD2' ' HB2' ' A' ' 16' ' ' LYS . 20.1 Cg_endo -59.25 130.63 36.93 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.492 2.128 . . . . 0.0 112.201 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.883 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 12.4 m-85 -131.72 132.15 43.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.539 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.597 ' HB2' HG23 ' A' ' 32' ' ' VAL . 6.1 m -94.01 93.59 7.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.39 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.73 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 2.8 m -85.31 111.28 19.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.931 0.396 . . . . 0.0 110.333 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -84.93 73.68 10.63 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.837 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.0 109.93 6.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.028 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -33.94 45.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.232 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 p -164.13 -110.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.851 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.37 82.19 1.54 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.96 112.02 21.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.92 0.39 . . . . 0.0 111.14 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.95 -52.72 7.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.254 0.55 . . . . 0.0 109.713 177.023 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -85.26 96.87 9.64 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.73 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -83.08 138.03 33.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.549 -170.885 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.43 94.72 1.93 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.891 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.883 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -95.98 149.21 21.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.116 0.484 . . . . 0.0 111.673 -177.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.597 HG23 ' HB2' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -127.21 163.4 30.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 171.067 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.56 128.52 32.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . . . . . . . . . . . -63.82 110.74 3.6 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.049 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.51 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -79.58 129.01 38.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.888 0.375 . . . . 0.0 110.739 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.2 mp -57.6 127.13 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.255 -178.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.04 15.5 81.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.794 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.51 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -118.23 163.07 17.22 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -102.14 157.29 16.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.906 0.384 . . . . 0.0 110.919 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.58 ' HB2' HD13 ' A' ' 5' ' ' ILE . 4.8 t -122.98 125.3 44.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.187 175.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.01 7.55 69.87 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.776 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.07 -166.24 1.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.56 119.63 18.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.013 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 t -86.9 104.3 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.35 164.26 11.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.994 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.0 m -115.81 88.94 2.99 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.464 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 57.9 m -112.52 163.45 14.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 -173.637 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.641 ' HG3' ' CE1' ' A' ' 15' ' ' TYR . 18.5 mtpt -82.06 171.19 14.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.967 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.66 48.92 1.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.344 -0.843 . . . . 0.0 108.996 169.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.86 121.48 18.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.045 -175.698 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.758 ' HB ' HG21 ' A' ' 54' ' ' THR . 0.0 OUTLIER -145.68 117.42 2.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.413 -175.107 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.43 -3.97 15.03 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.043 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -122.08 17.3 10.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.836 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.758 HG21 ' HB ' ' A' ' 51' ' ' VAL . 6.4 t -104.34 165.57 10.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.471 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.6 51.87 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.694 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.407 HD22 ' CG1' ' A' ' 60' ' ' ILE . 10.1 p30 -167.27 -157.83 0.26 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.509 0.195 . . . . 0.0 110.858 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -17.73 56.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -172.582 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.71 163.12 12.51 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.606 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.16 94.25 9.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.074 0.464 . . . . 0.0 110.076 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.407 ' CG1' HD22 ' A' ' 56' ' ' ASN . 35.7 mm -80.07 101.09 4.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.307 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.483 HG23 ' SG ' ' A' ' 66' ' ' CYS . 14.1 mt -105.02 134.7 45.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.027 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -88.74 36.06 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.651 -175.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 70.04 -42.78 0.52 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.85 -26.55 68.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.91 22.64 1.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.846 0.355 . . . . 0.0 110.773 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.483 ' SG ' HG23 ' A' ' 61' ' ' ILE . 3.2 m -133.14 143.15 49.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.89 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.75 -23.94 6.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.167 0.508 . . . . 0.0 110.341 176.06 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.16 178.459 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.202 0.525 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -92.62 100.66 13.14 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.306 -176.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 m -79.35 113.56 17.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.6 113.22 16.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.851 0.358 . . . . 0.0 110.04 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.42 ' HB ' ' O ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -89.16 131.1 37.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.471 0.653 . . . . 0.0 112.239 -173.449 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.0 156.79 20.88 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 166.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.16 -26.17 18.98 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.859 2.372 . . . . 0.0 113.241 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -89.53 33.82 0.83 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.962 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.43 -69.12 0.63 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.363 0.601 . . . . 0.0 109.95 175.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 m -92.68 137.03 32.72 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.05 38.9 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.419 0.628 . . . . 0.0 109.917 -168.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -116.53 -87.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.094 -177.194 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.652 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 21.7 t0 -100.14 63.68 1.17 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.764 -176.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 56.47 28.11 13.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.334 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.705 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 20.6 m-85 -90.78 134.51 34.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.12 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.98 153.33 47.08 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.192 -178.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . 0.63 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 20.6 Cg_endo -61.97 120.32 7.86 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.629 2.22 . . . . 0.0 112.324 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.799 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 37.5 m-85 -133.29 125.27 28.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.881 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.0 95.76 6.79 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.619 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 37.1 m -82.44 121.79 27.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.23 -175.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -76.48 174.26 10.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.415 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.7 m 60.93 -108.46 0.34 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 123.475 0.484 . . . . 0.0 110.598 -177.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.12 161.28 41.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 -177.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . 0.528 ' HA ' HD22 ' A' ' 29' ' ' LEU . 3.7 m -80.83 -18.01 48.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.943 0.402 . . . . 0.0 110.09 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.13 67.42 3.71 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.4 m -153.9 178.98 9.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.436 ' O ' ' HA ' ' A' ' 62' ' ' ASN . . . -84.01 -62.98 1.43 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.941 0.4 . . . . 0.0 110.328 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.23 120.78 43.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.03 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.528 HD22 ' HA ' ' A' ' 24' ' ' SER . 0.0 OUTLIER -106.71 137.53 44.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.841 0.353 . . . . 0.0 110.377 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.68 75.25 2.34 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.943 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.799 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 19.2 m -84.93 102.11 12.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.187 0.517 . . . . 0.0 110.831 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.545 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 16.1 m -78.89 150.59 5.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 t -61.96 135.84 26.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.378 0.424 . . . . 0.0 110.475 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.63 ' HA3' ' HB2' ' A' ' 17' ' ' PRO . . . -64.99 89.68 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.759 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 49.7 t -79.43 141.36 15.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.687 0.28 . . . . 0.0 110.287 -178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.35 101.98 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.442 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.02 -13.63 8.48 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.209 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.42 ' O ' ' HB ' ' A' ' 5' ' ' ILE . 53.6 m -72.83 129.11 37.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.008 0.433 . . . . 0.0 110.815 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -95.3 106.85 18.93 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.414 ' HB3' HG23 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -75.17 106.25 6.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.28 -176.167 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.87 -4.65 29.64 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.927 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.09 -82.79 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.346 . . . . 0.0 110.231 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.586 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 38.7 m -155.41 120.12 4.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.193 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.414 HG23 ' HB3' ' A' ' 40' ' ' CYS . 2.8 t -82.05 101.62 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.586 ' HE3' ' HB3' ' A' ' 43' ' ' SER . 1.2 mmpt? -114.24 136.16 53.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.708 ' HB2' HG21 ' A' ' 67' ' ' VAL . 74.5 m -101.01 96.33 7.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.514 174.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.3 m -111.76 163.69 13.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.382 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.441 ' HE2' ' O ' ' A' ' 13' ' ' ASP . 28.7 ttmt -110.18 -37.7 5.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.405 -176.616 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.478 ' CG ' ' H ' ' A' ' 50' ' ' ASP . 4.6 p-10 41.61 -100.75 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.898 0.879 . . . . 0.0 111.959 -172.166 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.478 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 16.1 t70 -169.15 -36.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.638 0.256 . . . . 0.0 111.131 -177.067 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.428 HG22 HD23 ' A' ' 59' ' ' LEU . 12.5 t -67.01 122.27 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.745 0.307 . . . . 0.0 110.825 -175.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -25.21 32.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.916 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -72.65 117.68 14.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.172 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.95 8.26 30.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.503 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.72 9.71 76.89 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.292 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -70.66 154.67 41.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.76 0.314 . . . . 0.0 110.675 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.62 -41.97 25.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.977 0.417 . . . . 0.0 110.53 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.545 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -170.03 133.98 3.0 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.428 HD23 HG22 ' A' ' 51' ' ' VAL . 0.1 OUTLIER -109.53 115.23 29.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.187 0.517 . . . . 0.0 111.057 -176.481 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.11 74.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.973 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mt -80.24 147.21 6.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.265 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.436 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 3.9 p-10 -85.92 151.97 23.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.02 94.03 0.31 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.77 0.319 . . . . 0.0 110.959 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -151.17 -78.94 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.249 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -85.03 54.21 3.02 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.157 0.504 . . . . 0.0 111.016 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 78.5 m -125.95 139.59 53.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.437 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.708 HG21 ' HB2' ' A' ' 46' ' ' CYS . 0.1 OUTLIER -57.69 -53.05 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -175.113 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.891 -176.318 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 120.888 0.375 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -113.67 139.21 49.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.134 -179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.35 141.32 46.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.99 -176.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.2 124.14 27.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 0.0 110.043 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.865 HG21 ' HA3' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -92.55 151.02 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.536 0.684 . . . . 0.0 112.343 -171.438 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 8' ' ' ASN . . . 159.1 176.26 30.95 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.256 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.915 ' HD3' HG12 ' A' ' 36' ' ' ILE . 24.1 Cg_exo -64.85 43.8 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.103 2.535 . . . . 0.0 112.785 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.452 ' H ' ' C ' ' A' ' 6' ' ' GLY . 48.3 t30 -131.22 -42.78 1.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.213 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -41.37 97.85 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.773 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -152.38 124.98 8.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.572 174.572 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -173.62 36.17 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -174.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.88 -82.39 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.822 -172.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -89.07 61.02 5.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.328 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.1 t0 51.51 54.04 11.74 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.543 0.687 . . . . 0.0 110.45 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -121.74 126.85 49.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.33 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.24 146.02 31.77 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.01 125.64 10.55 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.287 1.992 . . . . 0.0 111.454 177.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.633 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 10.1 m-85 -126.07 131.1 52.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.036 0.445 . . . . 0.0 111.409 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.9 m -103.16 101.63 11.6 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.87 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.632 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 2.0 m -82.03 120.6 25.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.222 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.05 -49.6 3.01 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.494 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.87 -144.91 0.63 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.422 172.596 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -128.98 -155.37 0.69 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.81 -178.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -67.68 -61.6 1.81 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.645 0.26 . . . . 0.0 110.974 178.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.22 96.09 0.87 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.829 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.21 114.44 11.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.995 0.426 . . . . 0.0 111.647 -176.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.23 -47.86 9.06 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 171.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.04 93.48 5.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 167.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.632 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -79.37 157.45 27.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.785 -169.668 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.41 89.41 0.78 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.577 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.633 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 1.1 m -89.68 129.37 36.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.39 . . . . 0.0 111.108 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.1 m -104.32 156.76 5.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.08 128.1 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.865 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -64.35 129.16 36.92 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.181 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.486 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -79.31 123.49 36.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.002 0.429 . . . . 0.0 110.412 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.915 HG12 ' HD3' ' A' ' 7' ' ' PRO . 6.2 mt -68.52 112.32 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.772 -176.191 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.99 -16.11 30.64 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.751 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.486 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 14.1 m -90.24 176.91 6.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -135.74 98.3 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.787 0.327 . . . . 0.0 110.599 -175.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.686 ' HB2' HD12 ' A' ' 5' ' ' ILE . 65.6 m -79.8 127.5 32.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.299 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.32 6.81 32.19 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.618 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.47 ' HB2' ' H ' ' A' ' 43' ' ' SER . . . -92.47 -141.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.699 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.584 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 1.3 m -82.89 80.49 8.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 110.097 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -79.8 109.06 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.448 ' HB3' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -122.6 178.09 5.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.596 0.712 . . . . 0.0 111.547 -173.284 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 92.0 m -129.93 111.85 12.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.659 176.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.504 ' SG ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -121.92 146.62 46.94 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.934 0.397 . . . . 0.0 111.589 -171.511 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.41 ' C ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -78.77 115.66 18.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.803 175.979 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.16 116.63 7.04 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.266 173.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.15 42.24 2.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.545 173.34 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.5 t -83.11 129.43 37.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.215 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.05 34.82 2.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.009 0.433 . . . . 0.0 111.421 -177.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -149.91 132.34 15.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.873 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.53 146.58 52.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.893 0.378 . . . . 0.0 111.093 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.73 49.23 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.82 161.58 35.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.67 -0.265 . . . . 0.0 110.324 -175.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -21.12 48.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.538 0.685 . . . . 0.0 109.693 175.801 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.09 160.34 33.2 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.17 123.67 41.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 117.142 0.471 . . . . 0.0 110.132 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.32 95.18 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.321 0.582 . . . . 0.0 109.992 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.592 HD11 ' HB2' ' A' ' 31' ' ' CYS . 0.2 OUTLIER -94.12 131.72 40.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.914 -177.755 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -86.16 15.57 5.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -173.311 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 72.93 -44.94 0.61 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.638 0.775 . . . . 0.0 112.496 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.39 18.37 0.31 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -128.04 16.89 6.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.593 0.711 . . . . 0.0 109.256 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.427 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER -114.15 140.32 48.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.155 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.86 -25.08 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.232 0.539 . . . . 0.0 110.536 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.448 ' O ' ' HB3' ' A' ' 45' ' ' LYS . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 117.839 -1.077 . . . . 0.0 109.976 -178.047 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 121.142 0.496 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.98 84.64 1.89 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.981 -179.413 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.402 ' HG1' HG22 ' A' ' 44' ' ' VAL . 0.2 OUTLIER -66.45 132.16 47.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.464 -178.838 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 m -78.97 109.18 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.778 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.546 HG22 ' HA3' ' A' ' 34' ' ' GLY . 13.0 mt -80.14 130.82 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.801 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.69 151.4 22.36 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 170.744 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.623 ' HD3' HG12 ' A' ' 36' ' ' ILE . 34.9 Cg_endo -64.91 -3.65 7.37 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 122.821 2.347 . . . . 0.0 113.323 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -82.62 -6.07 59.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.273 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.89 -79.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.239 0.542 . . . . 0.0 110.743 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 128.77 54.76 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.12 46.73 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.272 0.558 . . . . 0.0 110.213 -174.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -126.91 -87.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.035 -176.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.554 ' HB3' ' CD2' ' A' ' 15' ' ' TYR . 27.8 t70 -81.22 54.08 2.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.438 0.637 . . . . 0.0 110.298 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.04 25.75 4.32 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.538 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.554 ' CD2' ' HB3' ' A' ' 13' ' ' ASP . 26.8 m-85 -78.52 124.33 28.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.301 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.698 ' HZ3' ' HB3' ' A' ' 49' ' ' ASP . 35.3 mttp -119.51 145.58 39.25 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.32 115.55 3.39 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.329 2.019 . . . . 0.0 111.397 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.577 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 31.5 m-85 -126.11 135.28 51.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -176.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.87 86.35 2.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.516 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.728 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 1.1 m -67.62 116.72 8.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.185 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -92.19 112.19 24.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.327 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.5 128.32 52.4 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.844 177.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.26 -55.05 5.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.883 0.373 . . . . 0.0 110.455 -175.627 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.96 -87.6 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.775 178.4 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.4 57.96 2.7 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.7 m -93.24 116.64 29.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.842 0.353 . . . . 0.0 111.254 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.53 -54.66 4.43 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.58 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -81.55 124.45 29.51 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.111 172.349 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.728 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -104.5 138.08 41.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.522 -172.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . 0.405 ' HA2' ' HA ' ' A' ' 60' ' ' ILE . . . -89.01 100.68 2.68 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 177.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.9 OUTLIER -94.8 101.94 13.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.897 0.379 . . . . 0.0 111.187 -177.081 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.429 ' H ' HG23 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -83.27 151.43 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.646 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.6 t -63.48 133.71 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.546 ' HA3' HG22 ' A' ' 5' ' ' ILE . . . -62.56 116.91 10.02 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.096 177.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.404 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -79.59 125.28 38.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.755 0.312 . . . . 0.0 110.527 -178.553 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.623 HG12 ' HD3' ' A' ' 7' ' ' PRO . 0.8 OUTLIER -65.98 114.25 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.712 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.16 15.04 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.752 -177.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.404 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 5.7 m -134.11 176.88 8.19 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.157 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -113.57 135.43 53.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.958 0.409 . . . . 0.0 111.663 -174.543 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.14 99.04 12.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.684 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.68 13.19 58.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.8 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.406 ' HB2' ' H ' ' A' ' 43' ' ' SER . . . -114.7 -107.5 0.38 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.31 . . . . 0.0 110.342 179.554 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.406 ' H ' ' HB2' ' A' ' 42' ' ' ALA . 0.9 OUTLIER -123.59 118.95 28.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.815 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.402 HG22 ' HG1' ' A' ' 3' ' ' THR . 21.9 t -79.06 101.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.718 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -118.42 112.56 20.14 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.542 -176.363 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 33.3 m -81.77 93.59 6.86 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.718 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 38.7 m -108.83 144.69 36.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.748 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.2 123.78 29.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.698 ' HB3' ' HZ3' ' A' ' 16' ' ' LYS . 6.9 t0 -77.03 86.98 3.54 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.521 -174.568 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.83 5.51 16.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.851 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 p -111.31 27.76 2.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-O 122.111 0.958 . . . . 0.0 110.152 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.13 42.77 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.935 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -102.25 -19.64 14.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.49 119.36 20.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.384 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.39 54.12 4.93 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.746 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -169.59 171.15 7.72 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.58 8.66 9.14 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -175.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.77 71.37 2.61 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.548 HD23 ' HH ' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -77.99 80.77 4.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.378 0.609 . . . . 0.0 111.642 -174.688 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.58 HD12 ' HB2' ' A' ' 28' ' ' SER . 0.9 OUTLIER -82.54 117.24 28.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.297 174.484 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.482 HD12 ' HB2' ' A' ' 31' ' ' CYS . 37.6 mt -101.19 148.38 7.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.977 -173.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -79.83 19.35 0.69 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.642 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.478 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . 71.01 -43.0 0.55 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.637 0.775 . . . . 0.0 112.901 176.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.46 -38.17 71.31 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . 0.453 HD21 ' HA ' ' A' ' 65' ' ' ASN . 1.3 m120 -84.31 20.79 1.55 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.827 0.346 . . . . 0.0 111.447 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.2 m -120.25 165.34 14.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.434 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -92.78 175.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.444 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.662 -0.685 . . . . 0.0 110.731 178.759 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' SER . . . . . 0.448 ' HB2' ' H ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 . . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.448 ' H ' ' HB2' ' A' ' 1' ' ' SER . . . -81.01 93.34 6.35 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.122 0.487 . . . . 0.0 110.772 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.61 136.73 36.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.04 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.82 137.94 37.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.551 HG21 ' HA3' ' A' ' 34' ' ' GLY . 47.9 mt -114.47 121.58 66.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.211 0.529 . . . . 0.0 112.001 -174.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.64 149.39 18.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 167.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.0 -28.19 39.04 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.318 2.679 . . . . 0.0 113.049 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -91.08 43.39 1.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.944 0.402 . . . . 0.0 111.459 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.35 -27.79 25.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.507 0.67 . . . . 0.0 109.457 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.82 131.41 19.91 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.357 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.07 15.07 0.63 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.192 0.52 . . . . 0.0 110.601 -175.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.418 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -79.45 -79.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.457 0.646 . . . . 0.0 109.321 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.418 ' H ' ' HB ' ' A' ' 12' ' ' ILE . 43.2 t0 -79.18 -173.39 3.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 167.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -76.21 52.07 0.72 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.619 0.724 . . . . 0.0 109.678 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -89.74 132.35 35.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.445 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.584 ' HB2' ' CE2' ' A' ' 18' ' ' TYR . 2.1 mtmp? -120.09 152.27 54.14 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.169 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.38 119.07 6.06 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.572 2.181 . . . . 0.0 111.346 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.584 ' CE2' ' HB2' ' A' ' 16' ' ' LYS . 37.8 m-85 -127.92 125.65 39.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.243 0.544 . . . . 0.0 111.4 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.8 m -82.71 95.78 7.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.324 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.591 ' SG ' HD13 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -98.66 118.66 35.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.558 -174.602 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -90.6 115.95 28.12 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.554 ' HA ' HD11 ' A' ' 29' ' ' LEU . 0.8 OUTLIER -65.43 -27.45 68.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.956 0.408 . . . . 0.0 111.045 -177.923 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -138.11 67.2 1.42 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.183 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.11 65.79 1.17 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.717 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.51 15.13 56.81 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -175.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 m -153.48 -178.72 7.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.193 -0.504 . . . . 0.0 109.879 -172.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.39 12.94 35.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.509 . . . . 0.0 110.23 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.4 147.14 26.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.696 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.591 HD13 ' SG ' ' A' ' 20' ' ' CYS . 1.8 mm? -79.15 103.09 8.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.196 0.522 . . . . 0.0 110.139 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.76 79.54 1.86 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.727 -0.67 . . . . 0.0 113.077 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.495 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 1.2 m -78.71 122.31 25.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.25 0.548 . . . . 0.0 111.598 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.12 153.13 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.26 128.5 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.432 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.551 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -62.34 122.59 28.72 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.458 176.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.522 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -78.43 129.09 37.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.977 0.418 . . . . 0.0 110.418 -175.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.58 113.45 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.528 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.39 22.2 59.08 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.369 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.522 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 4.2 m -117.1 161.93 18.63 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 5.5 mt-30 -104.48 137.07 42.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.14 0.495 . . . . 0.0 111.007 -178.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.472 ' HB2' HD11 ' A' ' 5' ' ' ILE . 6.8 t -111.72 126.03 54.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.746 -179.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.52 10.1 64.79 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.194 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.0 -171.23 1.79 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.44 106.42 3.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.816 0.341 . . . . 0.0 110.85 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.52 105.11 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.808 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -112.28 161.9 16.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.98 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -115.15 100.24 8.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.506 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 62' ' ' ASN . 0.9 OUTLIER -116.76 152.88 33.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.677 -176.008 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.401 ' H ' ' HG2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -93.45 154.26 18.02 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 175.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.56 67.14 4.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.924 0.393 . . . . 0.0 110.997 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.35 34.17 2.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.224 0.535 . . . . 0.0 110.751 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.91 107.05 19.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.656 176.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.62 95.22 8.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.492 -175.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 58.61 65.04 1.31 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.99 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.42 76.38 8.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.086 174.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.23 92.25 0.09 OUTLIER Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.389 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 64.87 15.42 9.88 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.176 0.59 . . . . 0.0 111.609 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.49 -33.66 21.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.012 0.434 . . . . 0.0 110.956 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.18 -159.38 17.81 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.85 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 mt -115.65 71.34 0.77 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.253 0.549 . . . . 0.0 110.248 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -81.48 79.51 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 122.076 0.941 . . . . 0.0 110.502 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.79 110.67 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.27 177.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.544 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 3.4 t-20 -178.2 -22.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 O-C-N 123.406 0.441 . . . . 0.0 111.441 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.33 -53.12 55.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.55 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.7 5.02 1.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.823 0.344 . . . . 0.0 111.405 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 7.4 m120 -101.16 17.69 21.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.011 0.434 . . . . 0.0 111.124 -174.631 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.34 157.64 32.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.514 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.0 t -63.39 -55.52 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.521 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.6 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 120.833 0.349 . . . . 0.0 110.703 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -131.33 121.28 24.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.631 -177.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.68 139.68 33.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.063 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 113.16 17.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.885 0.374 . . . . 0.0 110.075 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.582 HD11 ' HB2' ' A' ' 40' ' ' CYS . 95.4 mt -83.38 129.48 37.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 0.0 112.473 -172.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.54 142.41 13.57 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 170.386 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.22 -20.62 39.6 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.37 2.714 . . . . 0.0 113.718 -176.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -82.55 19.16 1.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.853 0.358 . . . . 0.0 111.54 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -44.21 67.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 109.969 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.35 132.53 56.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.401 176.718 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.16 18.79 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.895 0.379 . . . . 0.0 111.223 -174.175 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -79.17 -68.05 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.402 ' C ' ' H ' ' A' ' 15' ' ' TYR . 19.0 t0 -100.27 -166.95 1.38 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.238 171.249 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -79.71 48.39 0.93 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.667 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 2.8 m-30 -79.54 124.17 28.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.758 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.417 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -100.84 148.08 34.55 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.102 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -67.31 122.1 9.32 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.231 1.954 . . . . 0.0 110.717 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.848 ' HH ' HD13 ' A' ' 59' ' ' LEU . 18.7 m-85 -124.63 124.47 42.28 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.979 0.419 . . . . 0.0 111.49 -174.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.7 m -87.12 86.35 7.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.068 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.8 m -76.18 99.19 4.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.506 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -67.21 148.77 51.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.63 -175.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.57 84.24 1.14 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.379 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.457 ' H ' ' HG2' ' A' ' 23' ' ' MET . 0.0 OUTLIER -79.78 -28.04 40.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.125 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.46 69.31 0.7 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.404 174.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 154.13 -53.49 0.45 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.227 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.4 m -60.85 131.43 50.66 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 176.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.34 -24.57 42.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.455 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.72 ' HB2' HD12 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -99.89 122.65 43.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.25 174.374 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.463 ' H ' ' HG ' ' A' ' 29' ' ' LEU . 0.0 OUTLIER -94.09 136.2 34.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.076 0.465 . . . . 0.0 111.586 -173.816 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.93 71.74 1.93 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.595 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.712 ' HB2' HD12 ' A' ' 61' ' ' ILE . 4.0 m -79.37 109.82 14.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 111.076 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -78.87 143.13 13.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.668 176.142 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.61 133.07 29.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.16 0.505 . . . . 0.0 111.204 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.407 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -77.78 106.59 2.29 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.417 ' H ' HG23 ' A' ' 35' ' ' VAL . 1.5 t -78.99 157.04 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.836 0.35 . . . . 0.0 110.489 -177.28 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.37 114.19 2.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.124 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.82 10.19 55.49 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.196 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.5 m -96.07 172.63 7.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.722 0.296 . . . . 0.0 110.297 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 74.8 mt-30 -128.18 162.9 25.86 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.582 ' HB2' HD11 ' A' ' 5' ' ' ILE . 1.6 t -137.02 146.98 45.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.751 0.31 . . . . 0.0 110.979 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.9 24.15 3.16 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.855 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.31 -151.51 0.4 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.76 89.79 3.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.871 0.367 . . . . 0.0 110.959 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 p -79.67 108.85 13.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.586 0.708 . . . . 0.0 109.692 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -117.5 -175.45 2.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.624 -177.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.667 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 95.2 m -134.73 101.92 5.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.65 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.2 m -121.75 167.35 13.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.34 . . . . 0.0 111.178 -173.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.437 ' HE3' ' HB3' ' A' ' 50' ' ' ASP . 2.4 mmmt -87.08 145.73 26.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.408 172.46 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -95.74 -21.92 17.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.437 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 15.5 t70 -78.32 68.82 4.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.787 0.804 . . . . 0.0 110.236 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -152.75 -57.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.93 175.545 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.89 -28.74 17.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.639 172.093 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.5 t30 60.39 34.85 20.61 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.337 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' THR . . . . . 0.431 ' HB ' ' HA ' ' A' ' 59' ' ' LEU . 0.2 OUTLIER -81.05 62.42 5.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.638 178.141 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.01 66.94 2.12 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.866 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.2 p30 -138.37 -142.92 0.16 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 176.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -35.18 43.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.671 0.272 . . . . 0.0 111.529 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -122.67 99.31 0.65 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.431 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.848 HD13 ' HH ' ' A' ' 18' ' ' TYR . 0.2 OUTLIER -86.07 116.36 24.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.022 0.439 . . . . 0.0 110.816 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.72 HD12 ' HB2' ' A' ' 28' ' ' SER . 0.9 OUTLIER -99.75 121.2 50.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.232 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.712 HD12 ' HB2' ' A' ' 31' ' ' CYS . 0.1 OUTLIER -124.34 164.29 22.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.085 0.469 . . . . 0.0 111.693 -174.434 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -85.05 145.58 27.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.943 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.66 92.97 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -171.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.95 14.83 3.76 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.43 15.66 25.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.64 0.733 . . . . 0.0 109.83 174.708 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.4 m -108.35 173.48 6.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.248 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.487 ' H ' HG22 ' A' ' 67' ' ' VAL . 0.2 OUTLIER -61.1 -39.81 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.252 0.549 . . . . 0.0 109.608 173.274 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.971 174.736 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 120.766 0.317 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -141.51 79.11 1.67 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.019 0.438 . . . . 0.0 110.014 178.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.58 130.84 42.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.266 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.08 122.38 26.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.993 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.823 HG22 ' HA3' ' A' ' 34' ' ' GLY . 56.5 mt -92.94 126.1 45.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.397 0.617 . . . . 0.0 112.18 -174.883 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -136.08 133.53 6.67 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 169.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.521 ' CG ' HG12 ' A' ' 36' ' ' ILE . 77.9 Cg_exo -51.28 -21.06 9.08 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.396 2.731 . . . . 0.0 113.828 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.64 13.4 3.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.68 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.46 -77.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.577 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.82 126.8 36.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.324 173.419 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.77 25.52 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.454 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -77.81 -64.37 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.464 ' C ' ' H ' ' A' ' 15' ' ' TYR . 2.6 t70 -100.03 -151.54 0.4 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 169.597 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -79.29 35.18 0.26 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.42 0.629 . . . . 0.0 110.179 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.464 ' H ' ' C ' ' A' ' 13' ' ' ASP . 22.4 m-85 -83.61 136.73 34.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.754 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.61 161.26 61.96 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.89 105.49 1.15 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.484 2.123 . . . . 0.0 111.605 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.415 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 41.9 m-85 -112.07 122.31 47.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.461 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.73 73.17 7.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.301 0.572 . . . . 0.0 109.699 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -71.26 107.85 4.46 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.016 -177.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -68.93 97.15 0.82 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.759 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.64 122.01 46.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.298 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.7 mtm -129.35 -166.78 1.7 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.9 m -61.91 111.4 1.89 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.865 0.365 . . . . 0.0 110.195 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.11 -99.83 2.1 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 m 57.28 83.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.108 0.563 . . . . 0.0 112.235 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.86 -24.03 36.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.002 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.66 104.6 12.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.647 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.499 ' HG ' ' HB3' ' A' ' 62' ' ' ASN . 1.6 mm? -79.75 110.83 15.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.101 -178.482 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.88 76.98 1.34 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.766 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.469 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -84.45 93.47 8.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.901 0.382 . . . . 0.0 110.976 178.519 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.428 ' H ' HG21 ' A' ' 32' ' ' VAL . 0.0 OUTLIER -89.34 139.22 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.582 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.2 p -66.72 134.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.261 0.553 . . . . 0.0 111.155 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.823 ' HA3' HG22 ' A' ' 5' ' ' ILE . . . -84.15 115.78 4.14 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.819 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.5 154.28 4.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.521 HG12 ' CG ' ' A' ' 7' ' ' PRO . 1.3 mt -60.85 117.21 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.074 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.17 -0.65 64.17 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.372 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -85.66 164.53 17.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.724 0.297 . . . . 0.0 110.3 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -108.57 139.41 43.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.783 0.325 . . . . 0.0 110.177 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.489 ' SG ' HG22 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -90.35 107.26 19.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.949 0.404 . . . . 0.0 110.733 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.18 -17.48 80.22 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.925 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.09 -163.9 0.9 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.76 128.45 34.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.525 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.489 HG22 ' SG ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -78.58 117.52 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -111.22 145.4 38.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.463 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 34.2 m -94.47 78.86 3.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.571 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.446 ' SG ' HG21 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -109.18 159.04 17.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.608 -176.645 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 pttm -87.28 -164.92 1.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.161 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.495 ' HB3' HG23 ' A' ' 51' ' ' VAL . 13.7 m-20 -68.11 -62.96 1.16 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.763 0.316 . . . . 0.0 110.214 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.8 45.04 22.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.719 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.495 HG23 ' HB3' ' A' ' 49' ' ' ASP . 0.9 OUTLIER -84.2 108.67 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.274 -175.952 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.97 -60.53 2.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 171.544 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -122.65 165.12 17.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.803 173.435 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.01 93.31 0.42 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.045 0.45 . . . . 0.0 111.589 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.82 65.98 0.36 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.489 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -78.79 -19.23 52.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.82 0.343 . . . . 0.0 111.001 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -79.58 61.67 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.399 0.619 . . . . 0.0 110.193 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.64 64.63 0.44 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -175.465 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.82 132.14 40.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.778 0.323 . . . . 0.0 110.553 -176.075 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mt -82.98 78.98 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.161 0.505 . . . . 0.0 110.503 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . 0.446 HG21 ' SG ' ' A' ' 47' ' ' CYS . 0.2 OUTLIER -111.94 -153.88 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.791 177.548 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.53 ' HA ' ' HB2' ' A' ' 66' ' ' CYS . 20.9 t-20 52.46 25.72 3.74 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.239 0.543 . . . . 0.0 112.103 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.23 -5.9 15.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.12 0.486 . . . . 0.0 110.302 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -164.34 -56.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.367 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.28 44.1 1.06 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -170.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . 0.53 ' HB2' ' HA ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -111.38 120.6 42.73 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.348 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.72 -26.54 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.801 -175.396 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.045 -177.771 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.603 0.239 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -79.75 90.74 5.24 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.03 117.4 7.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.604 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.48 128.39 33.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.685 178.569 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.548 HD11 ' HB2' ' A' ' 40' ' ' CYS . 50.8 mt -93.03 133.64 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.983 -176.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.81 130.4 9.34 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 169.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.66 -37.53 75.09 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.738 2.959 . . . . 0.0 114.127 -175.001 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -86.83 36.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.974 0.416 . . . . 0.0 111.663 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.82 -52.0 7.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 173.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.7 m -137.33 116.03 12.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.024 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.566 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 24.3 m -161.38 20.79 0.12 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.427 0.632 . . . . 0.0 109.452 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.415 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -79.18 -82.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.428 -176.625 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.688 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 7.2 t70 -79.28 60.26 3.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.456 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.8 t0 48.8 45.28 22.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.764 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.688 ' CE2' ' HB3' ' A' ' 13' ' ' ASP . 26.5 m-85 -97.56 152.48 18.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.181 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.636 ' HB2' ' CE2' ' A' ' 18' ' ' TYR . 9.6 mttp -132.79 143.11 47.27 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.45 103.65 1.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.019 1.813 . . . . 0.0 110.6 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.994 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 24.4 m-85 -104.55 125.81 51.05 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.632 -173.104 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -90.35 93.76 9.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.524 174.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.621 ' HB3' ' HB2' ' A' ' 29' ' ' LEU . 18.0 m -85.12 125.97 33.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.8 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -57.81 107.73 0.49 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 110.601 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.02 111.38 12.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.592 -176.353 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.17 7.1 38.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.707 173.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 m 57.64 74.7 0.41 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.034 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.8 12.05 3.4 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.852 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.65 125.46 29.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.501 0.191 . . . . 0.0 110.652 179.278 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.36 -49.44 6.95 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.2 100.42 11.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.02 171.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.621 ' HB2' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -95.58 143.09 27.17 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.255 -172.146 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.51 91.29 1.61 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.994 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 5.7 m -96.6 126.12 41.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.864 0.364 . . . . 0.0 111.627 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.42 144.47 14.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -60.66 129.84 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.173 0.511 . . . . 0.0 111.154 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.544 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -70.14 109.88 3.06 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.639 175.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.44 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -79.61 160.59 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -67.23 116.55 6.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.398 -175.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.12 23.66 60.93 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.446 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.44 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 49.8 m -95.2 126.62 40.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.689 0.281 . . . . 0.0 110.678 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 4.0 mp0 -81.12 117.9 22.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.129 177.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.548 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -119.01 141.86 48.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.033 0.444 . . . . 0.0 111.536 -176.205 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.74 8.83 10.74 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.37 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.9 -167.2 1.59 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.467 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.63 103.03 11.85 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.668 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.3 t -81.6 100.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -113.87 162.11 16.77 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.756 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 89.6 m -103.03 92.87 4.73 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.124 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -109.9 145.72 36.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.7 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.425 ' H ' ' HG2' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -82.41 156.23 24.26 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.111 0.481 . . . . 0.0 110.62 -177.861 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -79.26 69.67 5.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.189 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.62 -0.8 35.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.836 -178.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.538 HG23 HD22 ' A' ' 59' ' ' LEU . 15.3 m -111.46 178.31 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.841 177.586 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.3 42.85 0.97 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.651 0.262 . . . . 0.0 111.571 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.9 t30 49.83 40.63 20.94 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.641 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.2 66.18 0.89 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.202 0.525 . . . . 0.0 111.416 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.89 80.8 1.33 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.62 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.439 HD21 ' HA ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -78.02 -83.36 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.634 0.254 . . . . 0.0 110.875 -178.002 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.84 -1.68 48.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.699 0.761 . . . . 0.0 109.941 175.782 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.14 -166.18 26.43 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.538 HD22 HG23 ' A' ' 51' ' ' VAL . 5.3 mt -140.27 107.51 5.5 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 117.448 0.624 . . . . 0.0 110.598 176.532 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.457 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 73.2 mt -79.78 99.75 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 mt -112.52 148.57 15.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.764 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -79.53 136.19 36.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.03 -20.45 24.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.18 65.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -93.8 -1.61 54.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.095 0.474 . . . . 0.0 110.806 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.36 103.82 15.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.652 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.0 m -75.24 -29.21 21.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.476 -175.814 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.805 -0.616 . . . . 0.0 109.69 -179.94 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.831 0.348 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -122.49 105.96 10.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.0 110.22 179.074 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.88 129.5 38.29 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.228 -177.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.12 130.48 36.43 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.974 0.416 . . . . 0.0 110.457 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.667 HG23 ' HA3' ' A' ' 34' ' ' GLY . 29.0 mm -84.98 118.88 32.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.255 -174.118 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.53 117.55 4.37 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 169.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 0.9 OUTLIER -43.96 -34.39 6.25 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.166 3.244 . . . . 0.0 114.235 -176.951 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -83.21 44.91 0.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 111.652 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.43 -44.76 7.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.559 0.695 . . . . 0.0 109.343 174.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m -139.67 137.69 35.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.177 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.25 30.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -95.23 -92.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.657 -173.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -79.08 57.77 2.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.798 179.299 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.84 20.82 3.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.445 0.641 . . . . 0.0 110.257 -173.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.402 ' HD1' ' HA ' ' A' ' 15' ' ' TYR . 0.6 OUTLIER -79.68 132.33 36.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.643 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.95 152.99 63.82 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -66.18 114.64 3.1 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.168 1.912 . . . . 0.0 111.137 175.191 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.618 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 18.9 m-85 -120.09 128.98 53.97 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.238 0.542 . . . . 0.0 110.874 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.07 88.57 7.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.943 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 1.3 m -73.67 99.73 3.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.742 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.0 170.77 15.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.509 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.2 m 56.06 71.71 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.633 0.583 . . . . 0.0 110.427 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.2 mtm -79.84 83.25 5.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.237 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.24 100.42 0.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.017 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.78 16.35 68.24 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.292 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.7 m 72.74 -40.5 0.48 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.499 0.72 . . . . 0.0 112.793 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.29 -48.33 14.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.781 0.324 . . . . 0.0 111.435 -176.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.0 113.93 19.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.721 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.563 HD23 ' HB3' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -98.72 128.92 45.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.85 0.357 . . . . 0.0 110.732 178.817 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.69 72.42 2.56 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.704 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.618 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -79.22 92.54 5.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.003 0.43 . . . . 0.0 110.199 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.414 HG13 ' HA3' ' A' ' 58' ' ' GLY . 21.5 m -84.45 163.43 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.6 t -63.71 134.26 28.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.667 ' HA3' HG23 ' A' ' 5' ' ' ILE . . . -54.08 124.99 32.13 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.573 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.527 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -79.3 107.64 11.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.997 0.427 . . . . 0.0 110.721 -177.911 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.31 113.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.491 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.52 -2.44 77.52 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.502 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.527 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -112.72 171.8 7.31 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 10.2 mp0 -101.82 152.34 21.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.937 0.399 . . . . 0.0 111.273 -176.572 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.562 ' HB2' HD12 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -81.54 156.73 25.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.855 175.124 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.5 -49.9 1.77 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.405 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -108.51 -76.86 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.655 0.264 . . . . 0.0 111.433 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.59 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -142.64 119.93 11.55 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.465 -176.631 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 p -84.53 116.56 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.59 ' HD3' ' HB2' ' A' ' 43' ' ' SER . 0.1 OUTLIER -127.4 165.54 19.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.069 0.461 . . . . 0.0 110.909 -176.669 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.473 ' HB2' HG22 ' A' ' 67' ' ' VAL . 86.7 m -98.68 109.55 22.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.769 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 163.04 19.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.217 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -117.27 114.97 24.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.831 178.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -81.23 68.62 7.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.499 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.46 -30.91 71.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.307 0.575 . . . . 0.0 110.07 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.45 ' H ' HG12 ' A' ' 51' ' ' VAL . 0.9 OUTLIER -72.18 123.19 26.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.062 175.428 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 p -111.11 -24.1 10.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.252 -178.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.413 ' OD1' HG22 ' A' ' 51' ' ' VAL . 18.2 p-10 -72.58 -38.31 67.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.156 -177.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.67 131.68 46.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.603 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.02 80.1 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.858 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.514 ' HB3' ' H ' ' A' ' 57' ' ' SER . 4.3 t-20 -92.62 -100.03 0.13 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.688 0.28 . . . . 0.0 110.603 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.514 ' H ' ' HB3' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -79.65 -63.3 1.45 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.191 0.519 . . . . 0.0 109.643 177.597 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . 0.414 ' HA3' HG13 ' A' ' 32' ' ' VAL . . . -106.24 -166.59 22.97 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 173.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.98 120.72 14.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.042 0.421 . . . . 0.0 110.805 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.0 mt -81.12 95.73 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 11.9 mt -102.72 151.17 6.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.498 -175.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -83.27 131.04 35.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.829 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.563 ' HB3' HD23 ' A' ' 29' ' ' LEU . . . -61.21 -22.11 64.47 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -171.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -64.17 -33.69 76.37 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -174.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.38 0.91 53.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 111.326 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.45 127.82 39.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.939 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . 0.473 HG22 ' HB2' ' A' ' 46' ' ' CYS . 0.2 OUTLIER -87.15 -122.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.603 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.413 ' H ' ' HB ' ' A' ' 67' ' ' VAL . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.39 -0.814 . . . . 0.0 109.886 176.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 121.018 0.437 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.673 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . -129.78 126.61 38.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.01 178.901 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.98 121.06 27.23 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.624 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 109.71 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.032 0.444 . . . . 0.0 110.134 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.61 HD12 ' SG ' ' A' ' 19' ' ' CYS . 3.3 mt -91.46 134.2 30.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.426 0.632 . . . . 0.0 112.665 -170.21 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.69 164.11 16.99 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 170.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.69 ' HD3' HG21 ' A' ' 36' ' ' ILE . 37.8 Cg_endo -66.73 -13.57 40.42 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.719 2.279 . . . . 0.0 113.213 -177.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -97.05 19.39 12.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.968 0.413 . . . . 0.0 111.221 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.02 -59.63 2.7 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.472 0.653 . . . . 0.0 110.327 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.5 m -93.98 117.35 29.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.331 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.2 m -157.09 21.12 0.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.91 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 mt -78.38 -63.23 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -99.63 -165.01 1.18 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -80.05 47.84 0.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 10.0 m-30 -91.06 163.6 14.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.657 -176.409 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.43 ' HG3' ' CE2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -132.57 148.21 68.69 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.13 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.15 122.24 9.29 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.477 2.118 . . . . 0.0 112.128 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.851 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 34.2 m-85 -121.43 128.7 52.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.906 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.61 ' SG ' HD12 ' A' ' 5' ' ' ILE . 59.3 m -91.04 84.16 5.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.641 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.5 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 56.8 m -76.97 107.06 9.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.734 -176.351 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -75.84 68.98 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.049 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.461 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 1.2 m 54.3 -101.2 0.12 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.384 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' MET . . . . . 0.434 ' H ' ' HB2' ' A' ' 22' ' ' SER . 4.6 mtt -150.36 142.99 24.57 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.82 14.45 13.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.157 0.504 . . . . 0.0 110.793 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.24 -41.54 1.97 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.31 -172.85 4.25 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.294 . . . . 0.0 110.234 175.389 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.14 -17.88 51.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.224 0.535 . . . . 0.0 110.319 177.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.471 ' HA ' ' HA ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER -73.38 127.53 32.93 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.233 176.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.587 HD12 ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -89.4 148.14 23.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.391 -178.809 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.0 76.32 2.17 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.81 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.851 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 33.3 m -87.34 99.26 11.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.021 0.439 . . . . 0.0 111.366 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 m -89.69 151.37 3.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 171.455 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.16 129.62 20.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.577 ' HA3' HG22 ' A' ' 5' ' ' ILE . . . -48.19 126.64 15.26 Favored Glycine 0 N--CA 1.447 -0.584 0 O-C-N 123.83 0.706 . . . . 0.0 111.912 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.542 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -78.06 114.02 18.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -177.645 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.69 HG21 ' HD3' ' A' ' 7' ' ' PRO . 7.3 mm -61.24 110.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.452 -172.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.71 9.51 61.17 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.833 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.542 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 70.4 m -112.21 151.04 30.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.057 0.456 . . . . 0.0 110.663 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.673 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 4.0 mt-30 -86.24 113.85 22.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.792 176.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.3 m -92.79 123.08 35.8 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.81 45.44 2.51 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.991 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -142.09 -178.24 5.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.82 125.4 27.07 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.528 HG11 HD11 ' A' ' 5' ' ' ILE . 17.2 t -79.36 97.42 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.413 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 11.4 mmpt? -105.42 124.36 49.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.038 -174.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 93.9 m -87.64 89.6 8.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . 0.413 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 34.6 m -111.17 169.29 8.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.143 0.496 . . . . 0.0 111.498 -174.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.89 141.59 40.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.431 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -87.81 55.9 3.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.285 0.565 . . . . 0.0 110.043 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -126.73 63.05 1.3 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.262 0.553 . . . . 0.0 110.958 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.69 12.99 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.99 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 61.38 40.92 13.57 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.802 -177.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -162.58 134.19 5.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.836 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.62 -25.07 20.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.935 0.397 . . . . 0.0 110.768 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.67 -149.84 50.0 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.825 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.67 -66.24 0.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.135 0.493 . . . . 0.0 110.186 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.19 65.7 8.36 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.586 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.8 -163.18 24.53 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.724 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.74 110.21 14.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.037 0.446 . . . . 0.0 110.345 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . 0.443 ' H ' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -87.03 78.65 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 -178.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 14.2 mt -76.37 129.64 37.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.859 178.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.471 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.4 t30 -82.71 42.64 0.79 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.398 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 70.92 -54.2 0.66 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.005 0.922 . . . . 0.0 113.084 176.301 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.39 59.42 2.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -173.66 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.01 25.5 0.82 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.393 0.616 . . . . 0.0 109.823 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -135.63 177.28 7.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.671 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -67.12 -59.05 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.722 0.296 . . . . 0.0 110.576 177.854 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.63 179.257 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.48 116.59 31.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.951 0.405 . . . . 0.0 110.602 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.11 129.78 44.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.412 HG23 ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -88.23 122.52 31.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.085 178.491 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.59 HD11 ' HB2' ' A' ' 40' ' ' CYS . 14.9 mt -94.14 140.63 16.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.013 0.435 . . . . 0.0 111.934 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.55 151.83 23.46 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 174.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.869 ' HD3' HG12 ' A' ' 36' ' ' ILE . 60.3 Cg_endo -72.77 46.03 0.98 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.851 2.368 . . . . 0.0 112.758 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -135.79 0.51 2.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.583 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.27 -54.07 10.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.241 0.543 . . . . 0.0 110.246 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.594 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -120.2 139.71 52.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.3 177.392 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.5 m -162.01 12.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.809 0.338 . . . . 0.0 110.55 -173.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.44 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.0 OUTLIER -78.36 -84.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.44 ' H ' ' HB ' ' A' ' 12' ' ' ILE . 2.6 t70 -83.45 -152.84 0.13 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 173.308 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.62 48.15 1.48 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.937 0.875 . . . . 0.0 109.531 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.729 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 25.5 m-85 -96.16 110.0 22.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.273 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.4 mtmm -107.65 156.97 37.01 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.83 117.41 4.31 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.208 1.939 . . . . 0.0 111.678 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -122.11 122.33 38.98 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.58 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.404 ' SG ' ' HB1' ' A' ' 42' ' ' ALA . 5.1 t -88.3 100.84 13.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.74 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.854 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -101.96 135.7 43.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.887 -176.594 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -109.22 -159.34 0.68 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.356 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.41 145.7 55.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.168 0.509 . . . . 0.0 111.132 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.55 152.18 30.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.134 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -29.96 70.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.203 0.525 . . . . 0.0 110.766 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.48 -55.88 0.24 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.34 -179.36 4.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.539 -0.33 . . . . 0.0 110.443 175.139 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.69 53.25 1.57 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.082 0.467 . . . . 0.0 111.444 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -138.96 130.05 26.64 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.854 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -127.61 164.01 22.96 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.73 -174.573 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.54 76.95 0.25 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.759 -177.38 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.559 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -81.42 108.35 14.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.744 0.306 . . . . 0.0 110.227 176.135 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 m -91.46 161.53 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.84 130.5 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.766 0.317 . . . . 0.0 110.423 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.565 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -61.11 134.26 48.85 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.636 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . 0.487 ' H ' HG22 ' A' ' 35' ' ' VAL . 0.0 OUTLIER -78.94 116.65 23.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.055 0.455 . . . . 0.0 109.877 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.869 HG12 ' HD3' ' A' ' 7' ' ' PRO . 34.1 mt -67.22 120.12 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.849 -175.027 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.12 17.13 72.75 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.173 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' SER . . . . . 0.419 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -127.27 160.55 30.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.674 0.273 . . . . 0.0 110.695 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.412 ' HG3' HG23 ' A' ' 4' ' ' THR . 28.0 mt-30 -97.53 149.88 21.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.019 0.438 . . . . 0.0 110.873 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.59 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -121.41 156.99 31.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.231 178.881 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.56 16.3 21.68 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.753 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.404 ' HB1' ' SG ' ' A' ' 19' ' ' CYS . . . -124.35 -161.65 1.02 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -89.91 107.22 18.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.017 0.437 . . . . 0.0 111.084 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.45 109.38 17.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.952 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -130.93 -179.45 5.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.909 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 4.1 m -107.93 105.58 15.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.206 175.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 62.2 m -118.31 148.86 42.04 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.171 -174.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.524 ' HD2' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -91.64 116.04 28.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.095 0.474 . . . . 0.0 110.239 176.601 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.94 -36.35 77.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.09 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -76.38 65.05 2.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.837 -177.112 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.88 -44.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 168.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.4 -34.9 23.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.342 168.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 70.4 -65.38 0.33 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.515 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.15 131.48 35.3 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.772 0.32 . . . . 0.0 110.423 177.418 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.03 -176.96 23.68 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.411 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.43 ' HB3' ' H ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -147.08 -121.42 0.06 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.074 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . 0.43 ' H ' ' HB3' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -79.77 56.46 2.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.386 0.613 . . . . 0.0 109.92 175.609 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.81 -178.53 16.37 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -175.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -99.87 103.45 15.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.029 0.442 . . . . 0.0 110.316 179.951 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -87.99 105.44 15.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.796 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.5 mt -112.35 135.16 52.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.446 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -67.43 150.68 48.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.614 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.75 164.91 18.41 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.365 177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 69.62 8.97 7.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.811 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.44 21.04 13.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.537 0.684 . . . . 0.0 109.98 175.561 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.9 m -123.42 140.52 52.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.09 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.7 173.18 14.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.093 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.228 176.659 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.63 64.01 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.933 0.396 . . . . 0.0 110.701 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.52 133.53 35.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.774 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.74 121.94 25.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.017 0.437 . . . . 0.0 110.516 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.539 HG22 ' HA3' ' A' ' 34' ' ' GLY . 3.7 mt -92.13 147.36 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.397 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.85 157.01 26.98 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 172.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.862 ' HD3' HG12 ' A' ' 36' ' ' ILE . 14.2 Cg_endo -56.97 -33.72 96.04 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.858 2.372 . . . . 0.0 112.095 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.84 62.21 4.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.448 0.642 . . . . 0.0 110.187 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.34 -49.59 4.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.089 175.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -123.32 152.68 41.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.137 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -151.82 19.49 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.725 0.774 . . . . 0.0 109.211 -174.022 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -74.22 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.191 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -100.96 -156.46 0.56 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.267 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -86.84 49.84 1.89 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.866 0.841 . . . . 0.0 108.771 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' TYR . . . . . 0.656 ' HB3' ' HB2' ' A' ' 46' ' ' CYS . 8.6 m-85 -86.9 110.48 20.02 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.523 -176.9 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.539 ' HG3' ' CE2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -95.02 155.27 39.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.641 -177.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.91 127.48 22.5 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.18 2.587 . . . . 0.0 112.858 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' TYR . . . . . 0.875 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 21.4 m-85 -138.07 130.96 29.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' CYS . . . . . 0.422 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 18.2 m -89.49 87.36 7.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.565 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' CYS . . . . . 0.578 ' HB3' HD23 ' A' ' 29' ' ' LEU . 91.1 m -75.43 94.56 3.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.907 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.553 ' HG3' ' HB1' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -92.08 72.47 5.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.543 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.451 ' HB2' HD21 ' A' ' 29' ' ' LEU . 2.6 m -150.59 158.47 44.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.669 178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 ttm -81.3 163.93 22.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.93 -37.76 84.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.01 0.434 . . . . 0.0 110.659 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.59 66.97 1.16 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.494 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.8 m -142.24 -174.79 4.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.811 0.338 . . . . 0.0 111.064 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.436 ' O ' ' HB2' ' A' ' 28' ' ' SER . . . -143.01 139.87 30.77 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.436 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 65.0 m 73.69 98.19 0.07 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 124.241 0.963 . . . . 0.0 109.753 -175.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LEU . . . . . 0.578 HD23 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mt -79.69 115.36 19.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.969 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.91 62.98 4.46 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.88 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' CYS . . . . . 0.875 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 6.2 m -89.41 101.84 14.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.125 0.488 . . . . 0.0 110.98 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.94 152.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.769 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.2 t -59.53 132.97 24.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.713 0.292 . . . . 0.0 110.405 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLY . . . . . 0.539 ' HA3' HG22 ' A' ' 5' ' ' ILE . . . -66.41 113.94 6.1 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.65 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.6 122.01 32.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.063 0.458 . . . . 0.0 110.653 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ILE . . . . . 0.862 HG12 ' HD3' ' A' ' 7' ' ' PRO . 1.1 mt -59.13 130.17 22.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.104 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.87 80.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.45 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 m -122.32 166.73 14.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -101.39 137.0 40.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.903 0.383 . . . . 0.0 111.046 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' CYS . . . . . 0.494 ' HB2' HD13 ' A' ' 5' ' ' ILE . 7.7 t -101.01 128.41 47.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.796 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.05 -0.58 57.24 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.449 -178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . 0.553 ' HB1' ' HG3' ' A' ' 21' ' ' GLN . . . -121.04 -162.21 0.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.095 0.474 . . . . 0.0 111.169 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.89 104.25 3.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.783 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.41 111.42 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.512 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 6.1 mmtt -124.73 172.39 9.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.889 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' CYS . . . . . 0.656 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -118.16 119.94 36.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.657 0.265 . . . . 0.0 110.45 176.28 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.88 171.3 9.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.838 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.09 154.05 29.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.746 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASP . . . . . 0.4 ' CG ' ' HZ3' ' A' ' 16' ' ' LYS . 0.7 OUTLIER -104.51 60.16 0.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.137 0.494 . . . . 0.0 110.954 -178.084 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.98 -12.61 46.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.263 177.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . 0.469 ' H ' HG23 ' A' ' 51' ' ' VAL . 0.0 OUTLIER -72.63 140.7 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.6 175.816 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.65 -28.6 36.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.868 0.366 . . . . 0.0 111.353 -176.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -85.97 90.13 8.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.004 0.43 . . . . 0.0 110.237 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.97 -59.88 4.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.767 -176.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . 0.403 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . 100.59 -24.99 29.97 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.748 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.403 ' HB2' ' O ' ' A' ' 55' ' ' GLY . 6.3 m120 74.59 -53.78 0.67 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.803 0.841 . . . . 0.0 112.385 175.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -55.2 5.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.998 0.428 . . . . 0.0 110.642 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.15 142.56 11.88 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.421 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.7 tp -92.03 110.01 21.37 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 mt -79.97 97.48 2.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.014 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.6 mm -73.69 151.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.434 -179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -66.22 -68.35 0.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.275 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ALA . . . . . 0.431 ' HB3' ' H ' ' A' ' 64' ' ' ALA . . . -162.25 -96.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.397 177.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ALA . . . . . 0.431 ' H ' ' HB3' ' A' ' 63' ' ' ALA . . . -82.44 78.8 9.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.233 0.456 . . . . 0.0 112.233 -172.179 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.7 22.82 0.46 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.435 0.636 . . . . 0.0 109.923 171.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 87.0 m -123.23 86.95 2.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.612 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.7 m -89.11 132.16 34.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.965 0.412 . . . . 0.0 111.342 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.512 ' CB ' ' HA ' ' A' ' 45' ' ' LYS . . . . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.503 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.258 0.551 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.31 140.19 50.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.326 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.12 129.3 34.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.125 0.488 . . . . 0.0 110.317 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.913 HG21 ' HA3' ' A' ' 34' ' ' GLY . 80.9 mt -95.68 135.21 30.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.555 -176.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.93 161.3 34.19 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.91 ' HD3' HG12 ' A' ' 36' ' ' ILE . 25.8 Cg_exo -64.33 60.86 0.25 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 123.332 2.688 . . . . 0.0 112.871 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -150.73 -44.32 0.12 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -58.46 8.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.59 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 5.8 m -122.8 97.28 5.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.32 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -162.96 15.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.175 0.512 . . . . 0.0 110.201 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -78.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.996 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.659 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 26.9 t0 -77.75 59.12 1.97 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.165 0.507 . . . . 0.0 110.419 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t0 51.72 46.98 25.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.846 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.659 ' CE2' ' HB3' ' A' ' 13' ' ' ASP . 10.7 m-85 -102.2 160.79 14.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.543 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -125.04 145.5 50.52 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.607 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.487 ' HB2' HG23 ' A' ' 5' ' ' ILE . 61.4 Cg_endo -74.65 103.63 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.861 1.707 . . . . 0.0 111.154 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.925 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 33.9 m-85 -100.39 120.56 40.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.157 -175.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.29 87.35 7.27 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 57.8 m -78.15 113.62 16.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.954 -176.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.534 -179.467 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.557 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -80.13 123.39 27.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.806 0.336 . . . . 0.0 110.648 -175.868 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.61 78.69 1.62 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.925 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 14.7 m -86.9 99.32 11.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.012 0.434 . . . . 0.0 111.439 -175.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.86 142.7 13.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.36 122.42 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.913 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -66.25 117.9 10.3 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.292 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.14 139.18 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.91 HG12 ' HD3' ' A' ' 7' ' ' PRO . 2.4 mt -59.62 108.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.634 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.77 -21.27 9.09 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.982 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.0 m -76.08 160.85 29.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.575 0.226 . . . . 0.0 110.84 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.91 145.48 40.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.762 0.315 . . . . 0.0 110.269 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.5 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -100.21 110.76 23.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.882 175.928 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.46 -30.84 26.35 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.603 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.17 -142.24 0.24 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.716 0.293 . . . . 0.0 110.732 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.44 102.12 12.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 -176.295 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 p -80.29 115.8 23.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -116.32 143.91 44.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.089 0.471 . . . . 0.0 111.123 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 35.3 m -99.23 83.56 2.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.944 175.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 23.7 m -102.47 154.13 19.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.478 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.536 ' HA ' ' HD1' ' A' ' 15' ' ' TYR . 4.1 ttmt -65.68 -70.26 0.25 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.287 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.3 t70 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.808 -176.954 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.269 0 CA-C-O 121.066 0.46 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.3 mt -80.25 80.8 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.154 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 63' ' ' ALA . 15.3 mm -77.85 137.33 22.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.174 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -78.66 11.78 2.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.79 0.329 . . . . 0.0 111.107 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.543 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 66.28 4.18 3.07 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.392 0.677 . . . . 0.0 112.374 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.55 32.92 5.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.9 0.381 . . . . 0.0 111.207 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.3 25.7 3.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.986 0.422 . . . . 0.0 110.154 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.56 155.71 48.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.911 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.912 0.387 . . . . 0.0 110.014 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 120.984 0.421 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.9 137.25 32.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.186 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.93 138.48 33.13 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.861 HG21 ' HA3' ' A' ' 34' ' ' GLY . 6.2 mt -105.51 134.27 47.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.364 0.602 . . . . 0.0 112.196 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.42 147.1 19.03 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 171.686 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -51.47 -34.46 51.47 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.346 2.697 . . . . 0.0 112.992 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -101.58 67.75 1.14 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.103 0.478 . . . . 0.0 110.498 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.11 -61.52 1.36 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.025 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 54.4 m -116.24 142.93 46.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.5 m -159.63 32.86 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.073 0.463 . . . . 0.0 110.863 -172.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.06 -68.67 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -95.44 -165.55 1.31 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.591 167.364 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.59 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 3.7 t70 -77.85 50.72 0.88 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.377 0.608 . . . . 0.0 109.573 170.802 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.665 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 8.2 m-85 -85.85 79.61 9.2 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.627 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.687 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -79.3 156.97 75.94 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.329 -177.306 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.08 116.02 3.94 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.464 2.109 . . . . 0.0 111.305 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.579 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 25.8 m-85 -126.82 131.38 51.25 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.593 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.9 m -94.83 99.03 11.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.363 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HB3' HD22 ' A' ' 29' ' ' LEU . 1.6 m -82.92 121.25 26.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.724 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.605 179.377 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 20' ' ' CYS . 7.2 mt -80.23 88.0 5.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.004 0.431 . . . . 0.0 111.203 -175.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.14 79.84 1.15 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.784 175.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.5 OUTLIER -88.63 109.61 20.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 0.0 111.227 -178.373 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.95 153.39 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.987 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 t -62.09 130.64 26.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.744 0.307 . . . . 0.0 110.704 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.861 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -66.39 132.44 32.8 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.289 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.424 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 2.1 t -80.54 137.51 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.069 0.462 . . . . 0.0 110.703 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mt -64.15 111.75 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.265 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.13 59.11 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.497 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.424 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 15.1 m -110.36 170.89 7.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.715 0.293 . . . . 0.0 110.515 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.49 136.25 54.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.498 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.442 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -115.47 133.4 56.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.433 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.79 29.65 9.18 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.235 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -121.44 -156.09 0.67 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.5 83.86 4.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.009 0.433 . . . . 0.0 110.375 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 40' ' ' CYS . 2.0 t -79.59 109.72 14.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.027 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.13 160.07 28.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.992 0.425 . . . . 0.0 111.163 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.665 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 59.0 m -93.59 100.84 13.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 171.157 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.403 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 69.3 m -108.15 144.48 35.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.363 -172.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.59 ' HE3' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -79.3 117.36 20.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.51 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.687 ' HB2' ' HD2' ' A' ' 16' ' ' LYS . 65.8 t0 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.952 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.834 0.35 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.21 97.11 4.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.797 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.499 ' H ' HG12 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -88.63 150.44 3.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.387 -178.394 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -101.85 45.07 0.98 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.906 0.384 . . . . 0.0 110.661 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 73.27 -56.33 0.66 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.367 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.09 -27.04 65.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.615 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -92.66 17.08 10.81 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.476 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.0 m -127.41 119.79 26.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.798 0.332 . . . . 0.0 110.88 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.042 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 121.091 0.472 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -67.82 120.76 14.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.586 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.03 125.05 28.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.785 176.066 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.722 HG21 ' HA3' ' A' ' 34' ' ' GLY . 3.5 mt -104.28 132.9 49.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -170.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.72 149.0 16.85 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 167.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.11 43.06 0.8 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.648 2.232 . . . . 0.0 113.539 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -150.32 26.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.051 0.453 . . . . 0.0 110.677 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.19 -23.6 47.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.726 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 m -146.12 145.97 30.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.5 m -162.36 25.2 0.11 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.801 0.334 . . . . 0.0 111.075 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.16 -65.67 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -100.52 -151.12 0.4 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 168.366 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -83.03 47.46 1.23 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.933 0.873 . . . . 0.0 108.693 169.252 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.579 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 5.8 m-85 -82.35 78.81 8.95 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.677 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -79.81 149.92 71.55 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.27 126.63 19.0 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.397 2.065 . . . . 0.0 111.052 176.425 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.702 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 9.2 m-85 -129.1 129.85 45.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.971 0.415 . . . . 0.0 111.373 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 13.9 m -83.56 84.14 7.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.357 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 20.6 m -72.67 96.84 2.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.111 0.482 . . . . 0.0 111.386 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.84 175.37 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.237 0.443 0 CA-C-O 121.069 0.462 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.443 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -122.96 139.2 54.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.97 -177.071 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.93 76.05 2.3 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.793 ' HB2' HD12 ' A' ' 61' ' ' ILE . 3.8 m -79.54 100.75 7.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.998 0.428 . . . . 0.0 111.042 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.42 145.34 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 p -58.1 135.24 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.806 0.336 . . . . 0.0 110.708 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.722 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -56.81 118.97 13.21 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.003 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.23 118.92 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 120.91 0.386 . . . . 0.0 110.352 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.59 124.54 8.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.458 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.08 13.93 81.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.27 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.72 167.12 15.0 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 3' ' ' THR . 2.5 mt-30 -113.23 145.79 40.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.616 ' HB2' HD11 ' A' ' 5' ' ' ILE . 13.9 m -125.99 120.08 29.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.197 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.48 61.81 3.16 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.289 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.03 -166.16 2.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.77 98.44 1.96 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.904 0.383 . . . . 0.0 110.462 176.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.4 t -87.3 91.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.199 0.523 . . . . 0.0 109.661 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.44 162.67 17.94 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.511 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.579 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -87.5 112.62 22.41 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.783 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.448 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 64.0 m -115.24 149.24 38.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.932 0.396 . . . . 0.0 111.167 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.85 119.33 17.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.839 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.5 t0 . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 121.518 0.675 . . . . 0.0 110.252 175.826 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 120.937 0.399 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mt -79.97 102.35 5.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 31' ' ' CYS . 62.3 mt -99.61 135.33 35.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.56 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -64.23 145.04 56.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.28 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.37 45.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.108 0.48 . . . . 0.0 111.671 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -154.19 19.28 0.5 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.295 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -123.01 13.89 9.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.3 m -127.96 143.81 51.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.849 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 120.808 0.337 . . . . 0.0 110.684 178.005 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 121.062 0.458 . . . . 0.0 110.432 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.67 138.3 42.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.224 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.52 133.46 38.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.765 0.317 . . . . 0.0 110.181 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.579 HG21 ' HA3' ' A' ' 34' ' ' GLY . 12.3 mm -106.4 137.55 36.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.517 0.675 . . . . 0.0 112.466 -173.442 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.17 151.61 23.07 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.798 ' HD3' HG12 ' A' ' 36' ' ' ILE . 31.2 Cg_endo -64.68 58.46 0.27 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.136 2.557 . . . . 0.0 113.312 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -139.89 -26.39 0.79 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.126 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.64 -52.0 57.57 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.73 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.0 m -143.95 135.82 26.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.941 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.89 30.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.501 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.29 -73.53 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.02 177.783 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.459 ' C ' ' H ' ' A' ' 15' ' ' TYR . 9.9 t0 -83.79 -161.97 0.59 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 168.412 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.512 ' HB3' ' HG3' ' A' ' 48' ' ' LYS . 29.0 t0 -77.21 40.61 0.27 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.691 0.758 . . . . 0.0 109.541 172.041 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 8.1 m-30 -90.5 84.69 5.99 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.8 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 150.38 72.37 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.2 128.46 22.81 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.328 2.019 . . . . 0.0 111.846 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.88 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 9.4 m-85 -132.12 149.97 52.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.408 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.544 ' HB3' HG23 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -109.85 81.04 1.38 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.753 176.688 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 2.7 m -78.91 102.97 8.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.454 0.645 . . . . 0.0 110.937 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.431 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 4.9 tp-100 . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.908 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.971 HD12 ' HB ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -79.57 114.74 18.73 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.147 -177.009 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.5 85.65 1.15 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.529 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.88 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.93 143.74 28.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.326 0.584 . . . . 0.0 111.627 -177.206 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -123.68 158.84 29.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 168.184 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.8 t -64.06 133.29 29.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.579 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -55.63 119.83 15.76 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.574 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -78.72 108.53 12.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.24 0.543 . . . . 0.0 110.817 -174.83 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.798 HG12 ' HD3' ' A' ' 7' ' ' PRO . 3.1 mp -64.97 116.34 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.777 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.75 1.05 74.3 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.766 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.574 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -120.29 -173.91 2.67 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.618 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 12.8 mt-30 -114.86 143.63 44.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.01 0.433 . . . . 0.0 111.376 -176.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.7 152.54 40.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.757 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.37 -1.24 33.14 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.863 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -148.34 -161.92 1.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.563 -0.318 . . . . 0.0 110.576 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.14 128.76 37.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.168 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.22 122.48 34.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.314 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HG3' ' HB2' ' A' ' 20' ' ' CYS . 1.3 mmpm? -121.59 166.92 13.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.28 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 13.8 m -131.03 96.8 4.14 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 66' ' ' CYS . 0.8 OUTLIER -123.56 165.09 17.73 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 -174.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HG3' ' HB3' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -81.37 -151.09 0.08 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.322 -0.619 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.642 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.609 HD13 ' HE1' ' A' ' 18' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.58 0 CA-C-O 121.148 0.499 . . . . 0.0 109.882 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mt -78.93 93.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.741 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.971 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.1 mm -79.03 139.65 18.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.579 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -81.04 -0.38 39.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.332 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.817 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 64.8 28.68 12.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.013 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.4 -56.01 2.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.087 0.47 . . . . 0.0 110.899 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.91 54.18 2.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.178 0.513 . . . . 0.0 110.67 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 47' ' ' CYS . 16.0 t -150.7 164.16 36.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.435 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.815 178.348 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 121.001 0.429 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.63 151.63 44.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.263 176.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.0 136.64 37.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.921 0.391 . . . . 0.0 111.608 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.663 HG21 ' HA3' ' A' ' 34' ' ' GLY . 45.1 mt -103.53 126.4 57.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.793 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.88 156.43 27.78 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.812 ' HD3' HG12 ' A' ' 36' ' ' ILE . 25.4 Cg_endo -62.14 -5.58 6.68 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.811 2.341 . . . . 0.0 112.619 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.91 7.39 23.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.549 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.2 m -61.42 -48.0 83.18 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 170.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 3.6 m -96.15 163.47 13.09 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.52 33.59 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.897 0.855 . . . . 0.0 108.759 -169.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.03 -109.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.469 -172.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.02 80.58 2.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.4 t70 49.76 42.67 24.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.459 0.647 . . . . 0.0 111.323 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.48 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 11.4 m-85 -108.03 134.49 50.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.075 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.82 160.66 48.08 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.711 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.499 ' HB2' HG23 ' A' ' 5' ' ' ILE . 58.7 Cg_endo -68.69 115.54 3.98 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.497 2.131 . . . . 0.0 111.878 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.729 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 30.1 m-85 -123.61 126.92 47.5 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.14 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.76 88.59 7.71 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.731 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 65.8 m -75.08 103.27 5.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.073 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.871 -177.211 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.84 89.95 4.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.88 71.72 2.14 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.347 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 35.9 m -85.39 93.17 8.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.914 0.387 . . . . 0.0 110.265 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.21 145.78 7.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 t -58.56 131.31 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.663 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -64.83 144.54 48.32 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.634 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.46 103.68 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.812 HG12 ' HD3' ' A' ' 7' ' ' PRO . 2.7 mp -58.15 118.16 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.885 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.21 -8.17 41.32 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.796 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.25 -178.86 3.47 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.85 141.6 37.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.794 0.331 . . . . 0.0 110.694 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.557 ' HB3' HG22 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -86.55 124.05 32.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.625 175.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.56 -17.16 55.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.275 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.57 -170.0 1.7 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.549 0.214 . . . . 0.0 110.479 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.53 109.47 2.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.862 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 40' ' ' CYS . 0.9 OUTLIER -79.77 103.31 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.243 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.563 ' HB3' ' SG ' ' A' ' 66' ' ' CYS . 1.9 mmpt? -113.18 149.6 33.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.668 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 21.9 m -90.92 93.79 9.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.931 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -124.19 -175.48 3.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.413 -177.794 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.76 141.0 18.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 C--N 1.318 -0.792 0 CA-C-O 121.272 0.558 . . . . 0.0 109.532 176.342 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.155 0.503 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.01 115.58 49.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.068 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.3 mp -104.55 118.5 51.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -78.44 62.18 3.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.707 -173.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 67.46 -69.74 0.13 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.965 0.906 . . . . 0.0 113.314 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.34 54.89 0.94 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -171.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.24 28.56 0.25 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 174.689 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 45.5 t -160.42 147.98 16.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.003 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.166 0.507 . . . . 0.0 110.087 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.099 0.476 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.97 142.68 48.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.947 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.503 ' HA ' ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -77.54 125.2 28.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.999 0.428 . . . . 0.0 110.524 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.731 HG21 ' HA3' ' A' ' 34' ' ' GLY . 32.2 mt -89.76 127.2 42.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.072 -174.08 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.31 128.51 6.4 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 170.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.444 ' CG ' HG12 ' A' ' 36' ' ' ILE . 84.7 Cg_exo -43.45 -37.88 8.06 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.89 3.06 . . . . 0.0 114.476 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -86.58 33.57 0.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -45.56 42.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -132.32 141.54 48.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.102 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.3 17.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.417 0.627 . . . . 0.0 109.513 -175.379 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.43 -84.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.968 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -100.32 53.78 0.89 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.32 -173.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.419 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 23.4 t70 62.82 21.66 12.94 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.679 0.752 . . . . 0.0 110.229 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.525 ' HE2' HG22 ' A' ' 67' ' ' VAL . 3.9 m-85 -80.6 130.19 34.97 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.493 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.586 ' HE3' ' HB2' ' A' ' 49' ' ' ASP . 0.8 OUTLIER -126.82 157.63 70.91 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -177.802 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.15 115.02 3.8 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.589 2.193 . . . . 0.0 111.57 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.66 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 27.0 m-85 -120.3 133.4 55.47 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.993 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -81.88 84.83 6.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.717 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 m -78.55 79.7 4.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.296 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.421 HE22 ' HB3' ' A' ' 19' ' ' CYS . 2.4 mp0 . . . . . 0 C--N 1.324 -0.54 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.235 0.318 0 CA-C-O 121.184 0.516 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.715 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 4.2 mt -87.22 146.63 25.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.504 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.93 48.13 0.99 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.867 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 29' ' ' LEU . 2.0 m -79.03 106.85 11.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.124 0.488 . . . . 0.0 111.328 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.4 m -86.07 164.27 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.637 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.82 135.47 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 123.167 0.292 . . . . 0.0 110.484 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.731 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -64.59 116.51 9.1 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.209 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.02 135.02 26.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.78 0.324 . . . . 0.0 110.623 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.444 HG12 ' CG ' ' A' ' 7' ' ' PRO . 1.4 mt -64.93 110.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.51 -9.7 49.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.113 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.6 m -90.8 171.19 9.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.882 0.372 . . . . 0.0 110.48 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.503 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 1.6 mp0 -124.3 140.25 53.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.837 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -75.82 146.72 39.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.205 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.25 -51.78 3.43 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.385 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.41 -90.18 0.15 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.746 0.308 . . . . 0.0 110.642 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.17 138.37 29.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.648 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.42 HG22 ' HB2' ' A' ' 40' ' ' CYS . 1.2 t -80.89 125.94 39.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.013 175.822 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -117.85 157.69 26.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.436 ' HB3' ' HD2' ' A' ' 15' ' ' TYR . 32.9 m -102.55 99.95 10.01 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 4.0 m -116.07 147.28 41.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.993 0.425 . . . . 0.0 111.461 -175.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -98.74 136.39 38.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.776 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.586 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 48.7 t0 . . . . . 0 C--N 1.325 -0.488 0 CA-C-O 121.295 0.569 . . . . 0.0 110.628 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.425 HD13 ' HE1' ' A' ' 18' ' ' TYR . 1.3 mp . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 120.865 0.365 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.08 87.71 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.995 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 29' ' ' LEU . 37.9 mm -63.85 127.54 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.599 -178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.77 44.69 1.18 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.812 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 67.4 -68.08 0.16 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.536 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.18 54.43 2.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 0.0 112.028 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.557 ' HB2' HG23 ' A' ' 61' ' ' ILE . 35.7 m120 -126.48 -14.9 5.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.688 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 4.6 m -109.77 88.79 2.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.575 -174.569 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.525 HG22 ' HE2' ' A' ' 15' ' ' TYR . 2.6 t . . . . . 0 N--CA 1.467 0.423 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.94 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.88 118.91 29.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.619 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.68 119.84 22.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.049 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' A' ' 40' ' ' CYS . 85.4 mt -87.07 127.92 40.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -172.529 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -117.37 136.96 12.96 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 166.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.584 ' HG3' HG12 ' A' ' 36' ' ' ILE . 74.5 Cg_endo -72.96 44.73 0.82 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.031 2.488 . . . . 0.0 113.94 -172.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -157.18 26.01 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.739 0.304 . . . . 0.0 111.22 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -58.1 3.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.415 0.626 . . . . 0.0 109.629 174.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -92.64 136.16 33.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.285 174.588 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.89 26.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.027 0.441 . . . . 0.0 110.371 -175.201 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -66.48 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 15' ' ' TYR . 3.2 t70 -100.6 -149.07 0.37 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.348 169.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -81.84 40.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.686 0.755 . . . . 0.0 109.394 171.772 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.557 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 1.9 m-85 -82.96 111.7 19.07 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.606 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.4 143.16 26.07 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.0 125.1 16.27 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.481 2.12 . . . . 0.0 111.163 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.709 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 9.7 m-85 -134.84 123.9 24.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.028 0.442 . . . . 0.0 110.8 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.8 t -87.09 93.15 9.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.026 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 26.1 m -74.57 100.44 3.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.263 0.554 . . . . 0.0 109.793 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.892 -173.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.672 0.272 . . . . 0.0 110.639 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.509 HD11 ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -79.84 78.41 6.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.003 0.43 . . . . 0.0 110.918 -178.434 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.95 86.05 1.37 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.615 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 4.0 m -109.13 115.39 29.94 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.771 0.319 . . . . 0.0 110.955 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.9 154.78 4.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.98 139.33 15.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.464 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.509 ' CA ' HG21 ' A' ' 5' ' ' ILE . . . -65.26 88.34 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.849 174.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.457 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 61.1 t -79.45 137.04 22.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.914 0.388 . . . . 0.0 110.215 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.584 HG12 ' HG3' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -63.41 110.04 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.552 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.38 -4.61 33.19 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.585 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.457 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 43.1 m -78.08 127.58 32.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.991 0.424 . . . . 0.0 110.711 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -93.94 94.25 8.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.288 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.703 ' HB2' HD11 ' A' ' 5' ' ' ILE . 12.4 t -74.9 118.74 18.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.287 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.9 -2.82 59.41 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.195 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.3 -132.83 0.33 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.669 0.271 . . . . 0.0 111.018 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.567 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 70.5 m -86.93 99.42 11.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.013 0.435 . . . . 0.0 111.352 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -79.67 81.64 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.122 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HE3' HD11 ' A' ' 29' ' ' LEU . 3.7 mttm -91.35 175.72 6.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.794 -172.086 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 89.2 m -127.71 106.05 8.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.597 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 91.2 m -120.84 149.38 42.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.809 0.337 . . . . 0.0 111.088 -174.346 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.24 97.67 11.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.253 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 . . . . . 0 C--N 1.321 -0.669 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.096 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 3.4 mp . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 121.106 0.479 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.9 mt -79.63 102.57 5.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.38 146.83 5.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.292 -171.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -69.21 121.34 16.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.71 175.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.496 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . . . -78.94 35.32 0.25 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 111.894 -173.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.14 13.55 6.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.906 0.384 . . . . 0.0 110.561 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -138.71 38.29 2.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.239 0.542 . . . . 0.0 110.79 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 11.1 m -130.11 153.94 47.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.767 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.0 110.529 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.807 0.337 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -146.31 127.8 15.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.234 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.49 123.68 26.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.152 0.501 . . . . 0.0 110.189 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.698 HG21 ' HA3' ' A' ' 34' ' ' GLY . 8.6 mt -89.58 127.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.57 -172.1 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.4 137.48 14.21 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 168.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.77 -4.99 5.23 Favored 'Trans proline' 0 N--CA 1.478 0.581 0 C-N-CA 123.364 2.71 . . . . 0.0 114.114 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -119.74 34.32 5.27 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.36 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -33.86 76.22 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.572 0.701 . . . . 0.0 110.295 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 89.3 m -135.21 146.18 48.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.906 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.69 17.6 0.8 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.952 0.406 . . . . 0.0 110.652 -169.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.53 -71.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 15' ' ' TYR . 3.8 t0 -93.67 -159.73 0.71 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.578 171.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASP . . . . . 0.553 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 21.2 t70 -80.43 41.57 0.55 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.634 0.73 . . . . 0.0 109.295 172.472 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.793 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 10.4 m-85 -85.57 71.74 10.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.783 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HB2' ' HD2' ' A' ' 17' ' ' PRO . 4.3 ptpt -79.58 156.01 75.79 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.831 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 16' ' ' LYS . 29.7 Cg_endo -61.32 126.54 19.57 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.978 2.452 . . . . 0.0 112.777 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.919 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 21.6 m-85 -127.95 123.93 36.07 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.081 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.1 m -80.75 80.95 7.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 53.6 m -77.03 121.43 23.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.574 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.131 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.453 ' HB2' HG22 ' A' ' 60' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -103.09 148.27 25.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.401 -177.981 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.79 77.63 1.87 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.734 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.919 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 28.9 m -86.49 120.18 27.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.16 0.505 . . . . 0.0 112.112 -176.188 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.21 144.59 15.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 169.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 p -58.6 131.44 22.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.008 0.432 . . . . 0.0 111.058 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.698 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -67.56 117.08 8.46 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.699 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.401 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 11.2 t -78.92 131.22 34.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.904 0.383 . . . . 0.0 110.42 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.94 120.63 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.653 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.99 -4.95 68.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.642 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.401 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 15.8 m -95.24 166.34 11.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.643 0.259 . . . . 0.0 110.703 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 3' ' ' THR . 18.9 mt-30 -114.9 124.9 52.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.566 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.545 ' HB2' HD11 ' A' ' 5' ' ' ILE . 1.7 t -81.17 135.64 35.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.204 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.76 2.94 23.09 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.829 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -120.24 -157.59 0.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.1 92.38 4.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.965 0.412 . . . . 0.0 110.628 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.45 ' HB ' ' SG ' ' A' ' 40' ' ' CYS . 1.6 p -78.6 109.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.519 0.676 . . . . 0.0 109.613 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -118.22 171.11 8.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.827 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.793 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 59.7 m -112.71 104.01 12.04 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 173.843 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.508 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.8 OUTLIER -122.99 157.32 32.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.42 -177.498 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.669 ' HD2' ' HE1' ' A' ' 15' ' ' TYR . 2.5 ptmt -97.71 155.69 16.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.868 0.366 . . . . 0.0 110.76 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.844 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.138 0.494 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -79.98 76.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.438 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.508 HD13 ' HB3' ' A' ' 47' ' ' CYS . 1.3 mt -84.59 152.12 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.559 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -72.34 139.55 47.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.592 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -61.99 -25.57 67.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.596 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.27 -5.9 55.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.143 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.17 -12.64 26.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.988 0.423 . . . . 0.0 110.842 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.79 172.14 11.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.019 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.344 . . . . 0.0 111.48 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.186 0 CA-C-O 121.251 0.548 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.96 123.75 22.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.887 -176.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 m -79.82 134.33 36.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.308 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 40' ' ' CYS . 37.8 mt -98.19 136.27 29.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.229 0.538 . . . . 0.0 112.43 -172.726 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.437 ' HA2' ' HD3' ' A' ' 7' ' ' PRO . . . -136.3 128.84 4.66 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 168.382 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.509 ' HA ' ' HG3' ' A' ' 17' ' ' PRO . 38.5 Cg_exo -59.91 3.17 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.7 2.933 . . . . 0.0 114.58 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -85.59 -0.99 56.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.934 0.397 . . . . 0.0 110.827 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -56.61 13.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.204 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -135.59 149.48 49.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.137 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -173.76 16.89 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.094 0.473 . . . . 0.0 110.395 -175.732 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.465 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.63 -90.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.67 -175.32 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -86.16 66.46 9.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.211 -178.746 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t0 57.27 27.14 13.22 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.221 0.534 . . . . 0.0 110.897 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.657 ' CE1' ' HG3' ' A' ' 48' ' ' LYS . 54.5 m-85 -88.79 148.69 23.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.45 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.638 ' HB2' ' HD2' ' A' ' 17' ' ' PRO . 14.0 pttm -160.07 163.23 22.76 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.638 ' HD2' ' HB2' ' A' ' 16' ' ' LYS . 20.1 Cg_endo -59.25 130.63 36.93 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.492 2.128 . . . . 0.0 112.201 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.9 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 12.4 m-85 -131.72 132.15 43.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.539 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.63 ' HB2' HG23 ' A' ' 32' ' ' VAL . 6.1 m -94.01 93.59 7.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.39 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.74 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 2.8 m -85.31 111.28 19.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.931 0.396 . . . . 0.0 110.333 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.837 -176.492 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.447 -0.625 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.74 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -83.08 138.03 33.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.549 -170.885 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.43 94.72 1.93 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.891 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.9 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -95.98 149.21 21.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.116 0.484 . . . . 0.0 111.673 -177.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.63 HG23 ' HB2' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -127.21 163.4 30.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 171.067 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.56 128.52 32.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.605 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -63.82 110.74 3.6 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.049 177.054 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.518 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -79.58 129.01 38.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.888 0.375 . . . . 0.0 110.739 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.521 ' H ' HD12 ' A' ' 36' ' ' ILE . 1.2 mp -57.6 127.13 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.255 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.04 15.5 81.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.794 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.518 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -118.23 163.07 17.22 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -102.14 157.29 16.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.906 0.384 . . . . 0.0 110.919 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.756 ' HB2' HD11 ' A' ' 5' ' ' ILE . 4.8 t -122.98 125.3 44.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.187 175.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.01 7.55 69.87 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.776 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.07 -166.24 1.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.56 119.63 18.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.013 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 t -86.9 104.3 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.35 164.26 11.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.994 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.0 m -115.81 88.94 2.99 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 57.9 m -112.52 163.45 14.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 -173.637 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.657 ' HG3' ' CE1' ' A' ' 15' ' ' TYR . 18.5 mtpt -82.06 171.19 14.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.967 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.344 -0.843 . . . . 0.0 108.996 169.163 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.074 0.464 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.7 mm -80.07 101.09 4.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.307 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.614 HD12 ' HB2' ' A' ' 31' ' ' CYS . 14.1 mt -105.02 134.7 45.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.027 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -88.74 36.06 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.651 -175.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 70.04 -42.78 0.52 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.85 -26.55 68.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.91 22.64 1.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.846 0.355 . . . . 0.0 110.773 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 3.2 m -133.14 143.15 49.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.89 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 121.167 0.508 . . . . 0.0 110.341 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.538 ' HB1' ' HG2' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.958 0.409 . . . . 0.0 111.306 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 m -79.35 113.56 17.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.6 113.22 16.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.851 0.358 . . . . 0.0 110.04 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -89.16 131.1 37.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.471 0.653 . . . . 0.0 112.239 -173.449 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.0 156.79 20.88 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 166.947 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.16 -26.17 18.98 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.859 2.372 . . . . 0.0 113.241 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -89.53 33.82 0.83 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.962 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.43 -69.12 0.63 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.363 0.601 . . . . 0.0 109.95 175.999 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 m -92.68 137.03 32.72 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.05 38.9 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.419 0.628 . . . . 0.0 109.917 -168.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.462 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -116.53 -87.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.094 -177.194 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.661 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 21.7 t0 -100.14 63.68 1.17 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.764 -176.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 56.47 28.11 13.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.334 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.727 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 20.6 m-85 -90.78 134.51 34.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.12 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.98 153.33 47.08 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.192 -178.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.645 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 20.6 Cg_endo -61.97 120.32 7.86 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.629 2.22 . . . . 0.0 112.324 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.813 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 37.5 m-85 -133.29 125.27 28.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.881 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.0 95.76 6.79 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 37.1 m -82.44 121.79 27.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.23 -175.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.415 179.139 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.71 137.53 44.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.841 0.353 . . . . 0.0 110.377 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.68 75.25 2.34 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.943 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.813 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 19.2 m -84.93 102.11 12.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.187 0.517 . . . . 0.0 110.831 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.1 m -78.89 150.59 5.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 t -61.96 135.84 26.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.378 0.424 . . . . 0.0 110.475 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.645 ' HA3' ' HB2' ' A' ' 17' ' ' PRO . . . -64.99 89.68 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.759 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.412 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 49.7 t -79.43 141.36 15.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.687 0.28 . . . . 0.0 110.287 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.35 101.98 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.442 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.02 -13.63 8.48 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.209 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' A' ' 5' ' ' ILE . 53.6 m -72.83 129.11 37.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.008 0.433 . . . . 0.0 110.815 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.538 ' HG2' ' HB1' ' A' ' 2' ' ' ALA . 1.3 mp0 -95.3 106.85 18.93 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.406 ' HB3' HG22 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -75.17 106.25 6.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.28 -176.167 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.87 -4.65 29.64 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.927 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.09 -82.79 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.346 . . . . 0.0 110.231 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.604 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 38.7 m -155.41 120.12 4.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.193 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.406 HG22 ' HB3' ' A' ' 40' ' ' CYS . 2.8 t -82.05 101.62 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.604 ' HE3' ' HB3' ' A' ' 43' ' ' SER . 1.2 mmpt? -114.24 136.16 53.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 74.5 m -101.01 96.33 7.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.514 174.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.3 m -111.76 163.69 13.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.382 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 13' ' ' ASP . 28.7 ttmt -110.18 -37.7 5.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.405 -176.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 123.898 0.879 . . . . 0.0 111.959 -172.166 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.187 0.517 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.11 74.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.973 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mt -80.24 147.21 6.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.265 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -85.92 151.97 23.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.02 94.03 0.31 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.77 0.319 . . . . 0.0 110.959 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -151.17 -78.94 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.249 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -85.03 54.21 3.02 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.157 0.504 . . . . 0.0 111.016 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 78.5 m -125.95 139.59 53.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.437 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -175.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HB1' ' HG2' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.35 141.32 46.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.99 -176.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.2 124.14 27.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 0.0 110.043 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.887 HG21 ' HA3' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -92.55 151.02 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.536 0.684 . . . . 0.0 112.343 -171.438 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.431 ' HA2' HG12 ' A' ' 36' ' ' ILE . . . 159.1 176.26 30.95 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.256 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.909 ' HD3' HG12 ' A' ' 36' ' ' ILE . 24.1 Cg_exo -64.85 43.8 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.103 2.535 . . . . 0.0 112.785 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' A' ' 6' ' ' GLY . 48.3 t30 -131.22 -42.78 1.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.213 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -41.37 97.85 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.773 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -152.38 124.98 8.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.572 174.572 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -173.62 36.17 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -174.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.88 -82.39 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.822 -172.809 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -89.07 61.02 5.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.328 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.1 t0 51.51 54.04 11.74 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.543 0.687 . . . . 0.0 110.45 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -121.74 126.85 49.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.33 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.24 146.02 31.77 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.01 125.64 10.55 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.287 1.992 . . . . 0.0 111.454 177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.651 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 10.1 m-85 -126.07 131.1 52.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.036 0.445 . . . . 0.0 111.409 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.9 m -103.16 101.63 11.6 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.87 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 2.0 m -82.03 120.6 25.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.222 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.494 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.447 -0.609 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.645 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -79.37 157.45 27.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.785 -169.668 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.41 89.41 0.78 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.577 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.651 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 1.1 m -89.68 129.37 36.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.39 . . . . 0.0 111.108 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.1 m -104.32 156.76 5.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.08 128.1 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.887 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -64.35 129.16 36.92 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.181 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.492 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -79.31 123.49 36.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.002 0.429 . . . . 0.0 110.412 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.909 HG12 ' HD3' ' A' ' 7' ' ' PRO . 6.2 mt -68.52 112.32 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.772 -176.191 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.99 -16.11 30.64 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.751 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.492 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 14.1 m -90.24 176.91 6.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.423 ' HG2' ' HB1' ' A' ' 2' ' ' ALA . 1.6 tt0 -135.74 98.3 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.787 0.327 . . . . 0.0 110.599 -175.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.698 ' HB2' HD11 ' A' ' 5' ' ' ILE . 65.6 m -79.8 127.5 32.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.299 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.32 6.81 32.19 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.618 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.47 -141.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.626 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 1.3 m -82.89 80.49 8.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 110.097 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -79.8 109.06 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -122.6 178.09 5.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.596 0.712 . . . . 0.0 111.547 -173.284 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 92.0 m -129.93 111.85 12.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.659 176.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.51 ' SG ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -121.92 146.62 46.94 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.934 0.397 . . . . 0.0 111.589 -171.511 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.405 ' C ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -78.77 115.66 18.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.803 175.979 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.266 173.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.32 95.18 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.321 0.582 . . . . 0.0 109.992 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.51 HG12 ' SG ' ' A' ' 47' ' ' CYS . 0.2 OUTLIER -94.12 131.72 40.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.914 -177.755 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -86.16 15.57 5.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -173.311 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.416 ' H ' ' CG2' ' A' ' 61' ' ' ILE . . . 72.93 -44.94 0.61 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.638 0.775 . . . . 0.0 112.496 175.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.39 18.37 0.31 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -128.04 16.89 6.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.593 0.711 . . . . 0.0 109.256 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER -114.15 140.32 48.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.155 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.232 0.539 . . . . 0.0 110.536 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 121.2 0.524 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.45 132.16 47.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.464 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 m -78.97 109.18 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.778 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.688 HG21 ' HA3' ' A' ' 34' ' ' GLY . 13.0 mt -80.14 130.82 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.801 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.69 151.4 22.36 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 170.744 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.664 ' HD3' HG12 ' A' ' 36' ' ' ILE . 34.9 Cg_endo -64.91 -3.65 7.37 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 122.821 2.347 . . . . 0.0 113.323 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -82.62 -6.07 59.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.273 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.89 -79.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.239 0.542 . . . . 0.0 110.743 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 128.77 54.76 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.12 46.73 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.272 0.558 . . . . 0.0 110.213 -174.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.435 HD12 ' HD2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -126.91 -87.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.035 -176.18 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.559 ' HB3' ' CD2' ' A' ' 15' ' ' TYR . 27.8 t70 -81.22 54.08 2.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.438 0.637 . . . . 0.0 110.298 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.04 25.75 4.32 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.538 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.559 ' CD2' ' HB3' ' A' ' 13' ' ' ASP . 26.8 m-85 -78.52 124.33 28.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.301 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HZ2' ' HB3' ' A' ' 49' ' ' ASP . 35.3 mttp -119.51 145.58 39.25 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.32 115.55 3.39 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.329 2.019 . . . . 0.0 111.397 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.593 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 31.5 m-85 -126.11 135.28 51.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -176.382 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.87 86.35 2.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.516 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.737 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 1.1 m -67.62 116.72 8.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.185 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.327 178.88 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.741 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.737 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -104.5 138.08 41.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.522 -172.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 60' ' ' ILE . . . -89.01 100.68 2.68 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 177.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.9 OUTLIER -94.8 101.94 13.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.897 0.379 . . . . 0.0 111.187 -177.081 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.27 151.43 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.6 t -63.48 133.71 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.688 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -62.56 116.91 10.02 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.096 177.035 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.412 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -79.59 125.28 38.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.755 0.312 . . . . 0.0 110.527 -178.553 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.664 HG12 ' HD3' ' A' ' 7' ' ' PRO . 0.8 OUTLIER -65.98 114.25 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.712 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.16 15.04 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.752 -177.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.412 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 5.7 m -134.11 176.88 8.19 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.157 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.538 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 1.4 mm-40 -113.57 135.43 53.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.958 0.409 . . . . 0.0 111.663 -174.543 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.14 99.04 12.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.684 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.68 13.19 58.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.8 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.7 -107.5 0.38 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.31 . . . . 0.0 110.342 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.59 118.95 28.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.06 101.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.73 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -118.42 112.56 20.14 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.542 -176.363 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 33.3 m -81.77 93.59 6.86 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 38.7 m -108.83 144.69 36.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.748 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.2 123.78 29.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.97 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ASP . . . . . 0.55 ' HB3' ' HZ2' ' A' ' 16' ' ' LYS . 6.9 t0 . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.521 -174.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 59' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.378 0.609 . . . . 0.0 111.642 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.741 HD11 ' HB2' ' A' ' 28' ' ' SER . 0.9 OUTLIER -82.54 117.24 28.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.297 174.484 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.6 mt -101.19 148.38 7.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.977 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -79.83 19.35 0.69 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.642 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.492 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . 71.01 -43.0 0.55 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.637 0.775 . . . . 0.0 112.901 176.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.46 -38.17 71.31 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -84.31 20.79 1.55 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.827 0.346 . . . . 0.0 111.447 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.2 m -120.25 165.34 14.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.434 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.444 177.623 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.122 0.487 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.61 136.73 36.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.04 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.521 HG23 ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -78.82 137.94 37.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.638 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.564 HG21 ' HA3' ' A' ' 34' ' ' GLY . 47.9 mt -114.47 121.58 66.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.211 0.529 . . . . 0.0 112.001 -174.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.64 149.39 18.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 167.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.0 -28.19 39.04 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.318 2.679 . . . . 0.0 113.049 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -91.08 43.39 1.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.944 0.402 . . . . 0.0 111.459 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.35 -27.79 25.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.507 0.67 . . . . 0.0 109.457 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.82 131.41 19.91 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.357 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.07 15.07 0.63 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.192 0.52 . . . . 0.0 110.601 -175.755 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.431 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -79.45 -79.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.457 0.646 . . . . 0.0 109.321 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.431 ' H ' ' HB ' ' A' ' 12' ' ' ILE . 43.2 t0 -79.18 -173.39 3.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 167.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -76.21 52.07 0.72 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.619 0.724 . . . . 0.0 109.678 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -89.74 132.35 35.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.445 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.603 ' HB2' ' CE2' ' A' ' 18' ' ' TYR . 2.1 mtmp? -120.09 152.27 54.14 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.169 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.38 119.07 6.06 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.572 2.181 . . . . 0.0 111.346 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CE2' ' HB2' ' A' ' 16' ' ' LYS . 37.8 m-85 -127.92 125.65 39.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.243 0.544 . . . . 0.0 111.4 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.8 m -82.71 95.78 7.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.324 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.518 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -98.66 118.66 35.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.558 -174.602 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 . . . . . 0 C--N 1.319 -0.756 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.329 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.294 0 CA-C-O 120.797 0.332 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.518 HD12 ' SG ' ' A' ' 20' ' ' CYS . 1.8 mm? -79.15 103.09 8.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.196 0.522 . . . . 0.0 110.139 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.76 79.54 1.86 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.727 -0.67 . . . . 0.0 113.077 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 1.2 m -78.71 122.31 25.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.25 0.548 . . . . 0.0 111.598 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.12 153.13 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.26 128.5 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.432 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.564 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -62.34 122.59 28.72 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.458 176.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.526 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -78.43 129.09 37.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.977 0.418 . . . . 0.0 110.418 -175.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.58 113.45 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.528 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.39 22.2 59.08 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.369 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.526 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 4.2 m -117.1 161.93 18.63 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.521 ' HG3' HG23 ' A' ' 4' ' ' THR . 5.5 mt-30 -104.48 137.07 42.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.14 0.495 . . . . 0.0 111.007 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 6.8 t -111.72 126.03 54.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.746 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.52 10.1 64.79 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.194 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.0 -171.23 1.79 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.44 106.42 3.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.816 0.341 . . . . 0.0 110.85 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.52 105.11 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.808 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -112.28 161.9 16.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.98 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -115.15 100.24 8.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.506 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' ' 62' ' ' ASN . 0.9 OUTLIER -116.76 152.88 33.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.677 -176.008 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.493 ' H ' ' HG2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -93.45 154.26 18.02 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 175.632 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 120.924 0.393 . . . . 0.0 110.997 -177.061 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 mt . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 121.253 0.549 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -81.48 79.51 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 122.076 0.941 . . . . 0.0 110.502 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -134.79 110.67 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.27 177.889 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.565 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 5.7 t30 -178.2 -22.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 O-C-N 123.406 0.441 . . . . 0.0 111.441 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.33 -53.12 55.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.55 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.7 5.02 1.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.823 0.344 . . . . 0.0 111.405 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASN . . . . . 0.408 ' HB2' HG22 ' A' ' 61' ' ' ILE . 7.4 m120 -101.16 17.69 21.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.011 0.434 . . . . 0.0 111.124 -174.631 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.34 157.64 32.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.514 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.0 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.521 176.309 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.567 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.708 0.289 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.68 139.68 33.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.063 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 113.16 17.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.885 0.374 . . . . 0.0 110.075 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.782 HD11 ' HB2' ' A' ' 40' ' ' CYS . 95.4 mt -83.38 129.48 37.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 0.0 112.473 -172.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.54 142.41 13.57 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 170.386 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.22 -20.62 39.6 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.37 2.714 . . . . 0.0 113.718 -176.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -82.55 19.16 1.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.853 0.358 . . . . 0.0 111.54 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -44.21 67.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 109.969 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.35 132.53 56.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.401 176.718 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.16 18.79 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.895 0.379 . . . . 0.0 111.223 -174.175 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -79.17 -68.05 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.807 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -100.27 -166.95 1.38 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.238 171.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -79.71 48.39 0.93 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 2.8 m-30 -79.54 124.17 28.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.758 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -100.84 148.08 34.55 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.102 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -67.31 122.1 9.32 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.231 1.954 . . . . 0.0 110.717 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.691 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 18.7 m-85 -124.63 124.47 42.28 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.979 0.419 . . . . 0.0 111.49 -174.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.7 m -87.12 86.35 7.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.068 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.8 m -76.18 99.19 4.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.506 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.63 -175.942 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.743 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.575 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.424 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -94.09 136.2 34.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.076 0.465 . . . . 0.0 111.586 -173.816 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.93 71.74 1.93 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.595 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.691 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 4.0 m -79.37 109.82 14.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 111.076 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 32' ' ' VAL . 0.8 OUTLIER -78.87 143.13 13.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.668 176.142 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.61 133.07 29.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.16 0.505 . . . . 0.0 111.204 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.438 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -77.78 106.59 2.29 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.99 157.04 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.836 0.35 . . . . 0.0 110.489 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.37 114.19 2.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.124 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.82 10.19 55.49 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.196 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.5 m -96.07 172.63 7.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.722 0.296 . . . . 0.0 110.297 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.567 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 74.8 mt-30 -128.18 162.9 25.86 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.782 ' HB2' HD11 ' A' ' 5' ' ' ILE . 1.6 t -137.02 146.98 45.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.751 0.31 . . . . 0.0 110.979 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.9 24.15 3.16 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.855 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.31 -151.51 0.4 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.76 89.79 3.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.871 0.367 . . . . 0.0 110.959 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 p -79.67 108.85 13.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.586 0.708 . . . . 0.0 109.692 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -117.5 -175.45 2.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.624 -177.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.676 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 95.2 m -134.73 101.92 5.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.65 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.2 m -121.75 167.35 13.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.34 . . . . 0.0 111.178 -173.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 48' ' ' LYS . 2.4 mmmt -87.08 145.73 26.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.408 172.46 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 C--N 1.323 -0.573 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.922 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.022 0.439 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.743 HD11 ' HB2' ' A' ' 28' ' ' SER . 0.9 OUTLIER -99.75 121.2 50.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.232 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.34 164.29 22.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.085 0.469 . . . . 0.0 111.693 -174.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -85.05 145.58 27.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.943 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.66 92.97 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -171.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.95 14.83 3.76 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.43 15.66 25.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.64 0.733 . . . . 0.0 109.83 174.708 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.4 m -108.35 173.48 6.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.248 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.252 0.549 . . . . 0.0 109.608 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.516 ' HB1' ' HG2' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.019 0.438 . . . . 0.0 110.014 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.58 130.84 42.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.266 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.08 122.38 26.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.993 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.833 HG21 ' HA3' ' A' ' 34' ' ' GLY . 56.5 mt -92.94 126.1 45.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.397 0.617 . . . . 0.0 112.18 -174.883 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -136.08 133.53 6.67 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 169.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.527 ' CG ' HG12 ' A' ' 36' ' ' ILE . 77.9 Cg_exo -51.28 -21.06 9.08 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.396 2.731 . . . . 0.0 113.828 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.64 13.4 3.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.68 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.46 -77.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.577 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.82 126.8 36.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.324 173.419 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.77 25.52 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.535 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -77.81 -64.37 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 15' ' ' TYR . 2.6 t70 -100.03 -151.54 0.4 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 169.597 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -79.29 35.18 0.26 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.42 0.629 . . . . 0.0 110.179 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 13' ' ' ASP . 22.4 m-85 -83.61 136.73 34.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.754 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.61 161.26 61.96 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.89 105.49 1.15 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.484 2.123 . . . . 0.0 111.605 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.437 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 41.9 m-85 -112.07 122.31 47.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.461 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.73 73.17 7.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.301 0.572 . . . . 0.0 109.699 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -71.26 107.85 4.46 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.016 -177.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.759 177.224 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.51 ' HG ' ' HB3' ' A' ' 62' ' ' ASN . 1.6 mm? -79.75 110.83 15.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.101 -178.482 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.88 76.98 1.34 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.766 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -84.45 93.47 8.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.901 0.382 . . . . 0.0 110.976 178.519 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.34 139.22 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.582 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.2 p -66.72 134.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.261 0.553 . . . . 0.0 111.155 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.833 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -84.15 115.78 4.14 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.819 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.5 154.28 4.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.527 HG12 ' CG ' ' A' ' 7' ' ' PRO . 1.3 mt -60.85 117.21 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.074 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.17 -0.65 64.17 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.372 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -85.66 164.53 17.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.724 0.297 . . . . 0.0 110.3 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.516 ' HG2' ' HB1' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -108.57 139.41 43.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.783 0.325 . . . . 0.0 110.177 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.509 ' SG ' HG22 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -90.35 107.26 19.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.949 0.404 . . . . 0.0 110.733 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.18 -17.48 80.22 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.925 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.09 -163.9 0.9 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.76 128.45 34.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.525 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.509 HG22 ' SG ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -78.58 117.52 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -111.22 145.4 38.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.463 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 34.2 m -94.47 78.86 3.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.571 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -109.18 159.04 17.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.608 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 pttm -87.28 -164.92 1.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.161 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 120.763 0.316 . . . . 0.0 110.214 178.654 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 120.778 0.323 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mt -82.98 78.98 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.161 0.505 . . . . 0.0 110.503 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -111.94 -153.88 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.791 177.548 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.528 ' HA ' ' HB2' ' A' ' 66' ' ' CYS . 20.9 t-20 52.46 25.72 3.74 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.239 0.543 . . . . 0.0 112.103 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.23 -5.9 15.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.12 0.486 . . . . 0.0 110.302 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -164.34 -56.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.367 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.28 44.1 1.06 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -170.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' CYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -111.38 120.6 42.73 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.348 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.801 -175.396 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.625 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.03 117.4 7.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.604 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.48 128.39 33.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.685 178.569 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.649 HG21 ' HA3' ' A' ' 34' ' ' GLY . 50.8 mt -93.03 133.64 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.983 -176.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.81 130.4 9.34 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 169.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.66 -37.53 75.09 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.738 2.959 . . . . 0.0 114.127 -175.001 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -86.83 36.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.974 0.416 . . . . 0.0 111.663 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.82 -52.0 7.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 173.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.7 m -137.33 116.03 12.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.024 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 24.3 m -161.38 20.79 0.12 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.427 0.632 . . . . 0.0 109.452 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.451 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -79.18 -82.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.428 -176.625 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.702 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 7.2 t70 -79.28 60.26 3.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.456 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.8 t0 48.8 45.28 22.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.764 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.702 ' CE2' ' HB3' ' A' ' 13' ' ' ASP . 26.5 m-85 -97.56 152.48 18.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.181 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.648 ' HB2' ' CE2' ' A' ' 18' ' ' TYR . 9.6 mttp -132.79 143.11 47.27 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.45 103.65 1.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.019 1.813 . . . . 0.0 110.6 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.997 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 24.4 m-85 -104.55 125.81 51.05 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.632 -173.104 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 0.5 OUTLIER -90.35 93.76 9.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.524 174.69 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 29' ' ' LEU . 18.0 m -85.12 125.97 33.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.8 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 110.601 177.132 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.631 ' HB2' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -95.58 143.09 27.17 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.255 -172.146 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.51 91.29 1.61 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.997 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 5.7 m -96.6 126.12 41.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.864 0.364 . . . . 0.0 111.627 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.42 144.47 14.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -60.66 129.84 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.173 0.511 . . . . 0.0 111.154 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.649 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -70.14 109.88 3.06 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.639 175.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.45 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -79.61 160.59 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -67.23 116.55 6.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.398 -175.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.12 23.66 60.93 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.446 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.45 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 49.8 m -95.2 126.62 40.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.689 0.281 . . . . 0.0 110.678 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.625 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 4.0 mp0 -81.12 117.9 22.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.129 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.01 141.86 48.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.033 0.444 . . . . 0.0 111.536 -176.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.74 8.83 10.74 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.37 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -94.9 -167.2 1.59 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.63 103.03 11.85 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.668 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.3 t -81.6 100.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -113.87 162.11 16.77 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.756 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 89.6 m -103.03 92.87 4.73 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.124 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -109.9 145.72 36.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.7 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -82.41 156.23 24.26 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.111 0.481 . . . . 0.0 110.62 -177.861 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 t0 . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.189 178.613 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.3 mt . . . . . 0 N--CA 1.448 -0.574 0 CA-C-O 120.896 0.379 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 73.2 mt -79.78 99.75 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 mt -112.52 148.57 15.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.764 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -79.53 136.19 36.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.03 -20.45 24.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.18 65.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -93.8 -1.61 54.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.095 0.474 . . . . 0.0 110.806 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.36 103.82 15.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.652 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.0 m . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.476 -175.814 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.87 0.367 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.88 129.5 38.29 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.228 -177.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.12 130.48 36.43 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.974 0.416 . . . . 0.0 110.457 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.683 HG21 ' HA3' ' A' ' 34' ' ' GLY . 29.0 mm -84.98 118.88 32.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.255 -174.118 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLY . . . . . 0.485 ' HA2' ' HD2' ' A' ' 7' ' ' PRO . . . -112.53 117.55 4.37 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 169.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.485 ' HD2' ' HA2' ' A' ' 6' ' ' GLY . 0.9 OUTLIER -43.96 -34.39 6.25 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.166 3.244 . . . . 0.0 114.235 -176.951 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -83.21 44.91 0.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 111.652 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.43 -44.76 7.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.559 0.695 . . . . 0.0 109.343 174.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m -139.67 137.69 35.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.177 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.25 30.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -95.23 -92.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.657 -173.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.407 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 17.5 t70 -79.08 57.77 2.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.798 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.84 20.82 3.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.445 0.641 . . . . 0.0 110.257 -173.631 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.413 ' HE1' ' HB2' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -79.68 132.33 36.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.643 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.95 152.99 63.82 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' PRO . . . . . 0.436 ' HG3' ' HA ' ' A' ' 7' ' ' PRO . 36.6 Cg_endo -66.18 114.64 3.1 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.168 1.912 . . . . 0.0 111.137 175.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.642 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 18.9 m-85 -120.09 128.98 53.97 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.238 0.542 . . . . 0.0 110.874 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.07 88.57 7.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.943 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 1.3 m -73.67 99.73 3.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.742 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.509 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 120.741 0.305 . . . . 0.0 110.721 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -98.72 128.92 45.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.85 0.357 . . . . 0.0 110.732 178.817 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.69 72.42 2.56 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.704 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -79.22 92.54 5.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.003 0.43 . . . . 0.0 110.199 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 m -84.45 163.43 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.6 t -63.71 134.26 28.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.683 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -54.08 124.99 32.13 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.573 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -79.3 107.64 11.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.997 0.427 . . . . 0.0 110.721 -177.911 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.31 113.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.491 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.52 -2.44 77.52 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.502 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.52 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -112.72 171.8 7.31 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.477 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 10.2 mp0 -101.82 152.34 21.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.937 0.399 . . . . 0.0 111.273 -176.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.452 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -81.54 156.73 25.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.855 175.124 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.5 -49.9 1.77 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.405 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -108.51 -76.86 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.655 0.264 . . . . 0.0 111.433 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.616 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -142.64 119.93 11.55 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.465 -176.631 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 p -84.53 116.56 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.616 ' HD3' ' HB2' ' A' ' 43' ' ' SER . 0.1 OUTLIER -127.4 165.54 19.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.069 0.461 . . . . 0.0 110.909 -176.669 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.531 ' HB2' HG23 ' A' ' 67' ' ' VAL . 86.7 m -98.68 109.55 22.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.769 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 163.04 19.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.217 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.413 ' HB2' ' HE1' ' A' ' 15' ' ' TYR . 29.4 ttmt -117.27 114.97 24.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.831 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.499 178.036 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.822 0.344 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.0 mt -81.12 95.73 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 31' ' ' CYS . 11.9 mt -102.72 151.17 6.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.498 -175.841 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.41 ' OD1' ' HB3' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -83.27 131.04 35.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.829 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.585 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -61.21 -22.11 64.47 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -171.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ALA . . . . . 0.41 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . . . -64.17 -33.69 76.37 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -174.326 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.38 0.91 53.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 111.326 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.45 127.82 39.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.939 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 46' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.58 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 2' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.98 121.06 27.23 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.624 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 109.71 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.032 0.444 . . . . 0.0 110.134 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.587 HD12 ' SG ' ' A' ' 19' ' ' CYS . 3.3 mt -91.46 134.2 30.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.426 0.632 . . . . 0.0 112.665 -170.21 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.69 164.11 16.99 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 170.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.752 ' HD3' HD12 ' A' ' 36' ' ' ILE . 37.8 Cg_endo -66.73 -13.57 40.42 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.719 2.279 . . . . 0.0 113.213 -177.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -97.05 19.39 12.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.968 0.413 . . . . 0.0 111.221 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.02 -59.63 2.7 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.472 0.653 . . . . 0.0 110.327 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.5 m -93.98 117.35 29.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.331 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.2 m -157.09 21.12 0.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.91 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 mt -78.38 -63.23 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -99.63 -165.01 1.18 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -80.05 47.84 0.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.479 ' HE2' HG13 ' A' ' 67' ' ' VAL . 10.0 m-30 -91.06 163.6 14.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.657 -176.409 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -132.57 148.21 68.69 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.13 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.15 122.24 9.29 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.477 2.118 . . . . 0.0 112.128 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.844 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 34.2 m-85 -121.43 128.7 52.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.906 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.587 ' SG ' HD12 ' A' ' 5' ' ' ILE . 59.3 m -91.04 84.16 5.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.641 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 56.8 m -76.97 107.06 9.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.734 -176.351 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.049 -178.89 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 121.059 0.457 . . . . 0.0 110.233 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.494 HD11 ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -89.4 148.14 23.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.391 -178.809 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.0 76.32 2.17 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.81 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.844 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 33.3 m -87.34 99.26 11.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.021 0.439 . . . . 0.0 111.366 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 m -89.69 151.37 3.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 171.455 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.16 129.62 20.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.559 ' HA2' ' SG ' ' A' ' 19' ' ' CYS . . . -48.19 126.64 15.26 Favored Glycine 0 N--CA 1.447 -0.584 0 O-C-N 123.83 0.706 . . . . 0.0 111.912 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -78.06 114.02 18.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -177.645 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.752 HD12 ' HD3' ' A' ' 7' ' ' PRO . 7.3 mm -61.24 110.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.452 -172.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.71 9.51 61.17 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.833 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.56 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 70.4 m -112.21 151.04 30.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.057 0.456 . . . . 0.0 110.663 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.63 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 4.0 mt-30 -86.24 113.85 22.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.792 176.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.3 m -92.79 123.08 35.8 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.81 45.44 2.51 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.991 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -142.09 -178.24 5.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.82 125.4 27.07 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.2 t -79.36 97.42 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 11.4 mmpt? -105.42 124.36 49.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.038 -174.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 93.9 m -87.64 89.6 8.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 34.6 m -111.17 169.29 8.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.143 0.496 . . . . 0.0 111.498 -174.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.89 141.59 40.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.431 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--N 1.322 -0.629 0 CA-C-O 121.285 0.565 . . . . 0.0 110.043 176.838 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.037 0.446 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ILE . . . . . 0.526 ' H ' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -87.03 78.65 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 -178.726 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.467 HD12 ' HB2' ' A' ' 31' ' ' CYS . 14.2 mt -76.37 129.64 37.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.859 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.4 t30 -82.71 42.64 0.79 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.398 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ALA . . . . . 0.494 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . 70.92 -54.2 0.66 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.005 0.922 . . . . 0.0 113.084 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.39 59.42 2.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -173.66 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.01 25.5 0.82 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.393 0.616 . . . . 0.0 109.823 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -135.63 177.28 7.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.671 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' VAL . . . . . 0.479 HG13 ' HE2' ' A' ' 15' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.722 0.296 . . . . 0.0 110.576 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.951 0.405 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.11 129.78 44.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.488 HG23 ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -88.23 122.52 31.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.085 178.491 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.809 HG21 ' HA3' ' A' ' 34' ' ' GLY . 14.9 mt -94.14 140.63 16.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.013 0.435 . . . . 0.0 111.934 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.55 151.83 23.46 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 174.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.885 ' HD3' HG12 ' A' ' 36' ' ' ILE . 60.3 Cg_endo -72.77 46.03 0.98 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.851 2.368 . . . . 0.0 112.758 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -135.79 0.51 2.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.583 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.27 -54.07 10.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.241 0.543 . . . . 0.0 110.246 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -120.2 139.71 52.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.3 177.392 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.5 m -162.01 12.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.809 0.338 . . . . 0.0 110.55 -173.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ILE . . . . . 0.48 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -78.36 -84.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.407 ' H ' ' HB ' ' A' ' 12' ' ' ILE . 2.6 t70 -83.45 -152.84 0.13 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 173.308 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.62 48.15 1.48 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.937 0.875 . . . . 0.0 109.531 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.761 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 25.5 m-85 -96.16 110.0 22.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.273 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.4 mtmm -107.65 156.97 37.01 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.83 117.41 4.31 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.208 1.939 . . . . 0.0 111.678 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -122.11 122.33 38.98 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.58 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 5.1 t -88.3 100.84 13.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.74 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.865 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -101.96 135.7 43.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.887 -176.594 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.356 -178.035 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.235 0.292 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.865 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -127.61 164.01 22.96 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.73 -174.573 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.54 76.95 0.25 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.759 -177.38 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -81.42 108.35 14.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.744 0.306 . . . . 0.0 110.227 176.135 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 m -91.46 161.53 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.84 130.5 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.766 0.317 . . . . 0.0 110.423 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.809 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -61.11 134.26 48.85 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.636 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.422 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -78.94 116.65 23.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.055 0.455 . . . . 0.0 109.877 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.885 HG12 ' HD3' ' A' ' 7' ' ' PRO . 34.1 mt -67.22 120.12 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.849 -175.027 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.12 17.13 72.75 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.173 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' SER . . . . . 0.422 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -127.27 160.55 30.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.674 0.273 . . . . 0.0 110.695 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.488 ' HG3' HG23 ' A' ' 4' ' ' THR . 28.0 mt-30 -97.53 149.88 21.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.019 0.438 . . . . 0.0 110.873 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.56 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -121.41 156.99 31.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.231 178.881 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.56 16.3 21.68 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.753 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -124.35 -161.65 1.02 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -89.91 107.22 18.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.017 0.437 . . . . 0.0 111.084 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.45 109.38 17.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.952 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -130.93 -179.45 5.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.909 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.761 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 4.1 m -107.93 105.58 15.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.206 175.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 62.2 m -118.31 148.86 42.04 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.171 -174.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.544 ' HD2' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -91.64 116.04 28.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.095 0.474 . . . . 0.0 110.239 176.601 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.09 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 59' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.029 0.442 . . . . 0.0 110.316 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -87.99 105.44 15.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.796 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.5 mt -112.35 135.16 52.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.446 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -67.43 150.68 48.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.614 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.75 164.91 18.41 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.365 177.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 69.62 8.97 7.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.811 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.44 21.04 13.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.537 0.684 . . . . 0.0 109.98 175.561 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.9 m -123.42 140.52 52.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.09 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.313 -0.994 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.933 0.396 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.52 133.53 35.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.774 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.74 121.94 25.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.017 0.437 . . . . 0.0 110.516 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.684 HG21 ' HA3' ' A' ' 34' ' ' GLY . 3.7 mt -92.13 147.36 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.397 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.85 157.01 26.98 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 172.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.91 ' HD3' HG12 ' A' ' 36' ' ' ILE . 14.2 Cg_endo -56.97 -33.72 96.04 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.858 2.372 . . . . 0.0 112.095 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.84 62.21 4.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.448 0.642 . . . . 0.0 110.187 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.34 -49.59 4.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.089 175.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -123.32 152.68 41.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.137 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -151.82 19.49 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.725 0.774 . . . . 0.0 109.211 -174.022 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -74.22 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.191 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -100.96 -156.46 0.56 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.267 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -86.84 49.84 1.89 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.866 0.841 . . . . 0.0 108.771 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' TYR . . . . . 0.695 ' HB3' ' HB2' ' A' ' 46' ' ' CYS . 8.6 m-85 -86.9 110.48 20.02 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.523 -176.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.551 ' HG3' ' CE2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -95.02 155.27 39.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.641 -177.844 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.91 127.48 22.5 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.18 2.587 . . . . 0.0 112.858 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' TYR . . . . . 0.895 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 21.4 m-85 -138.07 130.96 29.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 18.2 m -89.49 87.36 7.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.565 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' CYS . . . . . 0.633 ' HB3' HD22 ' A' ' 29' ' ' LEU . 91.1 m -75.43 94.56 3.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.907 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.585 ' HG3' ' HB2' ' A' ' 42' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.543 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.0 m . . . . . 0 C--O 1.234 0.238 0 CA-C-O 121.445 0.641 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LEU . . . . . 0.633 HD22 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mt -79.69 115.36 19.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.969 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.91 62.98 4.46 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.88 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' CYS . . . . . 0.895 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 6.2 m -89.41 101.84 14.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.125 0.488 . . . . 0.0 110.98 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.94 152.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.2 t -59.53 132.97 24.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.713 0.292 . . . . 0.0 110.405 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLY . . . . . 0.684 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -66.41 113.94 6.1 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.65 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.6 122.01 32.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.063 0.458 . . . . 0.0 110.653 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ILE . . . . . 0.91 HG12 ' HD3' ' A' ' 7' ' ' PRO . 1.1 mt -59.13 130.17 22.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.104 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.87 80.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.45 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 m -122.32 166.73 14.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -101.39 137.0 40.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.903 0.383 . . . . 0.0 111.046 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' CYS . . . . . 0.53 ' HB2' HD11 ' A' ' 5' ' ' ILE . 7.7 t -101.01 128.41 47.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.796 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.05 -0.58 57.24 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.449 -178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.585 ' HB2' ' HG3' ' A' ' 21' ' ' GLN . . . -121.04 -162.21 0.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.095 0.474 . . . . 0.0 111.169 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.89 104.25 3.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.783 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.41 111.42 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -124.73 172.39 9.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.889 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' CYS . . . . . 0.695 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -118.16 119.94 36.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.657 0.265 . . . . 0.0 110.45 176.28 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.88 171.3 9.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.838 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.473 ' H ' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -115.09 154.05 29.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.746 -179.578 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.137 0.494 . . . . 0.0 110.954 -178.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.7 tp . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 mt -79.97 97.48 2.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.014 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 61' ' ' ILE . 3.6 mm -73.69 151.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.434 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -66.22 -68.35 0.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.275 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -162.25 -96.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.397 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.44 78.8 9.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.233 0.456 . . . . 0.0 112.233 -172.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.7 22.82 0.46 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.435 0.636 . . . . 0.0 109.923 171.484 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 87.0 m -123.23 86.95 2.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.612 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 120.965 0.412 . . . . 0.0 111.342 -175.232 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.548 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.778 0.323 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.68 35.36 0.62 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.258 0.551 . . . . 0.0 110.265 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.31 140.19 50.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.326 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.12 129.3 34.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.125 0.488 . . . . 0.0 110.317 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.913 HG21 ' HA3' ' A' ' 34' ' ' GLY . 80.9 mt -95.68 135.21 30.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.555 -176.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.93 161.3 34.19 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.91 ' HD3' HG12 ' A' ' 36' ' ' ILE . 25.8 Cg_exo -64.33 60.86 0.25 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 123.332 2.688 . . . . 0.0 112.871 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -150.73 -44.32 0.12 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -58.46 8.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.59 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 5.8 m -122.8 97.28 5.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.32 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -162.96 15.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.175 0.512 . . . . 0.0 110.201 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -78.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.996 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.659 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 26.9 t0 -77.75 59.12 1.97 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.165 0.507 . . . . 0.0 110.419 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t0 51.72 46.98 25.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.846 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.659 ' CE2' ' HB3' ' A' ' 13' ' ' ASP . 10.7 m-85 -102.2 160.79 14.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.543 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -125.04 145.5 50.52 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.607 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.487 ' HB2' HG23 ' A' ' 5' ' ' ILE . 61.4 Cg_endo -74.65 103.63 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.861 1.707 . . . . 0.0 111.154 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.925 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 33.9 m-85 -100.39 120.56 40.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.157 -175.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.29 87.35 7.27 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 57.8 m -78.15 113.62 16.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.954 -176.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -82.88 61.62 6.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.534 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.01 109.01 11.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.441 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.37 -164.79 1.08 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.693 -176.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.64 105.94 1.07 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.511 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.87 62.53 1.3 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.035 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.5 m -139.5 96.31 3.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.841 0.353 . . . . 0.0 110.753 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.93 -33.9 45.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.498 0.666 . . . . 0.0 110.226 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.44 129.82 55.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.019 173.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.557 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -80.13 123.39 27.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.806 0.336 . . . . 0.0 110.648 -175.868 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.61 78.69 1.62 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.925 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 14.7 m -86.9 99.32 11.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.012 0.434 . . . . 0.0 111.439 -175.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.86 142.7 13.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.36 122.42 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.913 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -66.25 117.9 10.3 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.292 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.14 139.18 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.91 HG12 ' HD3' ' A' ' 7' ' ' PRO . 2.4 mt -59.62 108.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.634 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.77 -21.27 9.09 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.982 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.0 m -76.08 160.85 29.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.575 0.226 . . . . 0.0 110.84 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.91 145.48 40.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.762 0.315 . . . . 0.0 110.269 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.5 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -100.21 110.76 23.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.882 175.928 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 1' ' ' SER . . . -84.46 -30.84 26.35 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.603 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.17 -142.24 0.24 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.716 0.293 . . . . 0.0 110.732 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.44 102.12 12.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 -176.295 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 p -80.29 115.8 23.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -116.32 143.91 44.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.089 0.471 . . . . 0.0 111.123 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 35.3 m -99.23 83.56 2.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.944 175.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 23.7 m -102.47 154.13 19.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.478 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.536 ' HA ' ' HD1' ' A' ' 15' ' ' TYR . 4.1 ttmt -65.68 -70.26 0.25 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.287 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -167.95 -51.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.808 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.418 ' C ' HG12 ' A' ' 51' ' ' VAL . 3.7 t0 78.54 -66.07 0.21 Allowed 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 124.32 1.013 . . . . 0.0 108.829 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.418 HG12 ' C ' ' A' ' 50' ' ' ASP . 0.4 OUTLIER 178.38 111.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.001 -178.023 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.97 45.01 1.04 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.181 0.515 . . . . 0.0 111.349 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -151.45 153.12 34.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.453 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 m 58.28 56.5 4.44 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.412 0.625 . . . . 0.0 109.974 -173.425 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 59' ' ' LEU . . . 151.56 57.29 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.605 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.8 -42.6 15.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.801 0.334 . . . . 0.0 110.223 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.85 67.03 7.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.408 0.623 . . . . 0.0 109.652 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.79 98.59 1.79 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -173.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 0.1 OUTLIER -60.96 123.3 17.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 110.992 -174.994 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.3 mt -80.25 80.8 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.154 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 63' ' ' ALA . 15.3 mm -77.85 137.33 22.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.174 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -78.66 11.78 2.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.79 0.329 . . . . 0.0 111.107 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.543 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 66.28 4.18 3.07 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.392 0.677 . . . . 0.0 112.374 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.55 32.92 5.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.9 0.381 . . . . 0.0 111.207 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.3 25.7 3.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.986 0.422 . . . . 0.0 110.154 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.56 155.71 48.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.911 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -53.16 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.912 0.387 . . . . 0.0 110.014 174.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.196 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.855 0.36 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.56 101.75 14.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.984 0.421 . . . . 0.0 110.628 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.9 137.25 32.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.186 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.93 138.48 33.13 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.861 HG21 ' HA3' ' A' ' 34' ' ' GLY . 6.2 mt -105.51 134.27 47.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.364 0.602 . . . . 0.0 112.196 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.42 147.1 19.03 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 171.686 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -51.47 -34.46 51.47 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.346 2.697 . . . . 0.0 112.992 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -101.58 67.75 1.14 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.103 0.478 . . . . 0.0 110.498 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.11 -61.52 1.36 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.025 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 54.4 m -116.24 142.93 46.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.5 m -159.63 32.86 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.073 0.463 . . . . 0.0 110.863 -172.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.06 -68.67 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -95.44 -165.55 1.31 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.591 167.364 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.59 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 3.7 t70 -77.85 50.72 0.88 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.377 0.608 . . . . 0.0 109.573 170.802 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.665 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 8.2 m-85 -85.85 79.61 9.2 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.627 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.687 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -79.3 156.97 75.94 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.329 -177.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.08 116.02 3.94 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.464 2.109 . . . . 0.0 111.305 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.579 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 25.8 m-85 -126.82 131.38 51.25 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.593 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.9 m -94.83 99.03 11.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.363 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HB3' HD22 ' A' ' 29' ' ' LEU . 1.6 m -82.92 121.25 26.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.724 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -93.55 107.45 19.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.605 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.33 107.71 11.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.521 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.7 mtm -97.97 167.98 10.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.022 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -51.64 49.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.388 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.18 -45.42 3.05 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.008 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.04 105.04 10.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.048 0.451 . . . . 0.0 110.752 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.53 0.66 56.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.963 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.52 141.77 48.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.01 176.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 20' ' ' CYS . 7.2 mt -80.23 88.0 5.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.004 0.431 . . . . 0.0 111.203 -175.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.14 79.84 1.15 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.784 175.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.5 OUTLIER -88.63 109.61 20.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 0.0 111.227 -178.373 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.95 153.39 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.987 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 t -62.09 130.64 26.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.744 0.307 . . . . 0.0 110.704 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.861 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -66.39 132.44 32.8 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.289 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.424 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 2.1 t -80.54 137.51 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.069 0.462 . . . . 0.0 110.703 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mt -64.15 111.75 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.265 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.13 59.11 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.497 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.424 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 15.1 m -110.36 170.89 7.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.715 0.293 . . . . 0.0 110.515 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.49 136.25 54.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.498 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.442 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -115.47 133.4 56.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.433 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.79 29.65 9.18 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.235 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -121.44 -156.09 0.67 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.5 83.86 4.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.009 0.433 . . . . 0.0 110.375 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 40' ' ' CYS . 2.0 t -79.59 109.72 14.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.027 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.753 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -124.13 160.07 28.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.992 0.425 . . . . 0.0 111.163 -176.135 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.665 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 59.0 m -93.59 100.84 13.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 171.157 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.403 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 69.3 m -108.15 144.48 35.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.363 -172.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.59 ' HE3' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -79.3 117.36 20.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.51 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.687 ' HB2' ' HD2' ' A' ' 16' ' ' LYS . 65.8 t0 -71.18 117.5 12.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.952 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -103.61 1.9 32.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.861 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.05 -55.51 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 m 51.91 57.93 6.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.544 0.687 . . . . 0.0 110.783 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -103.84 162.15 13.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.344 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.92 -4.43 31.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.179 0.514 . . . . 0.0 111.028 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.47 42.39 1.86 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -72.51 113.74 9.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.869 0.366 . . . . 0.0 110.217 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p -129.14 -93.86 0.43 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.835 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.94 98.26 1.22 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.28 118.06 22.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.834 0.35 . . . . 0.0 110.553 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.21 97.11 4.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.797 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.499 ' H ' HG12 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -88.63 150.44 3.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.387 -178.394 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -101.85 45.07 0.98 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.906 0.384 . . . . 0.0 110.661 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 73.27 -56.33 0.66 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.367 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.09 -27.04 65.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -92.66 17.08 10.81 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.476 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.0 m -127.41 119.79 26.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.798 0.332 . . . . 0.0 110.88 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.53 112.04 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.042 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.753 ' HB3' ' HA ' ' A' ' 45' ' ' LYS . . . . . . . . 0 C--O 1.245 0.863 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.186 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.423 ' HB2' ' H ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 120.525 0.203 . . . . 0.0 110.625 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' H ' ' HB2' ' A' ' 1' ' ' SER . . . -89.83 73.59 7.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.091 0.472 . . . . 0.0 110.391 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -67.82 120.76 14.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.586 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.03 125.05 28.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.785 176.066 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.722 HG21 ' HA3' ' A' ' 34' ' ' GLY . 3.5 mt -104.28 132.9 49.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -170.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.72 149.0 16.85 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 167.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.11 43.06 0.8 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.648 2.232 . . . . 0.0 113.539 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -150.32 26.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.051 0.453 . . . . 0.0 110.677 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.19 -23.6 47.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.726 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 m -146.12 145.97 30.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.5 m -162.36 25.2 0.11 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.801 0.334 . . . . 0.0 111.075 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.16 -65.67 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -100.52 -151.12 0.4 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 168.366 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -83.03 47.46 1.23 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.933 0.873 . . . . 0.0 108.693 169.252 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.579 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 5.8 m-85 -82.35 78.81 8.95 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.677 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -79.81 149.92 71.55 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.27 126.63 19.0 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.397 2.065 . . . . 0.0 111.052 176.425 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.702 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 9.2 m-85 -129.1 129.85 45.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.971 0.415 . . . . 0.0 111.373 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 13.9 m -83.56 84.14 7.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.357 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 20.6 m -72.67 96.84 2.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.111 0.482 . . . . 0.0 111.386 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -84.56 93.52 8.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.84 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.514 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -59.99 136.2 57.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.904 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.31 139.95 37.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.944 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.65 58.48 1.81 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.365 0.602 . . . . 0.0 110.995 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.21 -58.08 0.12 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.493 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.97 159.46 19.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.642 0.258 . . . . 0.0 110.349 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.13 -19.23 43.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.934 0.397 . . . . 0.0 110.724 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.08 153.9 42.6 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.863 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -122.96 139.2 54.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.97 -177.071 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.93 76.05 2.3 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.793 ' HB2' HD12 ' A' ' 61' ' ' ILE . 3.8 m -79.54 100.75 7.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.998 0.428 . . . . 0.0 111.042 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.42 145.34 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 p -58.1 135.24 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.806 0.336 . . . . 0.0 110.708 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.722 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -56.81 118.97 13.21 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.003 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.23 118.92 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 120.91 0.386 . . . . 0.0 110.352 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.59 124.54 8.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.458 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.08 13.93 81.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.27 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.72 167.12 15.0 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 3' ' ' THR . 2.5 mt-30 -113.23 145.79 40.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.616 ' HB2' HD11 ' A' ' 5' ' ' ILE . 13.9 m -125.99 120.08 29.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.197 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.48 61.81 3.16 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.289 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.03 -166.16 2.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.77 98.44 1.96 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.904 0.383 . . . . 0.0 110.462 176.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.4 t -87.3 91.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.199 0.523 . . . . 0.0 109.661 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.44 162.67 17.94 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.511 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.579 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -87.5 112.62 22.41 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.783 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.448 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 64.0 m -115.24 149.24 38.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.932 0.396 . . . . 0.0 111.167 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.85 119.33 17.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.839 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 53' ' ' ASN . 49.5 t0 -92.9 69.01 4.55 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.518 0.675 . . . . 0.0 110.252 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.73 -2.04 27.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.506 174.766 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -23.06 6.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.416 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.2 -53.35 0.79 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.276 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.409 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 7.2 t-20 63.88 43.01 5.59 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.484 0.659 . . . . 0.0 109.745 -175.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.9 -55.05 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.062 -176.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 134.09 153.32 6.94 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.257 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -155.25 154.66 32.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.968 0.384 . . . . 0.0 110.804 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.95 -16.45 40.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.821 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.55 68.44 0.5 Allowed Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.93 96.71 10.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.937 0.399 . . . . 0.0 110.938 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mt -79.97 102.35 5.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 31' ' ' CYS . 62.3 mt -99.61 135.33 35.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.56 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -64.23 145.04 56.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.28 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.37 45.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.108 0.48 . . . . 0.0 111.671 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -154.19 19.28 0.5 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.295 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -123.01 13.89 9.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.3 m -127.96 143.81 51.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.849 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 m -105.82 152.53 7.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.808 0.337 . . . . 0.0 110.684 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.867 -1.063 . . . . 0.0 109.528 179.058 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . -79.21 103.78 9.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.062 0.458 . . . . 0.0 110.432 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.67 138.3 42.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.224 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.52 133.46 38.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.765 0.317 . . . . 0.0 110.181 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.579 HG21 ' HA3' ' A' ' 34' ' ' GLY . 12.3 mm -106.4 137.55 36.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.517 0.675 . . . . 0.0 112.466 -173.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.17 151.61 23.07 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.798 ' HD3' HG12 ' A' ' 36' ' ' ILE . 31.2 Cg_endo -64.68 58.46 0.27 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.136 2.557 . . . . 0.0 113.312 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -139.89 -26.39 0.79 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.126 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.64 -52.0 57.57 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.73 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.0 m -143.95 135.82 26.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.941 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.89 30.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.501 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.29 -73.53 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.02 177.783 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.459 ' C ' ' H ' ' A' ' 15' ' ' TYR . 9.9 t0 -83.79 -161.97 0.59 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 168.412 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.512 ' HB3' ' HG3' ' A' ' 48' ' ' LYS . 29.0 t0 -77.21 40.61 0.27 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.691 0.758 . . . . 0.0 109.541 172.041 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 8.1 m-30 -90.5 84.69 5.99 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.8 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 150.38 72.37 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.2 128.46 22.81 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.328 2.019 . . . . 0.0 111.846 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.88 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 9.4 m-85 -132.12 149.97 52.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.408 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.544 ' HB3' HG23 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -109.85 81.04 1.38 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.753 176.688 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 2.7 m -78.91 102.97 8.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.454 0.645 . . . . 0.0 110.937 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.431 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 4.9 tp-100 -76.15 108.39 9.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.908 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 m -168.12 147.73 4.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.442 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -105.36 -44.06 4.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.989 0.423 . . . . 0.0 110.398 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.25 -78.13 0.21 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.336 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.82 73.95 0.18 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.551 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -95.45 -36.45 11.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.919 0.39 . . . . 0.0 110.224 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.53 -147.88 0.16 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.96 162.01 27.1 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.971 HD12 ' HB ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -79.57 114.74 18.73 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.147 -177.009 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.5 85.65 1.15 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.529 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.88 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.93 143.74 28.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.326 0.584 . . . . 0.0 111.627 -177.206 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -123.68 158.84 29.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 168.184 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.8 t -64.06 133.29 29.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.579 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -55.63 119.83 15.76 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.574 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -78.72 108.53 12.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.24 0.543 . . . . 0.0 110.817 -174.83 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.798 HG12 ' HD3' ' A' ' 7' ' ' PRO . 3.1 mp -64.97 116.34 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.777 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.75 1.05 74.3 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.766 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.574 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -120.29 -173.91 2.67 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.618 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 12.8 mt-30 -114.86 143.63 44.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.01 0.433 . . . . 0.0 111.376 -176.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.7 152.54 40.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.757 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.37 -1.24 33.14 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.863 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -148.34 -161.92 1.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.563 -0.318 . . . . 0.0 110.576 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.14 128.76 37.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.168 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.22 122.48 34.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.314 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HG3' ' HB2' ' A' ' 20' ' ' CYS . 1.3 mmpm? -121.59 166.92 13.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.28 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 13.8 m -131.03 96.8 4.14 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 66' ' ' CYS . 0.8 OUTLIER -123.56 165.09 17.73 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 -174.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HG3' ' HB3' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -81.37 -151.09 0.08 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.63 -66.23 0.59 Allowed 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.642 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.5 t70 68.25 -51.87 0.54 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.313 0.856 . . . . 0.0 113.313 173.008 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.583 HG13 HD13 ' A' ' 61' ' ' ILE . 3.8 m -46.25 126.11 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.05 42.68 1.04 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.153 170.95 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -145.99 154.24 41.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.987 -175.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.24 -7.9 55.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.475 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.58 28.35 7.55 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.561 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -81.42 -67.1 0.81 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.047 0.451 . . . . 0.0 110.545 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.12 49.94 1.84 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.645 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.07 -156.31 47.13 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.609 HD13 ' HE1' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -111.55 90.7 3.41 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.148 0.499 . . . . 0.0 109.882 178.146 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mt -78.93 93.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.741 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.971 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.1 mm -79.03 139.65 18.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.579 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -81.04 -0.38 39.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.332 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.817 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 64.8 28.68 12.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.013 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.4 -56.01 2.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.087 0.47 . . . . 0.0 110.899 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.91 54.18 2.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.178 0.513 . . . . 0.0 110.67 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 47' ' ' CYS . 16.0 t -150.7 164.16 36.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.435 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.4 m -118.41 151.47 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.815 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.33 178.249 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.411 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.03 121.22 37.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.001 0.429 . . . . 0.0 111.062 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.63 151.63 44.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.263 176.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.0 136.64 37.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.921 0.391 . . . . 0.0 111.608 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.663 HG21 ' HA3' ' A' ' 34' ' ' GLY . 45.1 mt -103.53 126.4 57.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.793 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.88 156.43 27.78 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.812 ' HD3' HG12 ' A' ' 36' ' ' ILE . 25.4 Cg_endo -62.14 -5.58 6.68 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.811 2.341 . . . . 0.0 112.619 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.91 7.39 23.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.549 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.2 m -61.42 -48.0 83.18 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 170.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 3.6 m -96.15 163.47 13.09 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.52 33.59 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.897 0.855 . . . . 0.0 108.759 -169.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.03 -109.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.469 -172.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.02 80.58 2.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.4 t70 49.76 42.67 24.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.459 0.647 . . . . 0.0 111.323 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.48 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 11.4 m-85 -108.03 134.49 50.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.075 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.82 160.66 48.08 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.711 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.499 ' HB2' HG23 ' A' ' 5' ' ' ILE . 58.7 Cg_endo -68.69 115.54 3.98 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.497 2.131 . . . . 0.0 111.878 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.729 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 30.1 m-85 -123.61 126.92 47.5 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.14 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.76 88.59 7.71 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.731 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 65.8 m -75.08 103.27 5.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.073 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -88.47 166.93 13.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.871 -177.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.13 172.58 11.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.259 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.683 ' HG2' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -85.15 70.92 10.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.201 -176.94 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -76.07 0.19 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.726 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.1 -12.15 37.42 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.143 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -122.43 129.29 51.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.683 ' HA ' ' HG2' ' A' ' 23' ' ' MET . . . -90.06 45.62 1.29 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.259 0.552 . . . . 0.0 110.94 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.57 174.3 10.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.757 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.84 89.95 4.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.88 71.72 2.14 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.347 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 35.9 m -85.39 93.17 8.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.914 0.387 . . . . 0.0 110.265 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.21 145.78 7.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 t -58.56 131.31 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.663 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -64.83 144.54 48.32 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.634 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.46 103.68 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.812 HG12 ' HD3' ' A' ' 7' ' ' PRO . 2.7 mp -58.15 118.16 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.885 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.21 -8.17 41.32 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.796 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.25 -178.86 3.47 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.85 141.6 37.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.794 0.331 . . . . 0.0 110.694 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.557 ' HB3' HG22 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -86.55 124.05 32.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.625 175.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 1' ' ' SER . . . -89.56 -17.16 55.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.275 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.57 -170.0 1.7 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.549 0.214 . . . . 0.0 110.479 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.53 109.47 2.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.862 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 40' ' ' CYS . 0.9 OUTLIER -79.77 103.31 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.243 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.563 ' HB3' ' SG ' ' A' ' 66' ' ' CYS . 1.9 mmpt? -113.18 149.6 33.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.668 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 21.9 m -90.92 93.79 9.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.931 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -124.19 -175.48 3.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.413 -177.794 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.76 141.0 18.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -91.13 100.23 13.11 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.272 0.558 . . . . 0.0 109.532 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.39 24.51 12.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.144 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -123.66 -38.98 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.152 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.16 -66.57 0.92 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.211 -0.196 . . . . 0.0 110.812 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 74.47 -20.5 0.32 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.428 0.691 . . . . 0.0 112.632 174.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -14.14 60.8 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.06 63.42 1.45 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.26 138.82 31.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.663 0.268 . . . . 0.0 110.994 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.64 122.09 25.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.975 0.417 . . . . 0.0 110.113 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.79 75.19 1.17 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -172.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -89.3 137.72 32.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.155 0.503 . . . . 0.0 111.106 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.01 115.58 49.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.068 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.3 mp -104.55 118.5 51.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -78.44 62.18 3.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.707 -173.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 67.46 -69.74 0.13 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.965 0.906 . . . . 0.0 113.314 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.34 54.89 0.94 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -171.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.24 28.56 0.25 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 174.689 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 45.5 t -160.42 147.98 16.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.003 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.02 104.5 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.166 0.507 . . . . 0.0 110.087 175.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.476 -0.774 . . . . 0.0 110.263 -178.035 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 120.724 0.297 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 40' ' ' CYS . . . -84.81 124.36 31.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.099 0.476 . . . . 0.0 110.997 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.97 142.68 48.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.947 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.503 ' HA ' ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -77.54 125.2 28.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.999 0.428 . . . . 0.0 110.524 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.731 HG21 ' HA3' ' A' ' 34' ' ' GLY . 32.2 mt -89.76 127.2 42.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.072 -174.08 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.31 128.51 6.4 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 170.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.444 ' CG ' HG12 ' A' ' 36' ' ' ILE . 84.7 Cg_exo -43.45 -37.88 8.06 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.89 3.06 . . . . 0.0 114.476 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -86.58 33.57 0.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -45.56 42.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -132.32 141.54 48.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.102 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.3 17.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.417 0.627 . . . . 0.0 109.513 -175.379 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.43 -84.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.968 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -100.32 53.78 0.89 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.32 -173.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.419 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 23.4 t70 62.82 21.66 12.94 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.679 0.752 . . . . 0.0 110.229 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.525 ' HE2' HG22 ' A' ' 67' ' ' VAL . 3.9 m-85 -80.6 130.19 34.97 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.493 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.586 ' HE3' ' HB2' ' A' ' 49' ' ' ASP . 0.8 OUTLIER -126.82 157.63 70.91 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -177.802 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.15 115.02 3.8 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.589 2.193 . . . . 0.0 111.57 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.66 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 27.0 m-85 -120.3 133.4 55.47 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.993 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -81.88 84.83 6.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.717 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 m -78.55 79.7 4.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.296 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.421 HE22 ' HB3' ' A' ' 19' ' ' CYS . 2.4 mp0 -77.52 130.68 37.28 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.09 179.68 7.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.551 0.691 . . . . 0.0 112.377 -170.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.7 174.69 10.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.373 174.479 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.45 -72.88 0.06 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.49 64.88 3.15 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.66 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.0 m -155.53 100.65 2.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.753 0.311 . . . . 0.0 110.634 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.47 -25.72 41.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.128 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.13 103.09 2.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.613 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.715 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 4.2 mt -87.22 146.63 25.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.504 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.93 48.13 0.99 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.867 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 29' ' ' LEU . 2.0 m -79.03 106.85 11.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.124 0.488 . . . . 0.0 111.328 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.4 m -86.07 164.27 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.637 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.82 135.47 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 123.167 0.292 . . . . 0.0 110.484 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.731 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -64.59 116.51 9.1 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.209 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.02 135.02 26.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.78 0.324 . . . . 0.0 110.623 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.444 HG12 ' CG ' ' A' ' 7' ' ' PRO . 1.4 mt -64.93 110.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.51 -9.7 49.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.113 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.6 m -90.8 171.19 9.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.882 0.372 . . . . 0.0 110.48 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.503 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 1.6 mp0 -124.3 140.25 53.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.837 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -75.82 146.72 39.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.205 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.25 -51.78 3.43 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.385 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.41 -90.18 0.15 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.746 0.308 . . . . 0.0 110.642 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.17 138.37 29.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.648 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.42 HG22 ' HB2' ' A' ' 40' ' ' CYS . 1.2 t -80.89 125.94 39.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.013 175.822 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -117.85 157.69 26.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.436 ' HB3' ' HD2' ' A' ' 15' ' ' TYR . 32.9 m -102.55 99.95 10.01 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 4.0 m -116.07 147.28 41.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.993 0.425 . . . . 0.0 111.461 -175.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -98.74 136.39 38.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.776 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.586 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 48.7 t0 -85.85 86.23 7.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.295 0.569 . . . . 0.0 110.628 -177.033 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.25 -75.06 0.18 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.966 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.31 32.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.785 0.802 . . . . 0.0 109.339 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.56 HG21 ' HA ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -94.09 -13.27 27.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.921 -172.756 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -60.59 -28.35 68.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.395 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.18 79.23 2.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.734 0.302 . . . . 0.0 111.365 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.3 12.72 1.4 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.458 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.7 m120 69.3 -85.32 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.151 0.58 . . . . 0.0 111.415 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.45 19.43 13.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.988 0.423 . . . . 0.0 110.989 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.0 165.79 34.32 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.425 HD13 ' HE1' ' A' ' 18' ' ' TYR . 1.3 mp -119.94 113.35 20.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.865 0.365 . . . . 0.0 110.203 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.08 87.71 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.995 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 29' ' ' LEU . 37.9 mm -63.85 127.54 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.599 -178.251 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.77 44.69 1.18 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.812 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 67.4 -68.08 0.16 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.536 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.18 54.43 2.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 0.0 112.028 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.557 ' HB2' HG23 ' A' ' 61' ' ' ILE . 35.7 m120 -126.48 -14.9 5.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.688 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 4.6 m -109.77 88.79 2.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.575 -174.569 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.525 HG22 ' HE2' ' A' ' 15' ' ' TYR . 2.6 t 51.24 -103.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.94 177.036 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.952 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -177.675 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 120.801 0.334 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.87 157.71 19.48 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.502 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.88 118.91 29.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.619 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.68 119.84 22.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.049 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' A' ' 40' ' ' CYS . 85.4 mt -87.07 127.92 40.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -172.529 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -117.37 136.96 12.96 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 166.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.584 ' HG3' HG12 ' A' ' 36' ' ' ILE . 74.5 Cg_endo -72.96 44.73 0.82 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.031 2.488 . . . . 0.0 113.94 -172.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -157.18 26.01 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.739 0.304 . . . . 0.0 111.22 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -58.1 3.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.415 0.626 . . . . 0.0 109.629 174.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -92.64 136.16 33.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.285 174.588 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.89 26.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.027 0.441 . . . . 0.0 110.371 -175.201 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -66.48 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 15' ' ' TYR . 3.2 t70 -100.6 -149.07 0.37 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.348 169.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -81.84 40.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.686 0.755 . . . . 0.0 109.394 171.772 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.557 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 1.9 m-85 -82.96 111.7 19.07 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.606 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.4 143.16 26.07 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.0 125.1 16.27 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.481 2.12 . . . . 0.0 111.163 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.709 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 9.7 m-85 -134.84 123.9 24.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.028 0.442 . . . . 0.0 110.8 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.8 t -87.09 93.15 9.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.026 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 26.1 m -74.57 100.44 3.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.263 0.554 . . . . 0.0 109.793 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.31 -25.8 4.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.892 -173.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.756 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 0.8 OUTLIER -78.34 71.32 4.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.41 0.624 . . . . 0.0 111.054 -177.91 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.423 ' HA ' ' O ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -133.66 26.27 4.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.727 177.393 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.81 -45.57 11.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.813 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -117.19 8.82 15.73 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.575 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 23' ' ' MET . 0.9 OUTLIER -144.59 150.56 37.66 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -99.44 8.53 44.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.246 0.546 . . . . 0.0 110.057 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.75 159.7 23.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.639 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.509 HD11 ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -79.84 78.41 6.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.003 0.43 . . . . 0.0 110.918 -178.434 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.756 ' HA3' ' HB2' ' A' ' 22' ' ' SER . . . -80.95 86.05 1.37 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.615 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 4.0 m -109.13 115.39 29.94 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.771 0.319 . . . . 0.0 110.955 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.9 154.78 4.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.98 139.33 15.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.464 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.509 ' CA ' HG21 ' A' ' 5' ' ' ILE . . . -65.26 88.34 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.849 174.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.457 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 61.1 t -79.45 137.04 22.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.914 0.388 . . . . 0.0 110.215 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.584 HG12 ' HG3' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -63.41 110.04 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.552 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.38 -4.61 33.19 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.585 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.457 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 43.1 m -78.08 127.58 32.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.991 0.424 . . . . 0.0 110.711 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -93.94 94.25 8.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.288 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.703 ' HB2' HD11 ' A' ' 5' ' ' ILE . 12.4 t -74.9 118.74 18.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.287 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.9 -2.82 59.41 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.195 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.3 -132.83 0.33 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.669 0.271 . . . . 0.0 111.018 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.567 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 70.5 m -86.93 99.42 11.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.013 0.435 . . . . 0.0 111.352 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -79.67 81.64 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.122 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HE3' HD11 ' A' ' 29' ' ' LEU . 3.7 mttm -91.35 175.72 6.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.794 -172.086 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 89.2 m -127.71 106.05 8.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.597 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 91.2 m -120.84 149.38 42.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.809 0.337 . . . . 0.0 111.088 -174.346 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.24 97.67 11.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.253 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -103.89 103.15 12.97 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.83 -61.2 2.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.048 0.452 . . . . 0.0 111.151 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 51' ' ' VAL . 2.7 m -84.6 172.74 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.76 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.56 155.6 20.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.299 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 70.24 23.38 5.15 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.703 0.627 . . . . 0.0 111.349 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.9 76.1 2.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.111 0.481 . . . . 0.0 111.017 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 59' ' ' LEU . . . 123.91 -12.49 8.17 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -176.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.477 ' HB3' ' H ' ' A' ' 57' ' ' SER . 0.6 OUTLIER 61.71 -105.01 0.17 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.754 0.422 . . . . 0.0 111.224 178.442 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.477 ' H ' ' HB3' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -89.47 -12.14 40.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 0.0 111.315 -179.387 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -134.94 83.72 0.28 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.497 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . 3.4 mp -80.88 91.96 6.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.106 0.479 . . . . 0.0 111.053 -174.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.9 mt -79.63 102.57 5.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.38 146.83 5.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.292 -171.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -69.21 121.34 16.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.71 175.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.496 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . . . -78.94 35.32 0.25 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 111.894 -173.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -128.14 13.55 6.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.906 0.384 . . . . 0.0 110.561 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -138.71 38.29 2.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.239 0.542 . . . . 0.0 110.79 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 11.1 m -130.11 153.94 47.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.767 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.07 -62.96 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.0 110.529 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.883 -0.58 . . . . 0.0 109.652 179.683 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.77 0.319 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.95 144.71 33.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.337 . . . . 0.0 110.632 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -146.31 127.8 15.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.234 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.49 123.68 26.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.152 0.501 . . . . 0.0 110.189 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.698 HG21 ' HA3' ' A' ' 34' ' ' GLY . 8.6 mt -89.58 127.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.57 -172.1 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.4 137.48 14.21 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 168.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.77 -4.99 5.23 Favored 'Trans proline' 0 N--CA 1.478 0.581 0 C-N-CA 123.364 2.71 . . . . 0.0 114.114 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -119.74 34.32 5.27 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.36 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -33.86 76.22 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.572 0.701 . . . . 0.0 110.295 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 89.3 m -135.21 146.18 48.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.906 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.69 17.6 0.8 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.952 0.406 . . . . 0.0 110.652 -169.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.53 -71.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 15' ' ' TYR . 3.8 t0 -93.67 -159.73 0.71 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.578 171.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASP . . . . . 0.553 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 21.2 t70 -80.43 41.57 0.55 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.634 0.73 . . . . 0.0 109.295 172.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.793 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 10.4 m-85 -85.57 71.74 10.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.783 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HB2' ' HD2' ' A' ' 17' ' ' PRO . 4.3 ptpt -79.58 156.01 75.79 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.831 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 16' ' ' LYS . 29.7 Cg_endo -61.32 126.54 19.57 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.978 2.452 . . . . 0.0 112.777 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.919 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 21.6 m-85 -127.95 123.93 36.07 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.081 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.1 m -80.75 80.95 7.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 53.6 m -77.03 121.43 23.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.574 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.4 152.06 44.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.131 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.87 116.29 1.9 Allowed 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.873 0.733 . . . . 0.0 111.571 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.447 ' O ' ' HG2' ' A' ' 23' ' ' MET . 0.0 OUTLIER -78.28 127.65 32.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.7 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.44 96.91 4.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.506 -177.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.83 -50.05 3.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.835 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -67.19 151.22 47.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.811 0.339 . . . . 0.0 110.665 177.547 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -92.38 -4.23 54.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.326 0.584 . . . . 0.0 110.127 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.453 ' HB2' HG22 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -108.36 135.86 48.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.024 178.6 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -103.09 148.27 25.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.401 -177.981 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.79 77.63 1.87 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.734 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.919 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 28.9 m -86.49 120.18 27.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.16 0.505 . . . . 0.0 112.112 -176.188 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.21 144.59 15.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 169.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 p -58.6 131.44 22.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.008 0.432 . . . . 0.0 111.058 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.698 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -67.56 117.08 8.46 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.699 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.401 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 11.2 t -78.92 131.22 34.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.904 0.383 . . . . 0.0 110.42 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.94 120.63 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.653 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.99 -4.95 68.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.642 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.401 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 15.8 m -95.24 166.34 11.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.643 0.259 . . . . 0.0 110.703 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 3' ' ' THR . 18.9 mt-30 -114.9 124.9 52.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.566 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.545 ' HB2' HD11 ' A' ' 5' ' ' ILE . 1.7 t -81.17 135.64 35.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.204 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.76 2.94 23.09 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.829 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -120.24 -157.59 0.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.1 92.38 4.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.965 0.412 . . . . 0.0 110.628 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.45 ' HB ' ' SG ' ' A' ' 40' ' ' CYS . 1.6 p -78.6 109.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.519 0.676 . . . . 0.0 109.613 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -118.22 171.11 8.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.827 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.793 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 59.7 m -112.71 104.01 12.04 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 173.843 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.508 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.8 OUTLIER -122.99 157.32 32.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.42 -177.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.669 ' HD2' ' HE1' ' A' ' 15' ' ' TYR . 2.5 ptmt -97.71 155.69 16.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.868 0.366 . . . . 0.0 110.76 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.3 68.56 5.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.844 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.88 -19.37 61.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.9 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.4 67.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.154 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.33 53.77 0.86 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.929 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -122.07 102.46 8.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.878 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.06 142.73 56.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.946 -175.575 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.59 -159.34 9.7 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -105.75 15.51 26.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.296 0.569 . . . . 0.0 110.069 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.09 159.44 22.56 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.932 -176.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.91 164.44 53.02 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.771 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.16 90.4 8.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.138 0.494 . . . . 0.0 110.484 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -79.98 76.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.438 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.508 HD13 ' HB3' ' A' ' 47' ' ' CYS . 1.3 mt -84.59 152.12 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.559 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -72.34 139.55 47.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.592 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -61.99 -25.57 67.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.596 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.27 -5.9 55.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.143 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -95.17 -12.64 26.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.988 0.423 . . . . 0.0 110.842 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.79 172.14 11.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.019 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -50.62 79.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.344 . . . . 0.0 111.48 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.865 0 CA-C-O 119.109 -0.472 . . . . 0.0 109.788 -178.339 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.787 0 CA-C-O 120.95 0.405 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.76 67.19 1.98 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.251 0.548 . . . . 0.0 109.622 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.96 123.75 22.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.887 -176.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 m -79.82 134.33 36.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.308 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 40' ' ' CYS . 37.8 mt -98.19 136.27 29.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.229 0.538 . . . . 0.0 112.43 -172.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.437 ' HA2' ' HD3' ' A' ' 7' ' ' PRO . . . -136.3 128.84 4.66 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 168.382 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.509 ' HA ' ' HG3' ' A' ' 17' ' ' PRO . 38.5 Cg_exo -59.91 3.17 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.7 2.933 . . . . 0.0 114.58 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -85.59 -0.99 56.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.934 0.397 . . . . 0.0 110.827 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -56.61 13.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.204 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -135.59 149.48 49.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.137 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -173.76 16.89 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.094 0.473 . . . . 0.0 110.395 -175.732 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.465 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.63 -90.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.67 -175.32 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -86.16 66.46 9.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.211 -178.746 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t0 57.27 27.14 13.22 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.221 0.534 . . . . 0.0 110.897 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.657 ' CE1' ' HG3' ' A' ' 48' ' ' LYS . 54.5 m-85 -88.79 148.69 23.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.45 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.638 ' HB2' ' HD2' ' A' ' 17' ' ' PRO . 14.0 pttm -160.07 163.23 22.76 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.638 ' HD2' ' HB2' ' A' ' 16' ' ' LYS . 20.1 Cg_endo -59.25 130.63 36.93 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.492 2.128 . . . . 0.0 112.201 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.9 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 12.4 m-85 -131.72 132.15 43.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.539 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.63 ' HB2' HG23 ' A' ' 32' ' ' VAL . 6.1 m -94.01 93.59 7.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.39 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.74 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 2.8 m -85.31 111.28 19.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.931 0.396 . . . . 0.0 110.333 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -84.93 73.68 10.63 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.837 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.0 109.93 6.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.028 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -33.94 45.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.232 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 p -164.13 -110.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.851 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.37 82.19 1.54 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.96 112.02 21.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.92 0.39 . . . . 0.0 111.14 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.95 -52.72 7.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.254 0.55 . . . . 0.0 109.713 177.023 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -85.26 96.87 9.64 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.74 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -83.08 138.03 33.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.549 -170.885 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.43 94.72 1.93 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.891 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.9 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -95.98 149.21 21.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.116 0.484 . . . . 0.0 111.673 -177.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.63 HG23 ' HB2' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -127.21 163.4 30.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 171.067 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.56 128.52 32.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.605 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -63.82 110.74 3.6 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.049 177.054 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.518 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -79.58 129.01 38.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.888 0.375 . . . . 0.0 110.739 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.521 ' H ' HD12 ' A' ' 36' ' ' ILE . 1.2 mp -57.6 127.13 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.255 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.04 15.5 81.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.794 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.518 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -118.23 163.07 17.22 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -102.14 157.29 16.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.906 0.384 . . . . 0.0 110.919 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.756 ' HB2' HD11 ' A' ' 5' ' ' ILE . 4.8 t -122.98 125.3 44.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.187 175.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.01 7.55 69.87 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.776 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.07 -166.24 1.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.56 119.63 18.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.013 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 t -86.9 104.3 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.35 164.26 11.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.994 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.0 m -115.81 88.94 2.99 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 57.9 m -112.52 163.45 14.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 -173.637 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.657 ' HG3' ' CE1' ' A' ' 15' ' ' TYR . 18.5 mtpt -82.06 171.19 14.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.967 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.66 48.92 1.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.344 -0.843 . . . . 0.0 108.996 169.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.86 121.48 18.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.045 -175.698 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.409 ' HB ' HG22 ' A' ' 54' ' ' THR . 0.0 OUTLIER -145.68 117.42 2.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.413 -175.107 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.43 -3.97 15.03 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.043 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -122.08 17.3 10.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.836 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.409 HG22 ' HB ' ' A' ' 51' ' ' VAL . 6.4 t -104.34 165.57 10.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.471 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.6 51.87 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.694 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.452 HD21 HG13 ' A' ' 60' ' ' ILE . 10.1 p30 -167.27 -157.83 0.26 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.509 0.195 . . . . 0.0 110.858 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -17.73 56.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -172.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.71 163.12 12.51 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.606 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.16 94.25 9.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.074 0.464 . . . . 0.0 110.076 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.452 HG13 HD21 ' A' ' 56' ' ' ASN . 35.7 mm -80.07 101.09 4.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.307 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.614 HD12 ' HB2' ' A' ' 31' ' ' CYS . 14.1 mt -105.02 134.7 45.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.027 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -88.74 36.06 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.651 -175.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 70.04 -42.78 0.52 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.85 -26.55 68.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.91 22.64 1.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.846 0.355 . . . . 0.0 110.773 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 3.2 m -133.14 143.15 49.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.89 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.75 -23.94 6.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.167 0.508 . . . . 0.0 110.341 176.06 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.16 178.459 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.202 0.525 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.538 ' HB1' ' HG2' ' A' ' 39' ' ' GLN . . . -92.62 100.66 13.14 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.306 -176.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 m -79.35 113.56 17.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.6 113.22 16.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.851 0.358 . . . . 0.0 110.04 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -89.16 131.1 37.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.471 0.653 . . . . 0.0 112.239 -173.449 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.0 156.79 20.88 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 166.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.16 -26.17 18.98 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.859 2.372 . . . . 0.0 113.241 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -89.53 33.82 0.83 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.962 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.43 -69.12 0.63 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.363 0.601 . . . . 0.0 109.95 175.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 m -92.68 137.03 32.72 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.05 38.9 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.419 0.628 . . . . 0.0 109.917 -168.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.462 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -116.53 -87.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.094 -177.194 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.661 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 21.7 t0 -100.14 63.68 1.17 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.764 -176.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 56.47 28.11 13.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.334 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.727 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 20.6 m-85 -90.78 134.51 34.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.12 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.98 153.33 47.08 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.192 -178.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.645 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 20.6 Cg_endo -61.97 120.32 7.86 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.629 2.22 . . . . 0.0 112.324 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.813 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 37.5 m-85 -133.29 125.27 28.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.881 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.0 95.76 6.79 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 37.1 m -82.44 121.79 27.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.23 -175.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -76.48 174.26 10.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.415 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.409 ' HB2' ' H ' ' A' ' 23' ' ' MET . 3.7 m 60.93 -108.46 0.34 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 123.475 0.484 . . . . 0.0 110.598 -177.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.433 ' HE2' ' HB2' ' A' ' 23' ' ' MET . 0.0 OUTLIER -147.12 161.28 41.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 -177.969 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.551 ' HA ' HD22 ' A' ' 29' ' ' LEU . 3.7 m -80.83 -18.01 48.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.943 0.402 . . . . 0.0 110.09 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.13 67.42 3.71 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.4 m -153.9 178.98 9.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 62' ' ' ASN . . . -84.01 -62.98 1.43 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.941 0.4 . . . . 0.0 110.328 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.23 120.78 43.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.03 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.551 HD22 ' HA ' ' A' ' 24' ' ' SER . 0.0 OUTLIER -106.71 137.53 44.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.841 0.353 . . . . 0.0 110.377 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.68 75.25 2.34 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.943 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.813 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 19.2 m -84.93 102.11 12.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.187 0.517 . . . . 0.0 110.831 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.572 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 16.1 m -78.89 150.59 5.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 t -61.96 135.84 26.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.378 0.424 . . . . 0.0 110.475 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.645 ' HA3' ' HB2' ' A' ' 17' ' ' PRO . . . -64.99 89.68 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.759 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.412 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 49.7 t -79.43 141.36 15.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.687 0.28 . . . . 0.0 110.287 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.35 101.98 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.442 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.02 -13.63 8.48 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.209 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' A' ' 5' ' ' ILE . 53.6 m -72.83 129.11 37.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.008 0.433 . . . . 0.0 110.815 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.538 ' HG2' ' HB1' ' A' ' 2' ' ' ALA . 1.3 mp0 -95.3 106.85 18.93 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.406 ' HB3' HG22 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -75.17 106.25 6.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.28 -176.167 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.87 -4.65 29.64 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.927 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.09 -82.79 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.346 . . . . 0.0 110.231 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.604 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 38.7 m -155.41 120.12 4.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.193 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.406 HG22 ' HB3' ' A' ' 40' ' ' CYS . 2.8 t -82.05 101.62 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.604 ' HE3' ' HB3' ' A' ' 43' ' ' SER . 1.2 mmpt? -114.24 136.16 53.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 74.5 m -101.01 96.33 7.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.514 174.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.3 m -111.76 163.69 13.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.382 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 13' ' ' ASP . 28.7 ttmt -110.18 -37.7 5.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.405 -176.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 50' ' ' ASP . 4.6 p-10 41.61 -100.75 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.898 0.879 . . . . 0.0 111.959 -172.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.446 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 16.1 t70 -169.15 -36.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.638 0.256 . . . . 0.0 111.131 -177.067 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.5 t -67.01 122.27 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.745 0.307 . . . . 0.0 110.825 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -25.21 32.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.916 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -72.65 117.68 14.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.172 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.95 8.26 30.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.503 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.72 9.71 76.89 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.292 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -70.66 154.67 41.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.76 0.314 . . . . 0.0 110.675 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.62 -41.97 25.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.977 0.417 . . . . 0.0 110.53 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -170.03 133.98 3.0 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.53 115.23 29.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.187 0.517 . . . . 0.0 111.057 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.11 74.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.973 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mt -80.24 147.21 6.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.265 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 3.9 p-10 -85.92 151.97 23.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.02 94.03 0.31 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.77 0.319 . . . . 0.0 110.959 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -151.17 -78.94 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.249 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -85.03 54.21 3.02 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.157 0.504 . . . . 0.0 111.016 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 78.5 m -125.95 139.59 53.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.437 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -57.69 -53.05 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -175.113 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.891 -176.318 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 120.888 0.375 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HB1' ' HG2' ' A' ' 39' ' ' GLN . . . -113.67 139.21 49.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.134 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.35 141.32 46.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.99 -176.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.2 124.14 27.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 0.0 110.043 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.887 HG21 ' HA3' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -92.55 151.02 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.536 0.684 . . . . 0.0 112.343 -171.438 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.431 ' HA2' HG12 ' A' ' 36' ' ' ILE . . . 159.1 176.26 30.95 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.256 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.909 ' HD3' HG12 ' A' ' 36' ' ' ILE . 24.1 Cg_exo -64.85 43.8 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.103 2.535 . . . . 0.0 112.785 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' A' ' 6' ' ' GLY . 48.3 t30 -131.22 -42.78 1.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.213 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -41.37 97.85 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.773 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -152.38 124.98 8.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.572 174.572 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -173.62 36.17 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -174.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.88 -82.39 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.822 -172.809 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -89.07 61.02 5.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.328 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.1 t0 51.51 54.04 11.74 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.543 0.687 . . . . 0.0 110.45 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -121.74 126.85 49.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.33 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.24 146.02 31.77 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.01 125.64 10.55 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.287 1.992 . . . . 0.0 111.454 177.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.651 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 10.1 m-85 -126.07 131.1 52.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.036 0.445 . . . . 0.0 111.409 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.9 m -103.16 101.63 11.6 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.87 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 2.0 m -82.03 120.6 25.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.222 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.05 -49.6 3.01 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.494 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.87 -144.91 0.63 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.422 172.596 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.446 ' HB3' ' H ' ' A' ' 24' ' ' SER . 1.6 mpp? -128.98 -155.37 0.69 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.81 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . 0.446 ' H ' ' HB3' ' A' ' 23' ' ' MET . 0.7 OUTLIER -67.68 -61.6 1.81 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.645 0.26 . . . . 0.0 110.974 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.22 96.09 0.87 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.829 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.21 114.44 11.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.995 0.426 . . . . 0.0 111.647 -176.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.23 -47.86 9.06 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 171.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.04 93.48 5.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 167.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.645 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -79.37 157.45 27.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.785 -169.668 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.41 89.41 0.78 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.577 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.651 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 1.1 m -89.68 129.37 36.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.39 . . . . 0.0 111.108 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.1 m -104.32 156.76 5.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.08 128.1 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.887 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -64.35 129.16 36.92 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.181 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.492 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -79.31 123.49 36.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.002 0.429 . . . . 0.0 110.412 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.909 HG12 ' HD3' ' A' ' 7' ' ' PRO . 6.2 mt -68.52 112.32 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.772 -176.191 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.99 -16.11 30.64 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.751 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.492 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 14.1 m -90.24 176.91 6.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.423 ' HG2' ' HB1' ' A' ' 2' ' ' ALA . 1.6 tt0 -135.74 98.3 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.787 0.327 . . . . 0.0 110.599 -175.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.698 ' HB2' HD11 ' A' ' 5' ' ' ILE . 65.6 m -79.8 127.5 32.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.299 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.32 6.81 32.19 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.618 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.47 -141.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.626 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 1.3 m -82.89 80.49 8.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 110.097 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -79.8 109.06 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -122.6 178.09 5.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.596 0.712 . . . . 0.0 111.547 -173.284 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 92.0 m -129.93 111.85 12.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.659 176.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.51 ' SG ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -121.92 146.62 46.94 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.934 0.397 . . . . 0.0 111.589 -171.511 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.405 ' C ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -78.77 115.66 18.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.803 175.979 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.16 116.63 7.04 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.266 173.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.15 42.24 2.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.545 173.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.5 t -83.11 129.43 37.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.215 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.05 34.82 2.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.009 0.433 . . . . 0.0 111.421 -177.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -149.91 132.34 15.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.873 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.53 146.58 52.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.893 0.378 . . . . 0.0 111.093 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.73 49.23 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.82 161.58 35.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.67 -0.265 . . . . 0.0 110.324 -175.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -21.12 48.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.538 0.685 . . . . 0.0 109.693 175.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.09 160.34 33.2 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.17 123.67 41.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 117.142 0.471 . . . . 0.0 110.132 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.32 95.18 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.321 0.582 . . . . 0.0 109.992 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.51 HG12 ' SG ' ' A' ' 47' ' ' CYS . 0.2 OUTLIER -94.12 131.72 40.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.914 -177.755 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -86.16 15.57 5.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -173.311 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.416 ' H ' ' CG2' ' A' ' 61' ' ' ILE . . . 72.93 -44.94 0.61 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.638 0.775 . . . . 0.0 112.496 175.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.39 18.37 0.31 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -128.04 16.89 6.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.593 0.711 . . . . 0.0 109.256 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER -114.15 140.32 48.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.155 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.86 -25.08 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.232 0.539 . . . . 0.0 110.536 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 45' ' ' LYS . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 117.839 -1.077 . . . . 0.0 109.976 -178.047 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 121.142 0.496 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . -141.98 84.64 1.89 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.981 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.45 132.16 47.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.464 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 m -78.97 109.18 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.778 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.688 HG21 ' HA3' ' A' ' 34' ' ' GLY . 13.0 mt -80.14 130.82 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.801 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.69 151.4 22.36 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 170.744 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.664 ' HD3' HG12 ' A' ' 36' ' ' ILE . 34.9 Cg_endo -64.91 -3.65 7.37 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 122.821 2.347 . . . . 0.0 113.323 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -82.62 -6.07 59.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.273 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.89 -79.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.239 0.542 . . . . 0.0 110.743 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 128.77 54.76 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.12 46.73 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.272 0.558 . . . . 0.0 110.213 -174.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.435 HD12 ' HD2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -126.91 -87.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.035 -176.18 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.559 ' HB3' ' CD2' ' A' ' 15' ' ' TYR . 27.8 t70 -81.22 54.08 2.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.438 0.637 . . . . 0.0 110.298 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.04 25.75 4.32 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.538 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.559 ' CD2' ' HB3' ' A' ' 13' ' ' ASP . 26.8 m-85 -78.52 124.33 28.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.301 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HZ2' ' HB3' ' A' ' 49' ' ' ASP . 35.3 mttp -119.51 145.58 39.25 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.32 115.55 3.39 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.329 2.019 . . . . 0.0 111.397 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.593 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 31.5 m-85 -126.11 135.28 51.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -176.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.87 86.35 2.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.516 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.737 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 1.1 m -67.62 116.72 8.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.185 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -92.19 112.19 24.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.327 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.5 128.32 52.4 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.844 177.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.26 -55.05 5.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.883 0.373 . . . . 0.0 110.455 -175.627 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.96 -87.6 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.775 178.4 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.4 57.96 2.7 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.7 m -93.24 116.64 29.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.842 0.353 . . . . 0.0 111.254 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.53 -54.66 4.43 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.741 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -81.55 124.45 29.51 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.111 172.349 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.737 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -104.5 138.08 41.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.522 -172.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 60' ' ' ILE . . . -89.01 100.68 2.68 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 177.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.9 OUTLIER -94.8 101.94 13.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.897 0.379 . . . . 0.0 111.187 -177.081 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.27 151.43 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.6 t -63.48 133.71 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.688 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -62.56 116.91 10.02 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.096 177.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.412 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -79.59 125.28 38.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.755 0.312 . . . . 0.0 110.527 -178.553 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.664 HG12 ' HD3' ' A' ' 7' ' ' PRO . 0.8 OUTLIER -65.98 114.25 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.712 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.16 15.04 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.752 -177.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.412 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 5.7 m -134.11 176.88 8.19 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.157 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.538 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 1.4 mm-40 -113.57 135.43 53.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.958 0.409 . . . . 0.0 111.663 -174.543 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.14 99.04 12.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.684 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.68 13.19 58.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.8 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.7 -107.5 0.38 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.31 . . . . 0.0 110.342 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.59 118.95 28.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.06 101.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.73 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -118.42 112.56 20.14 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.542 -176.363 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 33.3 m -81.77 93.59 6.86 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 38.7 m -108.83 144.69 36.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.748 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.2 123.78 29.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.55 ' HB3' ' HZ2' ' A' ' 16' ' ' LYS . 6.9 t0 -77.03 86.98 3.54 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.521 -174.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.83 5.51 16.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.851 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 p -111.31 27.76 2.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-O 122.111 0.958 . . . . 0.0 110.152 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.13 42.77 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.935 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -102.25 -19.64 14.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.49 119.36 20.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.384 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.39 54.12 4.93 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.746 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -169.59 171.15 7.72 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.58 8.66 9.14 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -175.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.77 71.37 2.61 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -77.99 80.77 4.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.378 0.609 . . . . 0.0 111.642 -174.688 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.741 HD11 ' HB2' ' A' ' 28' ' ' SER . 0.9 OUTLIER -82.54 117.24 28.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.297 174.484 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.6 mt -101.19 148.38 7.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.977 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -79.83 19.35 0.69 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.642 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.492 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . 71.01 -43.0 0.55 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.637 0.775 . . . . 0.0 112.901 176.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.46 -38.17 71.31 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -84.31 20.79 1.55 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.827 0.346 . . . . 0.0 111.447 -177.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.2 m -120.25 165.34 14.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.434 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -92.78 175.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.444 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.662 -0.685 . . . . 0.0 110.731 178.759 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' SER . . . . . 0.503 ' HB2' ' H ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 . . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.503 ' H ' ' HB2' ' A' ' 1' ' ' SER . . . -81.01 93.34 6.35 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.122 0.487 . . . . 0.0 110.772 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.61 136.73 36.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.04 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.521 HG23 ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -78.82 137.94 37.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.638 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.564 HG21 ' HA3' ' A' ' 34' ' ' GLY . 47.9 mt -114.47 121.58 66.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.211 0.529 . . . . 0.0 112.001 -174.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.64 149.39 18.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 167.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.0 -28.19 39.04 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.318 2.679 . . . . 0.0 113.049 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -91.08 43.39 1.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.944 0.402 . . . . 0.0 111.459 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.35 -27.79 25.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.507 0.67 . . . . 0.0 109.457 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.82 131.41 19.91 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.357 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.07 15.07 0.63 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.192 0.52 . . . . 0.0 110.601 -175.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.431 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -79.45 -79.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.457 0.646 . . . . 0.0 109.321 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' H ' ' HB ' ' A' ' 12' ' ' ILE . 43.2 t0 -79.18 -173.39 3.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 167.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -76.21 52.07 0.72 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.619 0.724 . . . . 0.0 109.678 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -89.74 132.35 35.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.445 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.603 ' HB2' ' CE2' ' A' ' 18' ' ' TYR . 2.1 mtmp? -120.09 152.27 54.14 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.169 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.38 119.07 6.06 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.572 2.181 . . . . 0.0 111.346 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CE2' ' HB2' ' A' ' 16' ' ' LYS . 37.8 m-85 -127.92 125.65 39.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.243 0.544 . . . . 0.0 111.4 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.8 m -82.71 95.78 7.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.324 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.518 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -98.66 118.66 35.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.558 -174.602 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -90.6 115.95 28.12 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -27.45 68.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.956 0.408 . . . . 0.0 111.045 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -138.11 67.2 1.42 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.183 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.11 65.79 1.17 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.717 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.51 15.13 56.81 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -175.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 m -153.48 -178.72 7.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.193 -0.504 . . . . 0.0 109.879 -172.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.39 12.94 35.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.509 . . . . 0.0 110.23 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.4 147.14 26.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.696 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.518 HD12 ' SG ' ' A' ' 20' ' ' CYS . 1.8 mm? -79.15 103.09 8.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.196 0.522 . . . . 0.0 110.139 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.76 79.54 1.86 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.727 -0.67 . . . . 0.0 113.077 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 1.2 m -78.71 122.31 25.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.25 0.548 . . . . 0.0 111.598 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.12 153.13 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.26 128.5 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.432 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.564 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -62.34 122.59 28.72 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.458 176.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.526 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -78.43 129.09 37.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.977 0.418 . . . . 0.0 110.418 -175.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.58 113.45 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.528 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.39 22.2 59.08 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.369 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.526 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 4.2 m -117.1 161.93 18.63 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.521 ' HG3' HG23 ' A' ' 4' ' ' THR . 5.5 mt-30 -104.48 137.07 42.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.14 0.495 . . . . 0.0 111.007 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 6.8 t -111.72 126.03 54.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.746 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.52 10.1 64.79 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.194 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.0 -171.23 1.79 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.44 106.42 3.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.816 0.341 . . . . 0.0 110.85 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.52 105.11 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.808 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -112.28 161.9 16.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.98 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -115.15 100.24 8.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.506 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' ' 62' ' ' ASN . 0.9 OUTLIER -116.76 152.88 33.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.677 -176.008 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.493 ' H ' ' HG2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -93.45 154.26 18.02 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 175.632 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.56 67.14 4.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.924 0.393 . . . . 0.0 110.997 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.35 34.17 2.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.224 0.535 . . . . 0.0 110.751 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.91 107.05 19.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.656 176.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.62 95.22 8.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.492 -175.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 58.61 65.04 1.31 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.99 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.42 76.38 8.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.086 174.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.23 92.25 0.09 OUTLIER Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.389 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 64.87 15.42 9.88 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.176 0.59 . . . . 0.0 111.609 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.49 -33.66 21.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.012 0.434 . . . . 0.0 110.956 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.18 -159.38 17.81 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.85 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 mt -115.65 71.34 0.77 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.253 0.549 . . . . 0.0 110.248 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -81.48 79.51 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 122.076 0.941 . . . . 0.0 110.502 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -134.79 110.67 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.27 177.889 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.565 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 5.7 t30 -178.2 -22.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 O-C-N 123.406 0.441 . . . . 0.0 111.441 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.33 -53.12 55.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.55 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.7 5.02 1.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.823 0.344 . . . . 0.0 111.405 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASN . . . . . 0.408 ' HB2' HG22 ' A' ' 61' ' ' ILE . 7.4 m120 -101.16 17.69 21.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.011 0.434 . . . . 0.0 111.124 -174.631 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.34 157.64 32.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.514 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.0 t -63.39 -55.52 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.521 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.6 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 120.833 0.349 . . . . 0.0 110.703 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.567 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . -131.33 121.28 24.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.631 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.68 139.68 33.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.063 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 113.16 17.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.885 0.374 . . . . 0.0 110.075 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.782 HD11 ' HB2' ' A' ' 40' ' ' CYS . 95.4 mt -83.38 129.48 37.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 0.0 112.473 -172.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.54 142.41 13.57 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 170.386 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.22 -20.62 39.6 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.37 2.714 . . . . 0.0 113.718 -176.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -82.55 19.16 1.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.853 0.358 . . . . 0.0 111.54 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -44.21 67.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 109.969 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.35 132.53 56.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.401 176.718 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.16 18.79 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.895 0.379 . . . . 0.0 111.223 -174.175 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -79.17 -68.05 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.807 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -100.27 -166.95 1.38 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.238 171.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -79.71 48.39 0.93 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 2.8 m-30 -79.54 124.17 28.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.758 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -100.84 148.08 34.55 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.102 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -67.31 122.1 9.32 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.231 1.954 . . . . 0.0 110.717 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.691 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 18.7 m-85 -124.63 124.47 42.28 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.979 0.419 . . . . 0.0 111.49 -174.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.7 m -87.12 86.35 7.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.068 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.8 m -76.18 99.19 4.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.506 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -67.21 148.77 51.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.63 -175.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.57 84.24 1.14 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.379 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' MET . . . . . 0.482 ' H ' ' HG2' ' A' ' 23' ' ' MET . 0.0 OUTLIER -79.78 -28.04 40.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.125 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.46 69.31 0.7 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.404 174.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 154.13 -53.49 0.45 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.227 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.4 m -60.85 131.43 50.66 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 176.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.34 -24.57 42.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.455 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.743 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -99.89 122.65 43.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.25 174.374 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.441 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -94.09 136.2 34.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.076 0.465 . . . . 0.0 111.586 -173.816 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.93 71.74 1.93 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.595 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.691 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 4.0 m -79.37 109.82 14.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 111.076 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 32' ' ' VAL . 0.8 OUTLIER -78.87 143.13 13.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.668 176.142 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.61 133.07 29.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.16 0.505 . . . . 0.0 111.204 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.438 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -77.78 106.59 2.29 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.99 157.04 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.836 0.35 . . . . 0.0 110.489 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.37 114.19 2.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.124 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.82 10.19 55.49 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.196 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.5 m -96.07 172.63 7.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.722 0.296 . . . . 0.0 110.297 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.567 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 74.8 mt-30 -128.18 162.9 25.86 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.782 ' HB2' HD11 ' A' ' 5' ' ' ILE . 1.6 t -137.02 146.98 45.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.751 0.31 . . . . 0.0 110.979 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.9 24.15 3.16 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.855 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.31 -151.51 0.4 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.76 89.79 3.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.871 0.367 . . . . 0.0 110.959 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 p -79.67 108.85 13.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.586 0.708 . . . . 0.0 109.692 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -117.5 -175.45 2.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.624 -177.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.676 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 95.2 m -134.73 101.92 5.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.65 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.2 m -121.75 167.35 13.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.34 . . . . 0.0 111.178 -173.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 50' ' ' ASP . 2.4 mmmt -87.08 145.73 26.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.408 172.46 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -95.74 -21.92 17.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.435 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 15.5 t70 -78.32 68.82 4.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.787 0.804 . . . . 0.0 110.236 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -152.75 -57.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.93 175.545 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.89 -28.74 17.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.639 172.093 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.5 t30 60.39 34.85 20.61 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.337 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' THR . . . . . 0.602 HG22 HD21 ' A' ' 56' ' ' ASN . 0.2 OUTLIER -81.05 62.42 5.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.638 178.141 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.01 66.94 2.12 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.866 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.602 HD21 HG22 ' A' ' 54' ' ' THR . 11.2 p30 -138.37 -142.92 0.16 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -35.18 43.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.671 0.272 . . . . 0.0 111.529 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -122.67 99.31 0.65 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.431 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.447 ' HA ' ' HB ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -86.07 116.36 24.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.022 0.439 . . . . 0.0 110.816 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.743 HD11 ' HB2' ' A' ' 28' ' ' SER . 0.9 OUTLIER -99.75 121.2 50.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.232 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.34 164.29 22.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.085 0.469 . . . . 0.0 111.693 -174.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -85.05 145.58 27.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.943 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.66 92.97 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -171.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.95 14.83 3.76 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.43 15.66 25.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.64 0.733 . . . . 0.0 109.83 174.708 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.4 m -108.35 173.48 6.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.248 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -61.1 -39.81 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.252 0.549 . . . . 0.0 109.608 173.274 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.971 174.736 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 120.766 0.317 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.516 ' HB1' ' HG2' ' A' ' 39' ' ' GLN . . . -141.51 79.11 1.67 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.019 0.438 . . . . 0.0 110.014 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.58 130.84 42.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.266 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.08 122.38 26.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.993 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.833 HG21 ' HA3' ' A' ' 34' ' ' GLY . 56.5 mt -92.94 126.1 45.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.397 0.617 . . . . 0.0 112.18 -174.883 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -136.08 133.53 6.67 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 169.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.527 ' CG ' HG12 ' A' ' 36' ' ' ILE . 77.9 Cg_exo -51.28 -21.06 9.08 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.396 2.731 . . . . 0.0 113.828 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.64 13.4 3.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.68 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.46 -77.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.577 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.82 126.8 36.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.324 173.419 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.77 25.52 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.535 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -77.81 -64.37 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 15' ' ' TYR . 2.6 t70 -100.03 -151.54 0.4 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 169.597 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -79.29 35.18 0.26 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.42 0.629 . . . . 0.0 110.179 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 13' ' ' ASP . 22.4 m-85 -83.61 136.73 34.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.754 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.61 161.26 61.96 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.89 105.49 1.15 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.484 2.123 . . . . 0.0 111.605 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.437 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 41.9 m-85 -112.07 122.31 47.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.461 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.73 73.17 7.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.301 0.572 . . . . 0.0 109.699 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -71.26 107.85 4.46 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.016 -177.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -68.93 97.15 0.82 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.759 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.64 122.01 46.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.298 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.7 mtm -129.35 -166.78 1.7 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.9 m -61.91 111.4 1.89 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.865 0.365 . . . . 0.0 110.195 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.11 -99.83 2.1 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 m 57.28 83.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.108 0.563 . . . . 0.0 112.235 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.86 -24.03 36.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.002 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.66 104.6 12.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.647 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.51 ' HG ' ' HB3' ' A' ' 62' ' ' ASN . 1.6 mm? -79.75 110.83 15.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.101 -178.482 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.88 76.98 1.34 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.766 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -84.45 93.47 8.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.901 0.382 . . . . 0.0 110.976 178.519 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.34 139.22 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.582 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.2 p -66.72 134.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.261 0.553 . . . . 0.0 111.155 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.833 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -84.15 115.78 4.14 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.819 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.5 154.28 4.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.527 HG12 ' CG ' ' A' ' 7' ' ' PRO . 1.3 mt -60.85 117.21 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.074 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.17 -0.65 64.17 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.372 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -85.66 164.53 17.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.724 0.297 . . . . 0.0 110.3 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.516 ' HG2' ' HB1' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -108.57 139.41 43.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.783 0.325 . . . . 0.0 110.177 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.509 ' SG ' HG22 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -90.35 107.26 19.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.949 0.404 . . . . 0.0 110.733 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.18 -17.48 80.22 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.925 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.09 -163.9 0.9 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.76 128.45 34.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.525 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.509 HG22 ' SG ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -78.58 117.52 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -111.22 145.4 38.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.463 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 34.2 m -94.47 78.86 3.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.571 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -109.18 159.04 17.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.608 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 pttm -87.28 -164.92 1.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.161 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASP . . . . . 0.506 ' HB3' HG23 ' A' ' 51' ' ' VAL . 13.7 m-20 -68.11 -62.96 1.16 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.763 0.316 . . . . 0.0 110.214 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.8 45.04 22.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.719 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 49' ' ' ASP . 0.9 OUTLIER -84.2 108.67 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.274 -175.952 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.97 -60.53 2.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 171.544 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -122.65 165.12 17.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.803 173.435 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.01 93.31 0.42 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.045 0.45 . . . . 0.0 111.589 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.82 65.98 0.36 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.489 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -78.79 -19.23 52.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.82 0.343 . . . . 0.0 111.001 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -79.58 61.67 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.399 0.619 . . . . 0.0 110.193 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.64 64.63 0.44 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -175.465 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.82 132.14 40.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.778 0.323 . . . . 0.0 110.553 -176.075 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mt -82.98 78.98 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.161 0.505 . . . . 0.0 110.503 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -111.94 -153.88 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.791 177.548 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.528 ' HA ' ' HB2' ' A' ' 66' ' ' CYS . 20.9 t-20 52.46 25.72 3.74 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.239 0.543 . . . . 0.0 112.103 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.23 -5.9 15.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.12 0.486 . . . . 0.0 110.302 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -164.34 -56.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.367 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.28 44.1 1.06 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -170.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' CYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -111.38 120.6 42.73 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.348 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.72 -26.54 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.801 -175.396 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.045 -177.771 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.603 0.239 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.625 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . -79.75 90.74 5.24 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.03 117.4 7.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.604 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.48 128.39 33.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.685 178.569 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.649 HG21 ' HA3' ' A' ' 34' ' ' GLY . 50.8 mt -93.03 133.64 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.983 -176.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.81 130.4 9.34 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 169.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.66 -37.53 75.09 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.738 2.959 . . . . 0.0 114.127 -175.001 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -86.83 36.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.974 0.416 . . . . 0.0 111.663 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.82 -52.0 7.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 173.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.7 m -137.33 116.03 12.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.024 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 24.3 m -161.38 20.79 0.12 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.427 0.632 . . . . 0.0 109.452 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.451 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -79.18 -82.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.428 -176.625 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.702 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 7.2 t70 -79.28 60.26 3.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.456 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.8 t0 48.8 45.28 22.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.764 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.702 ' CE2' ' HB3' ' A' ' 13' ' ' ASP . 26.5 m-85 -97.56 152.48 18.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.181 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.648 ' HB2' ' CE2' ' A' ' 18' ' ' TYR . 9.6 mttp -132.79 143.11 47.27 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.45 103.65 1.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.019 1.813 . . . . 0.0 110.6 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.997 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 24.4 m-85 -104.55 125.81 51.05 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.632 -173.104 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 0.5 OUTLIER -90.35 93.76 9.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.524 174.69 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 29' ' ' LEU . 18.0 m -85.12 125.97 33.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.8 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -57.81 107.73 0.49 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 110.601 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.02 111.38 12.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.592 -176.353 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.17 7.1 38.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.707 173.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 m 57.64 74.7 0.41 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.034 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.8 12.05 3.4 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.852 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.65 125.46 29.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.501 0.191 . . . . 0.0 110.652 179.278 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.36 -49.44 6.95 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.2 100.42 11.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.02 171.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.631 ' HB2' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -95.58 143.09 27.17 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.255 -172.146 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.51 91.29 1.61 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.997 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 5.7 m -96.6 126.12 41.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.864 0.364 . . . . 0.0 111.627 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.42 144.47 14.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -60.66 129.84 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.173 0.511 . . . . 0.0 111.154 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.649 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -70.14 109.88 3.06 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.639 175.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.45 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -79.61 160.59 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -67.23 116.55 6.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.398 -175.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.12 23.66 60.93 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.446 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.45 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 49.8 m -95.2 126.62 40.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.689 0.281 . . . . 0.0 110.678 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.625 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 4.0 mp0 -81.12 117.9 22.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.129 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.01 141.86 48.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.033 0.444 . . . . 0.0 111.536 -176.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.74 8.83 10.74 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.37 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -94.9 -167.2 1.59 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.63 103.03 11.85 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.668 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.3 t -81.6 100.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -113.87 162.11 16.77 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.756 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 89.6 m -103.03 92.87 4.73 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.124 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -109.9 145.72 36.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.7 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -82.41 156.23 24.26 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.111 0.481 . . . . 0.0 110.62 -177.861 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -79.26 69.67 5.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.189 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.62 -0.8 35.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.836 -178.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.3 m -111.46 178.31 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.841 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.3 42.85 0.97 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.651 0.262 . . . . 0.0 111.571 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.9 t30 49.83 40.63 20.94 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.641 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.2 66.18 0.89 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.202 0.525 . . . . 0.0 111.416 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.89 80.8 1.33 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.62 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.409 ' HB3' ' H ' ' A' ' 57' ' ' SER . 3.2 t30 -78.02 -83.36 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.634 0.254 . . . . 0.0 110.875 -178.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.409 ' H ' ' HB3' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -81.84 -1.68 48.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.699 0.761 . . . . 0.0 109.941 175.782 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.14 -166.18 26.43 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.3 mt -140.27 107.51 5.5 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 117.448 0.624 . . . . 0.0 110.598 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 73.2 mt -79.78 99.75 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 mt -112.52 148.57 15.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.764 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -79.53 136.19 36.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.03 -20.45 24.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.18 65.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -93.8 -1.61 54.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.095 0.474 . . . . 0.0 110.806 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.36 103.82 15.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.652 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.0 m -75.24 -29.21 21.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.476 -175.814 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.805 -0.616 . . . . 0.0 109.69 -179.94 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.831 0.348 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . -122.49 105.96 10.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.0 110.22 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.88 129.5 38.29 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.228 -177.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.12 130.48 36.43 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.974 0.416 . . . . 0.0 110.457 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.683 HG21 ' HA3' ' A' ' 34' ' ' GLY . 29.0 mm -84.98 118.88 32.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.255 -174.118 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLY . . . . . 0.485 ' HA2' ' HD2' ' A' ' 7' ' ' PRO . . . -112.53 117.55 4.37 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 169.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.485 ' HD2' ' HA2' ' A' ' 6' ' ' GLY . 0.9 OUTLIER -43.96 -34.39 6.25 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.166 3.244 . . . . 0.0 114.235 -176.951 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -83.21 44.91 0.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 111.652 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.43 -44.76 7.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.559 0.695 . . . . 0.0 109.343 174.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m -139.67 137.69 35.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.177 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.25 30.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -95.23 -92.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.657 -173.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.407 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 17.5 t70 -79.08 57.77 2.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.798 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.84 20.82 3.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.445 0.641 . . . . 0.0 110.257 -173.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.413 ' HE1' ' HB2' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -79.68 132.33 36.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.643 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.95 152.99 63.82 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' PRO . . . . . 0.436 ' HG3' ' HA ' ' A' ' 7' ' ' PRO . 36.6 Cg_endo -66.18 114.64 3.1 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.168 1.912 . . . . 0.0 111.137 175.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.642 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 18.9 m-85 -120.09 128.98 53.97 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.238 0.542 . . . . 0.0 110.874 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.07 88.57 7.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.943 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 1.3 m -73.67 99.73 3.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.742 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.0 170.77 15.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.509 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.2 m 56.06 71.71 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.633 0.583 . . . . 0.0 110.427 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.2 mtm -79.84 83.25 5.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.237 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.24 100.42 0.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.017 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.78 16.35 68.24 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.292 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.7 m 72.74 -40.5 0.48 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.499 0.72 . . . . 0.0 112.793 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.29 -48.33 14.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.781 0.324 . . . . 0.0 111.435 -176.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.0 113.93 19.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.721 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -98.72 128.92 45.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.85 0.357 . . . . 0.0 110.732 178.817 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.69 72.42 2.56 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.704 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -79.22 92.54 5.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.003 0.43 . . . . 0.0 110.199 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.434 HG12 ' HA3' ' A' ' 58' ' ' GLY . 21.5 m -84.45 163.43 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.6 t -63.71 134.26 28.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.683 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -54.08 124.99 32.13 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.573 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -79.3 107.64 11.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.997 0.427 . . . . 0.0 110.721 -177.911 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.31 113.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.491 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.52 -2.44 77.52 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.502 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.52 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -112.72 171.8 7.31 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.477 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 10.2 mp0 -101.82 152.34 21.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.937 0.399 . . . . 0.0 111.273 -176.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.452 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -81.54 156.73 25.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.855 175.124 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.5 -49.9 1.77 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.405 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -108.51 -76.86 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.655 0.264 . . . . 0.0 111.433 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.616 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -142.64 119.93 11.55 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.465 -176.631 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 p -84.53 116.56 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.616 ' HD3' ' HB2' ' A' ' 43' ' ' SER . 0.1 OUTLIER -127.4 165.54 19.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.069 0.461 . . . . 0.0 110.909 -176.669 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.531 ' HB2' HG23 ' A' ' 67' ' ' VAL . 86.7 m -98.68 109.55 22.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.769 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 163.04 19.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.217 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.413 ' HB2' ' HE1' ' A' ' 15' ' ' TYR . 29.4 ttmt -117.27 114.97 24.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.831 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -81.23 68.62 7.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.499 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.46 -30.91 71.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.307 0.575 . . . . 0.0 110.07 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . 0.469 HG23 ' OD1' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -72.18 123.19 26.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.062 175.428 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 p -111.11 -24.1 10.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.252 -178.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.469 ' OD1' HG23 ' A' ' 51' ' ' VAL . 18.2 p-10 -72.58 -38.31 67.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.156 -177.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.67 131.68 46.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.603 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.02 80.1 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.858 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.466 ' HB3' ' H ' ' A' ' 57' ' ' SER . 4.3 t-20 -92.62 -100.03 0.13 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.688 0.28 . . . . 0.0 110.603 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.466 ' H ' ' HB3' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -79.65 -63.3 1.45 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.191 0.519 . . . . 0.0 109.643 177.597 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.434 ' HA3' HG12 ' A' ' 32' ' ' VAL . . . -106.24 -166.59 22.97 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 173.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.98 120.72 14.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.042 0.421 . . . . 0.0 110.805 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.0 mt -81.12 95.73 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 31' ' ' CYS . 11.9 mt -102.72 151.17 6.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.498 -175.841 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.41 ' OD1' ' HB3' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -83.27 131.04 35.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.829 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.585 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -61.21 -22.11 64.47 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -171.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ALA . . . . . 0.41 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . . . -64.17 -33.69 76.37 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -174.326 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.38 0.91 53.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 111.326 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.45 127.82 39.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.939 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 46' ' ' CYS . 0.2 OUTLIER -87.15 -122.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.603 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.39 -0.814 . . . . 0.0 109.886 176.118 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 121.018 0.437 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . -129.78 126.61 38.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.01 178.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.98 121.06 27.23 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.624 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 109.71 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.032 0.444 . . . . 0.0 110.134 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.587 HD12 ' SG ' ' A' ' 19' ' ' CYS . 3.3 mt -91.46 134.2 30.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.426 0.632 . . . . 0.0 112.665 -170.21 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.69 164.11 16.99 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 170.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.752 ' HD3' HD12 ' A' ' 36' ' ' ILE . 37.8 Cg_endo -66.73 -13.57 40.42 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.719 2.279 . . . . 0.0 113.213 -177.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.9 t30 -97.05 19.39 12.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.968 0.413 . . . . 0.0 111.221 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.02 -59.63 2.7 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.472 0.653 . . . . 0.0 110.327 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.5 m -93.98 117.35 29.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.331 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.2 m -157.09 21.12 0.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.91 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 mt -78.38 -63.23 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -99.63 -165.01 1.18 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -80.05 47.84 0.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.479 ' HE2' HG13 ' A' ' 67' ' ' VAL . 10.0 m-30 -91.06 163.6 14.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.657 -176.409 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -132.57 148.21 68.69 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.13 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.15 122.24 9.29 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.477 2.118 . . . . 0.0 112.128 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.844 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 34.2 m-85 -121.43 128.7 52.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.906 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.587 ' SG ' HD12 ' A' ' 5' ' ' ILE . 59.3 m -91.04 84.16 5.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.641 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 56.8 m -76.97 107.06 9.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.734 -176.351 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -75.84 68.98 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.049 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 1.2 m 54.3 -101.2 0.12 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.384 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.6 mtt -150.36 142.99 24.57 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.82 14.45 13.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.157 0.504 . . . . 0.0 110.793 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.24 -41.54 1.97 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.31 -172.85 4.25 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.294 . . . . 0.0 110.234 175.389 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.14 -17.88 51.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.224 0.535 . . . . 0.0 110.319 177.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER -73.38 127.53 32.93 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.233 176.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.494 HD11 ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -89.4 148.14 23.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.391 -178.809 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.0 76.32 2.17 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.81 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.844 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 33.3 m -87.34 99.26 11.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.021 0.439 . . . . 0.0 111.366 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 m -89.69 151.37 3.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 171.455 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.16 129.62 20.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.559 ' HA2' ' SG ' ' A' ' 19' ' ' CYS . . . -48.19 126.64 15.26 Favored Glycine 0 N--CA 1.447 -0.584 0 O-C-N 123.83 0.706 . . . . 0.0 111.912 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -78.06 114.02 18.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -177.645 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.752 HD12 ' HD3' ' A' ' 7' ' ' PRO . 7.3 mm -61.24 110.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.452 -172.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.71 9.51 61.17 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.833 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.56 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 70.4 m -112.21 151.04 30.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.057 0.456 . . . . 0.0 110.663 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.63 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 4.0 mt-30 -86.24 113.85 22.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.792 176.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.3 m -92.79 123.08 35.8 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.81 45.44 2.51 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.991 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -142.09 -178.24 5.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.82 125.4 27.07 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.2 t -79.36 97.42 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 11.4 mmpt? -105.42 124.36 49.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.038 -174.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 93.9 m -87.64 89.6 8.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 34.6 m -111.17 169.29 8.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.143 0.496 . . . . 0.0 111.498 -174.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.89 141.59 40.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.431 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -87.81 55.9 3.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.285 0.565 . . . . 0.0 110.043 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -126.73 63.05 1.3 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.262 0.553 . . . . 0.0 110.958 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.69 12.99 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.99 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 61.38 40.92 13.57 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.802 -177.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -162.58 134.19 5.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.836 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.62 -25.07 20.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.935 0.397 . . . . 0.0 110.768 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.67 -149.84 50.0 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.825 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.67 -66.24 0.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.135 0.493 . . . . 0.0 110.186 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.19 65.7 8.36 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.586 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.8 -163.18 24.53 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.724 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.74 110.21 14.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.037 0.446 . . . . 0.0 110.345 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ILE . . . . . 0.526 ' H ' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -87.03 78.65 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 -178.726 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.467 HD12 ' HB2' ' A' ' 31' ' ' CYS . 14.2 mt -76.37 129.64 37.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.859 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.4 t30 -82.71 42.64 0.79 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.398 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ALA . . . . . 0.494 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . 70.92 -54.2 0.66 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.005 0.922 . . . . 0.0 113.084 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.39 59.42 2.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -173.66 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.01 25.5 0.82 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.393 0.616 . . . . 0.0 109.823 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -135.63 177.28 7.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.671 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' VAL . . . . . 0.479 HG13 ' HE2' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -67.12 -59.05 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.722 0.296 . . . . 0.0 110.576 177.854 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.63 179.257 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.48 116.59 31.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.951 0.405 . . . . 0.0 110.602 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.11 129.78 44.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.488 HG23 ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -88.23 122.52 31.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.085 178.491 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.809 HG21 ' HA3' ' A' ' 34' ' ' GLY . 14.9 mt -94.14 140.63 16.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.013 0.435 . . . . 0.0 111.934 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.55 151.83 23.46 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 174.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.885 ' HD3' HG12 ' A' ' 36' ' ' ILE . 60.3 Cg_endo -72.77 46.03 0.98 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.851 2.368 . . . . 0.0 112.758 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -135.79 0.51 2.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.583 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.27 -54.07 10.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.241 0.543 . . . . 0.0 110.246 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -120.2 139.71 52.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.3 177.392 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.5 m -162.01 12.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.809 0.338 . . . . 0.0 110.55 -173.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.48 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -78.36 -84.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.407 ' H ' ' HB ' ' A' ' 12' ' ' ILE . 2.6 t70 -83.45 -152.84 0.13 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 173.308 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.62 48.15 1.48 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.937 0.875 . . . . 0.0 109.531 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.761 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 25.5 m-85 -96.16 110.0 22.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.273 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.4 mtmm -107.65 156.97 37.01 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.83 117.41 4.31 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.208 1.939 . . . . 0.0 111.678 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -122.11 122.33 38.98 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.58 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 5.1 t -88.3 100.84 13.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.74 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.865 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -101.96 135.7 43.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.887 -176.594 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -109.22 -159.34 0.68 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.356 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.41 145.7 55.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.168 0.509 . . . . 0.0 111.132 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.55 152.18 30.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.134 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -29.96 70.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.203 0.525 . . . . 0.0 110.766 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.48 -55.88 0.24 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.34 -179.36 4.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.539 -0.33 . . . . 0.0 110.443 175.139 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.69 53.25 1.57 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.082 0.467 . . . . 0.0 111.444 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -138.96 130.05 26.64 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.865 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -127.61 164.01 22.96 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.73 -174.573 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.54 76.95 0.25 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.759 -177.38 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -81.42 108.35 14.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.744 0.306 . . . . 0.0 110.227 176.135 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 m -91.46 161.53 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.84 130.5 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.766 0.317 . . . . 0.0 110.423 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.809 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -61.11 134.26 48.85 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.636 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.422 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -78.94 116.65 23.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.055 0.455 . . . . 0.0 109.877 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.885 HG12 ' HD3' ' A' ' 7' ' ' PRO . 34.1 mt -67.22 120.12 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.849 -175.027 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.12 17.13 72.75 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.173 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' SER . . . . . 0.422 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -127.27 160.55 30.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.674 0.273 . . . . 0.0 110.695 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.488 ' HG3' HG23 ' A' ' 4' ' ' THR . 28.0 mt-30 -97.53 149.88 21.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.019 0.438 . . . . 0.0 110.873 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.56 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -121.41 156.99 31.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.231 178.881 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.56 16.3 21.68 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.753 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -124.35 -161.65 1.02 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -89.91 107.22 18.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.017 0.437 . . . . 0.0 111.084 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.45 109.38 17.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.952 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -130.93 -179.45 5.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.909 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.761 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 4.1 m -107.93 105.58 15.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.206 175.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 62.2 m -118.31 148.86 42.04 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.171 -174.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.544 ' HD2' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -91.64 116.04 28.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.095 0.474 . . . . 0.0 110.239 176.601 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.94 -36.35 77.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.09 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.41 ' H ' ' HE3' ' A' ' 48' ' ' LYS . 25.6 t0 -76.38 65.05 2.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.837 -177.112 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.88 -44.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 168.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.4 -34.9 23.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.342 168.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 70.4 -65.38 0.33 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.515 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.15 131.48 35.3 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.772 0.32 . . . . 0.0 110.423 177.418 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.03 -176.96 23.68 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.411 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.458 ' HB3' ' H ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -147.08 -121.42 0.06 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.074 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . 0.458 ' H ' ' HB3' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -79.77 56.46 2.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.386 0.613 . . . . 0.0 109.92 175.609 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.81 -178.53 16.37 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -175.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.447 HD13 ' HA ' ' A' ' 59' ' ' LEU . 0.7 OUTLIER -99.87 103.45 15.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.029 0.442 . . . . 0.0 110.316 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -87.99 105.44 15.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.796 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.5 mt -112.35 135.16 52.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.446 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -67.43 150.68 48.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.614 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.75 164.91 18.41 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.365 177.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 69.62 8.97 7.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.811 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.44 21.04 13.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.537 0.684 . . . . 0.0 109.98 175.561 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.9 m -123.42 140.52 52.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.09 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.7 173.18 14.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.228 176.659 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.63 64.01 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.933 0.396 . . . . 0.0 110.701 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.52 133.53 35.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.774 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.74 121.94 25.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.017 0.437 . . . . 0.0 110.516 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.684 HG21 ' HA3' ' A' ' 34' ' ' GLY . 3.7 mt -92.13 147.36 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.397 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.85 157.01 26.98 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 172.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.91 ' HD3' HG12 ' A' ' 36' ' ' ILE . 14.2 Cg_endo -56.97 -33.72 96.04 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.858 2.372 . . . . 0.0 112.095 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.84 62.21 4.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.448 0.642 . . . . 0.0 110.187 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.34 -49.59 4.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.089 175.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -123.32 152.68 41.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.137 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -151.82 19.49 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.725 0.774 . . . . 0.0 109.211 -174.022 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -74.22 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.191 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -100.96 -156.46 0.56 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.267 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -86.84 49.84 1.89 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.866 0.841 . . . . 0.0 108.771 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' TYR . . . . . 0.695 ' HB3' ' HB2' ' A' ' 46' ' ' CYS . 8.6 m-85 -86.9 110.48 20.02 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.523 -176.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.551 ' HG3' ' CE2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -95.02 155.27 39.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.641 -177.844 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.91 127.48 22.5 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.18 2.587 . . . . 0.0 112.858 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' TYR . . . . . 0.895 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 21.4 m-85 -138.07 130.96 29.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 18.2 m -89.49 87.36 7.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.565 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' CYS . . . . . 0.633 ' HB3' HD22 ' A' ' 29' ' ' LEU . 91.1 m -75.43 94.56 3.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.907 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.585 ' HG3' ' HB2' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -92.08 72.47 5.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.543 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.6 m -150.59 158.47 44.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.669 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 ttm -81.3 163.93 22.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.93 -37.76 84.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.01 0.434 . . . . 0.0 110.659 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.59 66.97 1.16 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.494 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.8 m -142.24 -174.79 4.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.811 0.338 . . . . 0.0 111.064 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 28' ' ' SER . . . -143.01 139.87 30.77 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 65.0 m 73.69 98.19 0.07 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 124.241 0.963 . . . . 0.0 109.753 -175.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LEU . . . . . 0.633 HD22 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mt -79.69 115.36 19.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.969 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.91 62.98 4.46 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.88 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' CYS . . . . . 0.895 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 6.2 m -89.41 101.84 14.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.125 0.488 . . . . 0.0 110.98 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.94 152.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.2 t -59.53 132.97 24.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.713 0.292 . . . . 0.0 110.405 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLY . . . . . 0.684 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -66.41 113.94 6.1 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.65 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.6 122.01 32.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.063 0.458 . . . . 0.0 110.653 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ILE . . . . . 0.91 HG12 ' HD3' ' A' ' 7' ' ' PRO . 1.1 mt -59.13 130.17 22.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.104 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.87 80.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.45 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 m -122.32 166.73 14.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -101.39 137.0 40.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.903 0.383 . . . . 0.0 111.046 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' CYS . . . . . 0.53 ' HB2' HD11 ' A' ' 5' ' ' ILE . 7.7 t -101.01 128.41 47.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.796 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.05 -0.58 57.24 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.449 -178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.585 ' HB2' ' HG3' ' A' ' 21' ' ' GLN . . . -121.04 -162.21 0.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.095 0.474 . . . . 0.0 111.169 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.89 104.25 3.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.783 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.41 111.42 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.526 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 6.1 mmtt -124.73 172.39 9.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.889 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' CYS . . . . . 0.695 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -118.16 119.94 36.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.657 0.265 . . . . 0.0 110.45 176.28 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.88 171.3 9.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.838 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.473 ' H ' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -115.09 154.05 29.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.746 -179.578 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.51 60.16 0.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.137 0.494 . . . . 0.0 110.954 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.98 -12.61 46.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.263 177.061 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.63 140.7 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.6 175.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.65 -28.6 36.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.868 0.366 . . . . 0.0 111.353 -176.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -85.97 90.13 8.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.004 0.43 . . . . 0.0 110.237 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.97 -59.88 4.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.767 -176.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . 100.59 -24.99 29.97 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.748 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 55' ' ' GLY . 6.3 m120 74.59 -53.78 0.67 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.803 0.841 . . . . 0.0 112.385 175.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -55.2 5.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.998 0.428 . . . . 0.0 110.642 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.15 142.56 11.88 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.421 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.7 tp -92.03 110.01 21.37 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 mt -79.97 97.48 2.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.014 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 61' ' ' ILE . 3.6 mm -73.69 151.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.434 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -66.22 -68.35 0.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.275 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -162.25 -96.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.397 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.44 78.8 9.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.233 0.456 . . . . 0.0 112.233 -172.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.7 22.82 0.46 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.435 0.636 . . . . 0.0 109.923 171.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 87.0 m -123.23 86.95 2.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.612 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.7 m -89.11 132.16 34.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.965 0.412 . . . . 0.0 111.342 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 45' ' ' LYS . . . . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.503 177.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 121.258 0.551 . . . . 0.0 110.265 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.31 140.19 50.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.326 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.12 129.3 34.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.125 0.488 . . . . 0.0 110.317 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.913 HG21 ' HA3' ' A' ' 34' ' ' GLY . 80.9 mt -95.68 135.21 30.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.555 -176.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.93 161.3 34.19 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.91 ' HD3' HG12 ' A' ' 36' ' ' ILE . 25.8 Cg_exo -64.33 60.86 0.25 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 123.332 2.688 . . . . 0.0 112.871 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -150.73 -44.32 0.12 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -58.46 8.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.59 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 5.8 m -122.8 97.28 5.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.32 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -162.96 15.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.175 0.512 . . . . 0.0 110.201 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -78.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.996 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.659 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 26.9 t0 -77.75 59.12 1.97 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.165 0.507 . . . . 0.0 110.419 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t0 51.72 46.98 25.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.846 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.659 ' CE2' ' HB3' ' A' ' 13' ' ' ASP . 10.7 m-85 -102.2 160.79 14.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.543 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -125.04 145.5 50.52 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.607 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.487 ' HB2' HG23 ' A' ' 5' ' ' ILE . 61.4 Cg_endo -74.65 103.63 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.861 1.707 . . . . 0.0 111.154 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.925 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 33.9 m-85 -100.39 120.56 40.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.157 -175.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.29 87.35 7.27 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 57.8 m -78.15 113.62 16.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.954 -176.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.534 -179.467 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.449 -0.504 0 N-CA-C 109.019 -0.734 . . . . 0.0 109.019 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.557 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -80.13 123.39 27.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.806 0.336 . . . . 0.0 110.648 -175.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.61 78.69 1.62 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.925 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 14.7 m -86.9 99.32 11.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.012 0.434 . . . . 0.0 111.439 -175.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.86 142.7 13.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.36 122.42 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.913 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -66.25 117.9 10.3 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.292 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.14 139.18 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.91 HG12 ' HD3' ' A' ' 7' ' ' PRO . 2.4 mt -59.62 108.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.634 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.77 -21.27 9.09 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.982 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.0 m -76.08 160.85 29.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.575 0.226 . . . . 0.0 110.84 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.91 145.48 40.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.762 0.315 . . . . 0.0 110.269 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.5 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -100.21 110.76 23.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.882 175.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.46 -30.84 26.35 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.603 179.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.17 -142.24 0.24 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.716 0.293 . . . . 0.0 110.732 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.44 102.12 12.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 -176.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 p -80.29 115.8 23.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -116.32 143.91 44.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.089 0.471 . . . . 0.0 111.123 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 35.3 m -99.23 83.56 2.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.944 175.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 23.7 m -102.47 154.13 19.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.478 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.536 ' HA ' ' HD1' ' A' ' 15' ' ' TYR . 4.1 ttmt -65.68 -70.26 0.25 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.287 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.3 t70 . . . . . 0 C--N 1.324 -0.515 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.808 -176.954 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.234 0.269 0 CA-C-O 121.066 0.46 . . . . 0.0 110.992 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.3 mt -80.25 80.8 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.154 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 63' ' ' ALA . 15.3 mm -77.85 137.33 22.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.174 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -78.66 11.78 2.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.79 0.329 . . . . 0.0 111.107 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.543 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 66.28 4.18 3.07 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.392 0.677 . . . . 0.0 112.374 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.55 32.92 5.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.9 0.381 . . . . 0.0 111.207 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.3 25.7 3.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.986 0.422 . . . . 0.0 110.154 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.56 155.71 48.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.911 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.327 -0.381 0 CA-C-O 120.912 0.387 . . . . 0.0 110.014 174.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.451 -0.424 0 CA-C-O 120.984 0.421 . . . . 0.0 110.628 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.9 137.25 32.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.186 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.93 138.48 33.13 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.861 HG21 ' HA3' ' A' ' 34' ' ' GLY . 6.2 mt -105.51 134.27 47.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.364 0.602 . . . . 0.0 112.196 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.42 147.1 19.03 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 171.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -51.47 -34.46 51.47 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.346 2.697 . . . . 0.0 112.992 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -101.58 67.75 1.14 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.103 0.478 . . . . 0.0 110.498 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.11 -61.52 1.36 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.025 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 54.4 m -116.24 142.93 46.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.5 m -159.63 32.86 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.073 0.463 . . . . 0.0 110.863 -172.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.06 -68.67 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -95.44 -165.55 1.31 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.591 167.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.59 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 3.7 t70 -77.85 50.72 0.88 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.377 0.608 . . . . 0.0 109.573 170.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.665 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 8.2 m-85 -85.85 79.61 9.2 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.627 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.687 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -79.3 156.97 75.94 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.329 -177.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.08 116.02 3.94 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.464 2.109 . . . . 0.0 111.305 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.579 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 25.8 m-85 -126.82 131.38 51.25 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.593 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.9 m -94.83 99.03 11.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.363 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HB3' HD22 ' A' ' 29' ' ' LEU . 1.6 m -82.92 121.25 26.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.724 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.605 179.377 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.448 -0.536 0 N-CA-C 110.01 -0.367 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 20' ' ' CYS . 7.2 mt -80.23 88.0 5.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.004 0.431 . . . . 0.0 111.203 -175.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.14 79.84 1.15 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.784 175.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.5 OUTLIER -88.63 109.61 20.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 0.0 111.227 -178.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.95 153.39 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.987 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 t -62.09 130.64 26.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.744 0.307 . . . . 0.0 110.704 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.861 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -66.39 132.44 32.8 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.289 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.424 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 2.1 t -80.54 137.51 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.069 0.462 . . . . 0.0 110.703 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mt -64.15 111.75 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.265 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.13 59.11 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.497 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.424 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 15.1 m -110.36 170.89 7.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.715 0.293 . . . . 0.0 110.515 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.49 136.25 54.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.498 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.442 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -115.47 133.4 56.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.433 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.79 29.65 9.18 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.235 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -121.44 -156.09 0.67 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.5 83.86 4.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.009 0.433 . . . . 0.0 110.375 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 40' ' ' CYS . 2.0 t -79.59 109.72 14.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.027 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -124.13 160.07 28.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.992 0.425 . . . . 0.0 111.163 -176.135 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.665 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 59.0 m -93.59 100.84 13.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 171.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.403 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 69.3 m -108.15 144.48 35.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.363 -172.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.59 ' HE3' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -79.3 117.36 20.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.51 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.687 ' HB2' ' HD2' ' A' ' 16' ' ' LYS . 65.8 t0 . . . . . 0 C--N 1.324 -0.505 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.952 175.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 120.834 0.35 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.21 97.11 4.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.797 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.499 ' H ' HG12 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -88.63 150.44 3.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.387 -178.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -101.85 45.07 0.98 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.906 0.384 . . . . 0.0 110.661 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 73.27 -56.33 0.66 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.367 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.09 -27.04 65.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -92.66 17.08 10.81 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.476 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.0 m -127.41 119.79 26.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.798 0.332 . . . . 0.0 110.88 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.042 179.746 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.215 0 CA-C-O 121.091 0.472 . . . . 0.0 110.391 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -67.82 120.76 14.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.586 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.03 125.05 28.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.785 176.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.722 HG21 ' HA3' ' A' ' 34' ' ' GLY . 3.5 mt -104.28 132.9 49.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -170.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.72 149.0 16.85 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 167.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.11 43.06 0.8 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.648 2.232 . . . . 0.0 113.539 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -150.32 26.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.051 0.453 . . . . 0.0 110.677 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.19 -23.6 47.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.726 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 m -146.12 145.97 30.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.5 m -162.36 25.2 0.11 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.801 0.334 . . . . 0.0 111.075 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.16 -65.67 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -100.52 -151.12 0.4 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 168.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -83.03 47.46 1.23 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.933 0.873 . . . . 0.0 108.693 169.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.579 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 5.8 m-85 -82.35 78.81 8.95 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.677 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -79.81 149.92 71.55 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.27 126.63 19.0 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.397 2.065 . . . . 0.0 111.052 176.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.702 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 9.2 m-85 -129.1 129.85 45.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.971 0.415 . . . . 0.0 111.373 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 13.9 m -83.56 84.14 7.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.357 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 20.6 m -72.67 96.84 2.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.111 0.482 . . . . 0.0 111.386 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 . . . . . 0 C--N 1.322 -0.616 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.84 175.37 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.237 0.443 0 CA-C-O 121.069 0.462 . . . . 0.0 110.863 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.443 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -122.96 139.2 54.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.97 -177.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.93 76.05 2.3 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.793 ' HB2' HD12 ' A' ' 61' ' ' ILE . 3.8 m -79.54 100.75 7.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.998 0.428 . . . . 0.0 111.042 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.42 145.34 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 p -58.1 135.24 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.806 0.336 . . . . 0.0 110.708 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.722 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -56.81 118.97 13.21 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.003 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.23 118.92 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 120.91 0.386 . . . . 0.0 110.352 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.59 124.54 8.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.458 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.08 13.93 81.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.27 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.72 167.12 15.0 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 3' ' ' THR . 2.5 mt-30 -113.23 145.79 40.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.616 ' HB2' HD11 ' A' ' 5' ' ' ILE . 13.9 m -125.99 120.08 29.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.197 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.48 61.81 3.16 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.289 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.03 -166.16 2.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.77 98.44 1.96 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.904 0.383 . . . . 0.0 110.462 176.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.4 t -87.3 91.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.199 0.523 . . . . 0.0 109.661 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.44 162.67 17.94 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.511 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.579 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -87.5 112.62 22.41 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.448 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 64.0 m -115.24 149.24 38.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.932 0.396 . . . . 0.0 111.167 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.85 119.33 17.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.839 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 49.5 t0 . . . . . 0 C--N 1.322 -0.623 0 CA-C-O 121.518 0.675 . . . . 0.0 110.252 175.826 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.453 -0.325 0 CA-C-O 120.937 0.399 . . . . 0.0 110.938 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mt -79.97 102.35 5.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 31' ' ' CYS . 62.3 mt -99.61 135.33 35.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.56 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -64.23 145.04 56.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.28 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.37 45.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.108 0.48 . . . . 0.0 111.671 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -154.19 19.28 0.5 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.295 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -123.01 13.89 9.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.3 m -127.96 143.81 51.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.849 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 m . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 120.808 0.337 . . . . 0.0 110.684 178.005 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.441 0 CA-C-O 121.062 0.458 . . . . 0.0 110.432 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.67 138.3 42.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.224 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.52 133.46 38.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.765 0.317 . . . . 0.0 110.181 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.579 HG21 ' HA3' ' A' ' 34' ' ' GLY . 12.3 mm -106.4 137.55 36.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.517 0.675 . . . . 0.0 112.466 -173.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.17 151.61 23.07 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.798 ' HD3' HG12 ' A' ' 36' ' ' ILE . 31.2 Cg_endo -64.68 58.46 0.27 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.136 2.557 . . . . 0.0 113.312 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -139.89 -26.39 0.79 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.126 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.64 -52.0 57.57 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.73 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.0 m -143.95 135.82 26.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.941 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.89 30.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.501 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.29 -73.53 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.02 177.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.459 ' C ' ' H ' ' A' ' 15' ' ' TYR . 9.9 t0 -83.79 -161.97 0.59 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 168.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.512 ' HB3' ' HG3' ' A' ' 48' ' ' LYS . 29.0 t0 -77.21 40.61 0.27 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.691 0.758 . . . . 0.0 109.541 172.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 8.1 m-30 -90.5 84.69 5.99 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.8 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 150.38 72.37 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.2 128.46 22.81 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.328 2.019 . . . . 0.0 111.846 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.88 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 9.4 m-85 -132.12 149.97 52.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.408 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.544 ' HB3' HG23 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -109.85 81.04 1.38 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.753 176.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 2.7 m -78.91 102.97 8.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.454 0.645 . . . . 0.0 110.937 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.431 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 4.9 tp-100 . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.908 -178.495 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.451 -0.421 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.971 HD12 ' HB ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -79.57 114.74 18.73 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.147 -177.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.5 85.65 1.15 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.529 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.88 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.93 143.74 28.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.326 0.584 . . . . 0.0 111.627 -177.206 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -123.68 158.84 29.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 168.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.8 t -64.06 133.29 29.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.579 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -55.63 119.83 15.76 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.574 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -78.72 108.53 12.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.24 0.543 . . . . 0.0 110.817 -174.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.798 HG12 ' HD3' ' A' ' 7' ' ' PRO . 3.1 mp -64.97 116.34 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.777 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.75 1.05 74.3 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.766 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.574 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -120.29 -173.91 2.67 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.618 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 12.8 mt-30 -114.86 143.63 44.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.01 0.433 . . . . 0.0 111.376 -176.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.7 152.54 40.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.757 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.37 -1.24 33.14 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.863 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -148.34 -161.92 1.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.563 -0.318 . . . . 0.0 110.576 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.14 128.76 37.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.168 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.22 122.48 34.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.314 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HG3' ' HB2' ' A' ' 20' ' ' CYS . 1.3 mmpm? -121.59 166.92 13.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.28 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 13.8 m -131.03 96.8 4.14 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 66' ' ' CYS . 0.8 OUTLIER -123.56 165.09 17.73 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 -174.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HG3' ' HB3' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -81.37 -151.09 0.08 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.322 -0.619 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.642 175.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.609 HD13 ' HE1' ' A' ' 18' ' ' TYR . 0.4 OUTLIER . . . . . 0 N--CA 1.447 -0.58 0 CA-C-O 121.148 0.499 . . . . 0.0 109.882 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mt -78.93 93.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.741 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.971 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.1 mm -79.03 139.65 18.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.579 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -81.04 -0.38 39.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.332 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.817 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 64.8 28.68 12.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.013 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.4 -56.01 2.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.087 0.47 . . . . 0.0 110.899 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.91 54.18 2.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.178 0.513 . . . . 0.0 110.67 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 47' ' ' CYS . 16.0 t -150.7 164.16 36.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.435 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.4 m . . . . . 0 C--N 1.327 -0.395 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.815 178.348 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.454 -0.24 0 CA-C-O 121.001 0.429 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.63 151.63 44.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.263 176.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.0 136.64 37.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.921 0.391 . . . . 0.0 111.608 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.663 HG21 ' HA3' ' A' ' 34' ' ' GLY . 45.1 mt -103.53 126.4 57.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.793 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.88 156.43 27.78 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.812 ' HD3' HG12 ' A' ' 36' ' ' ILE . 25.4 Cg_endo -62.14 -5.58 6.68 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.811 2.341 . . . . 0.0 112.619 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.91 7.39 23.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.549 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.2 m -61.42 -48.0 83.18 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 170.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 3.6 m -96.15 163.47 13.09 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.52 33.59 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.897 0.855 . . . . 0.0 108.759 -169.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.03 -109.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.469 -172.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.02 80.58 2.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.4 t70 49.76 42.67 24.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.459 0.647 . . . . 0.0 111.323 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.48 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 11.4 m-85 -108.03 134.49 50.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.075 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.82 160.66 48.08 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.711 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.499 ' HB2' HG23 ' A' ' 5' ' ' ILE . 58.7 Cg_endo -68.69 115.54 3.98 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.497 2.131 . . . . 0.0 111.878 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.729 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 30.1 m-85 -123.61 126.92 47.5 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.14 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.76 88.59 7.71 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.731 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 65.8 m -75.08 103.27 5.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.073 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.871 -177.211 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 109.757 -0.46 . . . . 0.0 109.757 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.84 89.95 4.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.88 71.72 2.14 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.347 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 35.9 m -85.39 93.17 8.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.914 0.387 . . . . 0.0 110.265 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.21 145.78 7.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 t -58.56 131.31 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.663 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -64.83 144.54 48.32 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.634 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.46 103.68 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.812 HG12 ' HD3' ' A' ' 7' ' ' PRO . 2.7 mp -58.15 118.16 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.885 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.21 -8.17 41.32 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.796 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.25 -178.86 3.47 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.85 141.6 37.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.794 0.331 . . . . 0.0 110.694 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.557 ' HB3' HG22 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -86.55 124.05 32.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.625 175.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -89.56 -17.16 55.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.275 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.57 -170.0 1.7 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.549 0.214 . . . . 0.0 110.479 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.53 109.47 2.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.862 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 40' ' ' CYS . 0.9 OUTLIER -79.77 103.31 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.243 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.563 ' HB3' ' SG ' ' A' ' 66' ' ' CYS . 1.9 mmpt? -113.18 149.6 33.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.668 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 21.9 m -90.92 93.79 9.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.931 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -124.19 -175.48 3.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.413 -177.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.76 141.0 18.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 . . . . . 0 C--N 1.318 -0.792 0 CA-C-O 121.272 0.558 . . . . 0.0 109.532 176.342 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt . . . . . 0 N--CA 1.452 -0.336 0 CA-C-O 121.155 0.503 . . . . 0.0 111.106 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.01 115.58 49.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.068 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.3 mp -104.55 118.5 51.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -78.44 62.18 3.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.707 -173.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 67.46 -69.74 0.13 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.965 0.906 . . . . 0.0 113.314 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.34 54.89 0.94 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -171.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.24 28.56 0.25 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 174.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 45.5 t -160.42 147.98 16.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.003 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.327 -0.379 0 CA-C-O 121.166 0.507 . . . . 0.0 110.087 175.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 40' ' ' CYS . . . . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.099 0.476 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.97 142.68 48.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.947 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.503 ' HA ' ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -77.54 125.2 28.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.999 0.428 . . . . 0.0 110.524 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.731 HG21 ' HA3' ' A' ' 34' ' ' GLY . 32.2 mt -89.76 127.2 42.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.072 -174.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.31 128.51 6.4 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 170.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.444 ' CG ' HG12 ' A' ' 36' ' ' ILE . 84.7 Cg_exo -43.45 -37.88 8.06 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.89 3.06 . . . . 0.0 114.476 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -86.58 33.57 0.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -45.56 42.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -132.32 141.54 48.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.102 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.3 17.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.417 0.627 . . . . 0.0 109.513 -175.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.43 -84.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.968 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -100.32 53.78 0.89 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.32 -173.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.419 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 23.4 t70 62.82 21.66 12.94 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.679 0.752 . . . . 0.0 110.229 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.525 ' HE2' HG22 ' A' ' 67' ' ' VAL . 3.9 m-85 -80.6 130.19 34.97 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.493 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.586 ' HE3' ' HB2' ' A' ' 49' ' ' ASP . 0.8 OUTLIER -126.82 157.63 70.91 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -177.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.15 115.02 3.8 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.589 2.193 . . . . 0.0 111.57 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.66 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 27.0 m-85 -120.3 133.4 55.47 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.993 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -81.88 84.83 6.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.717 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 m -78.55 79.7 4.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.296 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.421 HE22 ' HB3' ' A' ' 19' ' ' CYS . 2.4 mp0 . . . . . 0 C--N 1.324 -0.54 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.235 0.318 0 CA-C-O 121.184 0.516 . . . . 0.0 109.613 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.715 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 4.2 mt -87.22 146.63 25.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.504 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.93 48.13 0.99 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.867 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 29' ' ' LEU . 2.0 m -79.03 106.85 11.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.124 0.488 . . . . 0.0 111.328 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.4 m -86.07 164.27 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.637 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.82 135.47 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 123.167 0.292 . . . . 0.0 110.484 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.731 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -64.59 116.51 9.1 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.209 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.02 135.02 26.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.78 0.324 . . . . 0.0 110.623 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.444 HG12 ' CG ' ' A' ' 7' ' ' PRO . 1.4 mt -64.93 110.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.51 -9.7 49.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.113 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.6 m -90.8 171.19 9.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.882 0.372 . . . . 0.0 110.48 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.503 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 1.6 mp0 -124.3 140.25 53.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.837 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -75.82 146.72 39.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.205 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.25 -51.78 3.43 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.385 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.41 -90.18 0.15 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.746 0.308 . . . . 0.0 110.642 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.17 138.37 29.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.648 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.42 HG22 ' HB2' ' A' ' 40' ' ' CYS . 1.2 t -80.89 125.94 39.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.013 175.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -117.85 157.69 26.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.436 ' HB3' ' HD2' ' A' ' 15' ' ' TYR . 32.9 m -102.55 99.95 10.01 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 4.0 m -116.07 147.28 41.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.993 0.425 . . . . 0.0 111.461 -175.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -98.74 136.39 38.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.776 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.586 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 48.7 t0 . . . . . 0 C--N 1.325 -0.488 0 CA-C-O 121.295 0.569 . . . . 0.0 110.628 -177.033 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.425 HD13 ' HE1' ' A' ' 18' ' ' TYR . 1.3 mp . . . . . 0 CA--C 1.52 -0.185 0 CA-C-O 120.865 0.365 . . . . 0.0 110.203 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.08 87.71 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.995 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 29' ' ' LEU . 37.9 mm -63.85 127.54 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.599 -178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.77 44.69 1.18 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.812 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 67.4 -68.08 0.16 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.536 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.18 54.43 2.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 0.0 112.028 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.557 ' HB2' HG23 ' A' ' 61' ' ' ILE . 35.7 m120 -126.48 -14.9 5.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.688 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 4.6 m -109.77 88.79 2.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.575 -174.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.525 HG22 ' HE2' ' A' ' 15' ' ' TYR . 2.6 t . . . . . 0 N--CA 1.467 0.423 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.94 177.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.277 0 CA-C-O 120.899 0.38 . . . . 0.0 110.502 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.88 118.91 29.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.619 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.68 119.84 22.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.049 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' A' ' 40' ' ' CYS . 85.4 mt -87.07 127.92 40.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -172.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -117.37 136.96 12.96 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 166.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.584 ' HG3' HG12 ' A' ' 36' ' ' ILE . 74.5 Cg_endo -72.96 44.73 0.82 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.031 2.488 . . . . 0.0 113.94 -172.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -157.18 26.01 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.739 0.304 . . . . 0.0 111.22 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -58.1 3.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.415 0.626 . . . . 0.0 109.629 174.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -92.64 136.16 33.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.285 174.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.89 26.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.027 0.441 . . . . 0.0 110.371 -175.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -66.48 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 15' ' ' TYR . 3.2 t70 -100.6 -149.07 0.37 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.348 169.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -81.84 40.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.686 0.755 . . . . 0.0 109.394 171.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.557 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 1.9 m-85 -82.96 111.7 19.07 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.606 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.4 143.16 26.07 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.0 125.1 16.27 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.481 2.12 . . . . 0.0 111.163 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.709 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 9.7 m-85 -134.84 123.9 24.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.028 0.442 . . . . 0.0 110.8 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.8 t -87.09 93.15 9.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.026 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 26.1 m -74.57 100.44 3.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.263 0.554 . . . . 0.0 109.793 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.322 -0.611 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.892 -173.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.451 -0.408 0 CA-C-O 120.672 0.272 . . . . 0.0 110.639 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.509 HD11 ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -79.84 78.41 6.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.003 0.43 . . . . 0.0 110.918 -178.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -80.95 86.05 1.37 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.615 177.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 4.0 m -109.13 115.39 29.94 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.771 0.319 . . . . 0.0 110.955 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.9 154.78 4.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.98 139.33 15.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.464 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.509 ' CA ' HG21 ' A' ' 5' ' ' ILE . . . -65.26 88.34 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.849 174.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.457 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 61.1 t -79.45 137.04 22.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.914 0.388 . . . . 0.0 110.215 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.584 HG12 ' HG3' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -63.41 110.04 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.552 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.38 -4.61 33.19 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.585 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.457 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 43.1 m -78.08 127.58 32.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.991 0.424 . . . . 0.0 110.711 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -93.94 94.25 8.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.288 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.703 ' HB2' HD11 ' A' ' 5' ' ' ILE . 12.4 t -74.9 118.74 18.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.287 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.9 -2.82 59.41 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.195 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.3 -132.83 0.33 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.669 0.271 . . . . 0.0 111.018 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.567 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 70.5 m -86.93 99.42 11.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.013 0.435 . . . . 0.0 111.352 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -79.67 81.64 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.122 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HE3' HD11 ' A' ' 29' ' ' LEU . 3.7 mttm -91.35 175.72 6.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.794 -172.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 89.2 m -127.71 106.05 8.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.597 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 91.2 m -120.84 149.38 42.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.809 0.337 . . . . 0.0 111.088 -174.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.24 97.67 11.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.253 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 . . . . . 0 C--N 1.321 -0.669 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.096 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.452 ' HB2' ' O ' ' A' ' 31' ' ' CYS . 3.4 mp . . . . . 0 N--CA 1.456 -0.139 0 CA-C-O 121.106 0.479 . . . . 0.0 111.053 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.9 mt -79.63 102.57 5.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.38 146.83 5.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.292 -171.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.533 HD21 ' HB3' ' A' ' 64' ' ' ALA . 4.7 t30 -69.21 121.34 16.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.71 175.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.496 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . . . -78.94 35.32 0.25 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 111.894 -173.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.533 ' HB3' HD21 ' A' ' 62' ' ' ASN . . . -128.14 13.55 6.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.906 0.384 . . . . 0.0 110.561 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -138.71 38.29 2.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.239 0.542 . . . . 0.0 110.79 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 11.1 m -130.11 153.94 47.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.767 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.0 110.529 179.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.807 0.337 . . . . 0.0 110.632 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -146.31 127.8 15.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.234 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.49 123.68 26.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.152 0.501 . . . . 0.0 110.189 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.698 HG21 ' HA3' ' A' ' 34' ' ' GLY . 8.6 mt -89.58 127.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.57 -172.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.4 137.48 14.21 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 168.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.77 -4.99 5.23 Favored 'Trans proline' 0 N--CA 1.478 0.581 0 C-N-CA 123.364 2.71 . . . . 0.0 114.114 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -119.74 34.32 5.27 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.36 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -33.86 76.22 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.572 0.701 . . . . 0.0 110.295 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 89.3 m -135.21 146.18 48.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.906 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.69 17.6 0.8 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.952 0.406 . . . . 0.0 110.652 -169.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.53 -71.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 15' ' ' TYR . 3.8 t0 -93.67 -159.73 0.71 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.578 171.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . 0.553 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 21.2 t70 -80.43 41.57 0.55 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.634 0.73 . . . . 0.0 109.295 172.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.793 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 10.4 m-85 -85.57 71.74 10.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.783 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HB2' ' HD2' ' A' ' 17' ' ' PRO . 4.3 ptpt -79.58 156.01 75.79 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.831 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 16' ' ' LYS . 29.7 Cg_endo -61.32 126.54 19.57 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.978 2.452 . . . . 0.0 112.777 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.919 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 21.6 m-85 -127.95 123.93 36.07 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.081 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.1 m -80.75 80.95 7.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 53.6 m -77.03 121.43 23.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.574 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.131 176.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.453 ' HB2' HG22 ' A' ' 60' ' ' ILE . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.477 0 N-CA-C 110.024 -0.361 . . . . 0.0 110.024 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -103.09 148.27 25.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.401 -177.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.79 77.63 1.87 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.734 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.919 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 28.9 m -86.49 120.18 27.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.16 0.505 . . . . 0.0 112.112 -176.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.21 144.59 15.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 169.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 p -58.6 131.44 22.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.008 0.432 . . . . 0.0 111.058 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.698 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -67.56 117.08 8.46 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.699 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.401 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 11.2 t -78.92 131.22 34.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.904 0.383 . . . . 0.0 110.42 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.94 120.63 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.653 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.99 -4.95 68.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.642 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.401 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 15.8 m -95.24 166.34 11.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.643 0.259 . . . . 0.0 110.703 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 3' ' ' THR . 18.9 mt-30 -114.9 124.9 52.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.566 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.545 ' HB2' HD11 ' A' ' 5' ' ' ILE . 1.7 t -81.17 135.64 35.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.204 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.76 2.94 23.09 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.829 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -120.24 -157.59 0.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.1 92.38 4.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.965 0.412 . . . . 0.0 110.628 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.45 ' HB ' ' SG ' ' A' ' 40' ' ' CYS . 1.6 p -78.6 109.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.519 0.676 . . . . 0.0 109.613 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -118.22 171.11 8.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.827 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.793 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 59.7 m -112.71 104.01 12.04 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 173.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.508 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.8 OUTLIER -122.99 157.32 32.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.42 -177.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.669 ' HD2' ' HE1' ' A' ' 15' ' ' TYR . 2.5 ptmt -97.71 155.69 16.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.868 0.366 . . . . 0.0 110.76 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.493 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.844 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.349 0 CA-C-O 121.138 0.494 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -79.98 76.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.438 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.508 HD13 ' HB3' ' A' ' 47' ' ' CYS . 1.3 mt -84.59 152.12 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.559 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -72.34 139.55 47.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.592 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -61.99 -25.57 67.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.596 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.27 -5.9 55.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.143 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.17 -12.64 26.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.988 0.423 . . . . 0.0 110.842 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.79 172.14 11.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.019 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.344 . . . . 0.0 111.48 179.927 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.52 -0.186 0 CA-C-O 121.251 0.548 . . . . 0.0 109.622 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.96 123.75 22.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.887 -176.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 m -79.82 134.33 36.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.308 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 40' ' ' CYS . 37.8 mt -98.19 136.27 29.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.229 0.538 . . . . 0.0 112.43 -172.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.437 ' HA2' ' HD3' ' A' ' 7' ' ' PRO . . . -136.3 128.84 4.66 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 168.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.509 ' HA ' ' HG3' ' A' ' 17' ' ' PRO . 38.5 Cg_exo -59.91 3.17 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.7 2.933 . . . . 0.0 114.58 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -85.59 -0.99 56.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.934 0.397 . . . . 0.0 110.827 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -56.61 13.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.204 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -135.59 149.48 49.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.137 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -173.76 16.89 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.094 0.473 . . . . 0.0 110.395 -175.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.465 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.63 -90.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.67 -175.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -86.16 66.46 9.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.211 -178.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t0 57.27 27.14 13.22 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.221 0.534 . . . . 0.0 110.897 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.657 ' CE1' ' HG3' ' A' ' 48' ' ' LYS . 54.5 m-85 -88.79 148.69 23.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.45 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.638 ' HB2' ' HD2' ' A' ' 17' ' ' PRO . 14.0 pttm -160.07 163.23 22.76 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.638 ' HD2' ' HB2' ' A' ' 16' ' ' LYS . 20.1 Cg_endo -59.25 130.63 36.93 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.492 2.128 . . . . 0.0 112.201 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.9 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 12.4 m-85 -131.72 132.15 43.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.539 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.63 ' HB2' HG23 ' A' ' 32' ' ' VAL . 6.1 m -94.01 93.59 7.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.39 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.74 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 2.8 m -85.31 111.28 19.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.931 0.396 . . . . 0.0 110.333 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 . . . . . 0 C--N 1.322 -0.598 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.837 -176.492 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m . . . . . 0 N--CA 1.447 -0.625 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.74 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -83.08 138.03 33.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.549 -170.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.43 94.72 1.93 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.891 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.9 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -95.98 149.21 21.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.116 0.484 . . . . 0.0 111.673 -177.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.63 HG23 ' HB2' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -127.21 163.4 30.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 171.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.56 128.52 32.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.605 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -63.82 110.74 3.6 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.049 177.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.518 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -79.58 129.01 38.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.888 0.375 . . . . 0.0 110.739 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.521 ' H ' HD12 ' A' ' 36' ' ' ILE . 1.2 mp -57.6 127.13 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.255 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.04 15.5 81.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.794 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.518 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -118.23 163.07 17.22 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -102.14 157.29 16.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.906 0.384 . . . . 0.0 110.919 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.756 ' HB2' HD11 ' A' ' 5' ' ' ILE . 4.8 t -122.98 125.3 44.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.187 175.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.01 7.55 69.87 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.776 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.07 -166.24 1.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.56 119.63 18.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.013 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 t -86.9 104.3 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.35 164.26 11.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.994 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.0 m -115.81 88.94 2.99 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 57.9 m -112.52 163.45 14.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 -173.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.657 ' HG3' ' CE1' ' A' ' 15' ' ' TYR . 18.5 mtpt -82.06 171.19 14.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.967 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.344 -0.843 . . . . 0.0 108.996 169.163 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.34 0 CA-C-O 121.074 0.464 . . . . 0.0 110.076 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 35.7 mm -80.07 101.09 4.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.307 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.614 HD12 ' HB2' ' A' ' 31' ' ' CYS . 14.1 mt -105.02 134.7 45.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.027 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -88.74 36.06 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.651 -175.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 70.04 -42.78 0.52 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.85 -26.55 68.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.91 22.64 1.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.846 0.355 . . . . 0.0 110.773 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 3.2 m -133.14 143.15 49.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.89 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 121.167 0.508 . . . . 0.0 110.341 176.06 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.538 ' HB1' ' HG2' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.402 0 CA-C-O 120.958 0.409 . . . . 0.0 111.306 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 m -79.35 113.56 17.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.6 113.22 16.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.851 0.358 . . . . 0.0 110.04 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -89.16 131.1 37.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.471 0.653 . . . . 0.0 112.239 -173.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.0 156.79 20.88 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 166.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.16 -26.17 18.98 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.859 2.372 . . . . 0.0 113.241 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -89.53 33.82 0.83 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.962 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.43 -69.12 0.63 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.363 0.601 . . . . 0.0 109.95 175.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 m -92.68 137.03 32.72 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.05 38.9 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.419 0.628 . . . . 0.0 109.917 -168.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.462 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -116.53 -87.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.094 -177.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.661 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 21.7 t0 -100.14 63.68 1.17 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.764 -176.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 56.47 28.11 13.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.334 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.727 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 20.6 m-85 -90.78 134.51 34.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.12 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.98 153.33 47.08 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.192 -178.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.645 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 20.6 Cg_endo -61.97 120.32 7.86 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.629 2.22 . . . . 0.0 112.324 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.813 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 37.5 m-85 -133.29 125.27 28.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.881 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.0 95.76 6.79 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 37.1 m -82.44 121.79 27.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.23 -175.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 . . . . . 0 C--N 1.325 -0.49 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.415 179.139 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.317 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.71 137.53 44.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.841 0.353 . . . . 0.0 110.377 -179.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.68 75.25 2.34 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.943 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.813 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 19.2 m -84.93 102.11 12.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.187 0.517 . . . . 0.0 110.831 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 16.1 m -78.89 150.59 5.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 t -61.96 135.84 26.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.378 0.424 . . . . 0.0 110.475 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.645 ' HA3' ' HB2' ' A' ' 17' ' ' PRO . . . -64.99 89.68 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.759 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.412 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 49.7 t -79.43 141.36 15.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.687 0.28 . . . . 0.0 110.287 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.35 101.98 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.442 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.02 -13.63 8.48 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.209 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' A' ' 5' ' ' ILE . 53.6 m -72.83 129.11 37.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.008 0.433 . . . . 0.0 110.815 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.538 ' HG2' ' HB1' ' A' ' 2' ' ' ALA . 1.3 mp0 -95.3 106.85 18.93 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.406 ' HB3' HG22 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -75.17 106.25 6.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.28 -176.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.87 -4.65 29.64 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.927 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.09 -82.79 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.346 . . . . 0.0 110.231 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.604 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 38.7 m -155.41 120.12 4.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.193 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.406 HG22 ' HB3' ' A' ' 40' ' ' CYS . 2.8 t -82.05 101.62 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.604 ' HE3' ' HB3' ' A' ' 43' ' ' SER . 1.2 mmpt? -114.24 136.16 53.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 74.5 m -101.01 96.33 7.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.514 174.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.3 m -111.76 163.69 13.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.382 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 13' ' ' ASP . 28.7 ttmt -110.18 -37.7 5.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.405 -176.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 . . . . . 0 N--CA 1.469 0.482 0 C-N-CA 123.898 0.879 . . . . 0.0 111.959 -172.166 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.452 -0.362 0 CA-C-O 121.187 0.517 . . . . 0.0 111.057 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.11 74.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.973 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mt -80.24 147.21 6.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.265 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -85.92 151.97 23.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.02 94.03 0.31 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.77 0.319 . . . . 0.0 110.959 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -151.17 -78.94 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.249 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -85.03 54.21 3.02 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.157 0.504 . . . . 0.0 111.016 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 78.5 m -125.95 139.59 53.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.437 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -175.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HB1' ' HG2' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.453 -0.31 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.35 141.32 46.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.99 -176.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.2 124.14 27.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 0.0 110.043 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.887 HG21 ' HA3' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -92.55 151.02 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.536 0.684 . . . . 0.0 112.343 -171.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.431 ' HA2' HG12 ' A' ' 36' ' ' ILE . . . 159.1 176.26 30.95 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.256 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.909 ' HD3' HG12 ' A' ' 36' ' ' ILE . 24.1 Cg_exo -64.85 43.8 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.103 2.535 . . . . 0.0 112.785 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' A' ' 6' ' ' GLY . 48.3 t30 -131.22 -42.78 1.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.213 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -41.37 97.85 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.773 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -152.38 124.98 8.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.572 174.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -173.62 36.17 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -174.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.88 -82.39 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.822 -172.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -89.07 61.02 5.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.328 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.1 t0 51.51 54.04 11.74 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.543 0.687 . . . . 0.0 110.45 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -121.74 126.85 49.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.33 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.24 146.02 31.77 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.01 125.64 10.55 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.287 1.992 . . . . 0.0 111.454 177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.651 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 10.1 m-85 -126.07 131.1 52.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.036 0.445 . . . . 0.0 111.409 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.9 m -103.16 101.63 11.6 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.87 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 2.0 m -82.03 120.6 25.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.222 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.319 -0.722 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.494 -179.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.447 -0.609 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.645 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -79.37 157.45 27.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.785 -169.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.41 89.41 0.78 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.577 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.651 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 1.1 m -89.68 129.37 36.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.39 . . . . 0.0 111.108 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.1 m -104.32 156.76 5.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.08 128.1 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.887 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -64.35 129.16 36.92 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.181 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.492 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -79.31 123.49 36.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.002 0.429 . . . . 0.0 110.412 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.909 HG12 ' HD3' ' A' ' 7' ' ' PRO . 6.2 mt -68.52 112.32 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.772 -176.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.99 -16.11 30.64 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.751 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.492 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 14.1 m -90.24 176.91 6.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.423 ' HG2' ' HB1' ' A' ' 2' ' ' ALA . 1.6 tt0 -135.74 98.3 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.787 0.327 . . . . 0.0 110.599 -175.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.698 ' HB2' HD11 ' A' ' 5' ' ' ILE . 65.6 m -79.8 127.5 32.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.299 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.32 6.81 32.19 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.618 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.47 -141.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.626 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 1.3 m -82.89 80.49 8.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 110.097 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -79.8 109.06 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.438 ' HG2' ' O ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -122.6 178.09 5.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.596 0.712 . . . . 0.0 111.547 -173.284 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 92.0 m -129.93 111.85 12.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.659 176.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.51 ' SG ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -121.92 146.62 46.94 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.934 0.397 . . . . 0.0 111.589 -171.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.405 ' C ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -78.77 115.66 18.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.803 175.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.317 -0.823 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.266 173.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.451 -0.385 0 N-CA-C 110.132 -0.322 . . . . 0.0 110.132 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.32 95.18 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.321 0.582 . . . . 0.0 109.992 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.51 HG12 ' SG ' ' A' ' 47' ' ' CYS . 0.2 OUTLIER -94.12 131.72 40.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.914 -177.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -86.16 15.57 5.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -173.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.416 ' H ' ' CG2' ' A' ' 61' ' ' ILE . . . 72.93 -44.94 0.61 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.638 0.775 . . . . 0.0 112.496 175.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.39 18.37 0.31 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -128.04 16.89 6.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.593 0.711 . . . . 0.0 109.256 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER -114.15 140.32 48.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.155 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.324 -0.526 0 CA-C-O 121.232 0.539 . . . . 0.0 110.536 176.639 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.345 0 CA-C-O 121.2 0.524 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.45 132.16 47.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.464 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 m -78.97 109.18 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.778 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.688 HG21 ' HA3' ' A' ' 34' ' ' GLY . 13.0 mt -80.14 130.82 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.69 151.4 22.36 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 170.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.664 ' HD3' HG12 ' A' ' 36' ' ' ILE . 34.9 Cg_endo -64.91 -3.65 7.37 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 122.821 2.347 . . . . 0.0 113.323 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -82.62 -6.07 59.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.273 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.89 -79.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.239 0.542 . . . . 0.0 110.743 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 128.77 54.76 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.12 46.73 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.272 0.558 . . . . 0.0 110.213 -174.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.435 HD12 ' HD2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -126.91 -87.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.035 -176.18 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.559 ' HB3' ' CD2' ' A' ' 15' ' ' TYR . 27.8 t70 -81.22 54.08 2.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.438 0.637 . . . . 0.0 110.298 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.04 25.75 4.32 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.538 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.559 ' CD2' ' HB3' ' A' ' 13' ' ' ASP . 26.8 m-85 -78.52 124.33 28.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.301 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HZ2' ' HB3' ' A' ' 49' ' ' ASP . 35.3 mttp -119.51 145.58 39.25 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.32 115.55 3.39 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.329 2.019 . . . . 0.0 111.397 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.593 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 31.5 m-85 -126.11 135.28 51.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -176.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.87 86.35 2.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.516 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.737 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 1.1 m -67.62 116.72 8.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.185 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.327 178.88 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.741 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.448 -0.532 0 N-CA-C 109.111 -0.7 . . . . 0.0 109.111 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.737 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -104.5 138.08 41.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.522 -172.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 60' ' ' ILE . . . -89.01 100.68 2.68 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 177.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.9 OUTLIER -94.8 101.94 13.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.897 0.379 . . . . 0.0 111.187 -177.081 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.27 151.43 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.6 t -63.48 133.71 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.688 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -62.56 116.91 10.02 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.096 177.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.412 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -79.59 125.28 38.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.755 0.312 . . . . 0.0 110.527 -178.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.664 HG12 ' HD3' ' A' ' 7' ' ' PRO . 0.8 OUTLIER -65.98 114.25 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.712 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.16 15.04 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.752 -177.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.412 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 5.7 m -134.11 176.88 8.19 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.538 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 1.4 mm-40 -113.57 135.43 53.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.958 0.409 . . . . 0.0 111.663 -174.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.14 99.04 12.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.684 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.68 13.19 58.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.8 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.7 -107.5 0.38 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.31 . . . . 0.0 110.342 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.59 118.95 28.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.06 101.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.73 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -118.42 112.56 20.14 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.542 -176.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 33.3 m -81.77 93.59 6.86 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 38.7 m -108.83 144.69 36.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.748 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.2 123.78 29.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . 0.55 ' HB3' ' HZ2' ' A' ' 16' ' ' LYS . 6.9 t0 . . . . . 0 C--N 1.316 -0.849 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.521 -174.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 59' ' ' LEU . 0.4 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 CA-C-O 121.378 0.609 . . . . 0.0 111.642 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.741 HD11 ' HB2' ' A' ' 28' ' ' SER . 0.9 OUTLIER -82.54 117.24 28.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.297 174.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.6 mt -101.19 148.38 7.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.977 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -79.83 19.35 0.69 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.642 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.492 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . 71.01 -43.0 0.55 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.637 0.775 . . . . 0.0 112.901 176.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.46 -38.17 71.31 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.439 HD22 ' HA ' ' A' ' 65' ' ' ASN . 1.3 m120 -84.31 20.79 1.55 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.827 0.346 . . . . 0.0 111.447 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.2 m -120.25 165.34 14.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.434 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m . . . . . 0 C--N 1.323 -0.545 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.444 177.623 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.234 0.278 0 CA-C-O 121.122 0.487 . . . . 0.0 110.772 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.61 136.73 36.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.04 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.521 HG23 ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -78.82 137.94 37.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.564 HG21 ' HA3' ' A' ' 34' ' ' GLY . 47.9 mt -114.47 121.58 66.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.211 0.529 . . . . 0.0 112.001 -174.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.64 149.39 18.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 167.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.0 -28.19 39.04 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.318 2.679 . . . . 0.0 113.049 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -91.08 43.39 1.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.944 0.402 . . . . 0.0 111.459 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.35 -27.79 25.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.507 0.67 . . . . 0.0 109.457 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.82 131.41 19.91 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.357 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.07 15.07 0.63 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.192 0.52 . . . . 0.0 110.601 -175.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.431 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -79.45 -79.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.457 0.646 . . . . 0.0 109.321 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.431 ' H ' ' HB ' ' A' ' 12' ' ' ILE . 43.2 t0 -79.18 -173.39 3.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 167.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -76.21 52.07 0.72 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.619 0.724 . . . . 0.0 109.678 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -89.74 132.35 35.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.445 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.603 ' HB2' ' CE2' ' A' ' 18' ' ' TYR . 2.1 mtmp? -120.09 152.27 54.14 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.169 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.38 119.07 6.06 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.572 2.181 . . . . 0.0 111.346 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CE2' ' HB2' ' A' ' 16' ' ' LYS . 37.8 m-85 -127.92 125.65 39.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.243 0.544 . . . . 0.0 111.4 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.8 m -82.71 95.78 7.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.324 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.518 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -98.66 118.66 35.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.558 -174.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 . . . . . 0 C--N 1.319 -0.756 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.329 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.235 0.294 0 CA-C-O 120.797 0.332 . . . . 0.0 110.696 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.518 HD12 ' SG ' ' A' ' 20' ' ' CYS . 1.8 mm? -79.15 103.09 8.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.196 0.522 . . . . 0.0 110.139 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.76 79.54 1.86 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.727 -0.67 . . . . 0.0 113.077 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 1.2 m -78.71 122.31 25.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.25 0.548 . . . . 0.0 111.598 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.12 153.13 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.26 128.5 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.432 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.564 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -62.34 122.59 28.72 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.458 176.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.526 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -78.43 129.09 37.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.977 0.418 . . . . 0.0 110.418 -175.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.58 113.45 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.528 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.39 22.2 59.08 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.369 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.526 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 4.2 m -117.1 161.93 18.63 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.521 ' HG3' HG23 ' A' ' 4' ' ' THR . 5.5 mt-30 -104.48 137.07 42.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.14 0.495 . . . . 0.0 111.007 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 6.8 t -111.72 126.03 54.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.746 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.52 10.1 64.79 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.194 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.0 -171.23 1.79 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.44 106.42 3.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.816 0.341 . . . . 0.0 110.85 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.52 105.11 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.808 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -112.28 161.9 16.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.98 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -115.15 100.24 8.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.506 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' ' 62' ' ' ASN . 0.9 OUTLIER -116.76 152.88 33.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.677 -176.008 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.493 ' H ' ' HG2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -93.45 154.26 18.02 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 175.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 . . . . . 0 C--N 1.325 -0.484 0 CA-C-O 120.924 0.393 . . . . 0.0 110.997 -177.061 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 mt . . . . . 0 N--CA 1.454 -0.275 0 CA-C-O 121.253 0.549 . . . . 0.0 110.248 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -81.48 79.51 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 122.076 0.941 . . . . 0.0 110.502 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -134.79 110.67 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.27 177.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.565 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 3.4 t-20 -178.2 -22.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 O-C-N 123.406 0.441 . . . . 0.0 111.441 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.33 -53.12 55.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.55 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.7 5.02 1.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.823 0.344 . . . . 0.0 111.405 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . 0.408 ' HB2' HG22 ' A' ' 61' ' ' ILE . 7.4 m120 -101.16 17.69 21.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.011 0.434 . . . . 0.0 111.124 -174.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.34 157.64 32.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.514 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.0 t . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.521 176.309 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.567 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.453 -0.312 0 CA-C-O 120.708 0.289 . . . . 0.0 110.631 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.68 139.68 33.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.063 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 113.16 17.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.885 0.374 . . . . 0.0 110.075 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.782 HD11 ' HB2' ' A' ' 40' ' ' CYS . 95.4 mt -83.38 129.48 37.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 0.0 112.473 -172.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.54 142.41 13.57 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 170.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.22 -20.62 39.6 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.37 2.714 . . . . 0.0 113.718 -176.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -82.55 19.16 1.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.853 0.358 . . . . 0.0 111.54 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -44.21 67.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 109.969 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.35 132.53 56.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.401 176.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.16 18.79 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.895 0.379 . . . . 0.0 111.223 -174.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -79.17 -68.05 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -100.27 -166.95 1.38 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.238 171.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -79.71 48.39 0.93 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 2.8 m-30 -79.54 124.17 28.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.758 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -100.84 148.08 34.55 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.102 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -67.31 122.1 9.32 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.231 1.954 . . . . 0.0 110.717 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.691 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 18.7 m-85 -124.63 124.47 42.28 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.979 0.419 . . . . 0.0 111.49 -174.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.7 m -87.12 86.35 7.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.068 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.8 m -76.18 99.19 4.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.506 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 . . . . . 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.63 -175.942 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.743 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.448 -0.575 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.424 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -94.09 136.2 34.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.076 0.465 . . . . 0.0 111.586 -173.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.93 71.74 1.93 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.595 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.691 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 4.0 m -79.37 109.82 14.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 111.076 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 32' ' ' VAL . 0.8 OUTLIER -78.87 143.13 13.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.668 176.142 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.61 133.07 29.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.16 0.505 . . . . 0.0 111.204 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.438 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -77.78 106.59 2.29 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.99 157.04 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.836 0.35 . . . . 0.0 110.489 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.37 114.19 2.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.124 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.82 10.19 55.49 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.196 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.5 m -96.07 172.63 7.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.722 0.296 . . . . 0.0 110.297 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.567 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 74.8 mt-30 -128.18 162.9 25.86 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.782 ' HB2' HD11 ' A' ' 5' ' ' ILE . 1.6 t -137.02 146.98 45.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.751 0.31 . . . . 0.0 110.979 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.9 24.15 3.16 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.855 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.31 -151.51 0.4 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.76 89.79 3.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.871 0.367 . . . . 0.0 110.959 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 p -79.67 108.85 13.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.586 0.708 . . . . 0.0 109.692 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -117.5 -175.45 2.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.624 -177.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.676 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 95.2 m -134.73 101.92 5.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.65 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.2 m -121.75 167.35 13.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.34 . . . . 0.0 111.178 -173.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.425 ' HE3' ' HB3' ' A' ' 48' ' ' LYS . 2.4 mmmt -87.08 145.73 26.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.408 172.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 C--N 1.323 -0.573 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.922 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.454 -0.251 0 CA-C-O 121.022 0.439 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.743 HD11 ' HB2' ' A' ' 28' ' ' SER . 0.9 OUTLIER -99.75 121.2 50.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.232 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.34 164.29 22.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.085 0.469 . . . . 0.0 111.693 -174.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -85.05 145.58 27.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.943 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.66 92.97 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -171.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.95 14.83 3.76 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.43 15.66 25.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.64 0.733 . . . . 0.0 109.83 174.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.4 m -108.35 173.48 6.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.248 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.252 0.549 . . . . 0.0 109.608 173.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.516 ' HB1' ' HG2' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.346 0 CA-C-O 121.019 0.438 . . . . 0.0 110.014 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.58 130.84 42.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.266 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.08 122.38 26.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.993 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.833 HG21 ' HA3' ' A' ' 34' ' ' GLY . 56.5 mt -92.94 126.1 45.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.397 0.617 . . . . 0.0 112.18 -174.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -136.08 133.53 6.67 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 169.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.527 ' CG ' HG12 ' A' ' 36' ' ' ILE . 77.9 Cg_exo -51.28 -21.06 9.08 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.396 2.731 . . . . 0.0 113.828 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.64 13.4 3.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.68 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.46 -77.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.82 126.8 36.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.324 173.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.77 25.52 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.535 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -77.81 -64.37 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 15' ' ' TYR . 2.6 t70 -100.03 -151.54 0.4 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 169.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -79.29 35.18 0.26 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.42 0.629 . . . . 0.0 110.179 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 13' ' ' ASP . 22.4 m-85 -83.61 136.73 34.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.754 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.61 161.26 61.96 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.89 105.49 1.15 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.484 2.123 . . . . 0.0 111.605 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.437 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 41.9 m-85 -112.07 122.31 47.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.461 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.73 73.17 7.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.301 0.572 . . . . 0.0 109.699 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -71.26 107.85 4.46 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.016 -177.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 . . . . . 0 C--N 1.321 -0.643 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.759 177.224 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.416 0 N-CA-C 109.647 -0.501 . . . . 0.0 109.647 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.51 ' HG ' ' HB3' ' A' ' 62' ' ' ASN . 1.6 mm? -79.75 110.83 15.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.101 -178.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.88 76.98 1.34 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.766 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -84.45 93.47 8.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.901 0.382 . . . . 0.0 110.976 178.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.34 139.22 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.2 p -66.72 134.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.261 0.553 . . . . 0.0 111.155 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.833 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -84.15 115.78 4.14 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.819 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.5 154.28 4.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.527 HG12 ' CG ' ' A' ' 7' ' ' PRO . 1.3 mt -60.85 117.21 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.074 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.17 -0.65 64.17 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.372 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -85.66 164.53 17.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.724 0.297 . . . . 0.0 110.3 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.516 ' HG2' ' HB1' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -108.57 139.41 43.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.783 0.325 . . . . 0.0 110.177 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.509 ' SG ' HG22 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -90.35 107.26 19.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.949 0.404 . . . . 0.0 110.733 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.18 -17.48 80.22 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.925 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.09 -163.9 0.9 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.76 128.45 34.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.525 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.509 HG22 ' SG ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -78.58 117.52 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -111.22 145.4 38.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.463 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 34.2 m -94.47 78.86 3.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.571 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -109.18 159.04 17.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.608 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 pttm -87.28 -164.92 1.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.161 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 120.763 0.316 . . . . 0.0 110.214 178.654 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 120.778 0.323 . . . . 0.0 110.553 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mt -82.98 78.98 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.161 0.505 . . . . 0.0 110.503 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -111.94 -153.88 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.791 177.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.528 ' HA ' ' HB2' ' A' ' 66' ' ' CYS . 20.9 t-20 52.46 25.72 3.74 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.239 0.543 . . . . 0.0 112.103 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.23 -5.9 15.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.12 0.486 . . . . 0.0 110.302 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -164.34 -56.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.367 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.28 44.1 1.06 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -170.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -111.38 120.6 42.73 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.348 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.801 -175.396 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.625 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.437 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.03 117.4 7.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.604 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.48 128.39 33.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.685 178.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.649 HG21 ' HA3' ' A' ' 34' ' ' GLY . 50.8 mt -93.03 133.64 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.983 -176.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.81 130.4 9.34 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 169.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.66 -37.53 75.09 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.738 2.959 . . . . 0.0 114.127 -175.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -86.83 36.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.974 0.416 . . . . 0.0 111.663 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.82 -52.0 7.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 173.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.7 m -137.33 116.03 12.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.024 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 24.3 m -161.38 20.79 0.12 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.427 0.632 . . . . 0.0 109.452 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.451 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -79.18 -82.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.428 -176.625 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.702 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 7.2 t70 -79.28 60.26 3.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.456 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.8 t0 48.8 45.28 22.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.764 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.702 ' CE2' ' HB3' ' A' ' 13' ' ' ASP . 26.5 m-85 -97.56 152.48 18.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.181 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.648 ' HB2' ' CE2' ' A' ' 18' ' ' TYR . 9.6 mttp -132.79 143.11 47.27 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.45 103.65 1.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.019 1.813 . . . . 0.0 110.6 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.997 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 24.4 m-85 -104.55 125.81 51.05 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.632 -173.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 0.5 OUTLIER -90.35 93.76 9.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.524 174.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 29' ' ' LEU . 18.0 m -85.12 125.97 33.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.8 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 110.601 177.132 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.45 -0.431 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.631 ' HB2' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -95.58 143.09 27.17 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.255 -172.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.51 91.29 1.61 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.997 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 5.7 m -96.6 126.12 41.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.864 0.364 . . . . 0.0 111.627 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.42 144.47 14.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -60.66 129.84 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.173 0.511 . . . . 0.0 111.154 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.649 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -70.14 109.88 3.06 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.639 175.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.45 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -79.61 160.59 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -67.23 116.55 6.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.398 -175.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.12 23.66 60.93 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.446 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.45 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 49.8 m -95.2 126.62 40.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.689 0.281 . . . . 0.0 110.678 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.625 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 4.0 mp0 -81.12 117.9 22.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.129 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.01 141.86 48.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.033 0.444 . . . . 0.0 111.536 -176.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.74 8.83 10.74 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.37 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -94.9 -167.2 1.59 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.63 103.03 11.85 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.668 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.3 t -81.6 100.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -113.87 162.11 16.77 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.756 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 89.6 m -103.03 92.87 4.73 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.124 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -109.9 145.72 36.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.7 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -82.41 156.23 24.26 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.111 0.481 . . . . 0.0 110.62 -177.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 t0 . . . . . 0 C--N 1.321 -0.666 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.189 178.613 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.3 mt . . . . . 0 N--CA 1.448 -0.574 0 CA-C-O 120.896 0.379 . . . . 0.0 110.598 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 73.2 mt -79.78 99.75 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 mt -112.52 148.57 15.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.764 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -79.53 136.19 36.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.03 -20.45 24.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.18 65.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -93.8 -1.61 54.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.095 0.474 . . . . 0.0 110.806 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.36 103.82 15.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.652 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.0 m . . . . . 0 C--N 1.324 -0.517 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.476 -175.814 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.453 -0.278 0 CA-C-O 120.87 0.367 . . . . 0.0 110.22 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.88 129.5 38.29 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.228 -177.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.12 130.48 36.43 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.974 0.416 . . . . 0.0 110.457 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.683 HG21 ' HA3' ' A' ' 34' ' ' GLY . 29.0 mm -84.98 118.88 32.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.255 -174.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . 0.485 ' HA2' ' HD2' ' A' ' 7' ' ' PRO . . . -112.53 117.55 4.37 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 169.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.485 ' HD2' ' HA2' ' A' ' 6' ' ' GLY . 0.9 OUTLIER -43.96 -34.39 6.25 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.166 3.244 . . . . 0.0 114.235 -176.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -83.21 44.91 0.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 111.652 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.43 -44.76 7.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.559 0.695 . . . . 0.0 109.343 174.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m -139.67 137.69 35.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.177 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.25 30.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -95.23 -92.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.657 -173.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.407 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 17.5 t70 -79.08 57.77 2.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.798 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.84 20.82 3.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.445 0.641 . . . . 0.0 110.257 -173.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.413 ' HE1' ' HB2' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -79.68 132.33 36.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.643 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.95 152.99 63.82 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . 0.436 ' HG3' ' HA ' ' A' ' 7' ' ' PRO . 36.6 Cg_endo -66.18 114.64 3.1 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.168 1.912 . . . . 0.0 111.137 175.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.642 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 18.9 m-85 -120.09 128.98 53.97 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.238 0.542 . . . . 0.0 110.874 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.07 88.57 7.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.943 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 1.3 m -73.67 99.73 3.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.742 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.323 -0.55 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.509 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.451 -0.397 0 CA-C-O 120.741 0.305 . . . . 0.0 110.721 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -98.72 128.92 45.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.85 0.357 . . . . 0.0 110.732 178.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.69 72.42 2.56 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.704 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -79.22 92.54 5.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.003 0.43 . . . . 0.0 110.199 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.5 m -84.45 163.43 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 177.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.6 t -63.71 134.26 28.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.683 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -54.08 124.99 32.13 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.573 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -79.3 107.64 11.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.997 0.427 . . . . 0.0 110.721 -177.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.31 113.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.491 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.52 -2.44 77.52 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.502 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.52 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -112.72 171.8 7.31 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.477 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 10.2 mp0 -101.82 152.34 21.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.937 0.399 . . . . 0.0 111.273 -176.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.452 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -81.54 156.73 25.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.855 175.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.5 -49.9 1.77 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.405 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -108.51 -76.86 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.655 0.264 . . . . 0.0 111.433 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.616 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -142.64 119.93 11.55 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.465 -176.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 p -84.53 116.56 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.616 ' HD3' ' HB2' ' A' ' 43' ' ' SER . 0.1 OUTLIER -127.4 165.54 19.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.069 0.461 . . . . 0.0 110.909 -176.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.531 ' HB2' HG23 ' A' ' 67' ' ' VAL . 86.7 m -98.68 109.55 22.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.769 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 163.04 19.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.217 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.413 ' HB2' ' HE1' ' A' ' 15' ' ' TYR . 29.4 ttmt -117.27 114.97 24.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.831 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 . . . . . 0 C--N 1.322 -0.602 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.499 178.036 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.451 -0.379 0 CA-C-O 120.822 0.344 . . . . 0.0 110.805 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.0 mt -81.12 95.73 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 31' ' ' CYS . 11.9 mt -102.72 151.17 6.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.498 -175.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.41 ' OD1' ' HB3' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -83.27 131.04 35.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.585 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -61.21 -22.11 64.47 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -171.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . 0.41 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . . . -64.17 -33.69 76.37 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -174.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.38 0.91 53.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 111.326 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.45 127.82 39.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.939 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 46' ' ' CYS . 0.2 OUTLIER . . . . . 0 C--N 1.323 -0.58 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.603 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.359 0 CA-C-O 120.896 0.379 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.98 121.06 27.23 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.624 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 109.71 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.032 0.444 . . . . 0.0 110.134 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.587 HD12 ' SG ' ' A' ' 19' ' ' CYS . 3.3 mt -91.46 134.2 30.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.426 0.632 . . . . 0.0 112.665 -170.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.69 164.11 16.99 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 170.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.752 ' HD3' HD12 ' A' ' 36' ' ' ILE . 37.8 Cg_endo -66.73 -13.57 40.42 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.719 2.279 . . . . 0.0 113.213 -177.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -97.05 19.39 12.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.968 0.413 . . . . 0.0 111.221 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.02 -59.63 2.7 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.472 0.653 . . . . 0.0 110.327 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.5 m -93.98 117.35 29.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.331 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.2 m -157.09 21.12 0.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.91 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 mt -78.38 -63.23 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -99.63 -165.01 1.18 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -80.05 47.84 0.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.479 ' HE2' HG13 ' A' ' 67' ' ' VAL . 10.0 m-30 -91.06 163.6 14.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.657 -176.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -132.57 148.21 68.69 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.13 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.15 122.24 9.29 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.477 2.118 . . . . 0.0 112.128 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.844 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 34.2 m-85 -121.43 128.7 52.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.906 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.587 ' SG ' HD12 ' A' ' 5' ' ' ILE . 59.3 m -91.04 84.16 5.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.641 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 56.8 m -76.97 107.06 9.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.734 -176.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 . . . . . 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.049 -178.89 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER . . . . . 0 N--CA 1.448 -0.543 0 CA-C-O 121.059 0.457 . . . . 0.0 110.233 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.494 HD11 ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -89.4 148.14 23.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.391 -178.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.0 76.32 2.17 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.81 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.844 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 33.3 m -87.34 99.26 11.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.021 0.439 . . . . 0.0 111.366 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 m -89.69 151.37 3.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 171.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.16 129.62 20.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.559 ' HA2' ' SG ' ' A' ' 19' ' ' CYS . . . -48.19 126.64 15.26 Favored Glycine 0 N--CA 1.447 -0.584 0 O-C-N 123.83 0.706 . . . . 0.0 111.912 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -78.06 114.02 18.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -177.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.752 HD12 ' HD3' ' A' ' 7' ' ' PRO . 7.3 mm -61.24 110.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.452 -172.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.71 9.51 61.17 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.833 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.56 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 70.4 m -112.21 151.04 30.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.057 0.456 . . . . 0.0 110.663 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.63 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 4.0 mt-30 -86.24 113.85 22.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.792 176.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.3 m -92.79 123.08 35.8 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.81 45.44 2.51 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.991 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -142.09 -178.24 5.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.82 125.4 27.07 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.2 t -79.36 97.42 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 11.4 mmpt? -105.42 124.36 49.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.038 -174.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 93.9 m -87.64 89.6 8.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 34.6 m -111.17 169.29 8.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.143 0.496 . . . . 0.0 111.498 -174.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.89 141.59 40.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.431 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 . . . . . 0 C--N 1.322 -0.629 0 CA-C-O 121.285 0.565 . . . . 0.0 110.043 176.838 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.223 0 CA-C-O 121.037 0.446 . . . . 0.0 110.345 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . 0.526 ' H ' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -87.03 78.65 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 -178.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.467 HD12 ' HB2' ' A' ' 31' ' ' CYS . 14.2 mt -76.37 129.64 37.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.859 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.4 t30 -82.71 42.64 0.79 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.398 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . 0.494 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . 70.92 -54.2 0.66 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.005 0.922 . . . . 0.0 113.084 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.39 59.42 2.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -173.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.01 25.5 0.82 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.393 0.616 . . . . 0.0 109.823 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -135.63 177.28 7.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.671 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . 0.479 HG13 ' HE2' ' A' ' 15' ' ' TYR . 0.1 OUTLIER . . . . . 0 C--N 1.33 -0.246 0 CA-C-O 120.722 0.296 . . . . 0.0 110.576 177.854 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.452 -0.328 0 CA-C-O 120.951 0.405 . . . . 0.0 110.602 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.11 129.78 44.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.488 HG23 ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -88.23 122.52 31.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.085 178.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.809 HG21 ' HA3' ' A' ' 34' ' ' GLY . 14.9 mt -94.14 140.63 16.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.013 0.435 . . . . 0.0 111.934 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.55 151.83 23.46 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 174.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.885 ' HD3' HG12 ' A' ' 36' ' ' ILE . 60.3 Cg_endo -72.77 46.03 0.98 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.851 2.368 . . . . 0.0 112.758 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -135.79 0.51 2.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.583 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.27 -54.07 10.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.241 0.543 . . . . 0.0 110.246 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -120.2 139.71 52.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.3 177.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.5 m -162.01 12.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.809 0.338 . . . . 0.0 110.55 -173.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . 0.48 HG13 ' H ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -78.36 -84.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.407 ' H ' ' HB ' ' A' ' 12' ' ' ILE . 2.6 t70 -83.45 -152.84 0.13 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 173.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.62 48.15 1.48 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.937 0.875 . . . . 0.0 109.531 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.761 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 25.5 m-85 -96.16 110.0 22.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.273 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.4 mtmm -107.65 156.97 37.01 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.83 117.41 4.31 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.208 1.939 . . . . 0.0 111.678 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -122.11 122.33 38.98 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.58 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 5.1 t -88.3 100.84 13.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.74 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.865 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -101.96 135.7 43.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.887 -176.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 . . . . . 0 C--N 1.324 -0.506 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.356 -178.035 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.235 0.292 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.865 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -127.61 164.01 22.96 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.73 -174.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.54 76.95 0.25 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.759 -177.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -81.42 108.35 14.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.744 0.306 . . . . 0.0 110.227 176.135 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 m -91.46 161.53 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.84 130.5 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.766 0.317 . . . . 0.0 110.423 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.809 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -61.11 134.26 48.85 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.636 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.422 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -78.94 116.65 23.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.055 0.455 . . . . 0.0 109.877 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.885 HG12 ' HD3' ' A' ' 7' ' ' PRO . 34.1 mt -67.22 120.12 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.849 -175.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.12 17.13 72.75 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.173 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . 0.422 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -127.27 160.55 30.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.674 0.273 . . . . 0.0 110.695 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.488 ' HG3' HG23 ' A' ' 4' ' ' THR . 28.0 mt-30 -97.53 149.88 21.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.019 0.438 . . . . 0.0 110.873 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.56 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -121.41 156.99 31.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.231 178.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.56 16.3 21.68 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.753 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -124.35 -161.65 1.02 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -89.91 107.22 18.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.017 0.437 . . . . 0.0 111.084 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.45 109.38 17.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.952 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -130.93 -179.45 5.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.909 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.761 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 4.1 m -107.93 105.58 15.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.206 175.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 62.2 m -118.31 148.86 42.04 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.171 -174.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.544 ' HD2' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -91.64 116.04 28.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.095 0.474 . . . . 0.0 110.239 176.601 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.321 -0.646 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.09 178.671 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 59' ' ' LEU . 0.7 OUTLIER . . . . . 0 N--CA 1.452 -0.353 0 CA-C-O 121.029 0.442 . . . . 0.0 110.316 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -87.99 105.44 15.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.796 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.5 mt -112.35 135.16 52.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.446 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -67.43 150.68 48.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.614 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.75 164.91 18.41 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.365 177.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 69.62 8.97 7.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.811 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.44 21.04 13.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.537 0.684 . . . . 0.0 109.98 175.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.9 m -123.42 140.52 52.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.09 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.313 -0.994 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.093 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.113 0 CA-C-O 120.933 0.396 . . . . 0.0 110.701 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.52 133.53 35.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.774 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.74 121.94 25.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.017 0.437 . . . . 0.0 110.516 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.684 HG21 ' HA3' ' A' ' 34' ' ' GLY . 3.7 mt -92.13 147.36 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.397 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.85 157.01 26.98 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 172.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.91 ' HD3' HG12 ' A' ' 36' ' ' ILE . 14.2 Cg_endo -56.97 -33.72 96.04 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.858 2.372 . . . . 0.0 112.095 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.84 62.21 4.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.448 0.642 . . . . 0.0 110.187 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.34 -49.59 4.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.089 175.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -123.32 152.68 41.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.137 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -151.82 19.49 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.725 0.774 . . . . 0.0 109.211 -174.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -74.22 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.191 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -100.96 -156.46 0.56 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.267 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -86.84 49.84 1.89 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.866 0.841 . . . . 0.0 108.771 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' TYR . . . . . 0.695 ' HB3' ' HB2' ' A' ' 46' ' ' CYS . 8.6 m-85 -86.9 110.48 20.02 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.523 -176.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.551 ' HG3' ' CE2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -95.02 155.27 39.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.641 -177.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.91 127.48 22.5 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.18 2.587 . . . . 0.0 112.858 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' TYR . . . . . 0.895 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 21.4 m-85 -138.07 130.96 29.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 18.2 m -89.49 87.36 7.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.565 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' CYS . . . . . 0.633 ' HB3' HD22 ' A' ' 29' ' ' LEU . 91.1 m -75.43 94.56 3.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.907 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.585 ' HG3' ' HB2' ' A' ' 42' ' ' ALA . 0.1 OUTLIER . . . . . 0 C--N 1.324 -0.5 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.543 -179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 65.0 m . . . . . 0 C--O 1.234 0.238 0 CA-C-O 121.445 0.641 . . . . 0.0 109.753 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LEU . . . . . 0.633 HD22 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mt -79.69 115.36 19.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.969 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.91 62.98 4.46 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.88 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' CYS . . . . . 0.895 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 6.2 m -89.41 101.84 14.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.125 0.488 . . . . 0.0 110.98 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.94 152.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.2 t -59.53 132.97 24.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.713 0.292 . . . . 0.0 110.405 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLY . . . . . 0.684 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -66.41 113.94 6.1 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.65 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.6 122.01 32.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.063 0.458 . . . . 0.0 110.653 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ILE . . . . . 0.91 HG12 ' HD3' ' A' ' 7' ' ' PRO . 1.1 mt -59.13 130.17 22.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.104 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.87 80.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.45 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 m -122.32 166.73 14.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -101.39 137.0 40.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.903 0.383 . . . . 0.0 111.046 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' CYS . . . . . 0.53 ' HB2' HD11 ' A' ' 5' ' ' ILE . 7.7 t -101.01 128.41 47.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.796 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.05 -0.58 57.24 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.449 -178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.585 ' HB2' ' HG3' ' A' ' 21' ' ' GLN . . . -121.04 -162.21 0.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.095 0.474 . . . . 0.0 111.169 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.89 104.25 3.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.783 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.41 111.42 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.1 mmtt -124.73 172.39 9.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.889 -178.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' CYS . . . . . 0.695 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -118.16 119.94 36.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.657 0.265 . . . . 0.0 110.45 176.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.88 171.3 9.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.838 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.473 ' H ' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -115.09 154.05 29.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.746 -179.578 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.325 -0.485 0 CA-C-O 121.137 0.494 . . . . 0.0 110.954 -178.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.7 tp . . . . . 0 N--CA 1.451 -0.424 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 mt -79.97 97.48 2.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.014 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 61' ' ' ILE . 3.6 mm -73.69 151.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.434 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -66.22 -68.35 0.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.275 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -162.25 -96.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.397 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.44 78.8 9.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.233 0.456 . . . . 0.0 112.233 -172.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.7 22.82 0.46 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.435 0.636 . . . . 0.0 109.923 171.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 87.0 m -123.23 86.95 2.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.612 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.7 m . . . . . 0 C--N 1.324 -0.531 0 CA-C-O 120.965 0.412 . . . . 0.0 111.342 -175.232 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.548 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.882 0 CA-C-O 120.778 0.323 . . . . 0.0 110.835 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -150.68 35.36 0.62 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.258 0.551 . . . . 0.0 110.265 176.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.31 140.19 50.19 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.578 -0.737 . . . . 0.0 111.326 -177.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -79.12 129.3 34.31 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.125 0.488 . . . . 0.0 110.317 177.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.913 HG21 ' HA3' ' A' ' 34' ' ' GLY . 80.9 mt -95.68 135.21 30.48 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.555 -176.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -163.93 161.3 34.19 Favored Glycine 0 N--CA 1.445 -0.712 0 N-CA-C 110.974 -0.85 . . . . 0.0 110.974 174.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.91 ' HD3' HG12 ' A' ' 36' ' ' ILE . 25.8 Cg_exo -64.33 60.86 0.25 Allowed 'Trans proline' 0 CA--C 1.533 0.437 0 C-N-CA 123.332 2.688 . . . . 0.0 112.871 175.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -150.73 -44.32 0.12 Allowed 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 -179.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -59.51 -58.46 8.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.538 -0.755 . . . . 0.0 111.59 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 5.8 m -122.8 97.28 5.37 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.32 179.642 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.439 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -162.96 15.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.175 0.512 . . . . 0.0 110.201 -179.791 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -79.57 -78.1 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.996 -174.841 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.659 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 26.9 t0 -77.75 59.12 1.97 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.165 0.507 . . . . 0.0 110.419 178.896 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 5.0 t0 51.72 46.98 25.68 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 115.446 -0.797 . . . . 0.0 110.846 -176.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.659 ' CE2' ' HB3' ' A' ' 13' ' ' ASP . 10.7 m-85 -102.2 160.79 14.22 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.634 -0.712 . . . . 0.0 111.543 -173.5 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.0 mtmm -125.04 145.5 50.52 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.607 171.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.487 ' HB2' HG23 ' A' ' 5' ' ' ILE . 61.4 Cg_endo -74.65 103.63 1.74 Allowed 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 121.861 1.707 . . . . 0.0 111.154 176.222 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.925 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 33.9 m-85 -100.39 120.56 40.15 Favored 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.157 -175.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -88.29 87.35 7.27 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 174.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.649 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 57.8 m -78.15 113.62 16.26 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.954 -176.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 15.9 mm100 -82.88 61.62 6.01 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.534 -179.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -78.01 109.01 11.7 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.561 -0.745 . . . . 0.0 110.441 178.579 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -119.37 -164.79 1.08 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.693 -176.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.64 105.94 1.07 Allowed 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.511 176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.87 62.53 1.3 Allowed Glycine 0 N--CA 1.449 -0.473 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.035 -177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 18.5 m -139.5 96.31 3.07 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.841 0.353 . . . . 0.0 110.753 179.16 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -78.93 -33.9 45.03 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.498 0.666 . . . . 0.0 110.226 178.03 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -110.44 129.82 55.69 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.019 173.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.557 ' HB2' ' SG ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -80.13 123.39 27.85 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-O 120.806 0.336 . . . . 0.0 110.648 -175.868 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.61 78.69 1.62 Allowed Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.925 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 14.7 m -86.9 99.32 11.76 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-O 121.012 0.434 . . . . 0.0 111.439 -175.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.86 142.7 13.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 174.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 77.5 t -60.36 122.42 10.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 N-CA-C 110.03 -0.359 . . . . 0.0 110.03 179.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.913 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -66.25 117.9 10.3 Favored Glycine 0 N--CA 1.441 -0.973 0 C-N-CA 120.856 -0.687 . . . . 0.0 112.292 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.7 t -79.14 139.18 18.77 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.459 -0.571 . . . . 0.0 109.459 177.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.91 HG12 ' HD3' ' A' ' 7' ' ' PRO . 2.4 mt -59.62 108.61 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.634 -178.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 119.77 -21.27 9.09 Favored Glycine 0 N--CA 1.449 -0.479 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.982 -178.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 16.0 m -76.08 160.85 29.38 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.575 0.226 . . . . 0.0 110.84 179.762 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.91 145.48 40.67 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 120.762 0.315 . . . . 0.0 110.269 176.508 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.5 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -100.21 110.76 23.02 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.166 -0.47 . . . . 0.0 109.882 175.928 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.548 ' HA2' ' O ' ' A' ' 1' ' ' SER . . . -84.46 -30.84 26.35 Favored Glycine 0 N--CA 1.444 -0.786 0 C-N-CA 120.808 -0.71 . . . . 0.0 111.603 179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.17 -142.24 0.24 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.716 0.293 . . . . 0.0 110.732 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -84.44 102.12 12.55 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.414 -176.295 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 p -80.29 115.8 23.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 174.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -116.32 143.91 44.93 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 121.089 0.471 . . . . 0.0 111.123 -175.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.431 ' HB3' ' HB3' ' A' ' 10' ' ' CYS . 35.3 m -99.23 83.56 2.87 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 116.043 -0.526 . . . . 0.0 109.944 175.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 23.7 m -102.47 154.13 19.38 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.478 -177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.536 ' HA ' ' HD1' ' A' ' 15' ' ' TYR . 4.1 ttmt -65.68 -70.26 0.25 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.287 -178.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -167.95 -51.43 0.02 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.808 -176.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.418 ' C ' HG12 ' A' ' 51' ' ' VAL . 3.7 t0 78.54 -66.07 0.21 Allowed 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 124.32 1.013 . . . . 0.0 108.829 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.418 HG12 ' C ' ' A' ' 50' ' ' ASP . 0.4 OUTLIER 178.38 111.36 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.241 -0.891 . . . . 0.0 109.001 -178.023 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.97 45.01 1.04 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.181 0.515 . . . . 0.0 111.349 -176.821 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.6 t-20 -151.45 153.12 34.05 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.453 179.768 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 2.5 m 58.28 56.5 4.44 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-O 121.412 0.625 . . . . 0.0 109.974 -173.425 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.496 ' O ' ' HA ' ' A' ' 59' ' ' LEU . . . 151.56 57.29 0.01 OUTLIER Glycine 0 N--CA 1.447 -0.574 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.605 -177.149 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -84.8 -42.6 15.0 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.801 0.334 . . . . 0.0 110.223 -178.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -81.85 67.03 7.68 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 121.408 0.623 . . . . 0.0 109.652 177.402 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 95.79 98.59 1.79 Allowed Glycine 0 N--CA 1.445 -0.762 0 N-CA-C 110.487 -1.045 . . . . 0.0 110.487 -173.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.496 ' HA ' ' O ' ' A' ' 55' ' ' GLY . 0.1 OUTLIER -60.96 123.3 17.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.066 0.46 . . . . 0.0 110.992 -174.994 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 13.3 mt -80.25 80.8 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.542 -0.754 . . . . 0.0 110.154 179.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.543 HG22 ' H ' ' A' ' 63' ' ' ALA . 15.3 mm -77.85 137.33 22.4 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.174 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 23.3 t30 -78.66 11.78 2.39 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.79 0.329 . . . . 0.0 111.107 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.543 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 66.28 4.18 3.07 Favored 'General case' 0 N--CA 1.467 0.412 0 C-N-CA 123.392 0.677 . . . . 0.0 112.374 176.621 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -117.55 32.92 5.88 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.9 0.381 . . . . 0.0 111.207 -176.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.3 25.7 3.5 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.986 0.422 . . . . 0.0 110.154 178.478 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.56 155.71 48.18 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.911 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -75.2 -53.16 16.84 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-O 120.912 0.387 . . . . 0.0 110.014 174.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.126 0 CA-C-N 115.57 -0.741 . . . . 0.0 109.196 -179.919 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.479 1.017 0 CA-C-O 120.855 0.36 . . . . 0.0 111.097 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -88.56 101.75 14.26 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 120.984 0.421 . . . . 0.0 110.628 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -90.9 137.25 32.51 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.186 178.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -83.93 138.48 33.13 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 179.58 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.861 HG21 ' HA3' ' A' ' 34' ' ' GLY . 6.2 mt -105.51 134.27 47.49 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.65 0 CA-C-O 121.364 0.602 . . . . 0.0 112.196 -173.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -137.42 147.1 19.03 Favored Glycine 0 N--CA 1.447 -0.6 0 N-CA-C 110.465 -1.054 . . . . 0.0 110.465 171.686 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -51.47 -34.46 51.47 Favored 'Trans proline' 0 C--O 1.233 0.233 0 C-N-CA 123.346 2.697 . . . . 0.0 112.992 -179.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 37.8 t30 -101.58 67.75 1.14 Allowed 'General case' 0 C--N 1.324 -0.53 0 CA-C-O 121.103 0.478 . . . . 0.0 110.498 179.642 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -100.11 -61.52 1.36 Allowed 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.853 -0.612 . . . . 0.0 110.025 176.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.419 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 54.4 m -116.24 142.93 46.18 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 172.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 44.5 m -159.63 32.86 0.19 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 121.073 0.463 . . . . 0.0 110.863 -172.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -79.06 -68.67 0.49 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 171.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -95.44 -165.55 1.31 Allowed 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.078 -1.419 . . . . 0.0 107.591 167.364 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.59 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 3.7 t70 -77.85 50.72 0.88 Allowed 'General case' 0 C--N 1.318 -0.769 0 CA-C-O 121.377 0.608 . . . . 0.0 109.573 170.802 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.665 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 8.2 m-85 -85.85 79.61 9.2 Favored 'General case' 0 N--CA 1.451 -0.408 0 CA-C-N 115.145 -0.934 . . . . 0.0 109.627 -179.64 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.687 ' HD2' ' HB2' ' A' ' 49' ' ' ASP . 2.1 mttt -79.3 156.97 75.94 Favored Pre-proline 0 C--N 1.319 -0.757 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.329 -177.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -67.08 116.02 3.94 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.464 2.109 . . . . 0.0 111.305 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.579 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 25.8 m-85 -126.82 131.38 51.25 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.593 -177.778 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 70.9 m -94.83 99.03 11.16 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.363 178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.525 ' HB3' HD22 ' A' ' 29' ' ' LEU . 1.6 m -82.92 121.25 26.72 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.724 -179.263 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mm-40 -93.55 107.45 19.3 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.605 179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -78.33 107.71 11.14 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 174.521 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 27.7 mtm -97.97 167.98 10.57 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.022 -174.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -67.35 -51.64 49.81 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.079 -0.51 . . . . 0.0 111.388 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.18 -45.42 3.05 Favored Glycine 0 N--CA 1.446 -0.643 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.008 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.04 105.04 10.1 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.048 0.451 . . . . 0.0 110.752 -179.832 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -89.53 0.66 56.74 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.963 -179.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -72.52 141.77 48.51 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.863 -0.608 . . . . 0.0 110.01 176.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.525 HD22 ' HB3' ' A' ' 20' ' ' CYS . 7.2 mt -80.23 88.0 5.51 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.004 0.431 . . . . 0.0 111.203 -175.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.14 79.84 1.15 Allowed Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.958 -0.639 . . . . 0.0 111.784 175.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.579 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.5 OUTLIER -88.63 109.61 20.25 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.105 0.479 . . . . 0.0 111.227 -178.373 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.95 153.39 3.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.242 -0.435 . . . . 0.0 109.987 176.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 16.9 t -62.09 130.64 26.69 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 120.744 0.307 . . . . 0.0 110.704 -179.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.861 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -66.39 132.44 32.8 Favored Glycine 0 N--CA 1.443 -0.84 0 CA-C-N 115.794 -0.639 . . . . 0.0 112.289 177.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.424 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 2.1 t -80.54 137.51 21.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-O 121.069 0.462 . . . . 0.0 110.703 -179.02 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.0 mt -64.15 111.75 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.265 -178.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 89.4 15.13 59.11 Favored Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.497 176.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.424 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 15.1 m -110.36 170.89 7.79 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.715 0.293 . . . . 0.0 110.515 177.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.49 136.25 54.85 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.498 -178.557 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.442 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.8 OUTLIER -115.47 133.4 56.06 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.433 -179.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.79 29.65 9.18 Favored Glycine 0 N--CA 1.449 -0.484 0 C-N-CA 121.034 -0.603 . . . . 0.0 112.235 -179.501 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -121.44 -156.09 0.67 Allowed 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 109.864 -0.421 . . . . 0.0 109.864 178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -78.5 83.86 4.67 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.009 0.433 . . . . 0.0 110.375 177.437 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.412 HG22 ' HB3' ' A' ' 40' ' ' CYS . 2.0 t -79.59 109.72 14.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.027 177.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.753 ' HA ' ' HB3' ' A' ' 68' ' ' ALA . 0.1 OUTLIER -124.13 160.07 28.62 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.992 0.425 . . . . 0.0 111.163 -176.135 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.665 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 59.0 m -93.59 100.84 13.03 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 171.157 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.403 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 69.3 m -108.15 144.48 35.49 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.363 -172.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.59 ' HE3' ' HB3' ' A' ' 14' ' ' ASP . 0.0 OUTLIER -79.3 117.36 20.22 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.51 -179.427 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.687 ' HB2' ' HD2' ' A' ' 16' ' ' LYS . 65.8 t0 -71.18 117.5 12.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.952 175.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -103.61 1.9 32.64 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.71 -0.677 . . . . 0.0 110.861 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -117.05 -55.51 4.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.767 -177.093 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.1 m 51.91 57.93 6.0 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.544 0.687 . . . . 0.0 110.783 -176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -103.84 162.15 13.35 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.344 -177.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.92 -4.43 31.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.179 0.514 . . . . 0.0 111.028 178.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -117.47 42.39 1.86 Allowed Glycine 0 N--CA 1.446 -0.653 0 N-CA-C 111.312 -0.715 . . . . 0.0 111.312 176.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -72.51 113.74 9.87 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.869 0.366 . . . . 0.0 110.217 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.4 p -129.14 -93.86 0.43 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.835 -177.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -107.94 98.26 1.22 Allowed Glycine 0 N--CA 1.446 -0.667 0 N-CA-C 111.469 -0.653 . . . . 0.0 111.469 179.637 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -81.28 118.06 22.3 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.834 0.35 . . . . 0.0 110.553 -177.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -83.21 97.11 4.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.606 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.797 177.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.499 ' H ' HG12 ' A' ' 61' ' ' ILE . 0.3 OUTLIER -88.63 150.44 3.73 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.387 -178.394 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -101.85 45.07 0.98 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.906 0.384 . . . . 0.0 110.661 179.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 73.27 -56.33 0.66 Allowed 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 115.035 -0.984 . . . . 0.0 113.367 172.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -59.09 -27.04 65.18 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 113.129 0.789 . . . . 0.0 113.129 -171.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -92.66 17.08 10.81 Favored 'General case' 0 C--N 1.325 -0.477 0 C-N-CA 121.02 -0.272 . . . . 0.0 111.476 -177.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 65.0 m -127.41 119.79 26.96 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.798 0.332 . . . . 0.0 110.88 -179.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -127.53 112.04 26.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.616 -0.266 . . . . 0.0 111.042 179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.753 ' HB3' ' HA ' ' A' ' 45' ' ' LYS . . . . . . . . 0 C--O 1.245 0.863 0 CA-C-N 115.628 -0.714 . . . . 0.0 109.186 176.202 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.423 ' HB2' ' H ' ' A' ' 2' ' ' ALA . 0.0 OUTLIER . . . . . 0 N--CA 1.474 0.735 0 CA-C-O 120.525 0.203 . . . . 0.0 110.625 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' H ' ' HB2' ' A' ' 1' ' ' SER . . . -89.83 73.59 7.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.091 0.472 . . . . 0.0 110.391 -179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.495 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -67.82 120.76 14.67 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.586 -179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.03 125.05 28.88 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.785 176.066 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.722 HG21 ' HA3' ' A' ' 34' ' ' GLY . 3.5 mt -104.28 132.9 49.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 N-CA-C 112.745 0.646 . . . . 0.0 112.745 -170.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.72 149.0 16.85 Favored Glycine 0 N--CA 1.443 -0.871 0 N-CA-C 109.79 -1.324 . . . . 0.0 109.79 167.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -74.11 43.06 0.8 Allowed 'Trans proline' 0 CA--C 1.531 0.373 0 C-N-CA 122.648 2.232 . . . . 0.0 113.539 -174.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.2 m-20 -150.32 26.04 0.78 Allowed 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.051 0.453 . . . . 0.0 110.677 -179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.19 -23.6 47.5 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.726 176.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.1 m -146.12 145.97 30.7 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 177.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 66.5 m -162.36 25.2 0.11 Allowed 'General case' 0 C--N 1.333 -0.147 0 CA-C-O 120.801 0.334 . . . . 0.0 111.075 -170.731 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.16 -65.67 0.73 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 N-CA-C 108.577 -0.897 . . . . 0.0 108.577 177.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 t70 -100.52 -151.12 0.4 Allowed 'General case' 0 C--N 1.315 -0.907 0 N-CA-C 108.439 -0.948 . . . . 0.0 108.439 168.366 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 23.0 t0 -83.03 47.46 1.23 Allowed 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.933 0.873 . . . . 0.0 108.693 169.252 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.579 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 5.8 m-85 -82.35 78.81 8.95 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 114.598 -1.183 . . . . 0.0 109.677 -179.166 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.8 mtmm -79.81 149.92 71.55 Favored Pre-proline 0 C--N 1.315 -0.92 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.112 -179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_endo -62.27 126.63 19.0 Favored 'Trans proline' 0 N--CA 1.462 -0.327 0 C-N-CA 122.397 2.065 . . . . 0.0 111.052 176.425 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.702 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 9.2 m-85 -129.1 129.85 45.73 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 120.971 0.415 . . . . 0.0 111.373 -176.271 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.495 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 13.9 m -83.56 84.14 7.64 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.357 175.034 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.544 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 20.6 m -72.67 96.84 2.06 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.111 0.482 . . . . 0.0 111.386 -175.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.8 mt-30 -84.56 93.52 8.38 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.84 175.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.514 ' HB3' HD23 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -59.99 136.2 57.94 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.904 -179.635 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.31 139.95 37.68 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.232 -0.44 . . . . 0.0 109.944 179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.65 58.48 1.81 Allowed 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.365 0.602 . . . . 0.0 110.995 -179.456 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 175.21 -58.08 0.12 Allowed Glycine 0 N--CA 1.443 -0.856 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.493 -179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -85.97 159.46 19.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.642 0.258 . . . . 0.0 110.349 177.552 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.13 -19.23 43.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.934 0.397 . . . . 0.0 110.724 -179.512 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.08 153.9 42.6 Favored 'General case' 0 C--O 1.237 0.443 0 CA-C-N 115.658 -0.701 . . . . 0.0 110.863 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.514 HD23 ' HB3' ' A' ' 22' ' ' SER . 0.0 OUTLIER -122.96 139.2 54.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.97 -177.071 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -82.93 76.05 2.3 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 111.058 -0.817 . . . . 0.0 111.058 174.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.793 ' HB2' HD12 ' A' ' 61' ' ' ILE . 3.8 m -79.54 100.75 7.9 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-O 120.998 0.428 . . . . 0.0 111.042 -177.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -81.42 145.34 8.96 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 172.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 p -58.1 135.24 22.49 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.806 0.336 . . . . 0.0 110.708 -179.632 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.722 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -56.81 118.97 13.21 Favored Glycine 0 N--CA 1.447 -0.598 0 CA-C-N 115.84 -0.618 . . . . 0.0 112.003 179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.23 118.92 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.634 0 CA-C-O 120.91 0.386 . . . . 0.0 110.352 -177.375 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 1.5 mp -55.59 124.54 8.93 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 115.498 -0.774 . . . . 0.0 111.458 -176.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.08 13.93 81.32 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.916 -0.659 . . . . 0.0 112.27 177.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -124.72 167.12 15.0 Favored 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 110.195 -0.298 . . . . 0.0 110.195 -179.76 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.495 ' HA ' ' O ' ' A' ' 3' ' ' THR . 2.5 mt-30 -113.23 145.79 40.41 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.78 0.324 . . . . 0.0 110.906 -179.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.616 ' HB2' HD11 ' A' ' 5' ' ' ILE . 13.9 m -125.99 120.08 29.39 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.197 177.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -90.48 61.81 3.16 Favored Glycine 0 N--CA 1.454 -0.162 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.289 179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -155.03 -166.16 2.22 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 -179.538 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.77 98.44 1.96 Allowed 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.904 0.383 . . . . 0.0 110.462 176.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.4 t -87.3 91.27 3.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.199 0.523 . . . . 0.0 109.661 177.519 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -118.44 162.67 17.94 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.936 -0.575 . . . . 0.0 110.511 -175.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.579 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 0.2 OUTLIER -87.5 112.62 22.41 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 172.783 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.448 ' HB2' ' CD2' ' A' ' 18' ' ' TYR . 64.0 m -115.24 149.24 38.06 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.932 0.396 . . . . 0.0 111.167 -176.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -73.85 119.33 17.92 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.679 -0.691 . . . . 0.0 110.839 178.33 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.409 ' CG ' ' H ' ' A' ' 53' ' ' ASN . 49.5 t0 -92.9 69.01 4.55 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 121.518 0.675 . . . . 0.0 110.252 175.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -103.73 -2.04 27.07 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.502 -0.772 . . . . 0.0 109.506 174.766 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.03 -23.06 6.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.416 179.443 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -135.2 -53.35 0.79 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.276 179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.409 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 7.2 t-20 63.88 43.01 5.59 Favored 'General case' 0 N--CA 1.466 0.348 0 CA-C-O 121.484 0.659 . . . . 0.0 109.745 -175.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -163.9 -55.05 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.163 -0.926 . . . . 0.0 110.062 -176.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 134.09 153.32 6.94 Favored Glycine 0 N--CA 1.447 -0.614 0 CA-C-N 115.312 -0.858 . . . . 0.0 111.257 -178.113 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -155.25 154.66 32.5 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.968 0.384 . . . . 0.0 110.804 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -84.95 -16.45 40.93 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.821 179.325 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -138.55 68.44 0.5 Allowed Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.29 -0.724 . . . . 0.0 111.29 178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.93 96.71 10.82 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.937 0.399 . . . . 0.0 110.938 -177.044 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.8 mt -79.97 102.35 5.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.621 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 175.339 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.793 HD12 ' HB2' ' A' ' 31' ' ' CYS . 62.3 mt -99.61 135.33 35.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.649 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.56 -176.598 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 6.7 t-20 -64.23 145.04 56.64 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.482 -0.781 . . . . 0.0 110.28 177.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -77.37 45.22 0.46 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.108 0.48 . . . . 0.0 111.671 -176.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -154.19 19.28 0.5 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.295 178.092 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -123.01 13.89 9.82 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.071 -0.513 . . . . 0.0 111.176 -177.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 57.3 m -127.96 143.81 51.1 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.849 -177.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 2.6 m -105.82 152.53 7.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 CA-C-O 120.808 0.337 . . . . 0.0 110.684 178.005 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.251 1.167 0 CA-C-O 117.867 -1.063 . . . . 0.0 109.528 179.058 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.478 0.97 0 N-CA-C 110.217 -0.29 . . . . 0.0 110.217 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.618 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . -79.21 103.78 9.38 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-O 121.062 0.458 . . . . 0.0 110.432 178.305 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -74.67 138.3 42.76 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.747 -0.661 . . . . 0.0 111.224 179.417 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -77.52 133.46 38.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.765 0.317 . . . . 0.0 110.181 177.224 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.579 HG21 ' HA3' ' A' ' 34' ' ' GLY . 12.3 mm -106.4 137.55 36.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.517 0.675 . . . . 0.0 112.466 -173.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -156.17 151.61 23.07 Favored Glycine 0 N--CA 1.443 -0.885 0 N-CA-C 109.902 -1.279 . . . . 0.0 109.902 172.1 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.798 ' HD3' HG12 ' A' ' 36' ' ' ILE . 31.2 Cg_endo -64.68 58.46 0.27 Allowed 'Trans proline' 0 CA--C 1.533 0.468 0 C-N-CA 123.136 2.557 . . . . 0.0 113.312 177.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 12.8 t30 -139.89 -26.39 0.79 Allowed 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.126 177.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -52.64 -52.0 57.57 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.73 178.524 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 99.0 m -143.95 135.82 26.29 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.941 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -171.89 30.24 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.95 -0.759 . . . . 0.0 108.95 -179.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.501 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.29 -73.53 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.541 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.02 177.783 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.459 ' C ' ' H ' ' A' ' 15' ' ' TYR . 9.9 t0 -83.79 -161.97 0.59 Allowed 'General case' 0 C--N 1.317 -0.817 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 168.412 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.512 ' HB3' ' HG3' ' A' ' 48' ' ' LYS . 29.0 t0 -77.21 40.61 0.27 Allowed 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 121.691 0.758 . . . . 0.0 109.541 172.041 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.591 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 8.1 m-30 -90.5 84.69 5.99 Favored 'General case' 0 N--CA 1.45 -0.439 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.8 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.79 150.38 72.37 Favored Pre-proline 0 C--N 1.319 -0.75 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.2 128.46 22.81 Favored 'Trans proline' 0 C--O 1.235 0.329 0 C-N-CA 122.328 2.019 . . . . 0.0 111.846 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.88 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 9.4 m-85 -132.12 149.97 52.27 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 115.866 -0.606 . . . . 0.0 111.408 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.544 ' HB3' HG23 ' A' ' 32' ' ' VAL . 0.2 OUTLIER -109.85 81.04 1.38 Allowed 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.753 176.688 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 2.7 m -78.91 102.97 8.54 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-O 121.454 0.645 . . . . 0.0 110.937 -177.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.431 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 4.9 tp-100 -76.15 108.39 9.03 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 114.912 -1.04 . . . . 0.0 110.908 -178.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 3.1 m -168.12 147.73 4.73 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.277 -0.874 . . . . 0.0 109.442 176.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -105.36 -44.06 4.83 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.989 0.423 . . . . 0.0 110.398 -179.317 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -144.25 -78.13 0.21 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.336 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -163.82 73.95 0.18 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.499 -0.858 . . . . 0.0 112.551 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.5 m -95.45 -36.45 11.33 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-O 120.919 0.39 . . . . 0.0 110.224 178.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -160.53 -147.88 0.16 Allowed 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 108.537 -0.912 . . . . 0.0 108.537 175.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -77.96 162.01 27.1 Favored 'General case' 0 C--N 1.314 -0.946 0 N-CA-C 109.333 -0.617 . . . . 0.0 109.333 174.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.971 HD12 ' HB ' ' A' ' 61' ' ' ILE . 0.0 OUTLIER -79.57 114.74 18.73 Favored 'General case' 0 C--N 1.322 -0.612 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.147 -177.009 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -78.5 85.65 1.15 Allowed Glycine 0 N--CA 1.445 -0.721 0 C-N-CA 120.67 -0.776 . . . . 0.0 111.529 179.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.88 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -84.93 143.74 28.79 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.326 0.584 . . . . 0.0 111.627 -177.206 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.544 HG23 ' HB3' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -123.68 158.84 29.17 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 168.184 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 71.8 t -64.06 133.29 29.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 N-CA-C 109.916 -0.402 . . . . 0.0 109.916 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.579 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -55.63 119.83 15.76 Favored Glycine 0 N--CA 1.443 -0.876 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 175.826 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.574 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -78.72 108.53 12.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.24 0.543 . . . . 0.0 110.817 -174.83 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.798 HG12 ' HD3' ' A' ' 7' ' ' PRO . 3.1 mp -64.97 116.34 4.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.251 -0.886 . . . . 0.0 110.777 -175.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 90.75 1.05 74.3 Favored Glycine 0 N--CA 1.446 -0.671 0 C-N-CA 120.94 -0.647 . . . . 0.0 111.766 -179.326 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.574 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -120.29 -173.91 2.67 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.622 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.618 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 12.8 mt-30 -114.86 143.63 44.82 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.01 0.433 . . . . 0.0 111.376 -176.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -73.7 152.54 40.4 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.813 -0.631 . . . . 0.0 110.757 178.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -108.37 -1.24 33.14 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.674 -0.774 . . . . 0.0 111.863 178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.431 ' HB1' ' HA ' ' A' ' 21' ' ' GLN . . . -148.34 -161.92 1.44 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.563 -0.318 . . . . 0.0 110.576 -178.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -70.14 128.76 37.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.168 -179.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.7 t -79.22 122.48 34.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.314 178.957 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HG3' ' HB2' ' A' ' 20' ' ' CYS . 1.3 mmpm? -121.59 166.92 13.51 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.28 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.591 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 13.8 m -131.03 96.8 4.14 Favored 'General case' 0 C--N 1.322 -0.6 0 N-CA-C 108.982 -0.747 . . . . 0.0 108.982 176.135 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.436 ' HB3' ' HB2' ' A' ' 66' ' ' CYS . 0.8 OUTLIER -123.56 165.09 17.73 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.012 -174.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.512 ' HG3' ' HB3' ' A' ' 14' ' ' ASP . 0.1 OUTLIER -81.37 -151.09 0.08 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 171.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -67.63 -66.23 0.59 Allowed 'General case' 0 C--N 1.322 -0.619 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.642 175.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 10.5 t70 68.25 -51.87 0.54 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 113.313 0.856 . . . . 0.0 113.313 173.008 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.583 HG13 HD13 ' A' ' 61' ' ' ILE . 3.8 m -46.25 126.11 1.68 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 113.944 1.09 . . . . 0.0 113.944 -171.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -87.05 42.68 1.04 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.028 -0.987 . . . . 0.0 109.153 170.95 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -145.99 154.24 41.67 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.353 -0.84 . . . . 0.0 109.987 -175.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -76.24 -7.9 55.89 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.475 -179.449 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 99.58 28.35 7.55 Favored Glycine 0 N--CA 1.449 -0.477 0 C-N-CA 120.957 -0.64 . . . . 0.0 111.561 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.4 m-20 -81.42 -67.1 0.81 Allowed 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.047 0.451 . . . . 0.0 110.545 -177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.12 49.94 1.84 Allowed 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.645 179.96 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 76.07 -156.31 47.13 Favored Glycine 0 N--CA 1.447 -0.599 0 N-CA-C 111.399 -0.68 . . . . 0.0 111.399 -176.072 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.609 HD13 ' HE1' ' A' ' 18' ' ' TYR . 0.4 OUTLIER -111.55 90.7 3.41 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.148 0.499 . . . . 0.0 109.882 178.146 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.9 mt -78.93 93.82 1.64 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.579 0 CA-C-N 115.719 -0.673 . . . . 0.0 109.741 178.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.971 ' HB ' HD12 ' A' ' 29' ' ' LEU . 7.1 mm -79.03 139.65 18.07 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 115.373 -0.83 . . . . 0.0 110.579 -177.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.8 m-80 -81.04 -0.38 39.52 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.332 179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.817 ' H ' HG22 ' A' ' 61' ' ' ILE . . . 64.8 28.68 12.85 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-N 115.36 -0.836 . . . . 0.0 111.013 -178.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -102.4 -56.01 2.34 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.087 0.47 . . . . 0.0 110.899 -178.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -92.91 54.18 2.14 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.178 0.513 . . . . 0.0 110.67 -178.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 47' ' ' CYS . 16.0 t -150.7 164.16 36.79 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.813 -0.63 . . . . 0.0 110.435 -177.049 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 13.4 m -118.41 151.47 20.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-N 116.468 -0.333 . . . . 0.0 110.815 178.348 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.965 0 CA-C-O 118.552 -0.737 . . . . 0.0 110.33 178.249 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.411 ' O ' ' HA2' ' A' ' 41' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.906 0 N-CA-C 109.794 -0.447 . . . . 0.0 109.794 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -121.03 121.22 37.47 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.001 0.429 . . . . 0.0 111.062 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.63 151.63 44.78 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.263 176.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -78.0 136.64 37.99 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.921 0.391 . . . . 0.0 111.608 -175.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.663 HG21 ' HA3' ' A' ' 34' ' ' GLY . 45.1 mt -103.53 126.4 57.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.005 -0.543 . . . . 0.0 111.793 -179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -160.88 156.43 27.78 Favored Glycine 0 N--CA 1.443 -0.872 0 N-CA-C 111.014 -0.834 . . . . 0.0 111.014 174.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.812 ' HD3' HG12 ' A' ' 36' ' ' ILE . 25.4 Cg_endo -62.14 -5.58 6.68 Favored 'Trans proline' 0 CA--C 1.529 0.227 0 C-N-CA 122.811 2.341 . . . . 0.0 112.619 178.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -109.91 7.39 23.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.585 -0.279 . . . . 0.0 111.549 179.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 29.2 m -61.42 -48.0 83.18 Favored 'General case' 0 C--O 1.231 0.114 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 170.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 3.6 m -96.15 163.47 13.09 Favored 'General case' 0 C--N 1.321 -0.644 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 167.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -169.52 33.59 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.598 0 CA-C-O 121.897 0.855 . . . . 0.0 108.759 -169.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -128.03 -109.05 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 114.644 -1.162 . . . . 0.0 110.469 -172.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 34.6 t0 -101.02 80.58 2.14 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 112.759 0.651 . . . . 0.0 112.759 -171.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 26.4 t70 49.76 42.67 24.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 121.459 0.647 . . . . 0.0 111.323 176.576 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.48 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 11.4 m-85 -108.03 134.49 50.86 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.075 -178.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.82 160.66 48.08 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.13 -0.486 . . . . 0.0 109.711 -179.352 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.499 ' HB2' HG23 ' A' ' 5' ' ' ILE . 58.7 Cg_endo -68.69 115.54 3.98 Favored 'Trans proline' 0 C--N 1.344 0.311 0 C-N-CA 122.497 2.131 . . . . 0.0 111.878 178.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.729 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 30.1 m-85 -123.61 126.92 47.5 Favored 'General case' 0 C--N 1.32 -0.696 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.14 -179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -86.76 88.59 7.71 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.998 -0.546 . . . . 0.0 109.731 178.413 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.486 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 65.8 m -75.08 103.27 5.19 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.073 178.426 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.2 mt-30 -88.47 166.93 13.87 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.871 -177.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -74.13 172.58 11.48 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.667 -0.697 . . . . 0.0 111.259 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.683 ' HG2' ' HA ' ' A' ' 27' ' ' ALA . 0.5 OUTLIER -85.15 70.92 10.93 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.201 -176.94 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -77.47 -76.07 0.19 Allowed 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.726 177.168 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -101.1 -12.15 37.42 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.956 -0.64 . . . . 0.0 112.143 178.469 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 m -122.43 129.29 51.9 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 178.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.683 ' HA ' ' HG2' ' A' ' 23' ' ' MET . . . -90.06 45.62 1.29 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.259 0.552 . . . . 0.0 110.94 -178.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.57 174.3 10.66 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.757 -179.33 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -78.84 89.95 4.68 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 109.297 -0.631 . . . . 0.0 109.297 174.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -76.88 71.72 2.14 Favored Glycine 0 N--CA 1.446 -0.661 0 CA-C-N 115.5 -0.773 . . . . 0.0 112.347 -177.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.729 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 35.9 m -85.39 93.17 8.67 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 120.914 0.387 . . . . 0.0 110.265 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -84.21 145.78 7.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.4 t -58.56 131.31 22.71 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.249 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 178.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.663 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -64.83 144.54 48.32 Favored Glycine 0 N--CA 1.443 -0.899 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.634 -179.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -79.46 103.68 6.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.341 -0.615 . . . . 0.0 109.341 175.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.812 HG12 ' HD3' ' A' ' 7' ' ' PRO . 2.7 mp -58.15 118.16 2.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.885 -178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 106.21 -8.17 41.32 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 121.004 -0.617 . . . . 0.0 111.796 -177.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -114.25 -178.86 3.47 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 110.201 -0.296 . . . . 0.0 110.201 179.189 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -106.85 141.6 37.82 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.794 0.331 . . . . 0.0 110.694 -179.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.557 ' HB3' HG22 ' A' ' 44' ' ' VAL . 0.0 OUTLIER -86.55 124.05 32.42 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.05 -0.523 . . . . 0.0 109.625 175.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 1' ' ' SER . . . -89.56 -17.16 55.56 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.865 -0.684 . . . . 0.0 112.275 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -104.57 -170.0 1.7 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.549 0.214 . . . . 0.0 110.479 -179.335 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.53 109.47 2.36 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.862 179.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.557 HG22 ' HB3' ' A' ' 40' ' ' CYS . 0.9 OUTLIER -79.77 103.31 6.58 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.243 179.823 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.563 ' HB3' ' SG ' ' A' ' 66' ' ' CYS . 1.9 mmpt? -113.18 149.6 33.45 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.668 -177.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.46 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 21.9 m -90.92 93.79 9.36 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.931 176.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.521 ' HB3' ' HB2' ' A' ' 66' ' ' CYS . 0.7 OUTLIER -124.19 -175.48 3.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.413 -177.794 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.76 141.0 18.57 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 172.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -91.13 100.23 13.11 Favored 'General case' 0 C--N 1.318 -0.792 0 CA-C-O 121.272 0.558 . . . . 0.0 109.532 176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.39 24.51 12.98 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.628 -0.714 . . . . 0.0 110.144 -179.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 p -123.66 -38.98 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.04 -0.527 . . . . 0.0 111.152 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.16 -66.57 0.92 Allowed 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 121.211 -0.196 . . . . 0.0 110.812 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 74.47 -20.5 0.32 Allowed 'General case' 0 N--CA 1.472 0.628 0 C-N-CA 123.428 0.691 . . . . 0.0 112.632 174.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.45 -14.14 60.8 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 112.734 0.642 . . . . 0.0 112.734 -173.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 87.06 63.42 1.45 Allowed Glycine 0 N--CA 1.451 -0.339 0 N-CA-C 110.903 -0.879 . . . . 0.0 110.903 -177.453 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -94.26 138.82 31.82 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-O 120.663 0.268 . . . . 0.0 110.994 -175.01 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.64 122.09 25.51 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.975 0.417 . . . . 0.0 110.113 177.485 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 82.79 75.19 1.17 Allowed Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -172.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.6 mt -89.3 137.72 32.07 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 121.155 0.503 . . . . 0.0 111.106 -174.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mp -116.01 115.58 49.65 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.655 0 CA-C-N 115.637 -0.71 . . . . 0.0 110.068 179.039 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 1.3 mp -104.55 118.5 51.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.617 0 N-CA-C 108.604 -0.888 . . . . 0.0 108.604 175.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -78.44 62.18 3.01 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.467 -0.333 . . . . 0.0 111.707 -173.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 67.46 -69.74 0.13 Allowed 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 123.965 0.906 . . . . 0.0 113.314 172.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.34 54.89 0.94 Allowed 'General case' 0 N--CA 1.465 0.307 0 N-CA-C 112.825 0.676 . . . . 0.0 112.825 -171.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.24 28.56 0.25 Allowed 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.712 -0.847 . . . . 0.0 108.712 174.689 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.563 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 45.5 t -160.42 147.98 16.16 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.109 -0.95 . . . . 0.0 110.003 -174.635 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -90.02 104.5 15.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.379 0 CA-C-O 121.166 0.507 . . . . 0.0 110.087 175.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.97 0 CA-C-O 118.476 -0.774 . . . . 0.0 110.263 -178.035 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 N--CA 1.475 0.815 0 CA-C-O 120.724 0.297 . . . . 0.0 110.426 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HA ' ' O ' ' A' ' 40' ' ' CYS . . . -84.81 124.36 31.49 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-O 121.099 0.476 . . . . 0.0 110.997 -177.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -132.97 142.68 48.99 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.694 -0.685 . . . . 0.0 109.947 176.442 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.503 ' HA ' ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -77.54 125.2 28.97 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.999 0.428 . . . . 0.0 110.524 -179.076 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.731 HG21 ' HA3' ' A' ' 34' ' ' GLY . 32.2 mt -89.76 127.2 42.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.592 . . . . 0.0 112.072 -174.08 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -126.31 128.51 6.4 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 110.114 -1.194 . . . . 0.0 110.114 170.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.444 ' CG ' HG12 ' A' ' 36' ' ' ILE . 84.7 Cg_exo -43.45 -37.88 8.06 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 123.89 3.06 . . . . 0.0 114.476 -177.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 13.8 t30 -86.58 33.57 0.64 Allowed 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 112.383 0.512 . . . . 0.0 112.383 -174.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.88 -45.56 42.04 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.6 m -132.32 141.54 48.99 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.019 -0.991 . . . . 0.0 109.102 175.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -163.3 17.33 0.07 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.417 0.627 . . . . 0.0 109.513 -175.379 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -79.43 -84.14 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.255 -0.884 . . . . 0.0 110.968 -176.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 9.3 t0 -100.32 53.78 0.89 Allowed 'General case' 0 C--N 1.317 -0.838 0 CA-C-N 115.698 -0.683 . . . . 0.0 111.32 -173.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.419 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 23.4 t70 62.82 21.66 12.94 Favored 'General case' 0 N--CA 1.472 0.64 0 CA-C-O 121.679 0.752 . . . . 0.0 110.229 -174.645 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.525 ' HE2' HG22 ' A' ' 67' ' ' VAL . 3.9 m-85 -80.6 130.19 34.97 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.349 -0.842 . . . . 0.0 109.493 178.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.586 ' HE3' ' HB2' ' A' ' 49' ' ' ASP . 0.8 OUTLIER -126.82 157.63 70.91 Favored Pre-proline 0 C--N 1.319 -0.718 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 -177.802 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -69.15 115.02 3.8 Favored 'Trans proline' 0 N--CA 1.464 -0.235 0 C-N-CA 122.589 2.193 . . . . 0.0 111.57 175.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.66 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 27.0 m-85 -120.3 133.4 55.47 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.174 -0.467 . . . . 0.0 110.993 -178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.629 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -81.88 84.83 6.79 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.717 178.3 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 9.1 m -78.55 79.7 4.96 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.967 -0.56 . . . . 0.0 112.296 -174.283 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.421 HE22 ' HB3' ' A' ' 19' ' ' CYS . 2.4 mp0 -77.52 130.68 37.28 Favored 'General case' 0 C--N 1.324 -0.54 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 171.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -146.09 179.68 7.32 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.551 0.691 . . . . 0.0 112.377 -170.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -142.7 174.69 10.42 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.041 -0.982 . . . . 0.0 108.373 174.479 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -54.45 -72.88 0.06 Allowed 'General case' 0 C--O 1.237 0.432 0 N-CA-C 112.196 0.443 . . . . 0.0 112.196 -175.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -89.49 64.88 3.15 Favored Glycine 0 N--CA 1.45 -0.418 0 C-N-CA 120.728 -0.748 . . . . 0.0 112.66 -176.62 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 67.0 m -155.53 100.65 2.12 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.753 0.311 . . . . 0.0 110.634 177.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.47 -25.72 41.85 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.128 176.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.13 103.09 2.22 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.613 174.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.715 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 4.2 mt -87.22 146.63 25.91 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.464 -0.789 . . . . 0.0 111.504 -171.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.93 48.13 0.99 Allowed Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.995 -0.621 . . . . 0.0 111.867 177.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.715 ' SG ' ' HB3' ' A' ' 29' ' ' LEU . 2.0 m -79.03 106.85 11.36 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.124 0.488 . . . . 0.0 111.328 -179.165 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 5.4 m -86.07 164.27 2.45 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 115.694 -0.684 . . . . 0.0 109.637 173.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 57.7 t -65.82 135.47 28.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 O-C-N 123.167 0.292 . . . . 0.0 110.484 -179.111 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.731 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -64.59 116.51 9.1 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.209 177.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -79.02 135.02 26.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 120.78 0.324 . . . . 0.0 110.623 -179.215 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.444 HG12 ' CG ' ' A' ' 7' ' ' PRO . 1.4 mt -64.93 110.85 1.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.887 -177.568 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 104.51 -9.7 49.08 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.878 -0.677 . . . . 0.0 112.113 -179.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 55.6 m -90.8 171.19 9.5 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.882 0.372 . . . . 0.0 110.48 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.503 ' HG3' ' HA ' ' A' ' 4' ' ' THR . 1.6 mp0 -124.3 140.25 53.14 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.837 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.423 ' O ' ' HA ' ' A' ' 2' ' ' ALA . 0.1 OUTLIER -75.82 146.72 39.7 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.205 178.44 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.25 -51.78 3.43 Favored Glycine 0 N--CA 1.446 -0.689 0 C-N-CA 120.64 -0.79 . . . . 0.0 112.385 -179.897 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.41 -90.18 0.15 Allowed 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.746 0.308 . . . . 0.0 110.642 179.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -143.17 138.37 29.71 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.648 -179.721 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.42 HG22 ' HB2' ' A' ' 40' ' ' CYS . 1.2 t -80.89 125.94 39.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.013 175.822 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 mmtt -117.85 157.69 26.17 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 178.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.436 ' HB3' ' HD2' ' A' ' 15' ' ' TYR . 32.9 m -102.55 99.95 10.01 Favored 'General case' 0 C--N 1.32 -0.694 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 177.368 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 4.0 m -116.07 147.28 41.45 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-O 120.993 0.425 . . . . 0.0 111.461 -175.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt -98.74 136.39 38.86 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.445 -0.798 . . . . 0.0 109.776 177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.586 ' HB2' ' HE3' ' A' ' 16' ' ' LYS . 48.7 t0 -85.85 86.23 7.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 121.295 0.569 . . . . 0.0 110.628 -177.033 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.25 -75.06 0.18 Allowed 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.966 178.461 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -134.31 32.15 0.85 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.785 0.802 . . . . 0.0 109.339 177.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.56 HG21 ' HA ' ' A' ' 61' ' ' ILE . 0.2 OUTLIER -94.09 -13.27 27.0 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 114.951 -1.022 . . . . 0.0 111.921 -172.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -60.59 -28.35 68.42 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.822 -0.626 . . . . 0.0 112.395 -176.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -75.18 79.23 2.31 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.734 0.302 . . . . 0.0 111.365 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -147.3 12.72 1.4 Allowed Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.587 -0.816 . . . . 0.0 112.458 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 27.7 m120 69.3 -85.32 0.03 OUTLIER 'General case' 0 N--CA 1.465 0.319 0 C-N-CA 123.151 0.58 . . . . 0.0 111.415 178.106 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -118.45 19.43 13.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.988 0.423 . . . . 0.0 110.989 -179.505 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -159.0 165.79 34.32 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 111.225 -0.75 . . . . 0.0 111.225 178.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.425 HD13 ' HE1' ' A' ' 18' ' ' TYR . 1.3 mp -119.94 113.35 20.42 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 120.865 0.365 . . . . 0.0 110.203 -179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 2.1 mt -85.08 87.71 2.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.995 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.607 ' HB ' ' HB2' ' A' ' 29' ' ' LEU . 37.9 mm -63.85 127.54 24.54 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.599 -178.251 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -86.77 44.69 1.18 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.812 -175.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 67.4 -68.08 0.16 Allowed 'General case' 0 N--CA 1.467 0.387 0 CA-C-N 115.344 -0.844 . . . . 0.0 112.536 178.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -81.18 54.43 2.26 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.998 0.428 . . . . 0.0 112.028 -172.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.557 ' HB2' HG23 ' A' ' 61' ' ' ILE . 35.7 m120 -126.48 -14.9 5.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 116.499 -0.318 . . . . 0.0 110.688 176.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.493 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 4.6 m -109.77 88.79 2.83 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.575 -174.569 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.525 HG22 ' HE2' ' A' ' 15' ' ' TYR . 2.6 t 51.24 -103.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 CA-C-N 115.371 -0.831 . . . . 0.0 111.94 177.036 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.952 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 -177.675 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.478 0.944 0 CA-C-O 120.801 0.334 . . . . 0.0 110.692 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -86.87 157.71 19.48 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.502 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.88 118.91 29.81 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.619 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -78.68 119.84 22.49 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.049 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.703 HD11 ' HB2' ' A' ' 40' ' ' CYS . 85.4 mt -87.07 127.92 40.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 N-CA-C 112.659 0.614 . . . . 0.0 112.659 -172.529 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -117.37 136.96 12.96 Favored Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 109.471 -1.452 . . . . 0.0 109.471 166.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.584 ' HG3' HG12 ' A' ' 36' ' ' ILE . 74.5 Cg_endo -72.96 44.73 0.82 Allowed 'Trans proline' 0 CA--C 1.533 0.435 0 C-N-CA 123.031 2.488 . . . . 0.0 113.94 -172.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -157.18 26.01 0.31 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 120.739 0.304 . . . . 0.0 111.22 176.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -70.87 -58.1 3.94 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.415 0.626 . . . . 0.0 109.629 174.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.557 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -92.64 136.16 33.46 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.285 174.588 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -168.89 26.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.027 0.441 . . . . 0.0 110.371 -175.201 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -66.48 0.66 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 N-CA-C 108.949 -0.76 . . . . 0.0 108.949 176.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.411 ' C ' ' H ' ' A' ' 15' ' ' TYR . 3.2 t70 -100.6 -149.07 0.37 Allowed 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.348 169.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 16.2 t0 -81.84 40.58 0.61 Allowed 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.686 0.755 . . . . 0.0 109.394 171.772 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.557 ' O ' ' HB2' ' A' ' 10' ' ' CYS . 1.9 m-85 -82.96 111.7 19.07 Favored 'General case' 0 N--CA 1.446 -0.635 0 CA-C-N 115.149 -0.932 . . . . 0.0 109.606 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.4 143.16 26.07 Favored Pre-proline 0 C--N 1.315 -0.917 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -61.0 125.1 16.27 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.481 2.12 . . . . 0.0 111.163 174.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.709 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 9.7 m-85 -134.84 123.9 24.24 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 121.028 0.442 . . . . 0.0 110.8 -177.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 47.8 t -87.09 93.15 9.29 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.026 -179.624 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.641 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 26.1 m -74.57 100.44 3.9 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-O 121.263 0.554 . . . . 0.0 109.793 177.777 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.31 -25.8 4.05 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.264 -0.88 . . . . 0.0 110.892 -173.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.756 ' HB2' ' HA3' ' A' ' 30' ' ' GLY . 0.8 OUTLIER -78.34 71.32 4.8 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.41 0.624 . . . . 0.0 111.054 -177.91 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.423 ' HA ' ' O ' ' A' ' 26' ' ' SER . 0.0 OUTLIER -133.66 26.27 4.04 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.373 -0.83 . . . . 0.0 109.727 177.393 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.81 -45.57 11.46 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.813 -178.347 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -117.19 8.82 15.73 Favored Glycine 0 N--CA 1.449 -0.46 0 CA-C-N 115.824 -0.626 . . . . 0.0 111.575 178.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.423 ' O ' ' HA ' ' A' ' 23' ' ' MET . 0.9 OUTLIER -144.59 150.56 37.66 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -178.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -99.44 8.53 44.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.246 0.546 . . . . 0.0 110.057 176.425 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -81.75 159.7 23.79 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.378 -0.828 . . . . 0.0 110.639 -179.252 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.509 HD11 ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -79.84 78.41 6.44 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.003 0.43 . . . . 0.0 110.918 -178.434 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.756 ' HA3' ' HB2' ' A' ' 22' ' ' SER . . . -80.95 86.05 1.37 Allowed Glycine 0 N--CA 1.449 -0.495 0 C-N-CA 120.774 -0.727 . . . . 0.0 111.615 177.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.709 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 4.0 m -109.13 115.39 29.94 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-O 120.771 0.319 . . . . 0.0 110.955 -176.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -79.9 154.78 4.57 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 N-CA-C 110.022 -0.362 . . . . 0.0 110.022 176.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 t -55.98 139.33 15.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.464 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.509 ' CA ' HG21 ' A' ' 5' ' ' ILE . . . -65.26 88.34 0.09 OUTLIER Glycine 0 N--CA 1.445 -0.756 0 C-N-CA 120.913 -0.66 . . . . 0.0 111.849 174.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.457 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 61.1 t -79.45 137.04 22.43 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 CA-C-O 120.914 0.388 . . . . 0.0 110.215 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.584 HG12 ' HG3' ' A' ' 7' ' ' PRO . 0.9 OUTLIER -63.41 110.04 0.78 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.5 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.552 179.96 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 108.38 -4.61 33.19 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.505 -0.855 . . . . 0.0 112.585 179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.457 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 43.1 m -78.08 127.58 32.52 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.991 0.424 . . . . 0.0 110.711 178.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -93.94 94.25 8.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.288 178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.703 ' HB2' HD11 ' A' ' 5' ' ' ILE . 12.4 t -74.9 118.74 18.2 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.287 -178.172 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -96.9 -2.82 59.41 Favored Glycine 0 N--CA 1.447 -0.623 0 C-N-CA 120.68 -0.772 . . . . 0.0 112.195 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -115.3 -132.83 0.33 Allowed 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.669 0.271 . . . . 0.0 111.018 -177.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.567 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 70.5 m -86.93 99.42 11.85 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.013 0.435 . . . . 0.0 111.352 -177.011 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.41 HG23 ' H ' ' A' ' 44' ' ' VAL . 0.6 OUTLIER -79.67 81.64 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 174.122 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.509 ' HE3' HD11 ' A' ' 29' ' ' LEU . 3.7 mttm -91.35 175.72 6.82 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.758 -0.655 . . . . 0.0 111.794 -172.086 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 89.2 m -127.71 106.05 8.88 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 114.826 -1.079 . . . . 0.0 108.597 176.017 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 91.2 m -120.84 149.38 42.67 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-O 120.809 0.337 . . . . 0.0 111.088 -174.346 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.24 97.67 11.14 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.878 -0.601 . . . . 0.0 111.253 -179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -103.89 103.15 12.97 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 109.429 -0.582 . . . . 0.0 109.429 175.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -64.83 -61.2 2.32 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.048 0.452 . . . . 0.0 111.151 -175.518 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 51' ' ' VAL . 2.7 m -84.6 172.74 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 115.951 -0.568 . . . . 0.0 110.76 -179.033 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.56 155.6 20.46 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.299 -179.564 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 70.24 23.38 5.15 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 123.703 0.627 . . . . 0.0 111.349 176.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.9 76.1 2.15 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.111 0.481 . . . . 0.0 111.017 178.497 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.497 ' HA3' ' HA ' ' A' ' 59' ' ' LEU . . . 123.91 -12.49 8.17 Favored Glycine 0 N--CA 1.448 -0.509 0 N-CA-C 111.465 -0.654 . . . . 0.0 111.465 -176.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.477 ' HB3' ' H ' ' A' ' 57' ' ' SER . 0.6 OUTLIER 61.71 -105.01 0.17 Allowed 'General case' 0 N--CA 1.466 0.333 0 C-N-CA 122.754 0.422 . . . . 0.0 111.224 178.442 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.477 ' H ' ' HB3' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -89.47 -12.14 40.97 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.894 0.378 . . . . 0.0 111.315 -179.387 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -134.94 83.72 0.28 Allowed Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.287 -0.725 . . . . 0.0 111.287 -179.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.497 ' HA ' ' HA3' ' A' ' 55' ' ' GLY . 3.4 mp -80.88 91.96 6.06 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.106 0.479 . . . . 0.0 111.053 -174.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 46.9 mt -79.63 102.57 5.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 173.207 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -90.38 146.83 5.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.72 -0.673 . . . . 0.0 111.292 -171.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.533 HD21 ' HB3' ' A' ' 64' ' ' ALA . 4.7 t30 -69.21 121.34 16.61 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.608 -0.723 . . . . 0.0 109.71 175.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.496 ' HB2' ' HG ' ' A' ' 29' ' ' LEU . . . -78.94 35.32 0.25 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.98 0.419 . . . . 0.0 111.894 -173.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.533 ' HB3' HD21 ' A' ' 62' ' ' ASN . . . -128.14 13.55 6.71 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.906 0.384 . . . . 0.0 110.561 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -138.71 38.29 2.2 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 121.239 0.542 . . . . 0.0 110.79 -179.535 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 11.1 m -130.11 153.94 47.98 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.766 -0.652 . . . . 0.0 109.767 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -72.07 -62.96 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 120.768 0.318 . . . . 0.0 110.529 179.238 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.061 0 CA-C-O 118.883 -0.58 . . . . 0.0 109.652 179.683 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 120.77 0.319 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -106.95 144.71 33.19 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.807 0.337 . . . . 0.0 110.632 178.497 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.522 ' O ' ' HA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -146.31 127.8 15.04 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.234 178.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -77.49 123.68 26.89 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.152 0.501 . . . . 0.0 110.189 178.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.698 HG21 ' HA3' ' A' ' 34' ' ' GLY . 8.6 mt -89.58 127.6 42.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.57 -172.1 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.4 137.48 14.21 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 168.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.77 -4.99 5.23 Favored 'Trans proline' 0 N--CA 1.478 0.581 0 C-N-CA 123.364 2.71 . . . . 0.0 114.114 -175.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -119.74 34.32 5.27 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 121.023 -0.271 . . . . 0.0 111.36 -177.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.9 -33.86 76.22 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.572 0.701 . . . . 0.0 110.295 177.027 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.649 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 89.3 m -135.21 146.18 48.41 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.243 -0.889 . . . . 0.0 108.906 175.323 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -150.69 17.6 0.8 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.952 0.406 . . . . 0.0 110.652 -169.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -78.53 -71.42 0.31 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 N-CA-C 108.577 -0.898 . . . . 0.0 108.577 177.945 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.408 ' C ' ' H ' ' A' ' 15' ' ' TYR . 3.8 t0 -93.67 -159.73 0.71 Allowed 'General case' 0 C--N 1.315 -0.892 0 CA-C-N 114.988 -1.006 . . . . 0.0 108.578 171.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . 0.553 ' O ' ' HA ' ' A' ' 48' ' ' LYS . 21.2 t70 -80.43 41.57 0.55 Allowed 'General case' 0 C--N 1.318 -0.798 0 CA-C-O 121.634 0.73 . . . . 0.0 109.295 172.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.793 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 10.4 m-85 -85.57 71.74 10.71 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.145 -0.934 . . . . 0.0 110.783 -174.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.44 ' HB2' ' HD2' ' A' ' 17' ' ' PRO . 4.3 ptpt -79.58 156.01 75.79 Favored Pre-proline 0 C--N 1.317 -0.812 0 CA-C-N 116.168 -0.469 . . . . 0.0 109.831 178.89 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.44 ' HD2' ' HB2' ' A' ' 16' ' ' LYS . 29.7 Cg_endo -61.32 126.54 19.57 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.978 2.452 . . . . 0.0 112.777 -179.093 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.919 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 21.6 m-85 -127.95 123.93 36.07 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 115.146 -0.934 . . . . 0.0 110.081 179.197 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 6.1 m -80.75 80.95 7.12 Favored 'General case' 0 C--N 1.319 -0.72 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 175.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.6 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 53.6 m -77.03 121.43 23.51 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.683 -0.69 . . . . 0.0 110.574 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.4 152.06 44.79 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.131 176.116 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -50.87 116.29 1.9 Allowed 'General case' 0 C--O 1.236 0.349 0 O-C-N 123.873 0.733 . . . . 0.0 111.571 -178.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.447 ' O ' ' HG2' ' A' ' 23' ' ' MET . 0.0 OUTLIER -78.28 127.65 32.55 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.7 -179.53 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -127.44 96.91 4.7 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.506 -177.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.83 -50.05 3.68 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.796 -0.716 . . . . 0.0 111.835 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.436 ' O ' ' HG3' ' A' ' 23' ' ' MET . 0.0 OUTLIER -67.19 151.22 47.95 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.811 0.339 . . . . 0.0 110.665 177.547 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -92.38 -4.23 54.12 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-O 121.326 0.584 . . . . 0.0 110.127 177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.453 ' HB2' HG22 ' A' ' 60' ' ' ILE . 0.8 OUTLIER -108.36 135.86 48.96 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.463 -0.79 . . . . 0.0 110.024 178.6 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.586 ' HB2' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -103.09 148.27 25.95 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.401 -177.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.79 77.63 1.87 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 120.8 -0.714 . . . . 0.0 111.734 178.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.919 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 28.9 m -86.49 120.18 27.54 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-O 121.16 0.505 . . . . 0.0 112.112 -176.188 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -107.21 144.59 15.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 169.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.1 p -58.6 131.44 22.84 Favored 'Isoleucine or valine' 0 C--O 1.235 0.327 0 CA-C-O 121.008 0.432 . . . . 0.0 111.058 -177.259 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.698 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -67.56 117.08 8.46 Favored Glycine 0 N--CA 1.444 -0.825 0 C-N-CA 120.898 -0.668 . . . . 0.0 111.699 178.741 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.401 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 11.2 t -78.92 131.22 34.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 120.904 0.383 . . . . 0.0 110.42 -177.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -56.94 120.63 3.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 115.685 -0.688 . . . . 0.0 110.653 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.99 -4.95 68.38 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.824 -0.703 . . . . 0.0 112.642 177.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.401 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 15.8 m -95.24 166.34 11.95 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.643 0.259 . . . . 0.0 110.703 179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.522 ' HA ' ' O ' ' A' ' 3' ' ' THR . 18.9 mt-30 -114.9 124.9 52.88 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.566 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.545 ' HB2' HD11 ' A' ' 5' ' ' ILE . 1.7 t -81.17 135.64 35.79 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.204 177.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -114.76 2.94 23.09 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 121.132 -0.556 . . . . 0.0 111.829 177.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -120.24 -157.59 0.71 Allowed 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.109 -0.33 . . . . 0.0 110.109 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -78.1 92.38 4.39 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 120.965 0.412 . . . . 0.0 110.628 -179.619 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.45 ' HB ' ' SG ' ' A' ' 40' ' ' CYS . 1.6 p -78.6 109.87 13.72 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-O 121.519 0.676 . . . . 0.0 109.613 177.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 65.1 mmtt -118.22 171.11 8.34 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.366 -0.834 . . . . 0.0 110.827 -175.397 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.793 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 59.7 m -112.71 104.01 12.04 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 173.843 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.508 ' HB3' HD13 ' A' ' 61' ' ' ILE . 0.8 OUTLIER -122.99 157.32 32.93 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.429 -0.351 . . . . 0.0 110.42 -177.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.669 ' HD2' ' HE1' ' A' ' 15' ' ' TYR . 2.5 ptmt -97.71 155.69 16.89 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 120.868 0.366 . . . . 0.0 110.76 -177.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -79.3 68.56 5.33 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.844 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.88 -19.37 61.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.9 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -119.4 67.53 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.154 176.452 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.33 53.77 0.86 Allowed 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.929 -174.777 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 27.4 t30 -122.07 102.46 8.17 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.108 -0.496 . . . . 0.0 109.878 177.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -61.06 142.73 56.43 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.946 -175.575 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -159.59 -159.34 9.7 Favored Glycine 0 N--CA 1.447 -0.597 0 N-CA-C 111.444 -0.662 . . . . 0.0 111.444 179.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.1 m-80 -105.75 15.51 26.69 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-O 121.296 0.569 . . . . 0.0 110.069 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.09 159.44 22.56 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.932 -176.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -76.91 164.44 53.02 Favored Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.79 -0.719 . . . . 0.0 111.771 177.269 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.16 90.4 8.35 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 121.138 0.494 . . . . 0.0 110.484 -177.746 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.479 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 0.1 OUTLIER -79.98 76.34 0.83 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.755 -0.657 . . . . 0.0 110.438 178.271 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.508 HD13 ' HB3' ' A' ' 47' ' ' CYS . 1.3 mt -84.59 152.12 3.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.559 -178.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 11.1 t-20 -72.34 139.55 47.98 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.592 179.38 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.406 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . -61.99 -25.57 67.71 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.596 -178.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.27 -5.9 55.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.43 -0.35 . . . . 0.0 111.143 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.17 -12.64 26.02 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.988 0.423 . . . . 0.0 110.842 -179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -84.79 172.14 11.71 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.019 178.926 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -59.91 -50.62 79.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.821 0.344 . . . . 0.0 111.48 179.927 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.865 0 CA-C-O 119.109 -0.472 . . . . 0.0 109.788 -178.339 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.475 0.787 0 CA-C-O 120.95 0.405 . . . . 0.0 110.765 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -97.76 67.19 1.98 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 121.251 0.548 . . . . 0.0 109.622 177.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.96 123.75 22.76 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.545 -0.752 . . . . 0.0 111.887 -176.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 2.0 m -79.82 134.33 36.33 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.308 176.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.756 HD11 ' HB2' ' A' ' 40' ' ' CYS . 37.8 mt -98.19 136.27 29.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-O 121.229 0.538 . . . . 0.0 112.43 -172.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.437 ' HA2' ' HD3' ' A' ' 7' ' ' PRO . . . -136.3 128.84 4.66 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.087 -1.205 . . . . 0.0 110.087 168.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.509 ' HA ' ' HG3' ' A' ' 17' ' ' PRO . 38.5 Cg_exo -59.91 3.17 0.24 Allowed 'Trans proline' 0 C--N 1.351 0.672 0 C-N-CA 123.7 2.933 . . . . 0.0 114.58 -175.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -85.59 -0.99 56.64 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 120.934 0.397 . . . . 0.0 110.827 178.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.9 -56.61 13.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.204 -179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.404 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -135.59 149.48 49.41 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.137 179.385 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.445 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -173.76 16.89 0.01 OUTLIER 'General case' 0 C--N 1.334 -0.107 0 CA-C-O 121.094 0.473 . . . . 0.0 110.395 -175.732 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.465 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -79.63 -90.51 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.67 -175.32 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.449 ' O ' ' HG2' ' A' ' 48' ' ' LYS . 0.2 OUTLIER -86.16 66.46 9.57 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 115.86 -0.609 . . . . 0.0 111.211 -178.746 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 1.7 t0 57.27 27.14 13.22 Favored 'General case' 0 N--CA 1.466 0.36 0 CA-C-O 121.221 0.534 . . . . 0.0 110.897 -177.229 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.657 ' CE1' ' HG3' ' A' ' 48' ' ' LYS . 54.5 m-85 -88.79 148.69 23.79 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.695 -0.684 . . . . 0.0 110.45 179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.638 ' HB2' ' HD2' ' A' ' 17' ' ' PRO . 14.0 pttm -160.07 163.23 22.76 Favored Pre-proline 0 C--N 1.32 -0.678 0 N-CA-C 109.106 -0.702 . . . . 0.0 109.106 173.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.638 ' HD2' ' HB2' ' A' ' 16' ' ' LYS . 20.1 Cg_endo -59.25 130.63 36.93 Favored 'Trans proline' 0 C--N 1.346 0.398 0 C-N-CA 122.492 2.128 . . . . 0.0 112.201 -179.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.9 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 12.4 m-85 -131.72 132.15 43.65 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.671 -0.695 . . . . 0.0 110.539 -178.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.63 ' HB2' HG23 ' A' ' 32' ' ' VAL . 6.1 m -94.01 93.59 7.95 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.39 178.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.74 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 2.8 m -85.31 111.28 19.74 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.931 0.396 . . . . 0.0 110.333 179.402 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 2.7 mt-30 -84.93 73.68 10.63 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.837 -176.492 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.0 109.93 6.15 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.028 176.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -78.8 -33.94 45.78 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.232 -177.834 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 p -164.13 -110.97 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.783 -0.644 . . . . 0.0 109.851 179.078 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -88.37 82.19 1.54 Allowed Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.423 -0.671 . . . . 0.0 111.423 177.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -115.96 112.02 21.23 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-O 120.92 0.39 . . . . 0.0 111.14 -177.268 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.95 -52.72 7.5 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.254 0.55 . . . . 0.0 109.713 177.023 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 4.4 m -85.26 96.87 9.64 Favored 'General case' 0 N--CA 1.447 -0.625 0 N-CA-C 108.852 -0.796 . . . . 0.0 108.852 172.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.74 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -83.08 138.03 33.86 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.512 -0.767 . . . . 0.0 111.549 -170.885 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.43 94.72 1.93 Allowed Glycine 0 N--CA 1.449 -0.471 0 CA-C-N 115.727 -0.669 . . . . 0.0 111.891 178.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.9 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.8 OUTLIER -95.98 149.21 21.83 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.116 0.484 . . . . 0.0 111.673 -177.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.63 HG23 ' HB2' ' A' ' 19' ' ' CYS . 0.1 OUTLIER -127.21 163.4 30.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 171.067 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 63.5 t -68.56 128.52 32.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.753 0.311 . . . . 0.0 111.208 -176.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.605 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -63.82 110.74 3.6 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 121.156 -0.545 . . . . 0.0 112.049 177.054 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.518 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.1 OUTLIER -79.58 129.01 38.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-O 120.888 0.375 . . . . 0.0 110.739 -177.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.521 ' H ' HD12 ' A' ' 36' ' ' ILE . 1.2 mp -57.6 127.13 16.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.672 -0.694 . . . . 0.0 111.255 -178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 78.04 15.5 81.03 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.953 -0.641 . . . . 0.0 112.794 176.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.518 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -118.23 163.07 17.22 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.861 -0.422 . . . . 0.0 109.861 178.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 3.5 mm-40 -102.14 157.29 16.99 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.906 0.384 . . . . 0.0 110.919 -175.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.756 ' HB2' HD11 ' A' ' 5' ' ' ILE . 4.8 t -122.98 125.3 44.99 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.187 175.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -95.01 7.55 69.87 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.865 -0.683 . . . . 0.0 111.776 178.51 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -125.07 -166.24 1.51 Allowed 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 110.008 -0.367 . . . . 0.0 110.008 179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.56 119.63 18.05 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 116.521 -0.308 . . . . 0.0 111.013 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 11.9 t -86.9 104.3 13.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 176.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -102.35 164.26 11.77 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.994 -175.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 12.0 m -115.81 88.94 2.99 Favored 'General case' 0 C--N 1.32 -0.676 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 174.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 66' ' ' CYS . 57.9 m -112.52 163.45 14.46 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.085 -173.637 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.657 ' HG3' ' CE1' ' A' ' 15' ' ' TYR . 18.5 mtpt -82.06 171.19 14.66 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.663 -0.698 . . . . 0.0 110.967 180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -90.66 48.92 1.59 Allowed 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.344 -0.843 . . . . 0.0 108.996 169.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -136.86 121.48 18.44 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.117 -0.947 . . . . 0.0 109.045 -175.698 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.409 ' HB ' HG22 ' A' ' 54' ' ' THR . 0.0 OUTLIER -145.68 117.42 2.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.937 -0.574 . . . . 0.0 111.413 -175.107 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -111.43 -3.97 15.03 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 115.78 -0.646 . . . . 0.0 111.043 178.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -122.08 17.3 10.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.439 -0.346 . . . . 0.0 111.836 -176.285 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.409 HG22 ' HB ' ' A' ' 51' ' ' VAL . 6.4 t -104.34 165.57 10.97 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.563 -0.289 . . . . 0.0 110.471 179.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 178.6 51.87 0.07 OUTLIER Glycine 0 N--CA 1.448 -0.53 0 C-N-CA 120.271 -0.966 . . . . 0.0 112.694 179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.452 HD21 HG13 ' A' ' 60' ' ' ILE . 10.1 p30 -167.27 -157.83 0.26 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 120.509 0.195 . . . . 0.0 110.858 179.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.22 -17.73 56.34 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 112.022 0.379 . . . . 0.0 112.022 -172.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -109.71 163.12 12.51 Favored Glycine 0 N--CA 1.447 -0.567 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.606 178.66 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -88.16 94.25 9.75 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.074 0.464 . . . . 0.0 110.076 178.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.452 HG13 HD21 ' A' ' 56' ' ' ASN . 35.7 mm -80.07 101.09 4.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.307 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.614 HD12 ' HB2' ' A' ' 31' ' ' CYS . 14.1 mt -105.02 134.7 45.73 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.689 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.027 -179.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 30.0 t30 -88.74 36.06 0.79 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.651 -175.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . 70.04 -42.78 0.52 Allowed 'General case' 0 N--CA 1.474 0.726 0 N-CA-C 113.255 0.835 . . . . 0.0 113.255 174.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -61.85 -26.55 68.2 Favored 'General case' 0 C--N 1.327 -0.37 0 N-CA-C 112.206 0.447 . . . . 0.0 112.206 -175.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -84.91 22.64 1.34 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.846 0.355 . . . . 0.0 110.773 -178.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 3.2 m -133.14 143.15 49.06 Favored 'General case' 0 C--O 1.235 0.291 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.89 179.148 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -87.75 -23.94 6.39 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.167 0.508 . . . . 0.0 110.341 176.06 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.986 0 CA-C-O 117.848 -1.072 . . . . 0.0 109.16 178.459 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.907 0 CA-C-O 121.202 0.525 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.538 ' HB1' ' HG2' ' A' ' 39' ' ' GLN . . . -92.62 100.66 13.14 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.306 -176.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 m -79.35 113.56 17.59 Favored 'General case' 0 C--N 1.323 -0.564 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 172.643 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -78.6 113.22 16.46 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-O 120.851 0.358 . . . . 0.0 110.04 -179.177 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.426 ' HB ' ' O ' ' A' ' 38' ' ' SER . 0.5 OUTLIER -89.16 131.1 37.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.471 0.653 . . . . 0.0 112.239 -173.449 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -128.0 156.79 20.88 Favored Glycine 0 N--CA 1.444 -0.814 0 N-CA-C 109.496 -1.441 . . . . 0.0 109.496 166.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -51.16 -26.17 18.98 Favored 'Trans proline' 0 CA--C 1.529 0.262 0 C-N-CA 122.859 2.372 . . . . 0.0 113.241 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 27.3 p-10 -89.53 33.82 0.83 Allowed 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.962 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.526 ' OG1' ' HB3' ' A' ' 17' ' ' PRO . 0.1 OUTLIER -81.43 -69.12 0.63 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.363 0.601 . . . . 0.0 109.95 175.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 3.7 m -92.68 137.03 32.72 Favored 'General case' 0 C--N 1.322 -0.623 0 N-CA-C 108.838 -0.801 . . . . 0.0 108.838 174.633 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -169.05 38.9 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.419 0.628 . . . . 0.0 109.917 -168.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.462 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -116.53 -87.12 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.408 -0.814 . . . . 0.0 110.094 -177.194 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.661 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 21.7 t0 -100.14 63.68 1.17 Allowed 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.262 -0.881 . . . . 0.0 110.764 -176.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 31.4 m-20 56.47 28.11 13.22 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-N 115.74 -0.664 . . . . 0.0 111.334 178.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.727 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 20.6 m-85 -90.78 134.51 34.38 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.12 -177.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -114.98 153.33 47.08 Favored Pre-proline 0 C--N 1.319 -0.731 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.192 -178.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.645 ' HB2' ' HA3' ' A' ' 34' ' ' GLY . 20.6 Cg_endo -61.97 120.32 7.86 Favored 'Trans proline' 0 C--O 1.235 0.365 0 C-N-CA 122.629 2.22 . . . . 0.0 112.324 177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.813 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 37.5 m-85 -133.29 125.27 28.89 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.881 179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -101.0 95.76 6.79 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.62 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 37.1 m -82.44 121.79 27.19 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.743 -0.662 . . . . 0.0 111.23 -175.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 26.7 mm-40 -76.48 174.26 10.52 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.415 179.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.409 ' HB2' ' H ' ' A' ' 23' ' ' MET . 3.7 m 60.93 -108.46 0.34 Allowed 'General case' 0 CA--C 1.532 0.286 0 O-C-N 123.475 0.484 . . . . 0.0 110.598 -177.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.433 ' HE2' ' HB2' ' A' ' 23' ' ' MET . 0.0 OUTLIER -147.12 161.28 41.19 Favored 'General case' 0 C--N 1.327 -0.401 0 N-CA-C 110.067 -0.345 . . . . 0.0 110.067 -177.969 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.551 ' HA ' HD22 ' A' ' 29' ' ' LEU . 3.7 m -80.83 -18.01 48.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.943 0.402 . . . . 0.0 110.09 175.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -84.13 67.42 3.71 Favored Glycine 0 N--CA 1.449 -0.441 0 N-CA-C 111.459 -0.657 . . . . 0.0 111.459 175.45 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 19.4 m -153.9 178.98 9.32 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.726 -0.472 . . . . 0.0 109.726 179.664 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.459 ' O ' ' HA ' ' A' ' 62' ' ' ASN . . . -84.01 -62.98 1.43 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.941 0.4 . . . . 0.0 110.328 178.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.23 120.78 43.33 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.03 178.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.551 HD22 ' HA ' ' A' ' 24' ' ' SER . 0.0 OUTLIER -106.71 137.53 44.57 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-O 120.841 0.353 . . . . 0.0 110.377 -179.321 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.68 75.25 2.34 Favored Glycine 0 N--CA 1.445 -0.719 0 C-N-CA 120.706 -0.759 . . . . 0.0 111.943 178.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.813 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 19.2 m -84.93 102.11 12.87 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 121.187 0.517 . . . . 0.0 110.831 178.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.572 ' HA ' ' HA2' ' A' ' 58' ' ' GLY . 16.1 m -78.89 150.59 5.21 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 177.2 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 25.4 t -61.96 135.84 26.04 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 O-C-N 123.378 0.424 . . . . 0.0 110.475 -178.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.645 ' HA3' ' HB2' ' A' ' 17' ' ' PRO . . . -64.99 89.68 0.09 OUTLIER Glycine 0 N--CA 1.442 -0.929 0 C-N-CA 121.035 -0.602 . . . . 0.0 111.759 175.1 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.412 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 49.7 t -79.43 141.36 15.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 120.687 0.28 . . . . 0.0 110.287 -178.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -60.35 101.98 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.442 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 123.02 -13.63 8.48 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.952 -0.642 . . . . 0.0 112.209 -179.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.426 ' O ' ' HB ' ' A' ' 5' ' ' ILE . 53.6 m -72.83 129.11 37.42 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.008 0.433 . . . . 0.0 110.815 179.142 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.538 ' HG2' ' HB1' ' A' ' 2' ' ' ALA . 1.3 mp0 -95.3 106.85 18.93 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 109.511 -0.551 . . . . 0.0 109.511 176.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.406 ' HB3' HG22 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -75.17 106.25 6.59 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.28 -176.167 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.87 -4.65 29.64 Favored Glycine 0 N--CA 1.447 -0.607 0 C-N-CA 120.889 -0.672 . . . . 0.0 111.927 176.911 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -90.09 -82.79 0.26 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.828 0.346 . . . . 0.0 110.231 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.604 ' HB3' ' HE3' ' A' ' 45' ' ' LYS . 38.7 m -155.41 120.12 4.75 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.193 177.303 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.406 HG22 ' HB3' ' A' ' 40' ' ' CYS . 2.8 t -82.05 101.62 7.06 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.298 -0.63 . . . . 0.0 109.298 176.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.604 ' HE3' ' HB3' ' A' ' 43' ' ' SER . 1.2 mmpt? -114.24 136.16 53.26 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.825 -176.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.727 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 74.5 m -101.01 96.33 7.17 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 115.75 -0.659 . . . . 0.0 109.514 174.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.3 m -111.76 163.69 13.88 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.382 -179.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.447 ' HE2' ' O ' ' A' ' 13' ' ' ASP . 28.7 ttmt -110.18 -37.7 5.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.405 -176.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.446 ' CG ' ' H ' ' A' ' 50' ' ' ASP . 4.6 p-10 41.61 -100.75 0.03 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.898 0.879 . . . . 0.0 111.959 -172.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.446 ' H ' ' CG ' ' A' ' 49' ' ' ASP . 16.1 t70 -169.15 -36.31 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.638 0.256 . . . . 0.0 111.131 -177.067 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 12.5 t -67.01 122.27 17.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 120.745 0.307 . . . . 0.0 110.825 -175.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -83.19 -25.21 32.0 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.444 -0.344 . . . . 0.0 111.916 -177.288 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -72.65 117.68 14.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.172 -177.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -88.95 8.26 30.38 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.503 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.72 9.71 76.89 Favored Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.292 -179.715 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -70.66 154.67 41.63 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.76 0.314 . . . . 0.0 110.675 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -79.62 -41.97 25.9 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 120.977 0.417 . . . . 0.0 110.53 178.624 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.572 ' HA2' ' HA ' ' A' ' 32' ' ' VAL . . . -170.03 133.98 3.0 Favored Glycine 0 N--CA 1.447 -0.61 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -109.53 115.23 29.54 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 121.187 0.517 . . . . 0.0 111.057 -176.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -81.11 74.66 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 115.76 -0.654 . . . . 0.0 109.973 177.278 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 2.2 mt -80.24 147.21 6.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.265 -179.259 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.459 ' HA ' ' O ' ' A' ' 27' ' ' ALA . 3.9 p-10 -85.92 151.97 23.33 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 174.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.02 94.03 0.31 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 120.77 0.319 . . . . 0.0 110.959 -179.292 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -151.17 -78.94 0.12 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.249 -179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -85.03 54.21 3.02 Favored 'General case' 0 C--O 1.235 0.292 0 CA-C-O 121.157 0.504 . . . . 0.0 111.016 -176.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 78.5 m -125.95 139.59 53.32 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.711 -0.677 . . . . 0.0 109.437 177.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.429 HG22 ' H ' ' A' ' 67' ' ' VAL . 0.1 OUTLIER -57.69 -53.05 49.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 112.384 0.512 . . . . 0.0 112.384 -175.113 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.877 0 CA-C-O 118.23 -0.891 . . . . 0.0 110.891 -176.318 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.85 0 CA-C-O 120.888 0.375 . . . . 0.0 110.923 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' HB1' ' HG2' ' A' ' 39' ' ' GLN . . . -113.67 139.21 49.25 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.134 -179.36 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.35 141.32 46.22 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 116.537 -0.302 . . . . 0.0 110.99 -176.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.2 124.14 27.73 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.999 0.428 . . . . 0.0 110.043 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.887 HG21 ' HA3' ' A' ' 34' ' ' GLY . 1.0 OUTLIER -92.55 151.02 3.67 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.536 0.684 . . . . 0.0 112.343 -171.438 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.431 ' HA2' HG12 ' A' ' 36' ' ' ILE . . . 159.1 176.26 30.95 Favored Glycine 0 N--CA 1.441 -1.009 0 CA-C-N 114.679 -1.146 . . . . 0.0 110.256 178.17 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.909 ' HD3' HG12 ' A' ' 36' ' ' ILE . 24.1 Cg_exo -64.85 43.8 0.14 Allowed 'Trans proline' 0 CA--C 1.537 0.653 0 C-N-CA 123.103 2.535 . . . . 0.0 112.785 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.423 ' H ' ' C ' ' A' ' 6' ' ' GLY . 48.3 t30 -131.22 -42.78 1.07 Allowed 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.213 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -61.92 -41.37 97.85 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.773 179.145 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -152.38 124.98 8.33 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.742 -0.663 . . . . 0.0 109.572 174.572 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -173.62 36.17 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.512 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 -174.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -113.88 -82.39 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.032 -0.986 . . . . 0.0 110.822 -172.809 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t0 -89.07 61.02 5.66 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.328 -177.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.1 t0 51.51 54.04 11.74 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-O 121.543 0.687 . . . . 0.0 110.45 -177.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 11.5 m-85 -121.74 126.85 49.85 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.33 -176.567 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -104.24 146.02 31.77 Favored Pre-proline 0 C--N 1.319 -0.743 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 175.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.01 125.64 10.55 Favored 'Trans proline' 0 N--CA 1.46 -0.449 0 C-N-CA 122.287 1.992 . . . . 0.0 111.454 177.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.651 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 10.1 m-85 -126.07 131.1 52.2 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.036 0.445 . . . . 0.0 111.409 -174.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 58.9 m -103.16 101.63 11.6 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.87 176.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.645 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 2.0 m -82.03 120.6 25.48 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.576 . . . . 0.0 110.222 -179.285 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.05 -49.6 3.01 Favored 'General case' 0 C--N 1.319 -0.722 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.494 -179.516 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 53.87 -144.91 0.63 Allowed 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.422 172.596 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.446 ' HB3' ' H ' ' A' ' 24' ' ' SER . 1.6 mpp? -128.98 -155.37 0.69 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 109.81 -178.915 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . 0.446 ' H ' ' HB3' ' A' ' 23' ' ' MET . 0.7 OUTLIER -67.68 -61.6 1.81 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.645 0.26 . . . . 0.0 110.974 178.914 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -111.22 96.09 0.87 Allowed Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.496 -0.859 . . . . 0.0 111.829 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -136.21 114.44 11.56 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 120.995 0.426 . . . . 0.0 111.647 -176.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -86.23 -47.86 9.06 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 171.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.04 93.48 5.13 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 167.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.645 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -79.37 157.45 27.61 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.525 -0.762 . . . . 0.0 111.785 -169.668 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -101.41 89.41 0.78 Allowed Glycine 0 N--CA 1.445 -0.75 0 CA-C-N 115.485 -0.779 . . . . 0.0 111.577 -179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.651 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 1.1 m -89.68 129.37 36.12 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.92 0.39 . . . . 0.0 111.108 -179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 21.1 m -104.32 156.76 5.69 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.193 -0.669 . . . . 0.0 109.193 173.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.4 p -60.08 128.1 20.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 N-CA-C 110.051 -0.352 . . . . 0.0 110.051 178.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.887 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -64.35 129.16 36.92 Favored Glycine 0 N--CA 1.44 -1.097 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.181 179.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.492 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -79.31 123.49 36.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.705 0 CA-C-O 121.002 0.429 . . . . 0.0 110.412 -178.315 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.909 HG12 ' HD3' ' A' ' 7' ' ' PRO . 6.2 mt -68.52 112.32 3.35 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.772 -176.191 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 109.99 -16.11 30.64 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 121.007 -0.616 . . . . 0.0 111.751 -177.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.492 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 14.1 m -90.24 176.91 6.57 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 110.293 -0.262 . . . . 0.0 110.293 179.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.423 ' HG2' ' HB1' ' A' ' 2' ' ' ALA . 1.6 tt0 -135.74 98.3 3.88 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.787 0.327 . . . . 0.0 110.599 -175.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.698 ' HB2' HD11 ' A' ' 5' ' ' ILE . 65.6 m -79.8 127.5 32.29 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.299 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -109.32 6.81 32.19 Favored Glycine 0 N--CA 1.447 -0.6 0 C-N-CA 120.919 -0.657 . . . . 0.0 112.618 -179.659 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -92.47 -141.01 0.2 Allowed 'General case' 0 C--N 1.328 -0.35 0 N-CA-C 109.87 -0.419 . . . . 0.0 109.87 177.699 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.626 ' HB2' ' HB2' ' A' ' 20' ' ' CYS . 1.3 m -82.89 80.49 8.94 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 121.244 0.545 . . . . 0.0 110.097 177.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.6 p -79.8 109.06 13.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 175.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.456 ' HB3' ' O ' ' A' ' 68' ' ' ALA . 0.0 OUTLIER -122.6 178.09 5.15 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.596 0.712 . . . . 0.0 111.547 -173.284 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 92.0 m -129.93 111.85 12.95 Favored 'General case' 0 C--N 1.319 -0.757 0 CA-C-N 114.752 -1.113 . . . . 0.0 108.659 176.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.51 ' SG ' HG12 ' A' ' 61' ' ' ILE . 0.5 OUTLIER -121.92 146.62 46.94 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-O 120.934 0.397 . . . . 0.0 111.589 -171.511 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.405 ' C ' ' HD3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -78.77 115.66 18.61 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.803 175.979 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -147.16 116.63 7.04 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.536 -0.756 . . . . 0.0 109.266 173.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -114.15 42.24 2.1 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.545 173.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 22.5 t -83.11 129.43 37.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.215 177.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -99.05 34.82 2.03 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.009 0.433 . . . . 0.0 111.421 -177.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -149.91 132.34 15.66 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.062 -0.517 . . . . 0.0 109.873 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.53 146.58 52.03 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.893 0.378 . . . . 0.0 111.093 179.704 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 165.73 49.23 0.02 OUTLIER Glycine 0 N--CA 1.446 -0.668 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -179.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -135.82 161.58 35.21 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.67 -0.265 . . . . 0.0 110.324 -175.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.69 -21.12 48.66 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.538 0.685 . . . . 0.0 109.693 175.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -170.09 160.34 33.2 Favored Glycine 0 N--CA 1.443 -0.863 0 N-CA-C 110.47 -1.052 . . . . 0.0 110.47 176.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -97.17 123.67 41.01 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 117.142 0.471 . . . . 0.0 110.132 179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.5 mp -79.32 95.18 1.97 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.543 0 CA-C-O 121.321 0.582 . . . . 0.0 109.992 179.793 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.51 HG12 ' SG ' ' A' ' 47' ' ' CYS . 0.2 OUTLIER -94.12 131.72 40.23 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-N 115.519 -0.764 . . . . 0.0 109.914 -177.755 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 29.7 t30 -86.16 15.57 5.06 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 112.007 0.373 . . . . 0.0 112.007 -173.311 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.416 ' H ' ' CG2' ' A' ' 61' ' ' ILE . . . 72.93 -44.94 0.61 Allowed 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.638 0.775 . . . . 0.0 112.496 175.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -76.39 18.37 0.31 Allowed 'General case' 0 N--CA 1.464 0.26 0 N-CA-C 112.146 0.424 . . . . 0.0 112.146 -175.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 18.3 p-10 -128.04 16.89 6.74 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 121.593 0.711 . . . . 0.0 109.256 174.007 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.442 ' HA ' ' HA ' ' A' ' 47' ' ' CYS . 0.8 OUTLIER -114.15 140.32 48.62 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.241 -0.89 . . . . 0.0 110.155 -179.694 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -94.86 -25.08 4.67 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-O 121.232 0.539 . . . . 0.0 110.536 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 45' ' ' LYS . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 117.839 -1.077 . . . . 0.0 109.976 -178.047 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.476 0.843 0 CA-C-O 121.142 0.496 . . . . 0.0 110.484 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . -141.98 84.64 1.89 Allowed 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.981 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.45 132.16 47.67 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.464 -178.838 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.5 m -78.97 109.18 13.02 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.105 -0.498 . . . . 0.0 109.778 176.749 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.688 HG21 ' HA3' ' A' ' 34' ' ' GLY . 13.0 mt -80.14 130.82 35.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 112.837 0.68 . . . . 0.0 112.837 -171.801 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -140.69 151.4 22.36 Favored Glycine 0 N--CA 1.446 -0.663 0 N-CA-C 109.946 -1.261 . . . . 0.0 109.946 170.744 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.664 ' HD3' HG12 ' A' ' 36' ' ' ILE . 34.9 Cg_endo -64.91 -3.65 7.37 Favored 'Trans proline' 0 N--CA 1.476 0.498 0 C-N-CA 122.821 2.347 . . . . 0.0 113.323 -178.155 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 14.2 p30 -82.62 -6.07 59.16 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.273 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -65.89 -79.39 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.239 0.542 . . . . 0.0 110.743 179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.35 128.77 54.76 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 176.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -170.12 46.73 0.03 OUTLIER 'General case' 0 C--N 1.333 -0.128 0 CA-C-O 121.272 0.558 . . . . 0.0 110.213 -174.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.435 HD12 ' HD2' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -126.91 -87.31 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.035 -176.18 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.559 ' HB3' ' CD2' ' A' ' 15' ' ' TYR . 27.8 t70 -81.22 54.08 2.18 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 121.438 0.637 . . . . 0.0 110.298 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 53.04 25.75 4.32 Favored 'General case' 0 C--O 1.234 0.246 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.538 -174.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.559 ' CD2' ' HB3' ' A' ' 13' ' ' ASP . 26.8 m-85 -78.52 124.33 28.03 Favored 'General case' 0 N--CA 1.447 -0.593 0 CA-C-N 114.996 -1.002 . . . . 0.0 108.301 175.933 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.55 ' HZ2' ' HB3' ' A' ' 49' ' ' ASP . 35.3 mttp -119.51 145.58 39.25 Favored Pre-proline 0 C--N 1.313 -0.992 0 N-CA-C 109.618 -0.512 . . . . 0.0 109.618 -179.275 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_endo -65.32 115.55 3.39 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.329 2.019 . . . . 0.0 111.397 177.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.593 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 31.5 m-85 -126.11 135.28 51.52 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.948 -176.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -103.87 86.35 2.58 Favored 'General case' 0 C--N 1.32 -0.697 0 CA-C-N 115.878 -0.601 . . . . 0.0 109.516 175.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.737 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 1.1 m -67.62 116.72 8.65 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.8 -0.636 . . . . 0.0 111.185 -177.621 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.6 mm-40 -92.19 112.19 24.03 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.327 178.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -104.5 128.32 52.4 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 116.084 -0.507 . . . . 0.0 109.844 177.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.26 -55.05 5.37 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.883 0.373 . . . . 0.0 110.455 -175.627 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -159.96 -87.6 0.03 OUTLIER 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.839 -0.619 . . . . 0.0 109.775 178.4 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -92.4 57.96 2.7 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 6.7 m -93.24 116.64 29.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 120.842 0.353 . . . . 0.0 111.254 -177.099 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -85.53 -54.66 4.43 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 175.283 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.741 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.3 OUTLIER -81.55 124.45 29.51 Favored 'General case' 0 N--CA 1.448 -0.532 0 CA-C-N 115.584 -0.734 . . . . 0.0 109.111 172.349 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.737 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -104.5 138.08 41.41 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 116.48 -0.327 . . . . 0.0 111.522 -172.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.42 ' HA2' ' HA ' ' A' ' 60' ' ' ILE . . . -89.01 100.68 2.68 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 111.509 -0.636 . . . . 0.0 111.509 177.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.593 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.9 OUTLIER -94.8 101.94 13.78 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-O 120.897 0.379 . . . . 0.0 111.187 -177.081 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -83.27 151.43 3.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 N-CA-C 109.845 -0.428 . . . . 0.0 109.845 175.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 38.6 t -63.48 133.71 29.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.438 -0.346 . . . . 0.0 111.016 -177.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.688 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -62.56 116.91 10.02 Favored Glycine 0 N--CA 1.446 -0.663 0 CA-C-N 115.903 -0.59 . . . . 0.0 112.096 177.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.412 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -79.59 125.28 38.63 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-O 120.755 0.312 . . . . 0.0 110.527 -178.553 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.664 HG12 ' HD3' ' A' ' 7' ' ' PRO . 0.8 OUTLIER -65.98 114.25 3.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.712 -179.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 94.1 26.16 15.04 Favored Glycine 0 N--CA 1.447 -0.627 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.752 -177.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.412 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 5.7 m -134.11 176.88 8.19 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 177.157 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.538 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 1.4 mm-40 -113.57 135.43 53.91 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.958 0.409 . . . . 0.0 111.663 -174.543 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -89.14 99.04 12.11 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.684 175.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -101.68 13.19 58.01 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.8 -176.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.7 -107.5 0.38 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-O 120.752 0.31 . . . . 0.0 110.342 179.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.59 118.95 28.48 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 176.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.9 t -79.06 101.42 4.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 109.737 -0.468 . . . . 0.0 109.737 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.73 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 0.0 OUTLIER -118.42 112.56 20.14 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.918 -0.583 . . . . 0.0 111.542 -176.363 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 33.3 m -81.77 93.59 6.86 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 108.414 -0.958 . . . . 0.0 108.414 169.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.73 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 38.7 m -108.83 144.69 36.37 Favored 'General case' 0 C--N 1.317 -0.818 0 CA-C-N 116.483 -0.326 . . . . 0.0 110.748 -175.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.2 123.78 29.89 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 175.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.55 ' HB3' ' HZ2' ' A' ' 16' ' ' LYS . 6.9 t0 -77.03 86.98 3.54 Favored 'General case' 0 C--N 1.316 -0.849 0 CA-C-N 115.531 -0.759 . . . . 0.0 110.521 -174.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -113.83 5.51 16.33 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.851 177.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 9.0 p -111.31 27.76 2.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 CA-C-O 122.111 0.958 . . . . 0.0 110.152 -176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.13 42.77 0.2 Allowed 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.145 -0.934 . . . . 0.0 111.935 -179.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -102.25 -19.64 14.97 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 177.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -76.49 119.36 20.23 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.384 175.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -83.39 54.12 4.93 Favored Glycine 0 N--CA 1.453 -0.22 0 C-N-CA 120.826 -0.702 . . . . 0.0 112.746 -177.608 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.8 p30 -169.59 171.15 7.72 Favored 'General case' 0 C--N 1.325 -0.457 0 N-CA-C 109.824 -0.435 . . . . 0.0 109.824 178.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -81.58 8.66 9.14 Favored 'General case' 0 C--N 1.327 -0.371 0 N-CA-C 112.238 0.458 . . . . 0.0 112.238 -175.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -87.77 71.37 2.61 Favored Glycine 0 N--CA 1.448 -0.549 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 176.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.442 HD12 ' HA ' ' A' ' 59' ' ' LEU . 0.4 OUTLIER -77.99 80.77 4.41 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.378 0.609 . . . . 0.0 111.642 -174.688 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.741 HD11 ' HB2' ' A' ' 28' ' ' SER . 0.9 OUTLIER -82.54 117.24 28.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.297 174.484 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 37.6 mt -101.19 148.38 7.23 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.977 -173.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -79.83 19.35 0.69 Allowed 'General case' 0 CA--C 1.533 0.312 0 CA-C-N 115.818 -0.628 . . . . 0.0 111.642 -176.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.492 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . 71.01 -43.0 0.55 Allowed 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 123.637 0.775 . . . . 0.0 112.901 176.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -56.46 -38.17 71.31 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 112.096 0.406 . . . . 0.0 112.096 -177.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.439 HD22 ' HA ' ' A' ' 65' ' ' ASN . 1.3 m120 -84.31 20.79 1.55 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.827 0.346 . . . . 0.0 111.447 -177.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 42.2 m -120.25 165.34 14.96 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.434 -178.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 17.0 m -92.78 175.79 0.71 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.444 177.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.964 0 CA-C-O 118.662 -0.685 . . . . 0.0 110.731 178.759 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . 0.503 ' HB2' ' H ' ' A' ' 2' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 110.442 -0.207 . . . . 0.0 110.442 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.503 ' H ' ' HB2' ' A' ' 1' ' ' SER . . . -81.01 93.34 6.35 Favored 'General case' 0 C--O 1.234 0.278 0 CA-C-O 121.122 0.487 . . . . 0.0 110.772 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.61 136.73 36.29 Favored 'General case' 0 C--N 1.32 -0.715 0 CA-C-N 115.893 -0.594 . . . . 0.0 111.04 -179.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.521 HG23 ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -78.82 137.94 37.94 Favored 'General case' 0 C--N 1.323 -0.553 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 177.638 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.564 HG21 ' HA3' ' A' ' 34' ' ' GLY . 47.9 mt -114.47 121.58 66.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.211 0.529 . . . . 0.0 112.001 -174.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -112.64 149.39 18.41 Favored Glycine 0 N--CA 1.444 -0.829 0 N-CA-C 110.103 -1.199 . . . . 0.0 110.103 167.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -53.0 -28.19 39.04 Favored 'Trans proline' 0 C--N 1.343 0.273 0 C-N-CA 123.318 2.679 . . . . 0.0 113.049 -179.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 63.9 t30 -91.08 43.39 1.14 Allowed 'General case' 0 C--N 1.326 -0.449 0 CA-C-O 120.944 0.402 . . . . 0.0 111.459 -178.832 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -85.35 -27.79 25.64 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 121.507 0.67 . . . . 0.0 109.457 174.179 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 m -144.82 131.41 19.91 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.357 179.121 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -152.07 15.07 0.63 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.192 0.52 . . . . 0.0 110.601 -175.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.431 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.4 OUTLIER -79.45 -79.79 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 121.457 0.646 . . . . 0.0 109.321 179.078 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.431 ' H ' ' HB ' ' A' ' 12' ' ' ILE . 43.2 t0 -79.18 -173.39 3.6 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 167.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 11.2 t0 -76.21 52.07 0.72 Allowed 'General case' 0 C--N 1.319 -0.726 0 CA-C-O 121.619 0.724 . . . . 0.0 109.678 173.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -89.74 132.35 35.24 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.445 -177.353 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.603 ' HB2' ' CE2' ' A' ' 18' ' ' TYR . 2.1 mtmp? -120.09 152.27 54.14 Favored Pre-proline 0 C--N 1.318 -0.777 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.169 177.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -66.38 119.07 6.06 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 122.572 2.181 . . . . 0.0 111.346 173.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.603 ' CE2' ' HB2' ' A' ' 16' ' ' LYS . 37.8 m-85 -127.92 125.65 39.99 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-O 121.243 0.544 . . . . 0.0 111.4 -178.224 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 43.8 m -82.71 95.78 7.95 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.394 -0.821 . . . . 0.0 109.324 174.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.518 ' SG ' HD12 ' A' ' 29' ' ' LEU . 0.0 OUTLIER -98.66 118.66 35.89 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.558 -174.602 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.0 mt-30 -90.6 115.95 28.12 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 108.895 -0.78 . . . . 0.0 108.895 171.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -65.43 -27.45 68.53 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.956 0.408 . . . . 0.0 111.045 -177.923 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.2 mpt? -138.11 67.2 1.42 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.183 176.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -74.11 65.79 1.17 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.717 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 63.51 15.13 56.81 Favored Glycine 0 C--N 1.332 0.349 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 -175.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 m -153.48 -178.72 7.18 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.193 -0.504 . . . . 0.0 109.879 -172.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -102.39 12.94 35.82 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.17 0.509 . . . . 0.0 110.23 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -101.4 147.14 26.69 Favored 'General case' 0 C--N 1.321 -0.661 0 CA-C-N 115.668 -0.696 . . . . 0.0 110.696 -179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.518 HD12 ' SG ' ' A' ' 20' ' ' CYS . 1.8 mm? -79.15 103.09 8.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.196 0.522 . . . . 0.0 110.139 178.274 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -85.76 79.54 1.86 Allowed Glycine 0 N--CA 1.45 -0.421 0 CA-C-N 115.727 -0.67 . . . . 0.0 113.077 -176.252 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 1.2 m -78.71 122.31 25.83 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.25 0.548 . . . . 0.0 111.598 175.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.12 153.13 15.69 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 172.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 93.9 t -63.26 128.5 25.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 C-N-CA 121.048 -0.261 . . . . 0.0 110.432 -179.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.564 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -62.34 122.59 28.72 Favored Glycine 0 N--CA 1.445 -0.739 0 C-N-CA 120.769 -0.729 . . . . 0.0 111.458 176.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.526 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.2 OUTLIER -78.43 129.09 37.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.624 0 CA-C-O 120.977 0.418 . . . . 0.0 110.418 -175.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.3 mp -57.58 113.45 0.61 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.386 -0.824 . . . . 0.0 111.528 -177.043 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 82.39 22.2 59.08 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.369 176.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.526 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 4.2 m -117.1 161.93 18.63 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 110.321 -0.251 . . . . 0.0 110.321 178.464 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.521 ' HG3' HG23 ' A' ' 4' ' ' THR . 5.5 mt-30 -104.48 137.07 42.9 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 121.14 0.495 . . . . 0.0 111.007 -178.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 6.8 t -111.72 126.03 54.61 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.746 -179.421 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.52 10.1 64.79 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.797 -0.716 . . . . 0.0 112.194 178.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -111.0 -171.23 1.79 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.44 106.42 3.41 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.816 0.341 . . . . 0.0 110.85 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -79.52 105.11 8.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.808 176.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 7.9 mmmt -112.28 161.9 16.1 Favored 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.98 -175.85 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 1.6 m -115.15 100.24 8.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.506 176.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.565 ' SG ' ' HA ' ' A' ' 62' ' ' ASN . 0.9 OUTLIER -116.76 152.88 33.42 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.677 -176.008 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.493 ' H ' ' HG2' ' A' ' 48' ' ' LYS . 0.5 OUTLIER -93.45 154.26 18.02 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 175.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -78.56 67.14 4.25 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 120.924 0.393 . . . . 0.0 110.997 -177.061 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -98.35 34.17 2.05 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 121.224 0.535 . . . . 0.0 110.751 -178.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -95.91 107.05 19.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.49 0 CA-C-N 115.71 -0.677 . . . . 0.0 109.656 176.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.62 95.22 8.81 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.492 -175.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 58.61 65.04 1.31 Allowed 'General case' 0 C--O 1.236 0.371 0 CA-C-N 115.343 -0.844 . . . . 0.0 111.99 177.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -81.42 76.38 8.35 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.086 174.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -63.23 92.25 0.09 OUTLIER Glycine 0 C--N 1.333 0.371 0 CA-C-N 115.666 -0.697 . . . . 0.0 113.389 -175.046 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 64.87 15.42 9.88 Favored 'General case' 0 N--CA 1.465 0.293 0 C-N-CA 123.176 0.59 . . . . 0.0 111.609 177.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -85.49 -33.66 21.78 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.012 0.434 . . . . 0.0 110.956 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 123.18 -159.38 17.81 Favored Glycine 0 N--CA 1.449 -0.452 0 C-N-CA 120.805 -0.712 . . . . 0.0 111.85 -179.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 6.8 mt -115.65 71.34 0.77 Allowed 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 121.253 0.549 . . . . 0.0 110.248 179.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -81.48 79.51 1.22 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 122.076 0.941 . . . . 0.0 110.502 179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.408 HG22 ' HB2' ' A' ' 65' ' ' ASN . 0.0 OUTLIER -134.79 110.67 13.12 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.293 -0.867 . . . . 0.0 110.27 177.889 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.565 ' HA ' ' SG ' ' A' ' 47' ' ' CYS . 3.4 t-20 -178.2 -22.91 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 O-C-N 123.406 0.441 . . . . 0.0 111.441 177.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -53.33 -53.12 55.69 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.55 -173.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -140.7 5.02 1.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.823 0.344 . . . . 0.0 111.405 178.893 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . 0.408 ' HB2' HG22 ' A' ' 61' ' ' ILE . 7.4 m120 -101.16 17.69 21.81 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.011 0.434 . . . . 0.0 111.124 -174.631 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.34 157.64 32.82 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.514 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.0 t -63.39 -55.52 22.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.521 176.309 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.963 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 178.6 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.475 0.82 0 CA-C-O 120.833 0.349 . . . . 0.0 110.703 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.567 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . -131.33 121.28 24.41 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.631 -177.385 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -82.68 139.68 33.55 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.063 179.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.63 113.16 17.56 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.885 0.374 . . . . 0.0 110.075 177.31 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.782 HD11 ' HB2' ' A' ' 40' ' ' CYS . 95.4 mt -83.38 129.48 37.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 121.268 0.556 . . . . 0.0 112.473 -172.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -129.54 142.41 13.57 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 170.386 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -57.22 -20.62 39.6 Favored 'Trans proline' 0 N--CA 1.475 0.416 0 C-N-CA 123.37 2.714 . . . . 0.0 113.718 -176.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -82.55 19.16 1.33 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.853 0.358 . . . . 0.0 111.54 -178.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.78 -44.21 67.14 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.246 0.546 . . . . 0.0 109.969 177.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -114.35 132.53 56.17 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.382 -0.826 . . . . 0.0 109.401 176.718 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -149.16 18.79 0.97 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.895 0.379 . . . . 0.0 111.223 -174.175 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.4 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.6 OUTLIER -79.17 -68.05 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 173.807 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -100.27 -166.95 1.38 Allowed 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 114.635 -1.166 . . . . 0.0 108.238 171.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -79.71 48.39 0.93 Allowed 'General case' 0 C--N 1.321 -0.646 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 170.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.676 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 2.8 m-30 -79.54 124.17 28.26 Favored 'General case' 0 N--CA 1.449 -0.506 0 CA-C-N 115.075 -0.966 . . . . 0.0 109.758 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.426 ' O ' ' HA ' ' A' ' 46' ' ' CYS . 0.0 OUTLIER -100.84 148.08 34.55 Favored Pre-proline 0 C--N 1.316 -0.869 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 179.102 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 29.7 Cg_endo -67.31 122.1 9.32 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 122.231 1.954 . . . . 0.0 110.717 176.408 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.691 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 18.7 m-85 -124.63 124.47 42.28 Favored 'General case' 0 C--N 1.318 -0.804 0 CA-C-O 120.979 0.419 . . . . 0.0 111.49 -174.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 24.7 m -87.12 86.35 7.29 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 115.881 -0.6 . . . . 0.0 110.068 177.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . . . . . . . . . 57.8 m -76.18 99.19 4.62 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.794 -0.639 . . . . 0.0 109.506 177.222 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 13.5 mt-30 -67.21 148.77 51.33 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.77 -0.65 . . . . 0.0 110.63 -175.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.57 84.24 1.14 Allowed 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.379 -177.284 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . 0.482 ' H ' ' HG2' ' A' ' 23' ' ' MET . 0.0 OUTLIER -79.78 -28.04 40.35 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 176.125 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER 52.46 69.31 0.7 Allowed 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.613 -0.721 . . . . 0.0 112.404 174.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 154.13 -53.49 0.45 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.557 -0.83 . . . . 0.0 112.227 178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 7.4 m -60.85 131.43 50.66 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 176.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.34 -24.57 42.65 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.035 0.445 . . . . 0.0 110.455 -177.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.743 ' HB2' HD11 ' A' ' 60' ' ' ILE . 0.1 OUTLIER -99.89 122.65 43.14 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.638 -0.71 . . . . 0.0 109.25 174.374 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.441 ' HA ' ' SD ' ' A' ' 23' ' ' MET . 0.0 OUTLIER -94.09 136.2 34.63 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.076 0.465 . . . . 0.0 111.586 -173.816 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -90.93 71.74 1.93 Allowed Glycine 0 N--CA 1.447 -0.627 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.595 177.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.691 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 4.0 m -79.37 109.82 14.09 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.003 0.43 . . . . 0.0 111.076 -179.173 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.412 HG22 ' H ' ' A' ' 32' ' ' VAL . 0.8 OUTLIER -78.87 143.13 13.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.963 -0.562 . . . . 0.0 109.668 176.142 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.61 133.07 29.55 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.16 0.505 . . . . 0.0 111.204 -177.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.438 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -77.78 106.59 2.29 Favored Glycine 0 N--CA 1.443 -0.896 0 N-CA-C 111.102 -0.799 . . . . 0.0 111.102 175.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 1.5 t -78.99 157.04 4.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 120.836 0.35 . . . . 0.0 110.489 -177.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -64.37 114.19 2.13 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.124 179.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 96.82 10.19 55.49 Favored Glycine 0 N--CA 1.448 -0.55 0 C-N-CA 120.514 -0.851 . . . . 0.0 112.196 -178.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 71.5 m -96.07 172.63 7.87 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.722 0.296 . . . . 0.0 110.297 176.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.567 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 74.8 mt-30 -128.18 162.9 25.86 Favored 'General case' 0 C--N 1.324 -0.542 0 N-CA-C 110.125 -0.324 . . . . 0.0 110.125 -179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.782 ' HB2' HD11 ' A' ' 5' ' ' ILE . 1.6 t -137.02 146.98 45.93 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 120.751 0.31 . . . . 0.0 110.979 -178.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.9 24.15 3.16 Favored Glycine 0 N--CA 1.448 -0.561 0 C-N-CA 121.125 -0.56 . . . . 0.0 111.855 177.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.31 -151.51 0.4 Allowed 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.76 89.79 3.42 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-O 120.871 0.367 . . . . 0.0 110.959 179.332 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 2.2 p -79.67 108.85 13.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 CA-C-O 121.586 0.708 . . . . 0.0 109.692 176.37 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -117.5 -175.45 2.81 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-N 115.52 -0.763 . . . . 0.0 110.624 -177.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.676 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 95.2 m -134.73 101.92 5.1 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.65 179.048 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.2 m -121.75 167.35 13.07 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.34 . . . . 0.0 111.178 -173.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.435 ' HE3' ' HB3' ' A' ' 50' ' ' ASP . 2.4 mmmt -87.08 145.73 26.34 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.408 172.46 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -95.74 -21.92 17.85 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 174.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.435 ' HB3' ' HE3' ' A' ' 48' ' ' LYS . 15.5 t70 -78.32 68.82 4.41 Favored 'General case' 0 CA--C 1.533 0.306 0 CA-C-O 121.787 0.804 . . . . 0.0 110.236 177.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -152.75 -57.61 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.06 -0.973 . . . . 0.0 108.93 175.545 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -91.89 -28.74 17.1 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.787 -0.642 . . . . 0.0 109.639 172.093 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 12.5 t30 60.39 34.85 20.61 Favored 'General case' 0 C--O 1.231 0.094 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.337 177.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . 0.602 HG22 HD21 ' A' ' 56' ' ' ASN . 0.2 OUTLIER -81.05 62.42 5.02 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.638 178.141 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -75.01 66.94 2.12 Favored Glycine 0 N--CA 1.453 -0.233 0 CA-C-N 115.78 -0.645 . . . . 0.0 112.866 -176.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.602 HD21 HG22 ' A' ' 54' ' ' THR . 11.2 p30 -138.37 -142.92 0.16 Allowed 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.609 -0.515 . . . . 0.0 109.609 176.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -78.95 -35.18 43.6 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.671 0.272 . . . . 0.0 111.529 -177.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -122.67 99.31 0.65 Allowed Glycine 0 N--CA 1.449 -0.447 0 C-N-CA 120.444 -0.884 . . . . 0.0 112.431 -176.686 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.447 ' HA ' ' HB ' ' A' ' 54' ' ' THR . 0.2 OUTLIER -86.07 116.36 24.23 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.022 0.439 . . . . 0.0 110.816 179.976 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.743 HD11 ' HB2' ' A' ' 28' ' ' SER . 0.9 OUTLIER -99.75 121.2 50.15 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 176.232 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.34 164.29 22.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-O 121.085 0.469 . . . . 0.0 111.693 -174.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -85.05 145.58 27.6 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.489 -0.778 . . . . 0.0 109.943 177.097 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -61.76 -45.66 92.97 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 112.478 0.547 . . . . 0.0 112.478 -171.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -83.95 14.83 3.76 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 112.75 0.648 . . . . 0.0 112.75 -173.712 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -99.43 15.66 25.65 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 121.64 0.733 . . . . 0.0 109.83 174.708 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.4 m -108.35 173.48 6.3 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 114.887 -1.051 . . . . 0.0 109.248 176.742 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.415 HG23 ' H ' ' A' ' 67' ' ' VAL . 0.2 OUTLIER -61.1 -39.81 83.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 121.252 0.549 . . . . 0.0 109.608 173.274 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.966 0 CA-C-N 115.352 -0.84 . . . . 0.0 108.971 174.736 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 120.766 0.317 . . . . 0.0 110.452 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.516 ' HB1' ' HG2' ' A' ' 39' ' ' GLN . . . -141.51 79.11 1.67 Allowed 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 121.019 0.438 . . . . 0.0 110.014 178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -71.58 130.84 42.22 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.266 -178.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.08 122.38 26.15 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.993 177.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.833 HG21 ' HA3' ' A' ' 34' ' ' GLY . 56.5 mt -92.94 126.1 45.42 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-O 121.397 0.617 . . . . 0.0 112.18 -174.883 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -136.08 133.53 6.67 Favored Glycine 0 N--CA 1.445 -0.722 0 N-CA-C 110.121 -1.192 . . . . 0.0 110.121 169.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.527 ' CG ' HG12 ' A' ' 36' ' ' ILE . 77.9 Cg_exo -51.28 -21.06 9.08 Favored 'Trans proline' 0 C--N 1.347 0.486 0 C-N-CA 123.396 2.731 . . . . 0.0 113.828 -178.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -81.64 13.4 3.15 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.68 -178.039 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -73.46 -77.58 0.1 Allowed 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.318 -0.623 . . . . 0.0 109.318 173.577 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -90.82 126.8 36.13 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.397 -0.819 . . . . 0.0 109.324 173.419 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -163.77 25.52 0.08 Allowed 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.691 -0.485 . . . . 0.0 109.691 -178.191 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.535 ' H ' HG13 ' A' ' 12' ' ' ILE . 0.0 OUTLIER -77.81 -64.37 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.497 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 177.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.439 ' C ' ' H ' ' A' ' 15' ' ' TYR . 2.6 t70 -100.03 -151.54 0.4 Allowed 'General case' 0 C--N 1.317 -0.813 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 169.597 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -79.29 35.18 0.26 Allowed 'General case' 0 C--N 1.323 -0.581 0 CA-C-O 121.42 0.629 . . . . 0.0 110.179 172.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.439 ' H ' ' C ' ' A' ' 13' ' ' ASP . 22.4 m-85 -83.61 136.73 34.12 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.754 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.61 161.26 61.96 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.729 -0.471 . . . . 0.0 109.729 179.034 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_endo -67.89 105.49 1.15 Allowed 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.484 2.123 . . . . 0.0 111.605 175.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.437 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 41.9 m-85 -112.07 122.31 47.41 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.019 -0.537 . . . . 0.0 110.461 179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -80.73 73.17 7.72 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.301 0.572 . . . . 0.0 109.699 178.709 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 0.0 OUTLIER -71.26 107.85 4.46 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.202 -0.908 . . . . 0.0 111.016 -177.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.1 mm-40 -68.93 97.15 0.82 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.759 177.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -108.64 122.01 46.22 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.298 -178.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 3.7 mtm -129.35 -166.78 1.7 Allowed 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 179.771 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 55.9 m -61.91 111.4 1.89 Allowed 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.865 0.365 . . . . 0.0 110.195 176.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.11 -99.83 2.1 Favored Glycine 0 N--CA 1.446 -0.699 0 N-CA-C 111.519 -0.632 . . . . 0.0 111.519 -177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.2 m 57.28 83.67 0.1 Allowed 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.108 0.563 . . . . 0.0 112.235 178.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -81.86 -24.03 36.02 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 172.002 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -112.66 104.6 12.66 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 115.125 -0.943 . . . . 0.0 109.647 174.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.51 ' HG ' ' HB3' ' A' ' 62' ' ' ASN . 1.6 mm? -79.75 110.83 15.47 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.101 -178.482 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -75.88 76.98 1.34 Allowed Glycine 0 N--CA 1.452 -0.262 0 CA-C-N 115.873 -0.603 . . . . 0.0 112.766 -178.273 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.477 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.8 OUTLIER -84.45 93.47 8.31 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.901 0.382 . . . . 0.0 110.976 178.519 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -89.34 139.22 17.78 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.492 0 N-CA-C 109.504 -0.554 . . . . 0.0 109.504 173.582 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.2 p -66.72 134.32 30.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.261 0.553 . . . . 0.0 111.155 -177.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.833 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -84.15 115.78 4.14 Favored Glycine 0 N--CA 1.441 -0.999 0 C-N-CA 120.758 -0.734 . . . . 0.0 111.819 176.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 2.4 t -81.5 154.28 4.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 179.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.527 HG12 ' CG ' ' A' ' 7' ' ' PRO . 1.3 mt -60.85 117.21 2.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.074 -178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 95.17 -0.65 64.17 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.372 177.135 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 17.4 m -85.66 164.53 17.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.724 0.297 . . . . 0.0 110.3 178.529 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.516 ' HG2' ' HB1' ' A' ' 2' ' ' ALA . 0.0 OUTLIER -108.57 139.41 43.38 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-O 120.783 0.325 . . . . 0.0 110.177 -179.951 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.509 ' SG ' HG22 ' A' ' 44' ' ' VAL . 0.1 OUTLIER -90.35 107.26 19.04 Favored 'General case' 0 C--N 1.32 -0.674 0 CA-C-O 120.949 0.404 . . . . 0.0 110.733 179.335 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -75.18 -17.48 80.22 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.809 -0.71 . . . . 0.0 111.925 175.073 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.09 -163.9 0.9 Allowed 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 109.965 -0.383 . . . . 0.0 109.965 177.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -85.76 128.45 34.8 Favored 'General case' 0 C--N 1.319 -0.756 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.525 178.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.509 HG22 ' SG ' ' A' ' 40' ' ' CYS . 0.8 OUTLIER -78.58 117.52 24.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 179.803 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 mmtm -111.22 145.4 38.77 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.463 -179.444 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 34.2 m -94.47 78.86 3.85 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.909 -0.587 . . . . 0.0 109.571 178.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -109.18 159.04 17.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.608 -176.645 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 2.1 pttm -87.28 -164.92 1.16 Allowed 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.161 179.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . 0.506 ' HB3' HG23 ' A' ' 51' ' ' VAL . 13.7 m-20 -68.11 -62.96 1.16 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.763 0.316 . . . . 0.0 110.214 178.654 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 56.8 45.04 22.38 Favored 'General case' 0 N--CA 1.467 0.39 0 CA-C-N 115.445 -0.798 . . . . 0.0 110.719 178.553 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.506 HG23 ' HB3' ' A' ' 49' ' ' ASP . 0.9 OUTLIER -84.2 108.67 16.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-N 115.855 -0.612 . . . . 0.0 111.274 -175.952 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.97 -60.53 2.2 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 171.544 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 24.4 t30 -122.65 165.12 17.01 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.024 -0.989 . . . . 0.0 108.803 173.435 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -68.01 93.31 0.42 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.045 0.45 . . . . 0.0 111.589 -178.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -150.82 65.98 0.36 Allowed Glycine 0 N--CA 1.449 -0.481 0 CA-C-N 115.761 -0.654 . . . . 0.0 111.489 179.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -78.79 -19.23 52.68 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-O 120.82 0.343 . . . . 0.0 111.001 -175.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.2 m -79.58 61.67 3.65 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.399 0.619 . . . . 0.0 110.193 177.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.64 64.63 0.44 Allowed Glycine 0 N--CA 1.444 -0.782 0 N-CA-C 110.839 -0.904 . . . . 0.0 110.839 -175.465 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.82 132.14 40.2 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.778 0.323 . . . . 0.0 110.553 -176.075 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.3 mt -82.98 78.98 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 121.161 0.505 . . . . 0.0 110.503 -179.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.411 ' O ' ' HB2' ' A' ' 29' ' ' LEU . 0.2 OUTLIER -111.94 -153.88 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.791 177.548 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.528 ' HA ' ' HB2' ' A' ' 66' ' ' CYS . 20.9 t-20 52.46 25.72 3.74 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.239 0.543 . . . . 0.0 112.103 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -109.23 -5.9 15.74 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.12 0.486 . . . . 0.0 110.302 178.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -164.34 -56.39 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.367 -178.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -97.28 44.1 1.06 Allowed 'General case' 0 C--O 1.235 0.299 0 N-CA-C 112.92 0.711 . . . . 0.0 112.92 -170.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . 0.528 ' HB2' ' HA ' ' A' ' 62' ' ' ASN . 0.1 OUTLIER -111.38 120.6 42.73 Favored 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 172.348 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 1.4 m -90.72 -26.54 5.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.801 -175.396 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.016 0 CA-C-O 119.056 -0.497 . . . . 0.0 110.045 -177.771 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.477 0.901 0 CA-C-O 120.603 0.239 . . . . 0.0 110.464 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.625 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . -79.75 90.74 5.24 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 176.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -65.03 117.4 7.61 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.604 -177.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -79.48 128.39 33.3 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.685 178.569 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.649 HG21 ' HA3' ' A' ' 34' ' ' GLY . 50.8 mt -93.03 133.64 33.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.971 -0.558 . . . . 0.0 111.983 -176.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -113.81 130.4 9.34 Favored Glycine 0 N--CA 1.446 -0.683 0 N-CA-C 110.343 -1.103 . . . . 0.0 110.343 169.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 10.6 Cg_endo -52.66 -37.53 75.09 Favored 'Trans proline' 0 CA--C 1.531 0.346 0 C-N-CA 123.738 2.959 . . . . 0.0 114.127 -175.001 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -86.83 36.76 0.73 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.974 0.416 . . . . 0.0 111.663 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.82 -52.0 7.98 Favored 'General case' 0 C--N 1.323 -0.555 0 N-CA-C 109.003 -0.74 . . . . 0.0 109.003 173.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.7 m -137.33 116.03 12.16 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 114.703 -1.135 . . . . 0.0 109.024 175.689 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.576 ' HA ' ' O ' ' A' ' 15' ' ' TYR . 24.3 m -161.38 20.79 0.12 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.427 0.632 . . . . 0.0 109.452 -178.006 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.451 ' HB ' ' H ' ' A' ' 13' ' ' ASP . 0.2 OUTLIER -79.18 -82.2 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.417 -0.81 . . . . 0.0 110.428 -176.625 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.702 ' HB3' ' CE2' ' A' ' 15' ' ' TYR . 7.2 t70 -79.28 60.26 3.05 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.456 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 12.8 t0 48.8 45.28 22.11 Favored 'General case' 0 N--CA 1.465 0.314 0 CA-C-N 115.624 -0.716 . . . . 0.0 110.764 -174.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.702 ' CE2' ' HB3' ' A' ' 13' ' ' ASP . 26.5 m-85 -97.56 152.48 18.99 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.181 -178.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.648 ' HB2' ' CE2' ' A' ' 18' ' ' TYR . 9.6 mttp -132.79 143.11 47.27 Favored Pre-proline 0 C--N 1.32 -0.674 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_endo -71.45 103.65 1.45 Allowed 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 122.019 1.813 . . . . 0.0 110.6 173.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.997 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 24.4 m-85 -104.55 125.81 51.05 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-N 116.088 -0.506 . . . . 0.0 111.632 -173.104 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.504 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 0.5 OUTLIER -90.35 93.76 9.46 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 115.959 -0.564 . . . . 0.0 109.524 174.69 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.631 ' HB3' ' HB2' ' A' ' 29' ' ' LEU . 18.0 m -85.12 125.97 33.23 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.8 -178.309 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 mm-40 -57.81 107.73 0.49 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.988 0.423 . . . . 0.0 110.601 177.132 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -77.02 111.38 12.53 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.592 -176.353 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -103.17 7.1 38.69 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.991 -0.55 . . . . 0.0 109.707 173.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.0 m 57.64 74.7 0.41 Allowed 'General case' 0 C--O 1.232 0.162 0 CA-C-N 115.104 -0.953 . . . . 0.0 111.034 -178.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 126.8 12.05 3.4 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 120.852 -0.69 . . . . 0.0 111.852 -178.011 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -76.65 125.46 29.28 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 120.501 0.191 . . . . 0.0 110.652 179.278 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -88.36 -49.44 6.95 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 175.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -98.2 100.42 11.72 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.286 -0.87 . . . . 0.0 109.02 171.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.631 ' HB2' ' HB3' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -95.58 143.09 27.17 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.255 -172.146 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -83.51 91.29 1.61 Allowed Glycine 0 N--CA 1.448 -0.503 0 N-CA-C 111.205 -0.758 . . . . 0.0 111.205 176.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.997 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 5.7 m -96.6 126.12 41.55 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-O 120.864 0.364 . . . . 0.0 111.627 -176.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -104.42 144.47 14.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 173.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.7 p -60.66 129.84 23.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.173 0.511 . . . . 0.0 111.154 -179.52 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.649 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -70.14 109.88 3.06 Favored Glycine 0 N--CA 1.441 -1.008 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.639 175.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.45 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 1.0 OUTLIER -79.61 160.59 4.26 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 N-CA-C 109.956 -0.387 . . . . 0.0 109.956 179.633 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -67.23 116.55 6.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.398 -175.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 80.12 23.66 60.93 Favored Glycine 0 N--CA 1.446 -0.655 0 C-N-CA 120.882 -0.675 . . . . 0.0 112.446 177.206 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.45 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 49.8 m -95.2 126.62 40.65 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 120.689 0.281 . . . . 0.0 110.678 177.549 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.625 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 4.0 mp0 -81.12 117.9 22.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.129 177.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.01 141.86 48.31 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-O 121.033 0.444 . . . . 0.0 111.536 -176.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -120.74 8.83 10.74 Favored Glycine 0 N--CA 1.444 -0.798 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.37 178.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.53 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -94.9 -167.2 1.59 Allowed 'General case' 0 C--N 1.326 -0.441 0 N-CA-C 109.787 -0.449 . . . . 0.0 109.787 177.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -82.63 103.03 11.85 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.914 -0.314 . . . . 0.0 110.668 -178.835 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 12.3 t -81.6 100.67 5.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 109.488 -0.56 . . . . 0.0 109.488 176.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 4.2 mmtt -113.87 162.11 16.77 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.756 -176.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 89.6 m -103.03 92.87 4.73 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.124 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -109.9 145.72 36.37 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.859 -0.61 . . . . 0.0 109.7 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.417 ' HA ' ' HA ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -82.41 156.23 24.26 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.111 0.481 . . . . 0.0 110.62 -177.861 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 13.5 t0 -79.26 69.67 5.52 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.638 -0.71 . . . . 0.0 110.189 178.613 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -79.62 -0.8 35.27 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.836 -178.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 15.3 m -111.46 178.31 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 115.8 -0.636 . . . . 0.0 109.841 177.586 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.3 42.85 0.97 Allowed 'General case' 0 C--N 1.324 -0.51 0 CA-C-O 120.651 0.262 . . . . 0.0 111.571 -179.352 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 37.9 t30 49.83 40.63 20.94 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.641 178.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.2 66.18 0.89 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 121.202 0.525 . . . . 0.0 111.416 -177.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -90.89 80.8 1.33 Allowed Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 120.747 -0.74 . . . . 0.0 111.62 178.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.421 HD22 ' HA ' ' A' ' 56' ' ' ASN . 0.1 OUTLIER -78.02 -83.36 0.08 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.634 0.254 . . . . 0.0 110.875 -178.002 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.409 ' H ' ' HB3' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -81.84 -1.68 48.4 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 121.699 0.761 . . . . 0.0 109.941 175.782 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 142.14 -166.18 26.43 Favored Glycine 0 N--CA 1.44 -1.053 0 N-CA-C 109.591 -1.404 . . . . 0.0 109.591 -175.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 5.3 mt -140.27 107.51 5.5 Favored 'General case' 0 C--N 1.315 -0.912 0 CA-C-N 117.448 0.624 . . . . 0.0 110.598 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 29' ' ' LEU . 73.2 mt -79.78 99.75 3.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 3.1 mt -112.52 148.57 15.48 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.757 0 CA-C-N 115.498 -0.774 . . . . 0.0 109.764 -179.032 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -79.53 136.19 36.82 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 177.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -57.03 -20.45 24.55 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 112.487 0.551 . . . . 0.0 112.487 -175.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -65.17 -18.18 65.09 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.034 0.383 . . . . 0.0 112.034 179.571 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -93.8 -1.61 54.73 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-O 121.095 0.474 . . . . 0.0 110.806 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 1.3 m -100.36 103.82 15.23 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.89 -0.595 . . . . 0.0 109.652 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.0 m -75.24 -29.21 21.28 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.476 -175.814 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.805 -0.616 . . . . 0.0 109.69 -179.94 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.831 0.348 . . . . 0.0 111.357 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.477 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . -122.49 105.96 10.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.87 0.367 . . . . 0.0 110.22 179.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -72.88 129.5 38.29 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.228 -177.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.12 130.48 36.43 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-O 120.974 0.416 . . . . 0.0 110.457 179.01 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.683 HG21 ' HA3' ' A' ' 34' ' ' GLY . 29.0 mm -84.98 118.88 32.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.899 -0.591 . . . . 0.0 112.255 -174.118 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . 0.485 ' HA2' ' HD2' ' A' ' 7' ' ' PRO . . . -112.53 117.55 4.37 Favored Glycine 0 N--CA 1.444 -0.8 0 N-CA-C 110.22 -1.152 . . . . 0.0 110.22 169.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.485 ' HD2' ' HA2' ' A' ' 6' ' ' GLY . 0.9 OUTLIER -43.96 -34.39 6.25 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 124.166 3.244 . . . . 0.0 114.235 -176.951 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 t30 -83.21 44.91 0.98 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.915 0.388 . . . . 0.0 111.652 -177.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -94.43 -44.76 7.75 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.559 0.695 . . . . 0.0 109.343 174.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.2 m -139.67 137.69 35.42 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.049 -0.978 . . . . 0.0 109.177 177.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.25 30.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 -179.132 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -95.23 -92.51 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 114.423 -1.262 . . . . 0.0 110.657 -173.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.407 ' O ' ' HE2' ' A' ' 48' ' ' LYS . 17.5 t70 -79.08 57.77 2.3 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.798 179.299 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 54.84 20.82 3.25 Favored 'General case' 0 N--CA 1.469 0.499 0 CA-C-O 121.445 0.641 . . . . 0.0 110.257 -173.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.413 ' HE1' ' HB2' ' A' ' 48' ' ' LYS . 0.6 OUTLIER -79.68 132.33 36.19 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.389 -0.823 . . . . 0.0 109.643 -178.813 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -122.95 152.99 63.82 Favored Pre-proline 0 C--N 1.317 -0.835 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 178.568 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . 0.436 ' HG3' ' HA ' ' A' ' 7' ' ' PRO . 36.6 Cg_endo -66.18 114.64 3.1 Favored 'Trans proline' 0 N--CA 1.46 -0.446 0 C-N-CA 122.168 1.912 . . . . 0.0 111.137 175.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.642 ' HB3' ' SG ' ' A' ' 31' ' ' CYS . 18.9 m-85 -120.09 128.98 53.97 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-O 121.238 0.542 . . . . 0.0 110.874 -176.398 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -89.07 88.57 7.62 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.943 179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 1.3 m -73.67 99.73 3.18 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.742 178.73 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.0 170.77 15.38 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.509 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 18.2 m 56.06 71.71 0.54 Allowed 'General case' 0 C--N 1.33 -0.277 0 O-C-N 123.633 0.583 . . . . 0.0 110.427 -179.184 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.2 mtm -79.84 83.25 5.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.967 -0.56 . . . . 0.0 110.237 -177.529 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -62.24 100.42 0.17 Allowed 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.808 -0.633 . . . . 0.0 111.017 -179.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 83.78 16.35 68.24 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.613 -0.803 . . . . 0.0 112.292 -179.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 50.7 m 72.74 -40.5 0.48 Allowed 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 123.499 0.72 . . . . 0.0 112.793 176.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.29 -48.33 14.31 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.781 0.324 . . . . 0.0 111.435 -176.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -81.0 113.93 19.54 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.721 -179.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.585 HD21 ' HB2' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -98.72 128.92 45.13 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.85 0.357 . . . . 0.0 110.732 178.817 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.69 72.42 2.56 Favored Glycine 0 N--CA 1.446 -0.68 0 C-N-CA 120.93 -0.653 . . . . 0.0 111.704 175.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -79.22 92.54 5.11 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.003 0.43 . . . . 0.0 110.199 179.117 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.434 HG12 ' HA3' ' A' ' 58' ' ' GLY . 21.5 m -84.45 163.43 2.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.088 177.55 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 86.6 t -63.71 134.26 28.81 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 N-CA-C 109.779 -0.452 . . . . 0.0 109.779 177.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.683 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -54.08 124.99 32.13 Favored Glycine 0 N--CA 1.446 -0.652 0 CA-C-N 116.027 -0.533 . . . . 0.0 112.573 179.496 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.52 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -79.3 107.64 11.96 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-O 120.997 0.427 . . . . 0.0 110.721 -177.911 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . . . . . . . . . 2.2 mt -56.31 113.86 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.491 -178.216 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 91.52 -2.44 77.52 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.722 -0.752 . . . . 0.0 112.502 177.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.52 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 0.8 OUTLIER -112.72 171.8 7.31 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 110.247 -0.279 . . . . 0.0 110.247 179.844 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.477 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 10.2 mp0 -101.82 152.34 21.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.937 0.399 . . . . 0.0 111.273 -176.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.452 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.5 OUTLIER -81.54 156.73 25.09 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.855 175.124 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.5 -49.9 1.77 Allowed Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.555 -0.831 . . . . 0.0 112.405 -177.71 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -108.51 -76.86 0.61 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.655 0.264 . . . . 0.0 111.433 -177.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.616 ' HB2' ' HD3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -142.64 119.93 11.55 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.966 -0.294 . . . . 0.0 111.465 -176.631 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 1.9 p -84.53 116.56 28.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 174.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.616 ' HD3' ' HB2' ' A' ' 43' ' ' SER . 0.1 OUTLIER -127.4 165.54 19.59 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-O 121.069 0.461 . . . . 0.0 110.909 -176.669 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.531 ' HB2' HG23 ' A' ' 67' ' ' VAL . 86.7 m -98.68 109.55 22.29 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.855 -0.611 . . . . 0.0 109.769 175.486 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.48 163.04 19.44 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.233 -0.44 . . . . 0.0 111.217 -174.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.413 ' HB2' ' HE1' ' A' ' 15' ' ' TYR . 29.4 ttmt -117.27 114.97 24.38 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.831 178.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 2.8 p-10 -81.23 68.62 7.61 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.499 178.036 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -63.46 -30.91 71.96 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 121.307 0.575 . . . . 0.0 110.07 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . 0.469 HG23 ' OD1' ' A' ' 53' ' ' ASN . 0.9 OUTLIER -72.18 123.19 26.19 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.062 175.428 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 1.4 p -111.11 -24.1 10.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.252 -178.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.469 ' OD1' HG23 ' A' ' 51' ' ' VAL . 18.2 p-10 -72.58 -38.31 67.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.156 -177.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.67 131.68 46.45 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.603 177.549 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 163.02 80.1 0.04 OUTLIER Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 120.63 -0.795 . . . . 0.0 111.858 179.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.466 ' HB3' ' H ' ' A' ' 57' ' ' SER . 4.3 t-20 -92.62 -100.03 0.13 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 120.688 0.28 . . . . 0.0 110.603 -179.358 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.466 ' H ' ' HB3' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -79.65 -63.3 1.45 Allowed 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.191 0.519 . . . . 0.0 109.643 177.597 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.434 ' HA3' HG12 ' A' ' 32' ' ' VAL . . . -106.24 -166.59 22.97 Favored Glycine 0 N--CA 1.442 -0.931 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 173.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -139.98 120.72 14.36 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 117.042 0.421 . . . . 0.0 110.805 -179.729 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 29.0 mt -81.12 95.73 2.8 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 173.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.433 HD12 ' HB3' ' A' ' 31' ' ' CYS . 11.9 mt -102.72 151.17 6.15 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.723 -0.671 . . . . 0.0 110.498 -175.841 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.41 ' OD1' ' HB3' ' A' ' 64' ' ' ALA . 0.3 OUTLIER -83.27 131.04 35.11 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.46 -0.57 . . . . 0.0 109.46 176.829 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.585 ' HB2' HD21 ' A' ' 29' ' ' LEU . . . -61.21 -22.11 64.47 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 113.249 0.833 . . . . 0.0 113.249 -171.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . 0.41 ' HB3' ' OD1' ' A' ' 62' ' ' ASN . . . -64.17 -33.69 76.37 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 112.14 0.422 . . . . 0.0 112.14 -174.326 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -86.38 0.91 53.0 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 111.326 -178.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -93.45 127.82 39.26 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.005 -0.543 . . . . 0.0 109.939 177.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.531 HG23 ' HB2' ' A' ' 46' ' ' CYS . 0.2 OUTLIER -87.15 -122.93 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 109.939 -0.393 . . . . 0.0 109.939 177.603 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.012 0 CA-C-O 118.39 -0.814 . . . . 0.0 109.886 176.118 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.476 0.842 0 CA-C-O 121.018 0.437 . . . . 0.0 110.623 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.63 ' HB1' ' HB3' ' A' ' 39' ' ' GLN . . . -129.78 126.61 38.54 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.01 178.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.98 121.06 27.23 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.624 -176.514 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -79.42 109.71 14.03 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.032 0.444 . . . . 0.0 110.134 177.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.587 HD12 ' SG ' ' A' ' 19' ' ' CYS . 3.3 mt -91.46 134.2 30.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-O 121.426 0.632 . . . . 0.0 112.665 -170.21 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -123.69 164.11 16.99 Favored Glycine 0 N--CA 1.447 -0.615 0 N-CA-C 110.182 -1.167 . . . . 0.0 110.182 170.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.752 ' HD3' HD12 ' A' ' 36' ' ' ILE . 37.8 Cg_endo -66.73 -13.57 40.42 Favored 'Trans proline' 0 CA--C 1.53 0.309 0 C-N-CA 122.719 2.279 . . . . 0.0 113.213 -177.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -97.05 19.39 12.93 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 120.968 0.413 . . . . 0.0 111.221 -176.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -77.02 -59.63 2.7 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-O 121.472 0.653 . . . . 0.0 110.327 177.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 49.5 m -93.98 117.35 29.97 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.4 -0.818 . . . . 0.0 110.331 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 72.2 m -157.09 21.12 0.31 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.96 -0.564 . . . . 0.0 109.91 -177.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 3.7 mt -78.38 -63.23 1.14 Allowed 'Isoleucine or valine' 0 CA--C 1.513 -0.452 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 179.274 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.1 t0 -99.63 -165.01 1.18 Allowed 'General case' 0 C--N 1.315 -0.928 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 29.0 t0 -80.05 47.84 0.93 Allowed 'General case' 0 C--N 1.318 -0.771 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 172.794 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.479 ' HE2' HG13 ' A' ' 67' ' ' VAL . 10.0 m-30 -91.06 163.6 14.24 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.657 -176.409 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.438 ' HG3' ' CE2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -132.57 148.21 68.69 Favored Pre-proline 0 C--N 1.321 -0.642 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 174.13 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -68.15 122.24 9.29 Favored 'Trans proline' 0 C--O 1.234 0.283 0 C-N-CA 122.477 2.118 . . . . 0.0 112.128 179.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.844 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 34.2 m-85 -121.43 128.7 52.43 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.906 179.706 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.587 ' SG ' HD12 ' A' ' 5' ' ' ILE . 59.3 m -91.04 84.16 5.7 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.912 -0.586 . . . . 0.0 109.641 175.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.497 ' HA ' ' HA ' ' A' ' 31' ' ' CYS . 56.8 m -76.97 107.06 9.04 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.734 -176.351 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.5 mm-40 -75.84 68.98 2.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.049 -178.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.46 ' O ' ' HB3' ' A' ' 29' ' ' LEU . 1.2 m 54.3 -101.2 0.12 Allowed 'General case' 0 CA--C 1.531 0.225 0 CA-C-N 115.847 -0.615 . . . . 0.0 111.384 178.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 4.6 mtt -150.36 142.99 24.57 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 109.683 -0.488 . . . . 0.0 109.683 -178.134 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -90.82 14.45 13.58 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 121.157 0.504 . . . . 0.0 110.793 179.566 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 119.24 -41.54 1.97 Allowed Glycine 0 N--CA 1.45 -0.421 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 -176.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -86.31 -172.85 4.25 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.612 -0.294 . . . . 0.0 110.234 175.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -80.14 -17.88 51.28 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.224 0.535 . . . . 0.0 110.319 177.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.48 ' HA ' ' HA ' ' A' ' 62' ' ' ASN . 0.7 OUTLIER -73.38 127.53 32.93 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.706 -0.679 . . . . 0.0 110.233 176.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.494 HD11 ' HA ' ' A' ' 63' ' ' ALA . 0.0 OUTLIER -89.4 148.14 23.65 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.391 -178.809 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.0 76.32 2.17 Favored Glycine 0 N--CA 1.448 -0.556 0 C-N-CA 120.598 -0.81 . . . . 0.0 111.81 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.844 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 33.3 m -87.34 99.26 11.85 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-O 121.021 0.439 . . . . 0.0 111.366 -179.022 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.6 m -89.69 151.37 3.49 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 N-CA-C 109.076 -0.713 . . . . 0.0 109.076 171.455 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 69.9 t -58.16 129.62 20.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.559 ' HA2' ' SG ' ' A' ' 19' ' ' CYS . . . -48.19 126.64 15.26 Favored Glycine 0 N--CA 1.447 -0.584 0 O-C-N 123.83 0.706 . . . . 0.0 111.912 179.643 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.56 ' HB ' ' HB2' ' A' ' 38' ' ' SER . 0.1 OUTLIER -78.06 114.02 18.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 109.454 -0.573 . . . . 0.0 109.454 -177.645 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.752 HD12 ' HD3' ' A' ' 7' ' ' PRO . 7.3 mm -61.24 110.33 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.452 -172.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 92.71 9.51 61.17 Favored Glycine 0 N--CA 1.446 -0.684 0 CA-C-N 115.696 -0.684 . . . . 0.0 111.833 177.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.56 ' HB2' ' HB ' ' A' ' 35' ' ' VAL . 70.4 m -112.21 151.04 30.04 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 121.057 0.456 . . . . 0.0 110.663 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.63 ' HB3' ' HB1' ' A' ' 2' ' ' ALA . 4.0 mt-30 -86.24 113.85 22.58 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.792 176.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . . . . . . . . . 1.3 m -92.79 123.08 35.8 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -92.81 45.44 2.51 Favored Glycine 0 N--CA 1.449 -0.478 0 C-N-CA 120.915 -0.66 . . . . 0.0 111.991 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.474 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -142.09 -178.24 5.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 179.616 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -71.82 125.4 27.07 Favored 'General case' 0 C--N 1.323 -0.582 0 N-CA-C 110.221 -0.288 . . . . 0.0 110.221 177.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 17.2 t -79.36 97.42 2.59 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.56 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.433 ' HB3' ' SG ' ' A' ' 47' ' ' CYS . 11.4 mmpt? -105.42 124.36 49.42 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.038 -174.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . . . . . . . . . 93.9 m -87.64 89.6 8.06 Favored 'General case' 0 C--N 1.323 -0.575 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 173.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 45' ' ' LYS . 34.6 m -111.17 169.29 8.88 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.143 0.496 . . . . 0.0 111.498 -174.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -108.89 141.59 40.74 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-N 115.247 -0.888 . . . . 0.0 109.431 176.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -87.81 55.9 3.67 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.285 0.565 . . . . 0.0 110.043 176.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 1.3 t0 -126.73 63.05 1.3 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.262 0.553 . . . . 0.0 110.958 -177.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -113.69 12.99 8.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 115.863 -0.608 . . . . 0.0 109.99 178.314 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER 61.38 40.92 13.57 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.802 -177.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -162.58 134.19 5.21 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.836 178.711 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -90.62 -25.07 20.33 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.935 0.397 . . . . 0.0 110.768 177.19 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 68.67 -149.84 50.0 Favored Glycine 0 N--CA 1.445 -0.702 0 C-N-CA 120.826 -0.702 . . . . 0.0 111.825 -177.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -157.67 -66.24 0.09 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-O 121.135 0.493 . . . . 0.0 110.186 177.942 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.19 65.7 8.36 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.586 178.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.8 -163.18 24.53 Favored Glycine 0 N--CA 1.45 -0.384 0 CA-C-N 115.969 -0.56 . . . . 0.0 111.724 -178.425 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -123.74 110.21 14.65 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 121.037 0.446 . . . . 0.0 110.345 178.476 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . 0.526 ' H ' HG13 ' A' ' 60' ' ' ILE . 0.2 OUTLIER -87.03 78.65 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.975 -178.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.467 HD12 ' HB2' ' A' ' 31' ' ' CYS . 14.2 mt -76.37 129.64 37.0 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.934 -0.575 . . . . 0.0 109.859 178.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.48 ' HA ' ' HA ' ' A' ' 28' ' ' SER . 3.4 t30 -82.71 42.64 0.79 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.628 -0.26 . . . . 0.0 111.398 -177.23 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . 0.494 ' HA ' HD11 ' A' ' 29' ' ' LEU . . . 70.92 -54.2 0.66 Allowed 'General case' 0 N--CA 1.472 0.64 0 C-N-CA 124.005 0.922 . . . . 0.0 113.084 176.301 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -79.39 59.42 2.88 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 112.424 0.527 . . . . 0.0 112.424 -173.66 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -150.01 25.5 0.82 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 121.393 0.616 . . . . 0.0 109.823 174.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -135.63 177.28 7.95 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.671 179.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . 0.479 HG13 ' HE2' ' A' ' 15' ' ' TYR . 0.1 OUTLIER -67.12 -59.05 4.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-O 120.722 0.296 . . . . 0.0 110.576 177.854 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.904 0 CA-C-N 115.943 -0.571 . . . . 0.0 109.63 179.257 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.473 0.711 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -110.48 116.59 31.66 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.951 0.405 . . . . 0.0 110.602 179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.11 129.78 44.47 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.955 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.488 HG23 ' HG3' ' A' ' 39' ' ' GLN . 0.2 OUTLIER -88.23 122.52 31.87 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.085 178.491 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.809 HG21 ' HA3' ' A' ' 34' ' ' GLY . 14.9 mt -94.14 140.63 16.24 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 CA-C-O 121.013 0.435 . . . . 0.0 111.934 -173.485 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -154.55 151.83 23.46 Favored Glycine 0 N--CA 1.448 -0.563 0 N-CA-C 110.685 -0.966 . . . . 0.0 110.685 174.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.885 ' HD3' HG12 ' A' ' 36' ' ' ILE . 60.3 Cg_endo -72.77 46.03 0.98 Allowed 'Trans proline' 0 CA--C 1.531 0.334 0 C-N-CA 122.851 2.368 . . . . 0.0 112.758 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 42.7 t30 -135.79 0.51 2.69 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.583 179.708 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -72.27 -54.07 10.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.241 0.543 . . . . 0.0 110.246 177.025 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.61 ' HB2' ' O ' ' A' ' 15' ' ' TYR . 0.0 OUTLIER -120.2 139.71 52.24 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.705 -0.679 . . . . 0.0 109.3 177.392 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 67.5 m -162.01 12.72 0.08 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.809 0.338 . . . . 0.0 110.55 -173.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.48 HG13 ' H ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -78.36 -84.47 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.517 -0.313 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 179.786 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.407 ' H ' ' HB ' ' A' ' 12' ' ' ILE . 2.6 t70 -83.45 -152.84 0.13 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 109.063 -0.718 . . . . 0.0 109.063 173.308 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 33.8 t70 -84.62 48.15 1.48 Allowed 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.937 0.875 . . . . 0.0 109.531 174.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.761 ' HB3' ' HB3' ' A' ' 46' ' ' CYS . 25.5 m-85 -96.16 110.0 22.36 Favored 'General case' 0 N--CA 1.446 -0.637 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.273 177.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 10.4 mtmm -107.65 156.97 37.01 Favored Pre-proline 0 C--N 1.314 -0.942 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 178.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -62.83 117.41 4.31 Favored 'Trans proline' 0 N--CA 1.464 -0.231 0 C-N-CA 122.208 1.939 . . . . 0.0 111.678 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -122.11 122.33 38.98 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.58 -177.748 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 42' ' ' ALA . 5.1 t -88.3 100.84 13.31 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.071 -0.513 . . . . 0.0 109.74 178.606 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.865 ' SG ' ' HB2' ' A' ' 29' ' ' LEU . 0.5 OUTLIER -101.96 135.7 43.06 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.887 -176.594 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -109.22 -159.34 0.68 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.356 -178.035 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -63.41 145.7 55.07 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.168 0.509 . . . . 0.0 111.132 -179.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.55 152.18 30.27 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.134 178.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -66.87 -29.96 70.0 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 121.203 0.525 . . . . 0.0 110.766 -178.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 166.48 -55.88 0.24 Allowed Glycine 0 N--CA 1.444 -0.82 0 N-CA-C 110.415 -1.074 . . . . 0.0 110.415 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -75.34 -179.36 4.46 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.539 -0.33 . . . . 0.0 110.443 175.139 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -79.69 53.25 1.57 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.082 0.467 . . . . 0.0 111.444 -177.795 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.5 m -138.96 130.05 26.64 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 177.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.865 ' HB2' ' SG ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -127.61 164.01 22.96 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.73 -174.573 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -105.54 76.95 0.25 Allowed Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.847 -0.692 . . . . 0.0 112.759 -177.38 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.562 ' HA ' ' HA ' ' A' ' 20' ' ' CYS . 0.0 OUTLIER -81.42 108.35 14.95 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 120.744 0.306 . . . . 0.0 110.227 176.135 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 14.7 m -91.46 161.53 2.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 N-CA-C 110.084 -0.339 . . . . 0.0 110.084 178.366 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 48.4 t -61.84 130.5 26.19 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 120.766 0.317 . . . . 0.0 110.423 -179.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.809 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -61.11 134.26 48.85 Favored Glycine 0 N--CA 1.443 -0.843 0 CA-C-N 115.654 -0.703 . . . . 0.0 112.636 -179.562 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.422 ' HB ' ' OG ' ' A' ' 38' ' ' SER . 0.0 OUTLIER -78.94 116.65 23.18 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.055 0.455 . . . . 0.0 109.877 179.424 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.885 HG12 ' HD3' ' A' ' 7' ' ' PRO . 34.1 mt -67.22 120.12 14.0 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.849 -175.027 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 81.12 17.13 72.75 Favored Glycine 0 N--CA 1.449 -0.49 0 CA-C-N 115.768 -0.651 . . . . 0.0 112.173 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . 0.422 ' OG ' ' HB ' ' A' ' 35' ' ' VAL . 0.7 OUTLIER -127.27 160.55 30.98 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.674 0.273 . . . . 0.0 110.695 -179.784 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.488 ' HG3' HG23 ' A' ' 4' ' ' THR . 28.0 mt-30 -97.53 149.88 21.71 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 121.019 0.438 . . . . 0.0 110.873 -179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.56 ' HB2' HD11 ' A' ' 5' ' ' ILE . 0.1 OUTLIER -121.41 156.99 31.5 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.817 -0.628 . . . . 0.0 110.231 178.881 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -113.56 16.3 21.68 Favored Glycine 0 N--CA 1.449 -0.497 0 C-N-CA 120.845 -0.693 . . . . 0.0 111.753 179.344 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.435 ' HB1' ' O ' ' A' ' 20' ' ' CYS . . . -124.35 -161.65 1.02 Allowed 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 110.397 -0.223 . . . . 0.0 110.397 179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.7 m -89.91 107.22 18.98 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.017 0.437 . . . . 0.0 111.084 -178.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 4.0 t -83.45 109.38 17.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.977 -0.556 . . . . 0.0 109.952 176.088 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 5.9 mtmt -130.93 -179.45 5.33 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.909 -177.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.761 ' HB3' ' HB3' ' A' ' 15' ' ' TYR . 4.1 m -107.93 105.58 15.45 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.206 175.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 62.2 m -118.31 148.86 42.04 Favored 'General case' 0 C--N 1.318 -0.769 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.171 -174.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.544 ' HD2' ' HA ' ' A' ' 48' ' ' LYS . 0.4 OUTLIER -91.64 116.04 28.55 Favored 'General case' 0 N--CA 1.446 -0.651 0 CA-C-O 121.095 0.474 . . . . 0.0 110.239 176.601 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -68.94 -36.35 77.86 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.407 -0.815 . . . . 0.0 111.09 178.671 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.41 ' H ' ' HE3' ' A' ' 48' ' ' LYS . 25.6 t0 -76.38 65.05 2.21 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.605 -0.725 . . . . 0.0 111.837 -177.112 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -133.88 -44.07 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 168.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -84.4 -34.9 23.46 Favored 'General case' 0 N--CA 1.447 -0.583 0 CA-C-N 115.071 -0.968 . . . . 0.0 109.342 168.193 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 70.4 -65.38 0.33 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 115.042 -0.981 . . . . 0.0 111.515 177.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -81.15 131.48 35.3 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-O 120.772 0.32 . . . . 0.0 110.423 177.418 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -106.03 -176.96 23.68 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.785 -0.721 . . . . 0.0 112.411 -178.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.458 ' HB3' ' H ' ' A' ' 57' ' ' SER . 0.4 OUTLIER -147.08 -121.42 0.06 Allowed 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 179.074 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . 0.458 ' H ' ' HB3' ' A' ' 56' ' ' ASN . 0.0 OUTLIER -79.77 56.46 2.29 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 121.386 0.613 . . . . 0.0 109.92 175.609 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.81 -178.53 16.37 Favored Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 111.061 -0.816 . . . . 0.0 111.061 -175.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.447 ' HA ' HD13 ' A' ' 59' ' ' LEU . 0.7 OUTLIER -99.87 103.45 15.05 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.029 0.442 . . . . 0.0 110.316 179.951 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 1.1 mp -87.99 105.44 15.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 116.054 -0.521 . . . . 0.0 109.796 177.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . . . . . . . . . 13.5 mt -112.35 135.16 52.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.446 -177.545 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -67.43 150.68 48.59 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.614 177.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -67.75 164.91 18.41 Favored 'General case' 0 N--CA 1.448 -0.571 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.365 177.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . 69.62 8.97 7.02 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.324 -0.853 . . . . 0.0 111.811 -179.74 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -117.44 21.04 13.31 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 121.537 0.684 . . . . 0.0 109.98 175.561 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 86.9 m -123.42 140.52 52.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.354 -0.839 . . . . 0.0 110.09 178.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -130.7 173.18 14.9 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.994 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 176.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.304 -0.855 . . . . 0.0 110.228 176.659 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.477 0.898 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -160.63 64.01 0.31 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.933 0.396 . . . . 0.0 110.701 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -80.52 133.53 35.82 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.501 -0.318 . . . . 0.0 110.774 -179.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -78.74 121.94 25.37 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.017 0.437 . . . . 0.0 110.516 179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.684 HG21 ' HA3' ' A' ' 34' ' ' GLY . 3.7 mt -92.13 147.36 5.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.474 0 CA-C-N 115.704 -0.68 . . . . 0.0 112.397 -173.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLY . . . . . . . . . . . . . . . -150.85 157.01 26.98 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 110.347 -1.101 . . . . 0.0 110.347 172.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.91 ' HD3' HG12 ' A' ' 36' ' ' ILE . 14.2 Cg_endo -56.97 -33.72 96.04 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.858 2.372 . . . . 0.0 112.095 179.418 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.0 t30 -80.84 62.21 4.77 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 121.448 0.642 . . . . 0.0 110.187 177.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -101.34 -49.59 4.01 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.089 175.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.5 m -123.32 152.68 41.19 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.137 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 1.4 m -151.82 19.49 0.7 Allowed 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.725 0.774 . . . . 0.0 109.211 -174.022 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -79.51 -74.22 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 CA-C-N 114.978 -1.01 . . . . 0.0 109.191 176.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t70 -100.96 -156.46 0.56 Allowed 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 114.556 -1.202 . . . . 0.0 108.267 171.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -86.84 49.84 1.89 Allowed 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.866 0.841 . . . . 0.0 108.771 171.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' TYR . . . . . 0.695 ' HB3' ' HB2' ' A' ' 46' ' ' CYS . 8.6 m-85 -86.9 110.48 20.02 Favored 'General case' 0 N--CA 1.448 -0.567 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.523 -176.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.551 ' HG3' ' CE2' ' A' ' 18' ' ' TYR . 0.0 OUTLIER -95.02 155.27 39.23 Favored Pre-proline 0 C--N 1.323 -0.558 0 CA-C-N 115.835 -0.621 . . . . 0.0 110.641 -177.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -60.91 127.48 22.5 Favored 'Trans proline' 0 C--O 1.235 0.355 0 C-N-CA 123.18 2.587 . . . . 0.0 112.858 179.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' TYR . . . . . 0.895 ' HB3' ' HB3' ' A' ' 31' ' ' CYS . 21.4 m-85 -138.07 130.96 29.86 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-N 115.904 -0.589 . . . . 0.0 111.103 -179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' CYS . . . . . 0.435 ' O ' ' HA ' ' A' ' 31' ' ' CYS . 18.2 m -89.49 87.36 7.04 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.97 -0.559 . . . . 0.0 109.565 177.176 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' CYS . . . . . 0.633 ' HB3' HD22 ' A' ' 29' ' ' LEU . 91.1 m -75.43 94.56 3.11 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.923 -0.58 . . . . 0.0 110.907 -177.212 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.585 ' HG3' ' HB2' ' A' ' 42' ' ' ALA . 0.1 OUTLIER -92.08 72.47 5.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.543 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 2.6 m -150.59 158.47 44.19 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.669 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' MET . . . . . . . . . . . . . 1.3 ttm -81.3 163.93 22.57 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 110.13 -0.322 . . . . 0.0 110.13 -179.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -66.93 -37.76 84.93 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.01 0.434 . . . . 0.0 110.659 -178.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . -95.59 66.97 1.16 Allowed Glycine 0 N--CA 1.446 -0.654 0 C-N-CA 120.692 -0.766 . . . . 0.0 111.494 175.728 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 66.8 m -142.24 -174.79 4.21 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-O 120.811 0.338 . . . . 0.0 111.064 -177.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.426 ' O ' ' HB2' ' A' ' 28' ' ' SER . . . -143.01 139.87 30.77 Favored 'General case' 0 N--CA 1.44 -0.936 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 -179.226 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.426 ' HB2' ' O ' ' A' ' 27' ' ' ALA . 65.0 m 73.69 98.19 0.07 Allowed 'General case' 0 C--N 1.321 -0.654 0 O-C-N 124.241 0.963 . . . . 0.0 109.753 -175.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LEU . . . . . 0.633 HD22 ' HB3' ' A' ' 20' ' ' CYS . 3.8 mt -79.69 115.36 19.25 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 115.346 -0.843 . . . . 0.0 110.969 -174.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -81.91 62.98 4.46 Favored Glycine 0 N--CA 1.45 -0.427 0 CA-C-N 115.672 -0.695 . . . . 0.0 111.88 178.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' CYS . . . . . 0.895 ' HB3' ' HB3' ' A' ' 18' ' ' TYR . 6.2 m -89.41 101.84 14.52 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-O 121.125 0.488 . . . . 0.0 110.98 179.039 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.94 152.98 4.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 173.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 66.2 t -59.53 132.97 24.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-O 120.713 0.292 . . . . 0.0 110.405 -178.653 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLY . . . . . 0.684 ' HA3' HG21 ' A' ' 5' ' ' ILE . . . -66.41 113.94 6.1 Favored Glycine 0 N--CA 1.446 -0.668 0 C-N-CA 120.793 -0.718 . . . . 0.0 111.65 178.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -78.6 122.01 32.81 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.063 0.458 . . . . 0.0 110.653 -176.548 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ILE . . . . . 0.91 HG12 ' HD3' ' A' ' 7' ' ' PRO . 1.1 mt -59.13 130.17 22.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 CA-C-N 115.311 -0.859 . . . . 0.0 111.104 -178.869 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLY . . . . . . . . . . . . . . . 74.8 16.87 80.16 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.976 -0.63 . . . . 0.0 112.45 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' SER . . . . . . . . . . . . . 3.4 m -122.32 166.73 14.21 Favored 'General case' 0 C--N 1.32 -0.678 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.2 mp0 -101.39 137.0 40.31 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.903 0.383 . . . . 0.0 111.046 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' CYS . . . . . 0.53 ' HB2' HD11 ' A' ' 5' ' ' ILE . 7.7 t -101.01 128.41 47.07 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.796 174.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -99.05 -0.58 57.24 Favored Glycine 0 N--CA 1.445 -0.703 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.449 -178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.585 ' HB2' ' HG3' ' A' ' 21' ' ' GLN . . . -121.04 -162.21 0.95 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.095 0.474 . . . . 0.0 111.169 -179.233 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -72.89 104.25 3.98 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.619 -0.719 . . . . 0.0 110.783 178.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -79.41 111.42 16.21 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 N-CA-C 109.76 -0.459 . . . . 0.0 109.76 177.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.526 ' HA ' ' CB ' ' A' ' 68' ' ' ALA . 6.1 mmtt -124.73 172.39 9.33 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 116.183 -0.462 . . . . 0.0 109.889 -178.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' CYS . . . . . 0.695 ' HB2' ' HB3' ' A' ' 15' ' ' TYR . 0.8 OUTLIER -118.16 119.94 36.23 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 120.657 0.265 . . . . 0.0 110.45 176.28 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.8 m -121.88 171.3 9.01 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.462 -0.335 . . . . 0.0 110.838 -179.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.473 ' H ' ' HG3' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -115.09 154.05 29.62 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.746 -179.578 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -104.51 60.16 0.71 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-O 121.137 0.494 . . . . 0.0 110.954 -178.084 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -86.98 -12.61 46.97 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.263 177.061 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -72.63 140.7 17.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.385 0 CA-C-N 115.772 -0.649 . . . . 0.0 109.6 175.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.65 -28.6 36.83 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-O 120.868 0.366 . . . . 0.0 111.353 -176.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -85.97 90.13 8.0 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.004 0.43 . . . . 0.0 110.237 176.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -61.97 -59.88 4.45 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.771 -0.649 . . . . 0.0 111.767 -176.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.407 ' O ' ' HB2' ' A' ' 56' ' ' ASN . . . 100.59 -24.99 29.97 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.85 -0.691 . . . . 0.0 111.748 -178.316 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.407 ' HB2' ' O ' ' A' ' 55' ' ' GLY . 6.3 m120 74.59 -53.78 0.67 Allowed 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 123.803 0.841 . . . . 0.0 112.385 175.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.7 -55.2 5.36 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-O 120.998 0.428 . . . . 0.0 110.642 -178.076 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . -142.15 142.56 11.88 Favored Glycine 0 N--CA 1.446 -0.682 0 C-N-CA 120.709 -0.758 . . . . 0.0 111.421 178.499 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 25.7 tp -92.03 110.01 21.37 Favored 'General case' 0 C--N 1.321 -0.654 0 N-CA-C 109.608 -0.515 . . . . 0.0 109.608 -179.78 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ILE . . . . . . . . . . . . . 4.7 mt -79.97 97.48 2.91 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.014 -179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ILE . . . . . 0.4 ' H ' HG12 ' A' ' 61' ' ' ILE . 3.6 mm -73.69 151.55 7.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.434 -179.117 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 38.8 t30 -66.22 -68.35 0.38 Allowed 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.275 178.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ALA . . . . . . . . . . . . . . . -162.25 -96.47 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.383 -0.371 . . . . 0.0 111.397 177.736 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ALA . . . . . . . . . . . . . . . -82.44 78.8 9.04 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 112.233 0.456 . . . . 0.0 112.233 -172.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -154.7 22.82 0.46 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.435 0.636 . . . . 0.0 109.923 171.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' CYS . . . . . . . . . . . . . 87.0 m -123.23 86.95 2.66 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.612 178.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 19.7 m -89.11 132.16 34.59 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-O 120.965 0.412 . . . . 0.0 111.342 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 45' ' ' LYS . . . . . . . . 0 C--O 1.251 1.138 0 CA-C-O 117.668 -1.158 . . . . 0.0 108.503 177.038 . . . . . . . . 1 1 . 1 stop_ save_